{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "name": "Prétraitement_Dataframe_avec_Spacy.ipynb",
      "provenance": [],
      "collapsed_sections": []
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    }
  },
  "cells": [
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "4iawDP1K4PxQ",
        "outputId": "5cabcb10-d81d-4be8-98fd-0690430d3b35"
      },
      "source": [
        "\r\n",
        "from google.colab import drive\r\n",
        "drive.mount('/content/drive')"
      ],
      "execution_count": 1,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            "Mounted at /content/drive\n"
          ],
          "name": "stdout"
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "KezXUUSU7CY4"
      },
      "source": [
        "On importe notre Dataframe à traiter"
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "7052DyJfP1b6"
      },
      "source": [
        "import pandas as pd\r\n",
        "df_bibliovid=pd.read_json('/content/drive/MyDrive/data/bibliovid.json')\r\n",
        "df_bibliovid = df_bibliovid.dropna(subset=['abstract','topics'])\r\n",
        "df_bibliovid = df_bibliovid.drop(df_bibliovid[ df_bibliovid.abstract==''].index)\r\n",
        "df_bibliovid = df_bibliovid.drop(df_bibliovid[ df_bibliovid.topics==''].index)"
      ],
      "execution_count": 4,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "PbUhfvUF7Hf4"
      },
      "source": [
        "On éxécute le traitement de base appliqué dans le notebook servant de \"baseline\", de sorte à manipuler des objets de même structure"
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "XdiF5bmb-IrW"
      },
      "source": [
        "def vectorize(label_list,dico):\r\n",
        "    return [int(elt in label_list) for  elt in dico]"
      ],
      "execution_count": 5,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "Wnts6EK48_2H",
        "outputId": "fc1cf025-7a48-416c-954e-a4c225fc77c4"
      },
      "source": [
        "if True:\r\n",
        "  spec_dict=dict()\r\n",
        "  spec_list=[]\r\n",
        "  for elt in df_bibliovid['specialties'].values:\r\n",
        "      spec_list.append(elt[0]['name'])\r\n",
        "  spec_set=set(spec_list)\r\n",
        "  i=0\r\n",
        "  for elt in spec_set:\r\n",
        "    spec_dict[elt]=i\r\n",
        "    i+=1\r\n",
        "  print(spec_dict)\r\n",
        "  df_bibliovid['vect_specs']=df_bibliovid.topics.apply(lambda x: vectorize(x,spec_dict))\r\n",
        "  df_bibliovid['cat_text']=df_bibliovid['title']+df_bibliovid['abstract']\r\n",
        "  df_bibliovid['len']=df_bibliovid['cat_text'].apply(lambda x: len(x.split(' ')))\r\n",
        "  df_bibliovid['len_sentence']=df_bibliovid['cat_text'].apply(lambda x: len(x.split('.')))\r\n",
        "  df_bibliovid=df_bibliovid.reset_index(drop=True)"
      ],
      "execution_count": 6,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            "{'Gériatrie': 0, 'Hépato-gastro-entérologie': 1, 'Neurologie': 2, 'Confinement/Déconfinement': 3, 'Anesthésie-Réanimation': 4, 'Hématologie': 5, 'Cardiologie et maladies métaboliques': 6, 'Psychiatrie': 7, 'Gynécologie Obstétrique': 8, 'Hygiène': 9, 'Transversale': 10, 'Pédiatrie': 11, 'Radiologie': 12, 'Néphrologie': 13, 'Immunité': 14, 'Infectiologie': 15, 'Virologie': 16}\n"
          ],
          "name": "stdout"
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "H9UGPzde4_X8"
      },
      "source": [
        "Installation de Spacy et de Scispacy, ainsi que du modèle \"en_core_sci_sm\" utilisé"
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "Oi1uqZitUf1U",
        "outputId": "7f6d5cbe-e50a-4429-d8f4-d032d62111d2"
      },
      "source": [
        "!pip install -U spacy\r\n",
        "!pip install scispacy\r\n",
        "!pip install https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/releases/v0.2.4/en_core_sci_sm-0.2.4.tar.gz"
      ],
      "execution_count": 2,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            "Collecting spacy\n",
            "\u001b[?25l  Downloading https://files.pythonhosted.org/packages/e5/bf/ca7bb25edd21f1cf9d498d0023808279672a664a70585e1962617ca2740c/spacy-2.3.5-cp36-cp36m-manylinux2014_x86_64.whl (10.4MB)\n",
            "\u001b[K     |████████████████████████████████| 10.4MB 5.4MB/s \n",
            "\u001b[?25hCollecting thinc<7.5.0,>=7.4.1\n",
            "\u001b[?25l  Downloading https://files.pythonhosted.org/packages/c0/1a/c3e4ab982214c63d743fad57c45c5e68ee49e4ea4384d27b28595a26ad26/thinc-7.4.5-cp36-cp36m-manylinux2014_x86_64.whl (1.1MB)\n",
            "\u001b[K     |████████████████████████████████| 1.1MB 42.6MB/s \n",
            "\u001b[?25hRequirement already satisfied, skipping upgrade: plac<1.2.0,>=0.9.6 in /usr/local/lib/python3.6/dist-packages (from spacy) (1.1.3)\n",
            "Requirement already satisfied, skipping upgrade: murmurhash<1.1.0,>=0.28.0 in /usr/local/lib/python3.6/dist-packages (from spacy) (1.0.5)\n",
            "Requirement already satisfied, skipping upgrade: catalogue<1.1.0,>=0.0.7 in /usr/local/lib/python3.6/dist-packages (from spacy) (1.0.0)\n",
            "Requirement already satisfied, skipping upgrade: requests<3.0.0,>=2.13.0 in /usr/local/lib/python3.6/dist-packages (from spacy) (2.23.0)\n",
            "Requirement already satisfied, skipping upgrade: wasabi<1.1.0,>=0.4.0 in /usr/local/lib/python3.6/dist-packages (from spacy) (0.8.0)\n",
            "Requirement already satisfied, skipping upgrade: srsly<1.1.0,>=1.0.2 in /usr/local/lib/python3.6/dist-packages (from spacy) (1.0.5)\n",
            "Requirement already satisfied, skipping upgrade: setuptools in /usr/local/lib/python3.6/dist-packages (from spacy) (51.0.0)\n",
            "Requirement already satisfied, skipping upgrade: tqdm<5.0.0,>=4.38.0 in /usr/local/lib/python3.6/dist-packages (from spacy) (4.41.1)\n",
            "Requirement already satisfied, skipping upgrade: preshed<3.1.0,>=3.0.2 in /usr/local/lib/python3.6/dist-packages (from spacy) (3.0.5)\n",
            "Requirement already satisfied, skipping upgrade: cymem<2.1.0,>=2.0.2 in /usr/local/lib/python3.6/dist-packages (from spacy) (2.0.5)\n",
            "Requirement already satisfied, skipping upgrade: blis<0.8.0,>=0.4.0 in /usr/local/lib/python3.6/dist-packages (from spacy) (0.4.1)\n",
            "Requirement already satisfied, skipping upgrade: numpy>=1.15.0 in /usr/local/lib/python3.6/dist-packages (from spacy) (1.19.4)\n",
            "Requirement already satisfied, skipping upgrade: importlib-metadata>=0.20; python_version < \"3.8\" in /usr/local/lib/python3.6/dist-packages (from catalogue<1.1.0,>=0.0.7->spacy) (3.3.0)\n",
            "Requirement already satisfied, skipping upgrade: certifi>=2017.4.17 in /usr/local/lib/python3.6/dist-packages (from requests<3.0.0,>=2.13.0->spacy) (2020.12.5)\n",
            "Requirement already satisfied, skipping upgrade: idna<3,>=2.5 in /usr/local/lib/python3.6/dist-packages (from requests<3.0.0,>=2.13.0->spacy) (2.10)\n",
            "Requirement already satisfied, skipping upgrade: urllib3!=1.25.0,!=1.25.1,<1.26,>=1.21.1 in /usr/local/lib/python3.6/dist-packages (from requests<3.0.0,>=2.13.0->spacy) (1.24.3)\n",
            "Requirement already satisfied, skipping upgrade: chardet<4,>=3.0.2 in /usr/local/lib/python3.6/dist-packages (from requests<3.0.0,>=2.13.0->spacy) (3.0.4)\n",
            "Requirement already satisfied, skipping upgrade: typing-extensions>=3.6.4; python_version < \"3.8\" in /usr/local/lib/python3.6/dist-packages (from importlib-metadata>=0.20; python_version < \"3.8\"->catalogue<1.1.0,>=0.0.7->spacy) (3.7.4.3)\n",
            "Requirement already satisfied, skipping upgrade: zipp>=0.5 in /usr/local/lib/python3.6/dist-packages (from importlib-metadata>=0.20; python_version < \"3.8\"->catalogue<1.1.0,>=0.0.7->spacy) (3.4.0)\n",
            "Installing collected packages: thinc, spacy\n",
            "  Found existing installation: thinc 7.4.0\n",
            "    Uninstalling thinc-7.4.0:\n",
            "      Successfully uninstalled thinc-7.4.0\n",
            "  Found existing installation: spacy 2.2.4\n",
            "    Uninstalling spacy-2.2.4:\n",
            "      Successfully uninstalled spacy-2.2.4\n",
            "Successfully installed spacy-2.3.5 thinc-7.4.5\n",
            "Collecting scispacy\n",
            "\u001b[?25l  Downloading https://files.pythonhosted.org/packages/7b/0c/e1dc89d73122677cdee8a2d4e734c608c5f112e0c4ea2886f0944ceff1b6/scispacy-0.3.0-py3-none-any.whl (42kB)\n",
            "\u001b[K     |████████████████████████████████| 51kB 2.9MB/s \n",
            "\u001b[?25hRequirement already satisfied: joblib in /usr/local/lib/python3.6/dist-packages (from scispacy) (1.0.0)\n",
            "Requirement already satisfied: scikit-learn>=0.20.3 in /usr/local/lib/python3.6/dist-packages (from scispacy) (0.22.2.post1)\n",
            "Collecting pysbd\n",
            "\u001b[?25l  Downloading https://files.pythonhosted.org/packages/26/db/95bd39a94eae9a5149bfde3d27760fb3595a35e11a9a01f6e97288132475/pysbd-0.3.3-py3-none-any.whl (67kB)\n",
            "\u001b[K     |████████████████████████████████| 71kB 3.8MB/s \n",
            "\u001b[?25hRequirement already satisfied: requests<3.0.0conllu,>=2.0.0 in /usr/local/lib/python3.6/dist-packages (from scispacy) (2.23.0)\n",
            "Collecting nmslib>=1.7.3.6\n",
            "\u001b[?25l  Downloading https://files.pythonhosted.org/packages/55/98/44c0d5877ca3cd558755ccb3ed5824a17f56c52bc8745394d7045a4bb3dc/nmslib-2.0.8.tar.gz (188kB)\n",
            "\u001b[K     |████████████████████████████████| 194kB 20.1MB/s \n",
            "\u001b[?25hRequirement already satisfied: spacy<3.0.0,>=2.3.0 in /usr/local/lib/python3.6/dist-packages (from scispacy) (2.3.5)\n",
            "Requirement already satisfied: numpy in /usr/local/lib/python3.6/dist-packages (from scispacy) (1.19.4)\n",
            "Requirement already satisfied: scipy>=0.17.0 in /usr/local/lib/python3.6/dist-packages (from scikit-learn>=0.20.3->scispacy) (1.4.1)\n",
            "Requirement already satisfied: idna<3,>=2.5 in /usr/local/lib/python3.6/dist-packages (from requests<3.0.0conllu,>=2.0.0->scispacy) (2.10)\n",
            "Requirement already satisfied: urllib3!=1.25.0,!=1.25.1,<1.26,>=1.21.1 in /usr/local/lib/python3.6/dist-packages (from requests<3.0.0conllu,>=2.0.0->scispacy) (1.24.3)\n",
            "Requirement already satisfied: certifi>=2017.4.17 in /usr/local/lib/python3.6/dist-packages (from requests<3.0.0conllu,>=2.0.0->scispacy) (2020.12.5)\n",
            "Requirement already satisfied: chardet<4,>=3.0.2 in /usr/local/lib/python3.6/dist-packages (from requests<3.0.0conllu,>=2.0.0->scispacy) (3.0.4)\n",
            "Collecting pybind11>=2.2.3\n",
            "  Using cached https://files.pythonhosted.org/packages/00/84/fc9dc13ee536ba5e6b8fd10ce368fea5b738fe394c3b296cde7c9b144a92/pybind11-2.6.1-py2.py3-none-any.whl\n",
            "Requirement already satisfied: psutil in /usr/local/lib/python3.6/dist-packages (from nmslib>=1.7.3.6->scispacy) (5.4.8)\n",
            "Requirement already satisfied: murmurhash<1.1.0,>=0.28.0 in /usr/local/lib/python3.6/dist-packages (from spacy<3.0.0,>=2.3.0->scispacy) (1.0.5)\n",
            "Requirement already satisfied: tqdm<5.0.0,>=4.38.0 in /usr/local/lib/python3.6/dist-packages (from spacy<3.0.0,>=2.3.0->scispacy) (4.41.1)\n",
            "Requirement already satisfied: blis<0.8.0,>=0.4.0 in /usr/local/lib/python3.6/dist-packages (from spacy<3.0.0,>=2.3.0->scispacy) (0.4.1)\n",
            "Requirement already satisfied: thinc<7.5.0,>=7.4.1 in /usr/local/lib/python3.6/dist-packages (from spacy<3.0.0,>=2.3.0->scispacy) (7.4.5)\n",
            "Requirement already satisfied: wasabi<1.1.0,>=0.4.0 in /usr/local/lib/python3.6/dist-packages (from spacy<3.0.0,>=2.3.0->scispacy) (0.8.0)\n",
            "Requirement already satisfied: srsly<1.1.0,>=1.0.2 in /usr/local/lib/python3.6/dist-packages (from spacy<3.0.0,>=2.3.0->scispacy) (1.0.5)\n",
            "Requirement already satisfied: catalogue<1.1.0,>=0.0.7 in /usr/local/lib/python3.6/dist-packages (from spacy<3.0.0,>=2.3.0->scispacy) (1.0.0)\n",
            "Requirement already satisfied: cymem<2.1.0,>=2.0.2 in /usr/local/lib/python3.6/dist-packages (from spacy<3.0.0,>=2.3.0->scispacy) (2.0.5)\n",
            "Requirement already satisfied: plac<1.2.0,>=0.9.6 in /usr/local/lib/python3.6/dist-packages (from spacy<3.0.0,>=2.3.0->scispacy) (1.1.3)\n",
            "Requirement already satisfied: setuptools in /usr/local/lib/python3.6/dist-packages (from spacy<3.0.0,>=2.3.0->scispacy) (51.0.0)\n",
            "Requirement already satisfied: preshed<3.1.0,>=3.0.2 in /usr/local/lib/python3.6/dist-packages (from spacy<3.0.0,>=2.3.0->scispacy) (3.0.5)\n",
            "Requirement already satisfied: importlib-metadata>=0.20; python_version < \"3.8\" in /usr/local/lib/python3.6/dist-packages (from catalogue<1.1.0,>=0.0.7->spacy<3.0.0,>=2.3.0->scispacy) (3.3.0)\n",
            "Requirement already satisfied: zipp>=0.5 in /usr/local/lib/python3.6/dist-packages (from importlib-metadata>=0.20; python_version < \"3.8\"->catalogue<1.1.0,>=0.0.7->spacy<3.0.0,>=2.3.0->scispacy) (3.4.0)\n",
            "Requirement already satisfied: typing-extensions>=3.6.4; python_version < \"3.8\" in /usr/local/lib/python3.6/dist-packages (from importlib-metadata>=0.20; python_version < \"3.8\"->catalogue<1.1.0,>=0.0.7->spacy<3.0.0,>=2.3.0->scispacy) (3.7.4.3)\n",
            "Building wheels for collected packages: nmslib\n",
            "  Building wheel for nmslib (setup.py) ... \u001b[?25l\u001b[?25hdone\n",
            "  Created wheel for nmslib: filename=nmslib-2.0.8-cp36-cp36m-linux_x86_64.whl size=9168392 sha256=fe2a21e5ab03f720df0dd7286255535ce5d458a068afdbad33a3db35451ae05c\n",
            "  Stored in directory: /root/.cache/pip/wheels/e8/ac/90/494f2ecb0c10fe1ed32d9a64434576d04fae8fb4234097566b\n",
            "Successfully built nmslib\n",
            "Installing collected packages: pysbd, pybind11, nmslib, scispacy\n",
            "Successfully installed nmslib-2.0.8 pybind11-2.6.1 pysbd-0.3.3 scispacy-0.3.0\n",
            "Collecting https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/releases/v0.2.4/en_core_sci_sm-0.2.4.tar.gz\n",
            "\u001b[?25l  Downloading https://s3-us-west-2.amazonaws.com/ai2-s2-scispacy/releases/v0.2.4/en_core_sci_sm-0.2.4.tar.gz (17.0MB)\n",
            "\u001b[K     |████████████████████████████████| 17.0MB 76.8MB/s \n",
            "\u001b[?25hRequirement already satisfied: spacy>=2.2.1 in /usr/local/lib/python3.6/dist-packages (from en-core-sci-sm==0.2.4) (2.3.5)\n",
            "Requirement already satisfied: setuptools in /usr/local/lib/python3.6/dist-packages (from spacy>=2.2.1->en-core-sci-sm==0.2.4) (51.0.0)\n",
            "Requirement already satisfied: wasabi<1.1.0,>=0.4.0 in /usr/local/lib/python3.6/dist-packages (from spacy>=2.2.1->en-core-sci-sm==0.2.4) (0.8.0)\n",
            "Requirement already satisfied: thinc<7.5.0,>=7.4.1 in /usr/local/lib/python3.6/dist-packages (from spacy>=2.2.1->en-core-sci-sm==0.2.4) (7.4.5)\n",
            "Requirement already satisfied: srsly<1.1.0,>=1.0.2 in /usr/local/lib/python3.6/dist-packages (from spacy>=2.2.1->en-core-sci-sm==0.2.4) (1.0.5)\n",
            "Requirement already satisfied: catalogue<1.1.0,>=0.0.7 in /usr/local/lib/python3.6/dist-packages (from spacy>=2.2.1->en-core-sci-sm==0.2.4) (1.0.0)\n",
            "Requirement already satisfied: plac<1.2.0,>=0.9.6 in /usr/local/lib/python3.6/dist-packages (from spacy>=2.2.1->en-core-sci-sm==0.2.4) (1.1.3)\n",
            "Requirement already satisfied: numpy>=1.15.0 in /usr/local/lib/python3.6/dist-packages (from spacy>=2.2.1->en-core-sci-sm==0.2.4) (1.19.4)\n",
            "Requirement already satisfied: requests<3.0.0,>=2.13.0 in /usr/local/lib/python3.6/dist-packages (from spacy>=2.2.1->en-core-sci-sm==0.2.4) (2.23.0)\n",
            "Requirement already satisfied: preshed<3.1.0,>=3.0.2 in /usr/local/lib/python3.6/dist-packages (from spacy>=2.2.1->en-core-sci-sm==0.2.4) (3.0.5)\n",
            "Requirement already satisfied: murmurhash<1.1.0,>=0.28.0 in /usr/local/lib/python3.6/dist-packages (from spacy>=2.2.1->en-core-sci-sm==0.2.4) (1.0.5)\n",
            "Requirement already satisfied: cymem<2.1.0,>=2.0.2 in /usr/local/lib/python3.6/dist-packages (from spacy>=2.2.1->en-core-sci-sm==0.2.4) (2.0.5)\n",
            "Requirement already satisfied: tqdm<5.0.0,>=4.38.0 in /usr/local/lib/python3.6/dist-packages (from spacy>=2.2.1->en-core-sci-sm==0.2.4) (4.41.1)\n",
            "Requirement already satisfied: blis<0.8.0,>=0.4.0 in /usr/local/lib/python3.6/dist-packages (from spacy>=2.2.1->en-core-sci-sm==0.2.4) (0.4.1)\n",
            "Requirement already satisfied: importlib-metadata>=0.20; python_version < \"3.8\" in /usr/local/lib/python3.6/dist-packages (from catalogue<1.1.0,>=0.0.7->spacy>=2.2.1->en-core-sci-sm==0.2.4) (3.3.0)\n",
            "Requirement already satisfied: idna<3,>=2.5 in /usr/local/lib/python3.6/dist-packages (from requests<3.0.0,>=2.13.0->spacy>=2.2.1->en-core-sci-sm==0.2.4) (2.10)\n",
            "Requirement already satisfied: chardet<4,>=3.0.2 in /usr/local/lib/python3.6/dist-packages (from requests<3.0.0,>=2.13.0->spacy>=2.2.1->en-core-sci-sm==0.2.4) (3.0.4)\n",
            "Requirement already satisfied: certifi>=2017.4.17 in /usr/local/lib/python3.6/dist-packages (from requests<3.0.0,>=2.13.0->spacy>=2.2.1->en-core-sci-sm==0.2.4) (2020.12.5)\n",
            "Requirement already satisfied: urllib3!=1.25.0,!=1.25.1,<1.26,>=1.21.1 in /usr/local/lib/python3.6/dist-packages (from requests<3.0.0,>=2.13.0->spacy>=2.2.1->en-core-sci-sm==0.2.4) (1.24.3)\n",
            "Requirement already satisfied: typing-extensions>=3.6.4; python_version < \"3.8\" in /usr/local/lib/python3.6/dist-packages (from importlib-metadata>=0.20; python_version < \"3.8\"->catalogue<1.1.0,>=0.0.7->spacy>=2.2.1->en-core-sci-sm==0.2.4) (3.7.4.3)\n",
            "Requirement already satisfied: zipp>=0.5 in /usr/local/lib/python3.6/dist-packages (from importlib-metadata>=0.20; python_version < \"3.8\"->catalogue<1.1.0,>=0.0.7->spacy>=2.2.1->en-core-sci-sm==0.2.4) (3.4.0)\n",
            "Building wheels for collected packages: en-core-sci-sm\n",
            "  Building wheel for en-core-sci-sm (setup.py) ... \u001b[?25l\u001b[?25hdone\n",
            "  Created wheel for en-core-sci-sm: filename=en_core_sci_sm-0.2.4-cp36-none-any.whl size=17161110 sha256=8310315d09b84c068e691d931c395cf0b29170df0115b140a0b83e4e44ac129d\n",
            "  Stored in directory: /root/.cache/pip/wheels/34/60/b9/fabd9c3eeba17ed66df745479f2fc502a6702755cb4a9632f2\n",
            "Successfully built en-core-sci-sm\n",
            "Installing collected packages: en-core-sci-sm\n",
            "Successfully installed en-core-sci-sm-0.2.4\n"
          ],
          "name": "stdout"
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "azTahM027ZGH"
      },
      "source": [
        "On charge le modèle que nous allons utiliser"
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "fga9ulUhUh7I",
        "outputId": "957065ec-3528-49b4-fd49-a5a101e12392"
      },
      "source": [
        "import scispacy\r\n",
        "import spacy\r\n",
        "\r\n",
        "#Core models\r\n",
        "import en_core_sci_sm\r\n",
        "nlp = en_core_sci_sm.load()"
      ],
      "execution_count": 11,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            "/usr/local/lib/python3.6/dist-packages/spacy/util.py:275: UserWarning: [W031] Model 'en_core_sci_sm' (0.2.4) requires spaCy v2.2 and is incompatible with the current spaCy version (2.3.5). This may lead to unexpected results or runtime errors. To resolve this, download a newer compatible model or retrain your custom model with the current spaCy version. For more details and available updates, run: python -m spacy validate\n",
            "  warnings.warn(warn_msg)\n"
          ],
          "name": "stderr"
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "vcmEXWsF7fRC"
      },
      "source": [
        "Nous allons d'abord prendre en main l'outil petit à petit pour bien expliciter ce que nous faisons, on extrait donc d'abord dans une liste l'ensemble des textes concatenés"
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "Pa3PSQheUme_"
      },
      "source": [
        "test = list(df_bibliovid['cat_text'])\r\n"
      ],
      "execution_count": 7,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "M_Tw1DqOV42h",
        "outputId": "9ff228a1-1f35-4de8-fd99-ba12f94bc403"
      },
      "source": [
        "print(test[0])"
      ],
      "execution_count": 9,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            "Body Mass Index and Risk for Intubation or Death in SARS-CoV-2 Infection: A Retrospective Cohort StudyObesity is a risk factor for pneumonia and acute respiratory distress syndrome.\n",
            "To determine whether obesity is associated with intubation or death, inflammation, cardiac injury, or fibrinolysis in coronavirus disease 2019 (COVID-19).\n",
            "Retrospective cohort study.\n",
            "A quaternary academic medical center and community hospital in New York City.\n",
            "2466 adults hospitalized with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 infection over a 45-day period with at least 47 days of in-hospital observation.\n",
            "Body mass index (BMI), admission biomarkers of inflammation (C-reactive protein [CRP] level and erythrocyte sedimentation rate [ESR]), cardiac injury (troponin level), and fibrinolysis (D-dimer level). The primary end point was a composite of intubation or death in time-to-event analysis.\n",
            "Over a median hospital length of stay of 7 days (interquartile range, 3 to 14 days), 533 patients (22%) were intubated, 627 (25%) died, and 59 (2%) remained hospitalized. Compared with overweight patients, patients with obesity had higher risk for intubation or death, with the highest risk among those with class 3 obesity (hazard ratio, 1.6 [95% CI, 1.1 to 2.1]). This association was primarily observed among patients younger than 65 years and not in older patients (\n",
            "Body mass index was missing for 28% of patients. The primary analyses were conducted with multiple imputation for missing BMI. Upper bounding factor analysis suggested that the results are robust to possible selection bias.\n",
            "Obesity is associated with increased risk for intubation or death from COVID-19 in adults younger than 65 years, but not in adults aged 65 years or older.\n",
            "National Institutes of Health.\n"
          ],
          "name": "stdout"
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "gDUfzjV774Ok"
      },
      "source": [
        "La méthode .ents va extraire du texte en entrée de cette méthode les mots importants, pertinents selon le modèle que nous avons employé (rappel: le modèle ici employé est \"en_core_sci_sm\", adapté au données biomédicales)"
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "PkOzxu1uWShB",
        "outputId": "fa136898-b9df-4365-ff48-b77310f33729"
      },
      "source": [
        "doc = nlp(test[0])\r\n",
        "print(doc.ents)\r\n",
        "print(len(test[0]))\r\n",
        "print(len(doc.ents))"
      ],
      "execution_count": 12,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            "(Body Mass Index, Risk, Intubation, Death, SARS-CoV-2, Infection, Retrospective Cohort StudyObesity, risk factor, pneumonia, acute respiratory distress syndrome, obesity, associated with, intubation, death, inflammation, cardiac injury, fibrinolysis, coronavirus disease, COVID-19, Retrospective cohort study, community hospital, New York City, adults, hospitalized, laboratory-confirmed severe, acute respiratory syndrome coronavirus 2 infection, period, days, in-hospital observation, Body mass index, BMI, admission biomarkers, inflammation, C-reactive protein, CRP, level, erythrocyte, ESR, cardiac injury, troponin level, fibrinolysis, D-dimer level, primary end point, composite, intubation, death, time-to-event analysis, hospital length of stay, days, interquartile range, days, patients, died, hospitalized, Compared, overweight, patients, patients, obesity, higher, risk, intubation, death, highest, risk, class 3, obesity, hazard ratio, CI, association, patients, younger, years, older, patients, Body mass index, patients, primary analyses, imputation, missing, BMI, Upper bounding factor analysis, results, selection bias, Obesity, associated with, increased, risk, intubation, death, COVID-19, adults, younger, years, adults, years, older, National Institutes of Health)\n",
            "1793\n",
            "98\n"
          ],
          "name": "stdout"
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "Im3M26798hMU"
      },
      "source": [
        "on crée une liste où l'élément d'indice i est le texte d'indice i de la conlonne 'cat_text' où ne sont gardés que les mots extraits par la méthode .ents"
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "8TuRnsTPWPwY",
        "outputId": "6df760b1-10dc-4b89-c8a4-a5ef095fdbff"
      },
      "source": [
        "new_text = []\r\n",
        "for i in range(len(test)):\r\n",
        "  print(i)\r\n",
        "  new_text.append(nlp(test[i]).ents)\r\n"
      ],
      "execution_count": 13,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            "0\n",
            "1\n",
            "2\n",
            "3\n",
            "4\n",
            "5\n",
            "6\n",
            "7\n",
            "8\n",
            "9\n",
            "10\n",
            "11\n",
            "12\n",
            "13\n",
            "14\n",
            "15\n",
            "16\n",
            "17\n",
            "18\n",
            "19\n",
            "20\n",
            "21\n",
            "22\n",
            "23\n",
            "24\n",
            "25\n",
            "26\n",
            "27\n",
            "28\n",
            "29\n",
            "30\n",
            "31\n",
            "32\n",
            "33\n",
            "34\n",
            "35\n",
            "36\n",
            "37\n",
            "38\n",
            "39\n",
            "40\n",
            "41\n",
            "42\n",
            "43\n",
            "44\n",
            "45\n",
            "46\n",
            "47\n",
            "48\n",
            "49\n",
            "50\n",
            "51\n",
            "52\n",
            "53\n",
            "54\n",
            "55\n",
            "56\n",
            "57\n",
            "58\n",
            "59\n",
            "60\n",
            "61\n",
            "62\n",
            "63\n",
            "64\n",
            "65\n",
            "66\n",
            "67\n",
            "68\n",
            "69\n",
            "70\n",
            "71\n",
            "72\n",
            "73\n",
            "74\n",
            "75\n",
            "76\n",
            "77\n",
            "78\n",
            "79\n",
            "80\n",
            "81\n",
            "82\n",
            "83\n",
            "84\n",
            "85\n",
            "86\n",
            "87\n",
            "88\n",
            "89\n",
            "90\n",
            "91\n",
            "92\n",
            "93\n",
            "94\n",
            "95\n",
            "96\n",
            "97\n",
            "98\n",
            "99\n",
            "100\n",
            "101\n",
            "102\n",
            "103\n",
            "104\n",
            "105\n",
            "106\n",
            "107\n",
            "108\n",
            "109\n",
            "110\n",
            "111\n",
            "112\n",
            "113\n",
            "114\n",
            "115\n",
            "116\n",
            "117\n",
            "118\n",
            "119\n",
            "120\n",
            "121\n",
            "122\n",
            "123\n",
            "124\n",
            "125\n",
            "126\n",
            "127\n",
            "128\n",
            "129\n",
            "130\n",
            "131\n",
            "132\n",
            "133\n",
            "134\n",
            "135\n",
            "136\n",
            "137\n",
            "138\n",
            "139\n",
            "140\n",
            "141\n",
            "142\n",
            "143\n",
            "144\n",
            "145\n",
            "146\n",
            "147\n",
            "148\n",
            "149\n",
            "150\n",
            "151\n",
            "152\n",
            "153\n",
            "154\n",
            "155\n",
            "156\n",
            "157\n",
            "158\n",
            "159\n",
            "160\n",
            "161\n",
            "162\n",
            "163\n",
            "164\n",
            "165\n",
            "166\n",
            "167\n",
            "168\n",
            "169\n",
            "170\n",
            "171\n",
            "172\n",
            "173\n",
            "174\n",
            "175\n",
            "176\n",
            "177\n",
            "178\n",
            "179\n",
            "180\n",
            "181\n",
            "182\n",
            "183\n",
            "184\n",
            "185\n",
            "186\n",
            "187\n",
            "188\n",
            "189\n",
            "190\n",
            "191\n",
            "192\n",
            "193\n",
            "194\n",
            "195\n",
            "196\n",
            "197\n",
            "198\n",
            "199\n",
            "200\n",
            "201\n",
            "202\n",
            "203\n",
            "204\n",
            "205\n",
            "206\n",
            "207\n",
            "208\n",
            "209\n",
            "210\n",
            "211\n",
            "212\n",
            "213\n",
            "214\n",
            "215\n",
            "216\n",
            "217\n",
            "218\n",
            "219\n",
            "220\n",
            "221\n",
            "222\n",
            "223\n",
            "224\n",
            "225\n",
            "226\n",
            "227\n",
            "228\n",
            "229\n",
            "230\n",
            "231\n",
            "232\n",
            "233\n",
            "234\n",
            "235\n",
            "236\n",
            "237\n",
            "238\n",
            "239\n",
            "240\n",
            "241\n",
            "242\n",
            "243\n",
            "244\n",
            "245\n",
            "246\n",
            "247\n",
            "248\n",
            "249\n",
            "250\n",
            "251\n",
            "252\n",
            "253\n",
            "254\n",
            "255\n",
            "256\n",
            "257\n",
            "258\n",
            "259\n",
            "260\n",
            "261\n",
            "262\n",
            "263\n",
            "264\n",
            "265\n",
            "266\n",
            "267\n",
            "268\n",
            "269\n",
            "270\n",
            "271\n",
            "272\n",
            "273\n",
            "274\n",
            "275\n",
            "276\n",
            "277\n",
            "278\n",
            "279\n",
            "280\n",
            "281\n",
            "282\n",
            "283\n",
            "284\n",
            "285\n",
            "286\n",
            "287\n",
            "288\n",
            "289\n",
            "290\n",
            "291\n",
            "292\n",
            "293\n",
            "294\n",
            "295\n",
            "296\n",
            "297\n",
            "298\n",
            "299\n",
            "300\n",
            "301\n",
            "302\n",
            "303\n",
            "304\n",
            "305\n",
            "306\n",
            "307\n",
            "308\n",
            "309\n",
            "310\n",
            "311\n",
            "312\n",
            "313\n",
            "314\n",
            "315\n",
            "316\n",
            "317\n",
            "318\n",
            "319\n",
            "320\n",
            "321\n",
            "322\n",
            "323\n",
            "324\n",
            "325\n",
            "326\n",
            "327\n",
            "328\n",
            "329\n",
            "330\n",
            "331\n",
            "332\n",
            "333\n",
            "334\n",
            "335\n",
            "336\n",
            "337\n",
            "338\n",
            "339\n",
            "340\n",
            "341\n",
            "342\n",
            "343\n",
            "344\n",
            "345\n",
            "346\n",
            "347\n",
            "348\n",
            "349\n",
            "350\n",
            "351\n",
            "352\n",
            "353\n",
            "354\n",
            "355\n",
            "356\n",
            "357\n",
            "358\n",
            "359\n",
            "360\n",
            "361\n",
            "362\n",
            "363\n",
            "364\n",
            "365\n",
            "366\n",
            "367\n",
            "368\n",
            "369\n",
            "370\n"
          ],
          "name": "stdout"
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "NsygZvlGWvCL",
        "outputId": "e52311c2-b08f-43bb-8dc6-65ec09561fdf"
      },
      "source": [
        "new_text2 = list(new_text)\r\n",
        "new_text2[0]"
      ],
      "execution_count": 14,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "(Body Mass Index,\n",
              " Risk,\n",
              " Intubation,\n",
              " Death,\n",
              " SARS-CoV-2,\n",
              " Infection,\n",
              " Retrospective Cohort StudyObesity,\n",
              " risk factor,\n",
              " pneumonia,\n",
              " acute respiratory distress syndrome,\n",
              " obesity,\n",
              " associated with,\n",
              " intubation,\n",
              " death,\n",
              " inflammation,\n",
              " cardiac injury,\n",
              " fibrinolysis,\n",
              " coronavirus disease,\n",
              " COVID-19,\n",
              " Retrospective cohort study,\n",
              " community hospital,\n",
              " New York City,\n",
              " adults,\n",
              " hospitalized,\n",
              " laboratory-confirmed severe,\n",
              " acute respiratory syndrome coronavirus 2 infection,\n",
              " period,\n",
              " days,\n",
              " in-hospital observation,\n",
              " Body mass index,\n",
              " BMI,\n",
              " admission biomarkers,\n",
              " inflammation,\n",
              " C-reactive protein,\n",
              " CRP,\n",
              " level,\n",
              " erythrocyte,\n",
              " ESR,\n",
              " cardiac injury,\n",
              " troponin level,\n",
              " fibrinolysis,\n",
              " D-dimer level,\n",
              " primary end point,\n",
              " composite,\n",
              " intubation,\n",
              " death,\n",
              " time-to-event analysis,\n",
              " hospital length of stay,\n",
              " days,\n",
              " interquartile range,\n",
              " days,\n",
              " patients,\n",
              " died,\n",
              " hospitalized,\n",
              " Compared,\n",
              " overweight,\n",
              " patients,\n",
              " patients,\n",
              " obesity,\n",
              " higher,\n",
              " risk,\n",
              " intubation,\n",
              " death,\n",
              " highest,\n",
              " risk,\n",
              " class 3,\n",
              " obesity,\n",
              " hazard ratio,\n",
              " CI,\n",
              " association,\n",
              " patients,\n",
              " younger,\n",
              " years,\n",
              " older,\n",
              " patients,\n",
              " Body mass index,\n",
              " patients,\n",
              " primary analyses,\n",
              " imputation,\n",
              " missing,\n",
              " BMI,\n",
              " Upper bounding factor analysis,\n",
              " results,\n",
              " selection bias,\n",
              " Obesity,\n",
              " associated with,\n",
              " increased,\n",
              " risk,\n",
              " intubation,\n",
              " death,\n",
              " COVID-19,\n",
              " adults,\n",
              " younger,\n",
              " years,\n",
              " adults,\n",
              " years,\n",
              " older,\n",
              " National Institutes of Health)"
            ]
          },
          "metadata": {
            "tags": []
          },
          "execution_count": 14
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "8e7yznSl9SjJ"
      },
      "source": [
        "On transforme les tuples en listes"
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "Vhu3wkLQXj9F"
      },
      "source": [
        "len(new_text2)\r\n",
        "for i in range(len(new_text2)):\r\n",
        "  new_text2[i] = list(new_text2[i])\r\n",
        "\r\n",
        "\r\n"
      ],
      "execution_count": 15,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "23DrrQsk-hsL"
      },
      "source": [
        "On remplace les mots qui sont des éléments de spacy par des strings"
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "JjAi06DYX8q0"
      },
      "source": [
        "for i in range(len(new_text2[0])):\r\n",
        "  new_text2[0][i] = str(new_text2[0][i])\r\n"
      ],
      "execution_count": 16,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "dgZA4Hm3-pmo"
      },
      "source": [
        "On reforme les listes sous forme de texte"
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "sST-QGhiaNO4"
      },
      "source": [
        "essai = \" \".join(new_text2[0])"
      ],
      "execution_count": 17,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 120
        },
        "id": "AeTOxr-iaVcO",
        "outputId": "f11b5035-20da-4e2e-e1dd-f44767c92eb4"
      },
      "source": [
        "essai"
      ],
      "execution_count": 18,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            },
            "text/plain": [
              "'Body Mass Index Risk Intubation Death SARS-CoV-2 Infection Retrospective Cohort StudyObesity risk factor pneumonia acute respiratory distress syndrome obesity associated with intubation death inflammation cardiac injury fibrinolysis coronavirus disease COVID-19 Retrospective cohort study community hospital New York City adults hospitalized laboratory-confirmed severe acute respiratory syndrome coronavirus 2 infection period days in-hospital observation Body mass index BMI admission biomarkers inflammation C-reactive protein CRP level erythrocyte ESR cardiac injury troponin level fibrinolysis D-dimer level primary end point composite intubation death time-to-event analysis hospital length of stay days interquartile range days patients died hospitalized Compared overweight patients patients obesity higher risk intubation death highest risk class 3 obesity hazard ratio CI association patients younger years older patients Body mass index patients primary analyses imputation missing BMI Upper bounding factor analysis results selection bias Obesity associated with increased risk intubation death COVID-19 adults younger years adults years older National Institutes of Health'"
            ]
          },
          "metadata": {
            "tags": []
          },
          "execution_count": 18
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "Nmg7qay9aZHU",
        "outputId": "22746a69-6fb3-47a9-f140-71f962f1c9a1"
      },
      "source": [
        "print(test[0])"
      ],
      "execution_count": 19,
      "outputs": [
        {
          "output_type": "stream",
          "text": [
            "Body Mass Index and Risk for Intubation or Death in SARS-CoV-2 Infection: A Retrospective Cohort StudyObesity is a risk factor for pneumonia and acute respiratory distress syndrome.\n",
            "To determine whether obesity is associated with intubation or death, inflammation, cardiac injury, or fibrinolysis in coronavirus disease 2019 (COVID-19).\n",
            "Retrospective cohort study.\n",
            "A quaternary academic medical center and community hospital in New York City.\n",
            "2466 adults hospitalized with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 infection over a 45-day period with at least 47 days of in-hospital observation.\n",
            "Body mass index (BMI), admission biomarkers of inflammation (C-reactive protein [CRP] level and erythrocyte sedimentation rate [ESR]), cardiac injury (troponin level), and fibrinolysis (D-dimer level). The primary end point was a composite of intubation or death in time-to-event analysis.\n",
            "Over a median hospital length of stay of 7 days (interquartile range, 3 to 14 days), 533 patients (22%) were intubated, 627 (25%) died, and 59 (2%) remained hospitalized. Compared with overweight patients, patients with obesity had higher risk for intubation or death, with the highest risk among those with class 3 obesity (hazard ratio, 1.6 [95% CI, 1.1 to 2.1]). This association was primarily observed among patients younger than 65 years and not in older patients (\n",
            "Body mass index was missing for 28% of patients. The primary analyses were conducted with multiple imputation for missing BMI. Upper bounding factor analysis suggested that the results are robust to possible selection bias.\n",
            "Obesity is associated with increased risk for intubation or death from COVID-19 in adults younger than 65 years, but not in adults aged 65 years or older.\n",
            "National Institutes of Health.\n"
          ],
          "name": "stdout"
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "0vI6DngRbCqT"
      },
      "source": [
        "for j in range(len(new_text2)):\r\n",
        "  for i in range(len(new_text[j])):\r\n",
        "    new_text2[j][i] = str(new_text2[j][i])\r\n",
        "  new_text2[j] = \" \".join(new_text2[j])"
      ],
      "execution_count": 20,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "2Flyo16cbYwS",
        "outputId": "eabda486-7a53-4e54-be07-75f6a7d72d68"
      },
      "source": [
        "new_text2"
      ],
      "execution_count": 21,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "['Body Mass Index Risk Intubation Death SARS-CoV-2 Infection Retrospective Cohort StudyObesity risk factor pneumonia acute respiratory distress syndrome obesity associated with intubation death inflammation cardiac injury fibrinolysis coronavirus disease COVID-19 Retrospective cohort study community hospital New York City adults hospitalized laboratory-confirmed severe acute respiratory syndrome coronavirus 2 infection period days in-hospital observation Body mass index BMI admission biomarkers inflammation C-reactive protein CRP level erythrocyte ESR cardiac injury troponin level fibrinolysis D-dimer level primary end point composite intubation death time-to-event analysis hospital length of stay days interquartile range days patients died hospitalized Compared overweight patients patients obesity higher risk intubation death highest risk class 3 obesity hazard ratio CI association patients younger years older patients Body mass index patients primary analyses imputation missing BMI Upper bounding factor analysis results selection bias Obesity associated with increased risk intubation death COVID-19 adults younger years adults years older National Institutes of Health',\n",
              " 'mRNA Vaccine SARS-CoV-2 Preliminary ReportThe severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 international accelerate development vaccine candidate vaccine encodes prefusion SARS-CoV-2 phase 1 dose-escalation open-label trial healthy adults years age vaccinations days mRNA-1273 dose participants dose group vaccination antibody responses higher dose day enzyme-linked immunosorbent assay anti-S-2P geometric mean titer GMT group group group vaccination titers increased GMT vaccination serum-neutralizing activity detected methods participants evaluated values upper half distribution control convalescent serum specimens Solicited adverse events participants fatigue chills headache myalgia pain injection site Systemic adverse events vaccination highest dose participants dose group severe adverse events mRNA-1273 vaccine induced anti-SARS-CoV-2 immune responses participants no trial-limiting safety concerns findings development vaccine National Institute of Allergy Infectious Diseases',\n",
              " 'Pathophysiology Transmission Diagnosis Treatment Coronavirus Disease 2019 COVID-19 ReviewThe coronavirus disease 2019 COVID-19 pandemic severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 sudden increase hospitalizations pneumonia multiorgan disease review evidence pathophysiology transmission diagnosis management COVID-19 SARS-CoV-2 respiratory droplets face-to-face Infection asymptomatic presymptomatic symptomatic carriers exposure to symptom onset days people symptoms days symptoms fever dry cough shortness breath Radiographic laboratory abnormalities lymphopenia elevated lactate dehydrogenase nonspecific Diagnosis detection SARS-CoV-2 reverse transcription polymerase chain reaction testing false-negative test patients quality timing testing Manifestations COVID-19 asymptomatic carriers fulminant disease sepsis acute respiratory failure patients COVID-19 hospitalized severe symptoms intensive care patients hospitalized COVID-19 supplemental oxygen Treatment individuals COVID-19 practices supportive management acute hypoxic respiratory failure data dexamethasone therapy reduces mortality patients supplemental oxygen usual care age-adjusted rate ratio CI remdesivir recovery hospital discharge supplemental oxygen requirement days randomized trial patients COVID-19 convalescent plasma shorten recovery trials testing antiviral therapies immune modulators anticoagulants case-fatality rate COVID-19 age deaths cases patients years deaths cases patients years older US patients hospitalized intensive care unit case fatality SARS-CoV-2 vaccines development effective vaccine primary methods reduce spread face masks social distancing contact tracing Monoclonal antibodies hyperimmune globulin preventive strategies million people infected SARS-CoV-2 transmission infection treatment unclear prevention effective management COVID-19 clinical investigation public health clinical interventions',\n",
              " 'Introductions Early Spread SARS-CoV-2 France SARS-CoV-2 emergence China surveillance implemented France Phylogenetic analysis sequences surveillance detected initial introductions non-clade G viruses identification clade G variants country patient risk areas contact travellers SARS-CoV-2 local cases',\n",
              " \"Reopen Colleges Universities COVID-19 Experiences TaiwanReopening colleges universities coronavirus disease 2019 COVID-19 pandemic Taiwan countries schools secure safety students staff Ministry of Education Taiwan general guidelines college campuses guidelines creation task force university school-based risk screening travel history occupation contacts clusters measures self-management of health quarantine general hygiene measures wearing masks indoors principles ventilation sanitization regulations school assemblies process reporting suspected cases policies school closing make-up classes class student staff member tested positive school days cases cases Taiwanese universities pandemic university closed virtual classes quickly days contact tracing quarantine contacts Taiwan's circumstances colleges universities combination strategies containment access control contact tracing quarantine mitigation hygiene sanitation ventilation social distancing practices\",\n",
              " 'Estimation SARS-CoV-2 Infection Fatality Real-Time Antibody Screening Blood DonorsThe pandemic severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 societies seroprevalence SARS-CoV-2 epidemic calculate infection fatality rate IFR measures authorities decisions societal interventions objective real-time blood donors SARS-CoV-2 infections population IFR Danish blood donors years giving blood April May 3 tested SARS-CoV-2 immunoglobulin M G antibodies commercial lateral flow test Antibody status geographical areas estimate IFR calculated seroprevalence assay sensitivity specificity uncertainties test validation reporting confidence intervals CI blood donors tested seroprevalence CI calculated seroprevalence areas data fatalities population IFR patients younger estimated CI infections IFR countries seroprevalence data IFR estimate real-time nationwide blood donations tool monitoring epidemic',\n",
              " \"Multisystem Inflammatory Syndrome Children New York children MIS-C associated with coronavirus disease New York State Department of Health NYSDOH active statewide surveillance hospitalized patients syndrome Hospitals New York State Kawasaki's disease toxic shock syndrome myocarditis potential MIS-C hospitalized patients younger years age sent medical records NYSDOH clinical presentation complications outcomes patients NYSDOH MIS-C potential cases NYSDOH patients MIS-C laboratory-confirmed acute acute respiratory syndrome coronavirus 2 SARS-CoV-2 infection MIS-C clinical epidemiologic criteria male black Hispanic patients years age years age years age subjective fever chills tachycardia gastrointestinal symptoms rash conjunctival injection mucosal changes Elevated levels C-reactive protein d-dimer troponin patients vasopressor evidence myocarditis admitted intensive care unit died median hospital stay days emergence multisystem inflammatory syndrome children New York State SARS-CoV-2 transmission hyperinflammatory syndrome dermatologic mucocutaneous gastrointestinal manifestations associated with cardiac dysfunction\",\n",
              " \"Multisystem Inflammatory Syndrome U.S. Children AdolescentsUnderstanding epidemiology clinical course multisystem inflammatory syndrome children MIS-C temporal coronavirus disease Covid-19 clinical public health syndrome targeted surveillance MIS-C pediatric health centers United States case definition criteria illness hospitalization age years hours laboratory evidence inflammation multisystem organ involvement evidence infection severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 reverse-transcriptase polymerase chain reaction RT-PCR antibody testing exposure to persons Covid-19 month Clinicians abstracted data standardized forms patients MIS-C states median age years patients male healthy positive SARS-CoV-2 RT-PCR antibody testing hospitalized Organ-system involvement gastrointestinal system patients cardiovascular hematologic mucocutaneous respiratory median duration hospitalization days interquartile range patients intensive care mechanical ventilation vasoactive support died Coronary-artery aneurysms z scores documented patients Kawasaki's disease-like features documented patients elevations biomarkers inflammation immunomodulating therapies intravenous immune globulin glucocorticoids interleukin-6 inhibitors Multisystem inflammatory syndrome children associated with SARS-CoV-2 life-threatening illness healthy children adolescents Centers for Disease Control Prevention\",\n",
              " 'Convergent Antibody Responses SARS-CoV-2 Convalescent IndividualsDuring coronavirus disease-2019 COVID-19 pandemic severe acute respiratory syndrome-related coronavirus-2 SARS-CoV-2 infection millions people thousands lives entry virus cells receptor-binding domain RBD spike SARS-CoV-2 antibodies essential protection human antibody response SARS-CoV-2',\n",
              " 'Outcomes COVID-19 patients treated with hydroxychloroquine/azithromycin regimens Marseille France retrospective analysisIn Marseille France early massive screening coronavirus disease COVID-19 Hospitalization early treatment hydroxychloroquine azithromycin HCQ-AZ positive cases retrospectively clinical management screened patients treated with HCQ-AZ oral HCQ daily days oral AZ day daily days days patients treated regimen Outcomes death transfer intensive care unit ICU days hospitalization viral shedding patients mean age years male case fatality low-dose computed tomography lung lesions patients minimal clinical symptoms NEWS discrepancy spontaneous dyspnoea hypoxemia lung lesions Clinical factors age comorbidities NEWS-2 score biological factors lymphocytopenia eosinopenia decrease blood zinc increase D-dimers lactate dehydrogenase creatinine phosphokinase troponin C-reactive protein moderate severe lesions detected low-dose CT scans associated with poor clinical outcome Treatment HCQ-AZ associated with decreased risk transfer ICU death Hazard ratio HR decreased risk hospitalization days odds ratios CI shorter duration viral shedding negative PCR HR QTc prolongation patients cessation treatment cases cases QTc torsade de pointe sudden death retrospective analysis early diagnosis early isolation early treatment COVID-19 patients days HCQ-AZ clinical outcome viral load reduction treatments',\n",
              " 'Inhalational volatile-based sedation COVID-19 pneumonia ARDSHospitals shortage essential intravenous medications COVID-19 critical care patients disruption drug supply chains Inhaled anesthetic agents abundant resource solution ICU sedation Inhaled volatile agents pulmonary benefits COVID-19 patients ARDS improve gas exchange reduce time spent ventilator volatile agents technical overview algorithm administering inhaled volatile-based sedation ICUs',\n",
              " \"Key Questions Modelling COVID-19 Exit Strategies Combinations non-pharmaceutical interventions lockdowns reduce SARS-CoV-2 transmission governments implement exit relax restrictions risk surge cases Mathematical modelling interventions designing exit face ongoing transmission report discussions Isaac Newton Institute 'Models workshop community modellers evidence governments questions answered accurate predictions effects of exit strategies questions roadmap development models exit strategies roadmap scientific policymakers improve estimation epidemiological parameters sources heterogeneity populations requirements data collection information planning exit balance socio-economic public health\",\n",
              " 'Dynamics COVID-19 social distancing measures transmission network structure absence pharmaceutical interventions social distancing curb spread COVID-19 impact measures inconsistent regions nearing disease elimination seeing delayed peaks flat epidemic curves build stochastic epidemic model effects of COVID-19 clinical progression transmission outcomes social distancing interventions strength within-household transmission success timing size epidemic peak rate decline risks of infection success partial relaxation measures structure residual external connections participation essential businesses outcomes findings predictions timescale efficacy interventions outbreaks quantification control household transmission',\n",
              " 'Practical considerations measuring effective reproductive number Estimation effective reproductive number Rt detecting changes disease transmission Coronavirus Disease 2019 COVID-19 pandemic policy makers public health officials effectiveness interventions inform policy estimation Rt data interpretation course pandemic document challenges examples synthetic data recommendations real-time estimation Rt Cori colleagues data time t empirical estimates distribution infections data time t Wallinga Teunis conceptually real-time estimation retrospective analyses individuals infected time points spread caution methods Bettencourt Ribeiro estimates biased structural assumptions approaches accurate specification generation interval reconstruction time series infections observations long moment transmission Naive approaches observation subtracting delays distribution bias suggestions mitigate technical challenges open problems Rt estimation',\n",
              " 'Determinants COVID-19 Disease Severity Patients CancerAs New York State cases severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 deaths Patients cancer deceased individuals',\n",
              " 'Test sensitivity secondary to frequency turnaround time COVID-19 surveillance COVID-19 pandemic public health crisis SARS-CoV-2 individuals pre-symptomatic symptomatic asymptomatic infections re-opening societies control virus spread robust surveillance virus testing central infection individuals period incubation viral titers detect exponential growth virus peak viral load infectiousness declining viral levels clearance pattern viral load kinetics model surveillance effectiveness test sensitivities frequency sample-to-answer effective surveillance detection outbreak control frequency testing speed reporting high test sensitivity surveillance prioritize accessibility frequency sample-to-answer time analytical limits of detection',\n",
              " 'Clinical Presentation Outcomes Pregnant Women COVID-19 Systematic Review Meta-AnalysisDescriptions coronavirus disease-2019 COVID-19 non-pregnant adult population study clinical characteristics perinatal outcomes COVID-19 pregnancy databases clinical characteristics radiological findings laboratory testing pregnant women infection Data studies random-effects model women symptoms fever cough Laboratory findings elevated C-Reactive Protein lymphocytopenia Ground-glass opacity radiological finding Preterm birth rate cesarean delivery rate maternal death fetal COVID-19 cases clinical picture pregnant women COVID-19 non-pregnant population rate preterm birth cesarean delivery international averages',\n",
              " 'Posterior Oropharyngeal Saliva Detection SARS-CoV-2The coronavirus disease-2019 COVID-19 pandemic healthcare system Diagnostic testing limiting factors early identification isolation infected patients study evaluate posterior oropharyngeal saliva POPS severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 detection patients confirmed suspected COVID-19 laboratory information system retrospectively respiratory specimens POPS SARS-CoV-2 RNA detection Apr 15 agreement diagnostic performance POPS NPsp evaluated specimens study period POPS NPsp twenty-nine POPS-NPsp paired POPS NPsp positivity CI CI negative positive CI CI CI positive POPS-NPsp days CI compared days symptom onset CI positive Cp value Cp value NPsp Pearson coefficient 0.579 No significant temporal specimen POPS alternative nasopharyngeal detection SARS-CoV-2',\n",
              " 'National French Survey COVID-19 Symptoms People national French survey COVID-19 semiology seniors(n=353 patients thermal dysregulation(83.6 gastrointestinal signs(24.4% Patients≥80y asthenia(P=0.002 Patients neurocognitive disorders altered consciousness(P=0.001 Clinical peculiarities COVID-19 seniors',\n",
              " 'Association Angiotensin-Converting Enzyme Inhibitor Angiotensin Receptor Blocker COVID-19 Diagnosis MortalityIt angiotensin-converting enzyme inhibitors receptor blockers ARBs patients susceptible coronavirus disease COVID-19 outcomes upregulation functional receptor virus angiotensin-converting enzyme 2 ACEI/ARBs associated with COVID-19 diagnosis outcomes patients COVID-19 outcomes patients COVID-19 retrospective cohort study data Danish national administrative registries Patients COVID-19 ICD-10 codes followed up day diagnosis outcome study period susceptibility COVID-19 Cox regression model case-control framework association ACEI/ARBs antihypertensive drugs incidence rate COVID-19 diagnosis cohort patients hypertension February 1 ACEI/ARB prescription months index date retrospective cohort study primary outcome death secondary outcome composite outcome death severe COVID-19 case-control susceptibility analysis outcome COVID-19 diagnosis retrospective cohort study patients COVID-19 median age years interquartile range men users ACEI/ARBs nonusers ACEI/ARB group died days nonuser group association adjustment age sex medical history hazard ratio HR CI Death severe COVID-19 ACEI/ARB users nonusers days HR CI case-control analysis COVID-19 susceptibility patients COVID-19 hypertension median age years men sex-matched controls hypertension COVID-19 COVID-19 ACEI/ARBs controls ACEI/ARB antihypertensive drugs associated with higher incidence COVID-19 HR CI ACEI/ARBs associated with COVID-19 diagnosis patients hypertension mortality severe disease patients diagnosed COVID-19 findings discontinuation ACEI/ARB medications clinically context COVID-19 pandemic',\n",
              " 'personal protective equipment coronavirus disease healthcare professionals Wuhan China cross sectional protective effects personal protective equipment frontline healthcare professionals care patients coronavirus disease covid-19 Cross sectional study hospitals Wuhan China healthcare professionals doctors nurses Wuhan affiliated hospitals Sun Yat-sen University Nanfang Hospital Southern Medical University weeks January study participants personal protective equipment deliver healthcare patients admitted hospital covid-19 aerosol procedures healthcare professionals covid-19 patients covid-19 accuracy antibody testing Covid-19 symptoms fever cough dyspnoea evidence severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 positive test virus nucleic acids nasopharyngeal swabs positive test IgM IgG serum samples age study participants years women study participants hour shifts average days week week intensive care units study participants contact patients covid-19 performed aerosol procedure period Wuhan study participants covid-19 symptoms participants home tested negative SARS-CoV-2 nucleic acids IgM IgG antibodies confidence interval effective vaccine becomes healthcare professionals covid-19 exposure study participants contract infection protective immunity SARS-CoV-2 Healthcare systems priority procurement distribution personal protective equipment adequate training healthcare professionals',\n",
              " 'Feasibility physiological effects prone non-intubated patients acute respiratory failure COVID-19 PRON-COVID prospective cohort COVID-19 pandemic health systems patients intensive care respiratory failure intubation Prone positioning intubated patients reduce mortality moderate-to-severe acute respiratory distress syndrome investigate feasibility effect gas prone positioning awake non-intubated patients COVID-19-related pneumonia feasibility cohort study patients aged years diagnosis COVID-19-related pneumonia supplemental oxygen non-invasive continuous positive airway pressure San Gerardo Hospital Monza Italy baseline data demographics anthropometrics arterial blood gas ventilation parameters baseline data collection patients prone position minimum duration Clinical data re-collected prone positioning supine position study outcome variation oxygenation partial pressure oxygen PaO patients male mean age years SD BMI Prone positioning effective ameliorating blood oxygenation awake patients COVID-19-related pneumonia oxygen supplementation effect resupination patients studies benefit technique improving respiratory global outcomes University of Milan-Bicocca',\n",
              " 'SARS-CoV-2 shedding seroconversion passengers quarantined ship case ship closed-off environment simulates city living interpersonal interactions Diamond Princess ship quarantined onboard outbreak COVID-19 February shedding pattern severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 patient antibody responses symptoms adult years passengers Hong Kong board Diamond Princess ship docked Yokohama Japan February participants negative SARS-CoV-2 RT-PCR 4 days disembarking transferred quarantine public estate Hong Kong Participants quantitative RT-PCR RT-qPCR nasopharyngeal throat swabs serum IgG IgM internal nucleoprotein surface RBD SARS-CoV-2 baseline quarantine days quarantine adults CI positive SARS-CoV-2 RT-qPCR serology hospitalised patients nasopharyngeal swab RT-qPCR positive patients baseline patients positive anti-RBD IgG day simultaneously positive nasopharyngeal swab RT-PCR anti-RBD IgG. patient positive anti-RBD IgG negative viral load multifocal high-resolution CT COVID-19 patients ground-glass changes high-resolution CT OD values day anti-RBD IgG day patients ground-glass changes patients asymptomatic quarantine period Patients COVID-19 asymptomatic lung infection viral shedding evidence pneumonia imaging increased antibody response Positive IgG IgM infection COVID-19 symptomatic asymptomatic patients RT-PCR serology implemented case finding contact tracing early diagnosis isolation treatment Shaw Foundation Sanming-Project of Medicine Shenzhen High Level-Hospital Program Guangdong Health Commission',\n",
              " 'Genomewide Association Study Severe Covid-19 Respiratory FailureThere variation disease behavior patients infected severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 virus coronavirus disease Covid-19 Genomewide association analysis identification potential genetic factors development Covid-19 association study patients Covid-19 severe disease respiratory failure hospitals Italian Spanish epicenters SARS-CoV-2 pandemic Europe quality control exclusion population outliers patients control participants Italy patients control participants Spain final analysis analyzed single-nucleotide polymorphisms meta-analysis case-control panels detected cross-replicating rs11385942 locus 3p21.31 rs657152 locus level identified gene cluster genetic susceptibility locus patients Covid-19 respiratory failure potential involvement ABO blood-group system Stein Erik Hagen',\n",
              " \"Seroprevalence anti-SARS-CoV-2 IgG antibodies Geneva Switzerland SEROCoV-POP population-based studyAssessing burden COVID-19 medically case numbers suboptimal reliance testing strategy case definitions disease presentation Population-based serosurveys anti-severe acute respiratory syndrome coronavirus 2 method estimating infection rates monitoring progression epidemic estimate anti-SARS-CoV-2 antibodies population Geneva Switzerland epidemic SEROCoV-POP study population-based study former participants Bus Santé study household members consecutive weekly serosurveys participants population-representative survey household members years older participant anti-SARS-CoV-2-IgG antibodies ELISA seroprevalence Bayesian logistic regression model test performance age sex Geneva's population results weeks study May 9 participants households demographic distribution canton Geneva week seroprevalence CI estimate increased week week week fifth week Individuals aged years relative risk RR CI older years RR risk seropositive aged years seroconversion case infections community results population Geneva uninfected wave pandemic prevalence COVID-19 region clinical cases months population people IgG associated with immunity results epidemic susceptible people population seroprevalence children aged years adults years aged years results countries easing restrictions curbing transmission Public Health Swiss School Public Health Corona Immunitas research program Fondation Fondation Fondation Privée des Center Viral Diseases\",\n",
              " 'Age-dependent effects transmission control COVID-19 COVID-19 pandemic low proportion cases children',\n",
              " 'Factors Associated With Surgical Mortality Complications Patients Coronavirus Disease 2019 COVID-19 ItalyThere data mortality complications rates patients coronavirus disease 2019 COVID-19 surgery evaluate early surgical outcomes patients COVID-19 subspecialties cohort study general vascular thoracic surgery orthopedic neurosurgery units Spedali Civili Hospital Brescia Italy patients surgical treatment positive test COVID-19 week surgery Gynecological minor surgical procedures Patients COVID-19 patients COVID-19 ratio sex age group American Society of Anesthesiologists score comorbidities surgical risk American College of Surgeons National Surgical Quality Improvement Program Patients years Clinical Frailty Scale score Patients positive COVID-19 surgery surgical patients infection Screening COVID-19 reverse transcriptase-polymerase chain reaction assay nasopharyngeal swabs chest radiography computed tomography Diagnosis COVID-19 positivity investigations primary end point early surgical mortality complications patients COVID-19 secondary end points modeling complications COVID-19 surgical risk factors patients operation period surgery positive COVID-19 preoperatively positive results days surgery patients combined cohorts women SD age years mortality COVID-19 control patients COVID-19 odds ratio OR CI Complications OR CI pulmonary complications OR CI thrombotic complications associated with COVID-19 OR CI models cumulative link model classification tree COVID-19 associated with complications cohort study surgical mortality complications patients COVID-19 patients COVID-19 data surgery postponed patients COVID-19',\n",
              " \"Detection SARS-CoV-2 RNA fecal specimens patients COVID-19 studies SARS-CoV-2 RNA fecal specimens COVID-19 patients sample size systematic review meta-analysis detection rate SARS-CoV-2 RNA fecal specimens patients clinical characteristics MEDLINE Embase Scopus Chinese biomedical databases no language restriction observational studies detection rate SARS-CoV-2 RNA fecal specimens COVID-19 patients reviewers review Metaprop meta-analysis prevalence variances Freeman-Tukey Double Arcsine Transformation random-effects model Heterogeneity studies Cochran's Q test square statistics studies pooled detection fecal SARS-CoV-2 RNA CI C.I. C.I. patient specimens unit count Female individuals gastrointestinal symptoms patients severe disease detection rate proportion COVID-19 patients SARS-CoV-2 intestinal tract Feces self-collected specimen case identification community young children respiratory sampling home infection control spread fecal contamination faulty toilet drainage\",\n",
              " 'effect large-scale anti-contagion COVID-19 pandemicGovernments world responding coronavirus disease COVID-19 pandemic',\n",
              " 'Characteristics outcomes pregnant women admitted hospital SARS-CoV-2 infection UK national population cohort national cohort pregnant women admitted hospital severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 UK factors associated with infection outcomes transmission infection mothers infants Prospective national population cohort study UK Obstetric Surveillance System UKOSS obstetric units UK pregnant women hospital SARS-CoV-2 infection Incidence maternal hospital admission infant infection Rates maternal death critical care unit fetal loss caesarean birth preterm birth stillbirth early neonatal death neonatal unit admission incidence admission hospital SARS-CoV-2 infection pregnancy confidence interval maternities pregnant women hospital SARS-CoV-2 infection pregnancy black ethnic minority overweight obese aged pre-existing comorbidities women birth pregnancy loss birth term women admitted hospital respiratory support women died infants positive SARS-CoV-2 RNA hours birth pregnant women hospital SARS-CoV-2 infection guidance social distancing measures pregnancy outcomes transmission SARS-CoV-2 infants women black minority ethnic groups admitted infection investigation explanation ISRCTN',\n",
              " 'Clinical benefit remdesivir rhesus macaques infected SARS-CoV-2Effective treat coronavirus disease 2019 COVID-19 investigational drugs potential treatments preclinical data animal models effective treatments lack efficacy in vivo Remdesivir GS-5734 nucleotide analogue prodrug antiviral activity',\n",
              " 'Clinical Characteristics Children Pediatric Inflammatory Multisystem Syndrome Associated With SARS-CoV-2In communities coronavirus disease reports children unusual fever inflammation clinical laboratory characteristics hospitalized children criteria pediatric inflammatory multisystem syndrome associated with severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 PIMS-TS compare characteristics pediatric inflammatory disorders Case series children hospitals England persistent fever laboratory evidence inflammation published definitions PIMS-TS follow-up Clinical laboratory characteristics medical record review clinical characteristics patients Kawasaki disease KD KD shock syndrome toxic shock syndrome hospitals Europe US Signs symptoms laboratory imaging findings children definitional criteria PIMS-TS UK US World Health Organization laboratory imaging characteristics children definitional criteria PIMS-TS comparison characteristics pediatric inflammatory disorders children median age years interquartile range IQR girls identified criteria PIMS-TS SARS-CoV-2 polymerase chain reaction tests positive patients SARS-CoV-2 IgG test positive patients evidence current SARS-CoV-2 infection children fever nonspecific symptoms vomiting abdominal pain diarrhea Rash conjunctival injection cases Laboratory evaluation consistent with inflammation C-reactive protein IQR assessed ferritin IQR assessed children shock biochemical evidence myocardial dysfunction inotropic support fluid resuscitation mechanical ventilation American Heart Association definition KD fever inflammation features shock KD patients coronary artery dilatation aneurysm Comparison PIMS-TS KD KD shock syndrome clinical laboratory features older age median age years IQR years IQR years IQR elevation inflammatory markers C-reactive protein median IQR IQR IQR case series hospitalized children criteria PIMS-TS signs symptoms disease severity fever inflammation myocardial injury shock development coronary artery aneurysms comparison patients KD KD shock syndrome syndrome disorder pediatric inflammatory entities',\n",
              " \"Clinical Efficacy Chloroquine derivatives COVID-19 Infection Comparative meta-analysis Big data coronavirus disease COVID-19 pandemic meta-analysis effects of chloroquine derivatives patients unpublished published reports internet keywords ' chloroquine COVID-19 SARS-Cov-2' PubMed Google Scholar Google search engines restrictions language studies patients treated patients countries Brazil China France Iran Saudi Arabia South Korea Spain USA Big data observational studies associated with conflict lack treatment dosage duration absence favourable outcome Clinical studies associated with favourable outcomes details therapy clinical studies randomized controlled trials favourable effect clinical studies summary effect duration cough OR duration fever OR clinical cure OR death OR\",\n",
              " 'Estimating effects of non-pharmaceutical interventions COVID-19 detection',\n",
              " 'Association hypertension antihypertensive treatment COVID-19 mortality retrospective observational treatment hypertension influences mortality patients diagnosed coronavirus disease 2019 COVID-19 retrospective observational study patients admitted COVID-19 Huo Shen Shan Hospital hospital treatment COVID-19 Wuhan China Hypertension treatments stratified medical history medications infection hospitalized patients history of hypertension confounders patients hypertension increase relative risk mortality patients hypertension hazard ratio HR confidence interval CI Patients history of hypertension antihypertensive treatment associated with risk mortality compared antihypertensive treatments HR CI mortality rates renin-angiotensin-aldosterone system RAAS inhibitor non-RAAS inhibitor cohorts HR CI study-level meta-analysis studies result patients RAAS mortality relative risk CI hypertension discontinuation antihypertensive treatment increased risk mortality retrospective observational analysis detect harm RAAS inhibitors patients infected COVID-19 results exploratory interpreted',\n",
              " 'Effect Convalescent Plasma Therapy Time Clinical Improvement Patients Severe Life-threatening COVID-19 Randomized Clinical TrialConvalescent plasma therapeutic option patients coronavirus disease 2019 COVID-19 data randomized clinical trials evaluate efficacy adverse effects convalescent plasma therapy patients COVID-19 Open-label multicenter randomized clinical trial medical centers Wuhan China follow-up trial participants laboratory-confirmed COVID-19 severe respiratory distress hypoxemia life-threatening shock organ failure mechanical ventilation trial terminated early patients plasma standard treatment standard treatment control stratified disease severity Primary outcome clinical improvement days patient discharged alive reduction 6-point disease severity scale discharge death Secondary outcomes mortality discharge rate viral polymerase chain reaction PCR turned positive baseline negative patients randomized median age years male trial Clinical improvement days convalescent plasma control group CI hazard ratio HR CI severe disease primary outcome convalescent plasma group control group HR CI life-threatening disease primary outcome convalescent plasma control group HR CI interaction mortality OR CI time randomization discharge discharged day HR CI plasma treatment associated with negative conversion viral PCR hours convalescent plasma control group OR CI patients convalescent plasma group adverse events transfusion improved supportive care patients severe life-threatening COVID-19 plasma therapy standard treatment standard treatment statistically significant improvement clinical improvement days Interpretation early termination trial detect clinically Clinical Trial Registry ChiCTR2000029757',\n",
              " 'Acute myocarditis multisystem inflammatory emerging disease SARS-CoV-2 infection critically ill increase children admitted hypotensive shock fever context COVID-19 outbreak characterization assessment involvement SARS-CoV-2 infection case series academic tertiary care centers Paris children pediatric intensive care unit PICU shock fever suspected SARS-CoV-2 infection April children admitted shock acute myocarditis left ventricular ejection fraction troponin arterial hypotension vasoplegic clinical presentation symptoms PICU admission abdominal pain fever days children elevated C-reactive protein procalcitonin microbial cause Kawasaki disease children fever skin rash conjunctivitis cheilitis adenitis SARS-CoV-2 PCR serology positive children child negative SARS-CoV-2 PCR serology SARS-CoV-2 chest tomography scan children inotropic/vasoactive drug support epinephrine milrinone dobutamine norepinephrine children intravenous immunoglobulin adjuvant corticosteroids IL 1 receptor antagonist monoclonal antibody IL-6 receptor children afebrile left ventricular function PICU discharge Acute myocarditis intense systemic inflammation atypical Kawasaki disease severe pediatric disease SARS-CoV-2 infection Early recognition disease expert center delayed inappropriate host immunological response mechanisms unclear investigations target optimal treatment',\n",
              " 'Kawasaki-like multisystem inflammatory syndrome children covid-19 pandemic Paris France prospective observational characteristics children adolescents outbreak Kawasaki-like multisystem inflammatory syndrome temporal severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 Prospective observational study university hospital Paris France children adolescents aged years features Kawasaki disease admitted hospital April followed up discharge primary outcomes clinical biological data imaging echocardiographic findings treatment outcomes Nasopharyngeal swabs SARS-CoV-2 reverse transcription-polymerase chain reaction RT-PCR blood samples IgG virus children adolescents age years admitted features Kawasaki disease day period African ancestry Kawasaki disease shock syndrome myocarditis intensive care support patients gastrointestinal symptoms early stage illness inflammatory markers evidence SARS-CoV-2 infection positive RT-PCR positive IgG detection patients intravenous immunoglobulin corticosteroids clinical outcome patients Moderate coronary artery detected patients hospital stay days hospital stay patients discharged home outbreak Kawasaki-like multisystem inflammatory syndrome children adolescents Paris area SARS-CoV-2 affected children adolescents gastrointestinal symptoms Kawasaki disease shock syndrome African ancestry',\n",
              " 'Serodiagnostics Severe Acute Respiratory Syndrome– Coronavirus-2 narrative reviewAccurate detect host antibodies acute respiratory syndrome-related coronavirus 2 SARS-CoV-2 public health response coronavirus disease pandemic cases molecular methods diagnosis active disease immunity individuals population level seroepidemiologic studies characterization transmission dynamics refinement of disease burden estimates kinetics humoral immunity explosion number availability serologic assays antibodies SARS-CoV-2 minimal external hinders assay selection implementation interpretation study critical knowledge gaps serologic correlates protection infection disease assays cross-react antibodies coronaviruses article cases SARS-CoV-2 serologic studies reviews assays research proposes test implementation',\n",
              " 'Randomized Trial Hydroxychloroquine Postexposure Prophylaxis Covid-19Coronavirus disease Covid-19 exposure to severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 persons exposed standard of care observation quarantine hydroxychloroquine symptomatic infection SARS-CoV-2 exposure randomized double-blind placebo-controlled trial United States Canada testing hydroxychloroquine postexposure prophylaxis adults household occupational someone Covid-19 distance minutes wearing face mask eye shield high-risk exposure face mask eye shield moderate-risk exposure days exposure assigned participants placebo hydroxychloroquine hours daily days primary outcome incidence laboratory-confirmed Covid-19 illness Covid-19 days asymptomatic participants participants high-risk exposure to Covid-19 contact incidence illness Covid-19 participants hydroxychloroquine placebo absolute difference confidence interval Side effects hydroxychloroquine placebo adverse reactions high-risk moderate-risk Covid-19 hydroxychloroquine illness Covid-19 infection postexposure prophylaxis days exposure David Baszucki Baszucki ClinicalTrials.gov number',\n",
              " 'Effects of non-pharmaceutical interventions COVID-19 cases deaths hospital services UK modelling studyNon-pharmaceutical interventions reduce transmission severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 UK Projecting size epidemic potential effect control measures evidence-based early epidemic study impact control measures burden COVID-19 UK stochastic intervention scenarios tracking people county-level administrative units England Wales Scotland Northern Ireland base interventions modelled school closures physical distancing people years older self-isolation symptomatic cases modelled combination interventions programme intensive interventions lockdown-type restrictions contacts outside home periods triggers introduction interventions impact adherence interventions counties scenario projected cases time patients inpatient critical care admission intensive care units ICU treatment deaths effect intervention median burden million prediction interval clinical cases deaths COVID-19 UK December base interventions decrease characteristics SARS-CoV-2 measures epidemic control prevent numbers deaths excess demand hospital beds ICUs Medical Research Council',\n",
              " 'Neurologic manifestations hospitalized patients COVID-19 ALBACOVID registryThe coronavirus disease 2019 COVID-19 Neurologic symptoms clinical spectrum disease neurologic manifestations hospitalized patients COVID-19 characteristics systematically patients diagnosed COVID-19 hospital Spanish population Demographic characteristics systemic neurologic clinical manifestations complementary tests analyzed patients hospitalized COVID-19 years men neurologic symptom Nonspecific symptoms myalgias headache dizziness early infection Anosmia dysgeusia early clinical manifestation frequent severe cases Disorders consciousness older patients severe advanced COVID-19 stages Myopathy dysautonomia cerebrovascular diseases seizures movement disorders encephalitis Guillain-Barré syndrome optic neuritis frequent Neurologic complications death study participants Neurologic hospitalized patients COVID-19 patients neurologic symptom Clinicians neurologic surveillance recognition complications mechanisms consequences of severe acute respiratory syndrome coronavirus type 2 neurologic studies',\n",
              " 'association treatment heparin survival patients Covid-19This study investigates association treatment heparin mortality patients admitted Covid-19 clinical data patients Covid-19 admitted hospitals Spain variables study age gender temperature saturation oxygen admission treatment heparin hydroxychloroquine azithromycin steroids tocilizumab combination lopinavir ritonavir oseltamivir data mortality Multivariable logistic regression models investigate associations collecting data patients died discharged home hospitals admitted transferred hospitals study Median follow up IQR days Heparin patients Heparin associated with mortality model age gender OR CI association saturation oxygen\\u2009 temperature de model OR drugs covariates OR association heparin lower mortality study acknowledged clinicians hospitals community Randomized controlled trials heparin therapeutic regimes',\n",
              " 'CT coronavirus disease COVID-19 systematic review chest CT findings adult patientsThe systematic review evaluate imaging manifestations COVID-19 chest CT adult patients comprehensive review published literature systematic literature PubMed Google Scholar Embase WHO databases studies chest CT imaging findings adult COVID-19 patients studies patients Ground glass opacities GGO isolation coexisting consolidations lesions Distribution GGOs bilateral peripheral/subpleural posterior predilection lower lobes ancillary pulmonary vascular enlargement intralobular septal thickening adjacent pleural thickening air bronchograms subpleural lines crazy bronchus distortion bronchiectasis interlobular septal thickening CT follow-up period increase size number density GGOs progression mixed areas GGOs consolidations crazy paving peaking days persisting patchy fibrosis younger adults GGOs extensive/multilobar involvement consolidations older population severe disease review imaging diagnosis stratification follow-up COVID-19 patients CT manifestations bilateral peripheral/subpleural posterior GGOs consolidations lower lobe predominance imaging impact management patients Ground glass opacities GGOs isolated coexisting consolidations bilateral subpleural distribution chest CT findings adult COVID-19 patients Follow-up CT progression GGOs mixed pattern peak days persisting patchy fibrosis Younger people GGOs Older sicker people involvement consolidations',\n",
              " 'Physical distancing face masks eye protection person-to-person transmission SARS-CoV-2 COVID-19 systematic review acute respiratory syndrome coronavirus 2 SARS-CoV-2 COVID-19 contact investigate effects of physical distance face masks eye protection virus transmission health-care non-health-care community systematic review meta-analysis investigate optimum distance person-to-person virus assess face masks eye protection transmission viruses data SARS-CoV-2 betacoronaviruses severe acute respiratory syndrome Middle East respiratory syndrome standard WHO-specific COVID-19-specific sources data sources database inception May 3 restriction language comparative studies contextual factors acceptability feasibility resource use equity records extracted data assessed risk bias duplicate frequentist Bayesian meta-analyses random-effects meta-regressions certainty evidence Cochrane methods GRADE study PROSPERO CRD42020177047 observational studies countries continents no randomised controlled trials comparative studies health-care non-health-care settings patients Transmission viruses physical distancing distance pooled odds ratio aOR CI risk difference RD CI moderate certainty protection increased distance lengthened change relative risk RR findings systematic review meta-analysis physical distancing quantitative estimates models contact tracing inform policy Optimum face masks respirators eye protection public health-care settings findings contextual factors randomised trials inform evidence interventions systematic evidence interim guidance',\n",
              " 'Anosmia dysgeusia associated with SARS-CoV-2 infection case-control studyAnosmia dysgeusia potential symptoms coronavirus disease study anosmia dysgeusia symptoms tested positive severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 case-control study Eastern Townships region Quebec adults age tested positive SARS-CoV-2 reverse transcription polymerase chain reaction Cases age control patents patients tested negative SARS-CoV-2 period Demographic laboratory information medical records Clinical symptoms comorbidities associated with anosmia dysgeusia telephone interview standardized questionnaire people SARS-CoV-2 positive cases women men age interquartile range symptoms associated with SARS-CoV-2 positivity conditional logistic regression anosmia dysgeusia odds ratio OR confidence interval CI myalgia OR CI blurred vision OR CI chest pain OR CI association olfactory gustatory symptoms SARS-CoV-2 positivity symptoms SARS-CoV-2 infection indication testing retesting people negative',\n",
              " 'Early Transmission Dynamics Wuhan China Novel Coronavirus-Infected cases coronavirus NCIP Wuhan Hubei Province China analyzed data cases Wuhan epidemiologic characteristics NCIP information demographic characteristics exposure history illness timelines laboratory-confirmed cases NCIP characteristics cases estimated epidemiologic exponential growth epidemic doubling time patients NCIP median age years male cases Huanan Seafood Wholesale Market cases incubation period days confidence interval CI percentile distribution days early stages epidemic size days serial interval days CI reproductive number CI information evidence human-to-human transmission middle reduce transmission control outbreaks dynamics Measures prevent reduce transmission implemented populations risk Ministry of Science Technology China',\n",
              " 'Ethnic socioeconomic SARS-CoV-2 infection prospective cohort study UK BiobankUnderstanding ethnicity socioeconomic position risk SARS-CoV-2 infection investigated UK Biobank study UK Biobank study general population collecting information self-defined ethnicity socioeconomic variables area-level socioeconomic deprivation educational attainment SARS-CoV-2 test Public Health England baseline UK Biobank data Poisson regression robust standard errors assess risk ratios RRs exposures dichotomous variables tested positive test testing hospital investigated ethnicity socioeconomic position associated with positive test tested covariates age sex social variables healthcare work household size behavioural risk factors baseline health participants England tested SARS-CoV-2 tested positive hospital Black south Asian groups test positive RR CI RR CI Pakistani ethnicity risk south Asian group RR CI ethnic groups hospital white British Adjustment baseline health behavioural risk factors modest attenuation socioeconomic variables Socioeconomic deprivation no qualifications associated with higher risk confirmed infection RR deprived quartile CI RR degree CI minority ethnic groups risk SARS-CoV-2 infection UK Biobank study socioeconomic conditions baseline behavioural risk factors response elevated risks',\n",
              " 'Mortality pulmonary complications patients surgery perioperative SARS-CoV-2 infection international cohort studyThe severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 postoperative recovery clinical decision COVID-19 pandemic study mortality pulmonary complication rates patients perioperative SARS-CoV-2 infection international multicentre cohort study hospitals countries patients surgery SARS-CoV-2 infection days days surgery primary outcome measure postoperative mortality assessed patients secondary outcome measure pulmonary complications pneumonia acute respiratory distress syndrome postoperative ventilation analysis patients surgery emergency surgery elective surgery SARS-CoV-2 infection patients mortality Pulmonary complications patients mortality patients deaths analyses mortality associated with male sex odds ratio CI age years older younger years American Society of Anesthesiologists grades 3-5 grades malignant benign obstetric diagnosis p=0·046 emergency elective surgery p=0·026 major minor surgery p=0·047 Postoperative patients perioperative SARS-CoV-2 infection associated with mortality Thresholds surgery COVID-19 pandemic normal practice men years older Consideration postponing non-urgent procedures non-operative treatment delay surgery National Institute for Health Research NIHR Association Coloproctology Great Britain Ireland Bowel Cancer Research Bowel Disease Association Upper Gastrointestinal Surgeons British Association Surgical Oncology British Gynaecological Cancer Society European Society of Coloproctology NIHR Academy Sarcoma UK Vascular Society for Great Britain Ireland Yorkshire Cancer Research',\n",
              " 'Clinical impact COVID-19 patients cancer CCC19 cohort studyData patients COVID-19 cancer lacking outcomes cohort patients cancer COVID-19 prognostic factors mortality severe illness cohort study de-identified data patients active malignancy years older severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 USA Canada Spain COVID-19 Cancer Consortium CCC19 database baseline data data baseline clinical conditions medications cancer diagnosis treatment COVID-19 disease course primary endpoint mortality days diagnosis COVID-19 assessed association outcome potential prognostic variables logistic regression analyses age sex smoking status obesity study ClinicalTrials.gov records CCC19 database study patients inclusion criteria analysis Median age years IQR aged years older patients male malignancies breast prostate patients active anticancer treatment active analysis patients died logistic regression analysis factors associated with increased mortality partial increased age years odds ratio CI male sex smoking status former smoker comorbidities Eastern Cooperative Oncology higher status active cancer remission azithromycin hydroxychloroquine treatment confounding indication Compared residence US-Northeast residence Canada US-Midwest associated with decreased mortality Race ethnicity obesity status cancer type type anticancer therapy surgery associated with mortality patients cancer COVID-19 mortality associated with general risk factors risk factors patients cancer Longer follow-up effect COVID-19 outcomes patients cancer cancer treatments National Institutes of Health Cancer Research',\n",
              " 'Characterization clinical course patients coronavirus disease New York retrospective case patients coronavirus disease covid-19 New York City medical center clinical course emergency department hospital wards intensive care units Retrospective manual medical record review quaternary care academic medical center New York City consecutive patients positive reverse transcriptase polymerase chain reaction assay severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 emergency department admitted hospital Patient data electronic medical records Characterization patients demographics presenting symptoms comorbidities presentation hospital course intubation complications mortality disposition patients emergency department hospital intensive care units admitted transferred intensive care units presenting symptoms cough fever dyspnea Patients hospital treated intensive care units baseline comorbidities hypertension diabetes obesity Patients intensive care units older male long lengths of stay days interquartile range days acute kidney injury needed dialysis patients mechanical ventilation days symptom intubation symptom bimodal distribution modes days days patients hospital died hospital Patients hospital covid-19 medical center morbidity mortality rates acute kidney injury inpatient dialysis prolonged intubations bimodal distribution intubation symptom onset',\n",
              " 'Hydroxychloroquine Chloroquine Treatment Prophylaxis COVID-19 Living Systematic ReviewHydroxychloroquine chloroquine antiviral effects in vitro severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 evidence benefits harms hydroxychloroquine chloroquine treatment prophylaxis coronavirus disease COVID-19 PubMed MEDLINE EMBASE Ovid Scopus Web of Science Cochrane Library bioRxiv Preprints ClinicalTrials.gov World Health Organization Chinese Clinical Trials Registry language reporting efficacy safety outcomes hydroxychloroquine chloroquine adults children suspected COVID-19 risk SARS-CoV-2 infection dually data extraction quality randomized controlled trials cohort studies case series assessed treatment medications evaluated prophylaxis Evidence conflicting insufficient effect hydroxychloroquine outcomes mortality progression severe disease clinical symptoms upper respiratory virologic antigen testing studies patients hydroxychloroquine QTc greater proportion patients finding studies studies assessed efficacy chloroquine trial higher-dose daily days lower-dose daily day daily days therapy stopped higher dose therapy increased lethality QTc interval prolongation observational study adults COVID-19 chloroquine phosphate daily patients chloroquine fever resolution virologic clearance benefits chloroquine controlled studies control confounding inadequate observational studies Evidence benefits harms hydroxychloroquine chloroquine treat COVID-19 weak conflicting Agency Healthcare Research Quality',\n",
              " 'Features UK patients hospital covid-19 ISARIC WHO Clinical Characterisation Protocol prospective observational cohort clinical features patients hospital coronavirus disease covid-19 United Kingdom growth phase outbreak International Severe Acute Respiratory WHO Clinical Characterisation Protocol UK CCP-UK risk factors associated with mortality hospital Prospective observational cohort study data gathering near real time analysis acute care hospitals England Wales Scotland February case report ISARIC WHO collect clinical data minimal follow-up weeks patients hospital admission hospital inpatients covid-19 Admission critical care high dependency unit intensive care unit mortality hospital age patients hospital covid-19 diagnosis covid-19 hospital years interquartile range men admitted women men women n=8065 median duration symptoms admission days interquartile range 1 commonest comorbidities chronic cardiac disease uncomplicated diabetes non-asthmatic chronic pulmonary disease chronic kidney disease comorbidity patients discharged alive died receive care admission dependency intensive care units discharged alive died receive care mechanical ventilation discharged alive died hospital Increasing age male sex comorbidities chronic cardiac disease non-asthmatic chronic pulmonary disease chronic kidney disease liver disease obesity associated with mortality hospital WHO CCP-UK prospective cohort study patients hospital covid-19 study enrol report study participants mortality independent risk factors increasing age male sex chronic comorbidity obesity study pandemic preparedness launch research studies response outbreaks ISRCTN66726260',\n",
              " 'Spread dynamics COVID-19 epidemic Italy Effects of emergency measuresThe coronavirus disease COVID-19 Italy drastic measures transmission containment effects interventions modeling unfolding epidemic modeling options spatially explicit type infections spreading foci Italy estimate parameters metacommunity Susceptible-Exposed-Infected-Recovered (SEIR)-like transmission model network provinces mobility resolution contribution presymptomatic asymptomatic transmission generalized reproduction number Formula spectral radius next-generation matrix measures spread absence containment interventions model implementation progressive restrictions Italy uncertainty epidemiological reporting time human mobility matrices awareness-dependent exposure probabilities scenarios containment measures impact sequence restrictions mobility human-to-human interactions reduced transmission Averted hospitalizations running scenarios imposed restrictions individuals assumptions age structure social mixing patterns distribution mobility hospitalization fatality evidence planning emergency measures',\n",
              " 'Routine Venous Thromboembolism Prophylaxis Hypercoagulable State of Severe Coronavirus Disease study frequency venous thromboembolism critically ill coronavirus disease patients associate inflammatory marker venous thromboembolism observational study identified patients severe coronavirus disease Data multicenter study Indianapolis academic hospitals Two-hundred forty consecutive patients severe acute respiratory syndrome coronavirus 2 infection hospitals One-hundred patients ICU analysis patients routine subcutaneous chemical venous thromboembolism prophylaxis study frequency venous thromboembolism degree inflammatory coagulation marker associated with venous thromboembolism development Descriptive statistics frequency venous thromboembolism severe coronavirus disease Clinical course laboratory metrics patients venous thromboembolism patients venous thromboembolism Hypercoagulable thromboelastography hypercoagulable parameters One-hundred patients severe ICU care age years male patients discharged home patients hospital patients died Venous thromboembolism diagnosed patients days hospital admission patients diagnosed venous thromboembolism presentation hospital Elevated admission D-dimer peak D-dimer associated with venous thromboembolism development D-dimer venous thromboembolism area receiver operating characteristic curve CI sensitivity specificity patients thromboelastography patients study calculated coagulation index patients thromboelastography data coronavirus disease results hypercoagulable state Routine chemical inadequate preventing venous thromboembolism severe coronavirus disease',\n",
              " 'Remdesivir Days Patients Severe Covid-19Remdesivir RNA polymerase inhibitor antiviral activity in vitro efficacy animal models coronavirus disease Covid-19 randomized open-label phase 3 trial hospitalized patients SARS-CoV-2 infection oxygen saturation breathing ambient air radiologic evidence pneumonia Patients randomly assigned ratio intravenous remdesivir days days patients remdesivir day daily days primary end point clinical status day assessed ordinal scale patients randomization treatment patients days days median duration treatment days interquartile range group days interquartile range group baseline patients group clinical status assigned group day clinical improvement ordinal scale patients group group baseline clinical status patients group distribution clinical status day patients group adverse events nausea patients worsening respiratory failure elevated alanine aminotransferase level constipation patients severe Covid-19 mechanical ventilation trial remdesivir no placebo control magnitude benefit Gilead Sciences',\n",
              " 'Hospitalization Mortality Black Patients White Patients Covid-19Many reports coronavirus disease Covid-19 health outcomes information racial ethnic differences outcomes Covid-19 retrospective cohort study analyzed data patients integrated-delivery health system Ochsner Health Louisiana tested positive severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 virus Covid-19 qualitative polymerase-chain-reaction assay Ochsner Health population black non-Hispanic white primary outcomes hospitalization in-hospital death patients tested positive excluded missing data race ethnic group Hispanic Asian race ethnic group patients analyses female black white non-Hispanic Black patients higher prevalences obesity diabetes hypertension chronic kidney disease white patients Covid-19-positive patients patients hospitalized black multivariable analyses black race increasing age score Charlson Comorbidity Index burden illness public insurance Medicare Medicaid residence low-income area obesity associated with increased odds hospital admission patients died Covid-19 black time-to-event analyses variables associated with higher in-hospital mortality age presentation elevated respiratory rate elevated levels venous lactate creatinine procalcitonin low platelet lymphocyte counts black race associated with higher mortality hazard ratio death white race confidence interval cohort Louisiana patients hospitalized Covid-19 died black blacks Ochsner Health population Black race associated with higher in-hospital mortality white race adjustment differences sociodemographic clinical characteristics admission',\n",
              " 'Neurologic Manifestations Hospitalized Patients Coronavirus Disease Wuhan ChinaThe outbreak coronavirus disease COVID-19 Wuhan China epidemic studies clinical manifestations fever cough diarrhea fatigue patients COVID-19 neurologic manifestations neurologic manifestations patients COVID-19 retrospective observational case series Data designated special care centers COVID-19 West Branch Tumor Center Union Hospital Huazhong University of Science Technology Wuhan China study consecutive hospitalized patients laboratory-confirmed diagnosis severe acute respiratory syndrome coronavirus 2 infection Clinical data electronic medical records data neurologic symptoms trained Neurologic manifestations categories central nervous system dizziness headache impaired consciousness acute cerebrovascular disease ataxia seizure peripheral nervous system taste impairment smell impairment vision impairment nerve pain skeletal muscular injury manifestations patients mean age years men COVID-19 patients infection patients severe infection respiratory status patients neurologic manifestations Compared patients nonsevere infection patients severe infection older disorders hypertension symptoms COVID-19 fever cough Patients severe infection neurologic manifestations acute cerebrovascular diseases impaired consciousness skeletal muscle injury Patients COVID-19 neurologic manifestations epidemic period COVID-19 seeing patients neurologic manifestations clinicians severe acute respiratory syndrome coronavirus 2 infection differential diagnosis delayed diagnosis misdiagnosis treat transmission',\n",
              " 'Systematic assessment venous thromboembolism COVID-19 patients thromboprophylaxis incidence D-dimer factorsCoagulopathy COVID-19 burning issue prevent thromboembolic events heterogeneous objective incidence risk factors venous thromboembolism VTE COVID-19 inpatients thromboprophylaxis retrospective French cohort study patients hospitalized medical wards non-ICU COVID-19 adequate thromboprophylaxis systematic low limb venous duplex ultrasonography hospital discharge deep venous thrombosis DVT clinically Chest angio-CT scan pulmonary embolism PE patients VTE PE adequate thromboprophylaxis D-dimers baseline patients DVT Demographics comorbidities disease manifestations severity score biological parameters inflammatory markers patients VTE negative predictive value baseline D-dimer VTE PE positive predictive value VTE D-dimer level\\u2009 association D-dimer level VTE risk increased D-dimer level venous duplex patients monitoring D-dimer thromboprophylaxis risk VTE COVID-19 non-ICU inpatients Increased D-dimer concentrations risk venous thromboembolism aggressive doses heparin evaluated prospective studies',\n",
              " 'Correlation immune response self-reported depression convalescence COVID-19Self-reported depression coronavirus disease-2019 COVID-19 patients infected severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 discharge hospital self-reported depression period mental health status convalescent COVID-19 patients surveyed online questionnaire Shenzhen Samii Medical Center Shenzhen China consent retrospectively analyzed clinical characteristics patients routine blood biochemical data results patients self-reported depression increased immune response increased white blood cell neutrophil counts neutrophil-to-lymphocyte ratio mechanism self-reported depression cellular changes study self-reported depression early stage convalescent COVID-19 patients changes immune function apparent short-term follow-up patients discharge psychological interventions changes immune function long-term follow up patients',\n",
              " 'Scope quality inclusivity clinical guidelines early covid-19 pandemic reviewTo availability quality inclusivity clinical guidelines early stage coronavirus disease covid-19 pandemic Ovid Embase Ovid Global Health Scopus Web of Science Core Collection WHO Global Index Medicus inception Search strategies CADTH database guidelines no limits studies identified searches grey literature ISARIC network Clinical guidelines management covid-19 Middle East respiratory syndrome MERS severe acute respiratory syndrome SARS international national scientific organisations government non-governmental organisations global health language Regional/hospital guidelines version guideline Quality assessed Appraisal Guidelines Research Evaluation AGREE quality contents early covid-19 guidelines clinical guidelines MERS SARS studies identified screening guidelines inclusion covid-19 clinical guidelines topics Recommendations antiviral drugs quality poor domains stakeholder involvement applicability editorial independence evidence recommendations Minimal provision vulnerable groups pregnant women children older people Guidelines early covid-19 pandemic methodological weaknesses vulnerable groups older people development clinical guidelines public health rigorous methods inclusion vulnerable populations',\n",
              " 'Clinical features rheumatic patients infected COVID-19 Wuhan clinical features rheumatic patients coronavirus disease 2019 COVID-19 study clinical features COVID-19 rheumatic patients information situation clinical practice retrospective case series study data gender age laboratory radiological results symptoms signs medication history patients diagnosed COVID-19 cases combination rheumatic disease Tongji Hospital January Length of hospital stay mortality rate rheumatic non-rheumatic groups respiratory failure rheumatic cases Symptoms fever fatigue diarrhoea patients rheumatic patients flare rheumatic disease hospital stay symptoms muscle aches back pain joint pain rash lymphocytopaenia rheumatic patients patient leucopenia rheumatic cases Rheumatic patients radiological features ground-glass opacity consolidation Patients pre-existing interstitial lung disease massive fibrous stripes crazy-paving signs early stage rheumatic hydroxychloroquine diagnosis COVID-19 ill stage Respiratory failure rheumatic patients infected COVID-19 Differential diagnosis COVID-19 flare rheumatic disease ChiCTR2000030795',\n",
              " 'Clinical characteristics outcomes inpatients neurologic disease COVID-19 Brescia Lombardy report clinical laboratory characteristics treatment clinical outcomes patients admitted neurologic diseases coronavirus disease COVID-19 retrospective single-center cohort study adult inpatients COVID-19 neuro-COVID unit discharged died April 5 Demographic clinical treatment laboratory data medical records compared false discovery rate neurologic patients COVID-19 admitted period seventy-three patients study positive negative COVID-19 Patients COVID-19 older years interquartile range IQR years IQR years Patients COVID-19 admitted neurologic disease stroke in-hospital mortality incident delirium higher disability patients COVID-19',\n",
              " 'Factors associated with hospital admission critical illness people coronavirus disease New York City prospective cohort outcomes people hospital coronavirus disease covid-19 United States clinical laboratory characteristics associated with severity illness Prospective cohort study academic medical center New York City Long Island patients laboratory acute respiratory syndrome coronavirus 2 follow up Outcomes admission hospital critical illness intensive care mechanical ventilation discharge hospice care death discharge hospice care death Predictors patient characteristics medical history vital signs laboratory results Multivariable logistic regression risk factors adverse outcomes risk survival analysis mortality people SARS-Cov-2 positive exclusions admitted hospital discharged alive hospice care hospice care died patients mechanical ventilation died extubated discharged risk hospital admission associated with age odds ratio age groups years confidence interval ages years older risks heart failure male sex chronic kidney disease increase body mass index BMI BMI risks illness age associated with heart failure BMI male sex Admission oxygen saturation troponin level C reactive protein level D-dimer level associated with critical illness age comorbidities Risk critical illness decreased study period associations mortality Age comorbidities predictors hospital admission lesser extent critical illness mortality people covid-19 impairment oxygen admission markers inflammation associated with critical illness mortality Outcomes improving time improvements care',\n",
              " 'Incidence clinical outcomes transmission dynamics severe coronavirus disease California Washington prospective cohort epidemiology burden severe coronavirus disease covid-19 epidemic United States Prospective cohort study Kaiser Permanente integrated healthcare delivery systems populations northern California southern California Washington state people acute hospital admission covid-19 healthcare plan enrollees Analyses hospital length of stay clinical outcomes people admitted northern California southern California Washington Cumulative incidence acute hospital admission covid-19 probabilities admission intensive care unit ICU mortality duration hospital stay ICU stay effective reproduction number cumulative incidences acute hospital admission covid-19 cohort members northern California southern California Washington censoring incomplete hospital stays admitted median duration survivors days days non-survivors days days censoring probability ICU admission male patients confidence interval female patients patients critical care median duration ICU days days censoring case fatality ratio confidence interval male inpatients female inpatients mortality risk increased age male female patients Reductions residents California Washington state Kaiser Permanente healthcare plans hospital covid-19 probabilities ICU admission long hospital stay mortality Incidence rates hospital admissions conjunction implementation social distancing interventions',\n",
              " 'Individual variation susceptibility exposure to SARS-CoV-2 lowers herd immunity acute respiratory syndrome coronavirus 2 SARS-CoV-2 spreads susceptible subpopulation depleted incidence cases decline Variation individual susceptibility exposure to infection effect Individuals susceptible exposed infected susceptible subpopulation risk infection depletion susceptibles intensifies deceleration incidence susceptible numbers epidemic growth words herd immunity threshold HIT estimates calculations herd immunity SARS-CoV-2 population immune epidemiological models heterogeneity SARS-CoV-2 outbreaks globe variation susceptibility exposure to infection estimates Accurate measurements heterogeneity controlling COVID-19 pandemic',\n",
              " 'Susceptible supply climate early SARS-CoV-2 pandemicPreliminary climate modulate transmission severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 seasonal geographic variations climate pandemic trajectory susceptibility core climate-dependent epidemic model SARS-CoV-2 pandemic scenarios coronavirus biology variations weather endemic infections pandemic stage pathogen climate drives changes pandemic size preliminary analysis nonpharmaceutical control pandemic-climate interaction susceptible depletion findings effective control measures outbreaks humid climates summer weather pandemic growth',\n",
              " 'Individual quarantine active monitoring contacts mitigation COVID-19 studyVoluntary individual quarantine voluntary active monitoring contacts core disease control infectious diseases COVID-19 impact quarantine resources individual liberty assess individual quarantine control COVID-19 active monitoring epidemic grows interventions mitigation measures implemented comparative efficacy individual quarantine active monitoring contacts control acute respiratory syndrome coronavirus 2 SARS-CoV-2 stochastic branching model parameters dynamics disease model incubation period distribution days estimates serial interval distribution shorter serial interval days days variable resource settings feasibility settings high-feasibility setting contacts half-day average delay tracing symptom recognition effective isolation low-feasibility contacts average delay effective isolation sequential Monte Carlo infectiousness onset symptom days CI shorter serial interval serial interval infectiousness onset symptom days CI Individual quarantine high-feasibility settings infected contacts quarantined outbreak SARS-CoV-2 short serial interval days time settings outbreak grow low-feasibility settings burden contacts active monitoring quarantine uninfected contacts never symptoms resources scalable interventions physical distancing active monitoring quarantine high-risk contacts synergistically mitigation shorter serial interval physical distancing reproductive number active monitoring contacts result overall outbreak control effective reproductive number model data serial interval presymptomatic transmission data-driven policy decisions cost-benefit comparisons individual quarantine active monitoring contacts interventions implemented mitigate spread SARS-CoV-2 National Institute of General Medical Sciences National Institutes of Health',\n",
              " 'Lifestyle Risk Factors Inflammatory Mechanisms COVID-19 Hospitalization Community-Based Cohort Study Adults UKWe general population study lifestyle risk factors smoking physical inactivity obesity excessive alcohol intake COVID-19 prospective cohort data national registry linkage hospitalisation Participants men women women England UK Biobank study Physical activity smoking alcohol intake assessed questionnaire baseline Body mass index measured height weight indicator obesity Outcome cases COVID-19 hospital admission COVID-19 cases age sex lifestyle factor physical inactivity Relative risk confidence interval smoking obesity heavy alcohol consumption COVID-19 dose-dependent increase risk COVID-19 lifestyle participants adverse category higher risk people optimal lifestyle C-reactive protein levels associated with elevated risk COVID-19 dose-dependent associations adverse lifestyle COVID-19 UK risk factor unhealthy behaviours combination population severe COVID-19 findings unhealthy lifestyle synonymous elevated risk non-communicable disease risk factor COVID-19 hospital admission low grade inflammation lifestyle changes risk severe infection',\n",
              " 'Estimation epidemics Biases infectious disease outbreaks observational data period time parameters estimate growth rate reproduction',\n",
              " 'effect control strategies reduce social outcomes COVID-19 epidemic Wuhan China modelling severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 Wuhan China city Wuhan measures response outbreak extended school workplace closures estimate effects of physical distancing progression COVID-19 epidemic hoping rest world changes population outbreak progression Wuhan synthetic location-specific contact patterns Wuhan presence school closures workplace closures reduction mixing general community matrices estimates epidemiological parameters Wuhan outbreak trajectory outbreak Wuhan age-structured susceptible-exposed-infected-removed model physical distancing estimates epidemic parameters transmission model data local internationally Wuhan age-structured epidemic framework investigated age distribution cases lifting control measures people return to phased-in effects of stages outbreak March April projections physical distancing measures effective staggered return to beginning April reduced infections IQR mid-2020 end-2020 benefits measures April reducing height peak median epidemic size end-2020 health-care systems respond modelled effects physical distancing duration infectiousness school children epidemic Restrictions activities Wuhan April delay epidemic peak projections premature sudden lifting interventions secondary peak interventions limitations analysis uncertainties estimates R\\nBill & Melinda Foundation National Institute for Health Research Wellcome Trust Health Data Research UK',\n",
              " 'mathematical model influence population heterogeneity herd immunity SARS-CoV-2Despite levels preventive measures countries coronavirus disease 2019 COVID-19 pandemic severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 model population heterogeneity disease-induced immunity proportion infected individuals groups contact rates groups low contact rates',\n",
              " 'Safety tolerability immunogenicity recombinant adenovirus type-5 COVID-19 vaccine dose-escalation open-label non-randomised first-in-human trialA vaccine COVID-19 assess safety tolerability immunogenicity recombinant adenovirus type-5 Ad5 COVID-19 vaccine expressing spike glycoprotein severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 strain dose-escalation single-centre open-label non-randomised phase 1 trial Ad5 vectored COVID-19 vaccine Wuhan China Healthy adults years dose groups individuals eligibility participants male female years low dose middle dose high dose vaccine participants analysis adverse reaction days vaccination participants low participants middle dose group participants high dose group injection site adverse reaction pain vaccine recipients systematic adverse reactions fever fatigue headache muscle pain adverse reactions dose groups mild moderate severity adverse days post-vaccination ELISA antibodies neutralising antibodies increased day days post-vaccination T-cell response peaked day post-vaccination Ad5 vectored COVID-19 vaccine tolerable immunogenic days post-vaccination Humoral responses SARS-CoV-2 peaked day post-vaccination healthy adults T-cell responses day post-vaccination findings Ad5 vectored COVID-19 investigation National Key R&D Program China National Science Technology Major Project CanSino Biologics',\n",
              " \"internet investigate symptom characteristics COVID-19 big data symptom characteristics Coronavirus Disease 2019(COVID-19 control prevention Baidu Index Platform http://index.baidu.com website Chinese Center for Disease Control Prevention data search volume SV keywords symptoms associated with COVID-19 year epidemic data Hubei province impacted provinces China Data compared years Data Hubei province provinces differences characteristics SV COVID-19-related symptoms correlations SV COVID-19 confirmed/suspected cases analyzed effects SV January 1 period years Hubei's SV cough fever diarrhea chest tightness dyspnea symptoms increased SV lower respiratory symptoms upper respiratory symptoms SV lower respiratory symptoms upper respiratory symptoms SV diarrhea increased significantly warned symptoms lower respiratory tract gastrointestinal symptoms diarrhea patients COVID-19 Internet search behavior positive correlation confirmed/suspected cases data early infectious diseases\",\n",
              " 'Epidemiology clinical course outcomes critically ill adults COVID-19 New York City prospective cohort studyNearly patients coronavirus disease-2019 COVID-19 hospitalized New York City Data epidemiology clinical course outcomes critically ill patients COVID-19 clinical biomarker treatment data critically ill adults laboratory-confirmed-COVID-19 admitted hospitals northern Manhattan primary outcome in-hospital mortality Secondary outcomes frequency duration invasive frequency vasopressor renal-replacement-therapy clinical deterioration hospital admission relationship clinical risk factors biomarkers in-hospital mortality Cox-proportional-hazards regression patient days observation adults hospitalized COVID-19 study period critically ill median age years interquartile range IQR male Two-hundred twelve chronic illness hypertension diabetes mellitus patients obese healthcare workers in-hospital mortality patients hospitalized patients invasive mechanical ventilation median days IQR vasopressors renal-replacement-therapy median clinical deterioration hospital admission days IQR Older age hypertension chronic lung disease higher concentrations interleukin-6 d-dimer admission associated with in-hospital mortality Critical illness patients hospitalized COVID-19 New York City associated with invasive extra-pulmonary organ dysfunction in-hospital mortality',\n",
              " 'COVID-19 solid organ transplant recipients US epicenterSolid organ transplant recipients high risk SARS-CoV-2 infection poor outcomes experience solid organ transplant recipients SARS-CoV-2 infection centers weeks outbreak New York City Baseline characteristics clinical presentation antiviral immunosuppressive management patients mild/moderate severe disease ICU admission intubation death Ninety patients analyzed age years kidney recipients lung liver heart dual-organ transplants presenting symptoms fever cough dyspnea mild moderate severe disease hospitalized patients non-rebreather intubation hydroxychloroquine azithromycin remdesivir tocilizumab bolus steroids patients died hospitalized ICU discharged cohort transplant recipients COVID-19 severe outcomes testing limitations mild/asymptomatic cases outbreak unfolds COVID-19 impact solid organ transplant recipients',\n",
              " 'Pulmonary Arterial Thrombosis COVID-19 Fatal Outcome Results Prospective Single-Center Clinicopathologic Case SeriesCoronavirus disease 2019 COVID-19 severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 pandemic evaluate pathologic changes organ systems clinicopathologic basis severe fatal outcomes Prospective autopsy study deceased patients COVID-19 random autopsy Systematic macroscopic histopathologic viral analysis SARS-CoV-2 real-time polymerase chain reaction assay correlation pathologic clinical features comorbidities comedication laboratory values Patients age years years men women patients prophylactic anticoagulant therapy venous thromboembolism antemortem patients lungs stages diffuse alveolar damage DAD edema hyaline membranes proliferation pneumocytes fibroblasts Thrombosis small mid-sized pulmonary arteries degrees patients associated with infarction patients bronchopneumonia patients Kupffer cell proliferation patients chronic hepatic congestion patients liver hepatic steatosis portal fibrosis lymphocytic infiltrates ductular proliferation lobular cholestasis acute liver cell necrosis central vein thrombosis findings renal proximal focal pancreatitis adrenocortical hyperplasia lymphocyte depletion spleen lymph nodes Viral RNA pharyngeal bronchial colonic mucosa bile sample COVID-19 lungs DAD acute respiratory insufficiency Death thrombosis segmental subsegmental prophylactic anticoagulation Studies thrombotic complications COVID-19 thrombosis prophylaxis laboratory imaging studies anticoagulant therapy pulmonary arterial thrombosis thromboembolism',\n",
              " 'Artificial intelligence diagnosis patients COVID-19For diagnosis coronavirus disease COVID-19 SARS-CoV-2 virus-specific reverse transcriptase polymerase chain reaction RT-PCR test serial testing false RT-PCR test kits alternative methods rapid accurate diagnosis patients COVID-19 Chest computed tomography CT evaluation patients SARS-CoV-2 infection CT negative predictive value SARS-CoV-2 infection patients radiological findings early disease study artificial intelligence AI algorithms integrate chest CT findings clinical symptoms exposure history laboratory testing diagnose patients positive COVID-19 patients real-time RT-PCR assay next-generation sequencing RT-PCR tested positive SARS-CoV-2 patients AI system area sensitivity senior AI system detection patients positive COVID-19 RT-PCR normal CT scans patients radiologists patients COVID-19 negative CT scans clinical history AI system diagnose COVID-19 patients',\n",
              " 'Arrhythmic profile 24-hour QT interval variability COVID-19 patients treated Hydroxychloroquine azithromycinHydroxychloroquine azithromycin coronavirus disease COVID-19 Electrocardiographic ECG monitoring medications QTc prolongation QTc duration day multiple ECGs ECGs Holter ECG monitoring patients aged years medical unit COVID-19 oral therapy hydroxychloroquine daily azithromycin daily days group healthy individuals age sex control patients age men inclusion criteria ECG therapy longer QTc-interval therapy patients QTc values aspartate aminotransferase alanine aminotransferase compared QTc Holter ECG monitoring COVID-19 patient no control non-sustained ventricular tachycardia patients R T premature ventricular Analysis QTc dynamics COVID-19 patients higher QTc values controls no significant hourly variability Therapy hydroxychloroquine azithromycin QTc interval patients COVID-19 transaminases QTc duration daily ECG',\n",
              " 'Acute chloroquine poisoning comprehensive experimental diazepamResurgence chloroquine treatment COVID-19 fatal toxicity unintentional overdoses Protocols management poisoning recommend uncertainties pharmacology efficacy assess effects of diazepam experimental models chloroquine cardiotoxicity In vitro experiments cardiac tissues isolated rats incubated chloroquine combination diazepam In vivo models toxicity chloroquine pentobarbitone-anaesthetised rats rabbits Randomised controlled treatment studies rats assessed diazepam clonazepam Ro5 administered prior chloroquine effects of diazepam high dose urethane-anaesthetised rats co-administered adrenaline Chloroquine decreased tension left atria effective refractory period atria ventricular tissue right papillary muscles dose-dependent impairment haemodynamic electrocardiographic parameters Cardiac arrhythmias impairment atrioventricular conduction Studies treatments control Diazepam increased heart rate study clonazepam prolonged QTc interval study Combined administration diazepam adrenaline study improved cardiac contractility hypokalaemia diazepam ligands benzodiazepine binding against attenuate chloroquine cardiotoxicity diazepam effects of positive inotropes reducing chloroquine cardiotoxicity themed issue Pharmacology COVID-19 articles section visit',\n",
              " 'Neurological manifestations neuro-invasive mechanisms severe acute respiratory syndrome coronavirus type 2Infections coronaviruses respiratory tract neurological manifestations study review neurological manifestations patients COVID-19 neuro-invasive mechanisms Sars-CoV-2 PubMed Web of Science COVID-dedicated databases combination COVID-19 terminology neurology terminology Social media channels postings scope Neurological manifestations identified papers clinical practice Neurological manifestations COVID-19 studies case series case reports acute cerebrovascular diseases impaired consciousness cranial nerve manifestations autoimmune disorders Guillain-Barré syndrome patients severe COVID-19 Cranial nerve symptoms olfactory gustatory dysfunctions patients mild COVID-19 nasal symptoms early stage disease Physicians neurological manifestations patients COVID-19 clinical deterioration neurological symptoms COVID-19 patients viral neurological injury indirect neuroinflammatory autoimmune mechanisms antiviral treatments virus vaccines prevention long-term consequences infection human health neurological system',\n",
              " 'Modeling impact mass influenza vaccination public health interventions COVID-19 epidemics detection capabilityThe coronavirus SARS-CoV-2 COVID-19 pandemic SARS-CoV-2 mild severe life-threatening infection COVID-19 effective vaccines drugs global public authorities non pharmaceutical interventions NPIs COVID-19 symptoms aspecific cold seasonal pattern coincide influenza season overwhelming straining healthcare systems resource-limited contexts increase likelihood nosocomial transmission study devised mathematical model treatment people influenza-like-illness ILI symptoms risk contracting COVID-19 respiratory infectious agents admission health-care setting detection kits severe testing resources model assess effect mass influenza vaccination spread COVID-19 respiratory pathogens case outbreak influenza season influenza vaccine uptake public health management respiratory outbreaks peak flu season compensate shortage detection resources increase influenza vaccination coverage Public health decision- policy-makers evidence-informed strategies influenza vaccine uptake',\n",
              " 'Reduction hospitalizations myocardial infarction Italy COVID-19 evaluate impact COVID-19 pandemic patient admissions Italian cardiac care units CCUs multicentre observational nationwide survey data admissions acute myocardial infarction AMI Italian CCUs week period COVID-19 outbreak week reduction admissions AMI equivalent week reduction ST-segment elevation myocardial infarction STEMI confidence interval CI non-STEMI NSTEMI CI STEMIs reduction women men reduction AMI admissions North Italy Central Italy South Italy STEMI pandemic increased compared risk ratio RR CI increase complications RR CI Admissions AMI reduced COVID-19 pandemic Italy increase fatality complication rates social issue attention scientific healthcare communities public regulatory agencies',\n",
              " 'Risk factors SARS-CoV-2 patients Oxford Royal College of General Practitioners Research Surveillance Centre primary care cross-sectional studyThere primary care studies COVID-19 pandemic demographic clinical risk factors testing severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 Oxford Royal College of General Practitioners RCGP Research Surveillance Centre primary care data patients RCGP Research Surveillance Centre primary care network tested SARS-CoV-2 multivariable logistic regression models imputation risk factors positive SARS-CoV-2 tests surveillance network SARS-CoV-2 test positive multivariable analysis male sex associated with testing SARS-CoV-2 men women odds ratio OR CI Adults increased risk testing positive SARS-CoV-2 children people aged years risk multivariable model adults years children OR CI Compared white people odds positive test black people white people black people OR CI People urban areas rural areas urban areas rural areas OR CI deprived areas deprived deprived OR CI test positive People chronic kidney disease positive analysis chronic kidney disease OR CI association chronic conditions analysis increased odds positive test people obese people obesity normal-weight people OR CI active smoking decreased odds positive test result active smokers non-smokers OR CI positive SARS-CoV-2 test primary care cohort associated with risk factors severe outcomes COVID-19 hospital settings smoking evidence potential sociodemographic factors associated with positive test deprivation population density ethnicity chronic kidney disease',\n",
              " 'experience SARS-CoV-2 infections solid organ transplant recipients Swiss Transplant Cohort StudyImmunocompromised patients increased risk complications severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 comprehensive data SARS-CoV-2 infection solid organ transplant SOT recipients lacking multicenter nationwide observational study Swiss Transplant Cohort Study STCS epidemiology clinical presentation treatment outcomes documented SARS-CoV-2 infection SOT recipients patients age years kidney liver pancreas lung heart combined transplantations presenting symptoms fever dry cough nausea diarrhea patients hospital ICU admission median days follow-up patients discharged hospitalized patients died data clinical manifestations SARS-CoV-2 infection middle-aged SOT recipients general population apparent rate complications cohorts',\n",
              " 'Real-time tracking self-reported symptoms potential COVID-19A total participants potential symptoms COVID-19 smartphone-based app SARS-CoV-2 test proportion participants loss of smell taste positive test result individuals negative test result participants odds ratio\\u2009 confidence interval\\u2009 model symptoms infection data app users symptoms participants COVID-19',\n",
              " 'Management acute kidney injury patients COVID-19The outbreak coronavirus disease COVID-19 global pandemic patients COVID-19 mild symptoms severe symptoms acute respiratory distress syndrome septic shock multiple organ failure Kidney frequent clinical presentation mild proteinuria progressive acute kidney injury AKI renal replacement therapy RRT pathophysiology mechanisms kidney damage AKI critical illness COVID-19 research patients risk AKI management strategies treatment AKI COVID-19 intensive care supportive prevention management AKI identification indications RRT sequential extracorporeal therapies clinical experience AKI strategies patients COVID-19 International collaborative cross-disciplinary research adequate evidence clinical approaches management',\n",
              " 'Estimating 1-year associated with COVID-19 pandemic conditions age population-based cohort studyThe medical societal economic impact coronavirus disease COVID-19 pandemic overall population mortality models population mortality death days infected people conditions Models information high-risk longer-term baseline pre-COVID-19 mortality deaths year COVID-19 incidence scenarios levels transmission suppression mortality impacts relative risks disease population-based cohort study secondary care electronic health records England Health Data Research UK-CALIBER prevalence conditions Public Health England guidelines individuals years older validated phenotypes condition 1-year mortality condition models calculation excess COVID-19-related deaths impact relative risks RRs COVID-19 pandemic background mortality infection rate scenarios suppression partial suppression mitigation nothing online public prototype risk calculator death estimation individuals women men study population high-risk category years aged years younger condition mortality high-risk population CI Age conditions influence background risk conditions suppression UK population deaths baseline deaths RR RR RR mitigation deaths RR RR RR nothing scenario deaths RR RR RR policy makers researchers public model online tool excess mortality year COVID-19 pandemic age sex condition-specific estimates signal sustained suppression measures target risk conditions preventive interventions Countries assess overall direct indirect pandemic mortality National Institute for Health Research University College London Health Data Research UK',\n",
              " 'Variation False-Negative Rate Reverse Transcriptase Polymerase Chain Reaction– SARS-CoV-2 Tests Time Since ExposureTests severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 reverse transcriptase polymerase chain reaction RT-PCR infection high-risk persons exposed inpatients health care workers predictive value test varies time exposure symptom negative test false-negative rate day infection Literature review pooled analysis published studies data RT-PCR performance time symptom onset SARS-CoV-2 exposure samples upper respiratory tract inpatients outpatients SARS-CoV-2 infection Bayesian hierarchical model estimate false-negative rate day exposure symptom onset days infection typical time symptom onset day probability false-negative result infected person decreases CI day CI day day symptom onset median false-negative rate CI decreased CI day days symptom increase CI day CI day Imprecise estimates heterogeneity design studies results interpreting RT-PCR tests SARS-CoV-2 infection-particularly course infection-when results removing precautions prevent onward transmission clinical suspicion infection RT-PCR clinical epidemiologic situation National Institute of Allergy Infectious Diseases Johns Hopkins Health System U.S. Prevention',\n",
              " 'Impact Low Dose Tocilizumab Mortality Rate Patients COVID-19 PneumoniaPneumonia respiratory failure death COVID-19 hyper inflammation lung damage study evaluate tocilizumab anti-soluble IL-6 receptor patients mortality consecutive patients admitted Montichiari Hospital Italy COVID-19 pneumonia respiratory failure mechanical ventilation satisfying respiratory rate breaths/min peripheral capillary oxygen saturation PaO2/FiO2<=300 mmHg Patients admitted prescribed standard therapy hydroxychloroquine lopinavir ritonavir controls tocilizumab patients tocilizumab days admission standard care Patients tocilizumab survival rate control patients hazard ratio death confidence interval CI baseline clinical characteristics patients tocilizumab group control group died discharged patients tocilizumab control group respiratory function observations tocilizumab patients hospitalized controls worsened mechanical ventilation No infections Tocilizumab positive impact early Covid-19 pneumonia severe respiratory syndrome increased survival favorable clinical course',\n",
              " 'Incubation Period Coronavirus Disease 2019 COVID-19 Publicly Estimation ApplicationA human coronavirus severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 China epidemiologic features incubation period clinical disease coronavirus disease COVID-19 surveillance control activities estimate length incubation period COVID-19 public health COVID-19 News reports press releases provinces regions countries Wuhan Hubei province China Persons SARS-CoV-2 infection Hubei province China Patient demographic characteristics dates exposure symptom onset fever hospitalization cases identifiable exposure symptom onset windows estimate incubation period COVID-19 median incubation period days CI days symptoms days CI days infection estimates conservative assumptions cases percentile symptoms days active monitoring quarantine cases overrepresent cases incubation period mild cases evidence median incubation period COVID-19 days SARS proposals length quarantine active monitoring persons exposed to SARS-CoV-2 monitoring periods cases U.S. Centers for Disease Control Prevention National Institute of Allergy Infectious Diseases National Institute of General Medical Sciences Alexander von Humboldt Foundation',\n",
              " 'outbreak severe Kawasaki-like disease Italian SARS-CoV-2 epidemic observational cohort Bergamo province affected severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 epidemic natural observatory virus general population month outbreak Kawasaki disease evaluate incidence features patients Kawasaki-like disease diagnosed SARS-CoV-2 epidemic patients diagnosed Kawasaki-like disease years symptomatic presentation group 1 group 2 SARS-CoV-2 epidemic presentations Kawasaki disease American Heart Association indications Kawasaki disease shock syndrome KDSS presence circulatory dysfunction macrophage activation syndrome MAS Paediatric Rheumatology International Trials Current infection reverse-transcriptase quantitative PCR nasopharyngeal oropharyngeal swabs serological qualitative test SARS-CoV-2 IgM IgG Group patients boys girls years diagnosed Group patients boys girls aged years SD diagnosed positive IgG IgM groups disease incidence group group 2 month mean age years cardiac involvement KDSS MAS adjunctive steroid treatment p<0·01 month increased incidence Kawasaki-like disease Children diagnosed SARS-CoV-2 epidemic evidence immune response virus older rate cardiac involvement features MAS SARS-CoV-2 epidemic associated with incidence severe Kawasaki disease outbreak Kawasaki-like disease countries SARS-CoV-2 epidemic',\n",
              " \"Development Validation Clinical Risk Score Occurrence Critical Illness Hospitalized Patients COVID-19Early identification patients coronavirus disease COVID-19 critical illness delivering treatment resources clinical score hospital admission predicting patients COVID-19 critical illness cohort China National Health Commission of China retrospective cohort patients COVID-19 hospitals provincial administrative regions Epidemiological clinical laboratory imaging variables hospital admission screened Least Absolute Shrinkage Selection Operator LASSO logistic regression predictive risk score COVID-GRAM score estimate risk hospitalized patient COVID-19 critical illness Accuracy score area receiver operating characteristic curve AUC Data cohorts China hospitalized COVID-19 score Data analyzed patients COVID-19 hospital critical illness composite measure admission intensive care unit invasive ventilation death development cohort patients SD age patients cohort years men validation cohort patients SD age years men potential predictors variables predictive factors risk score chest radiographic abnormality OR CI age OR CI hemoptysis OR CI dyspnea OR CI unconsciousness OR CI comorbidities OR CI cancer history OR CI neutrophil-to-lymphocyte ratio OR CI lactate dehydrogenase OR CI direct bilirubin OR CI AUC development cohort CI AUC validation cohort CI score online risk public http://118.126.104.170/ study risk score characteristics COVID-19 patients admission hospital patient's risk illness\",\n",
              " 'COVID‐19 people living human immunodeficiency virus case series patientsData people living human immunodeficiency virus PLWH SARS-CoV-2 pandemic case series PLWH patients COVID-19 symptoms outcome special population Retrospective analysis anonymized data age gender HIV-associated parameters symptoms outcome patients documented outcomes died patients mild cases patients antiretroviral treatment tenofovir-containing regimen protease inhibitor darunavir case series morbidity mortality symptomatic COVID-19 PLWH viral suppression ART SARS-CoV-2 infections darunavir-based tenofovir-containing ART',\n",
              " 'Manifestations prognosis gastrointestinal liver involvement patients COVID-19 systematic review prevalence prognosis digestive system involvement gastrointestinal symptoms liver injury patients COVID-19 quantify effects of COVID-19 digestive system systematic review meta-analysis systematically searched PubMed Embase Web of Science studies websites WHO CDC journals studies epidemiological clinical features COVID-19 prevalence gastrointestinal findings infected patients excluded preprints duplicate publications reviews editorials single case reports studies coronavirus-related illnesses small case series cases Extracted data author study design country patient demographics participants severe non-severe disease prevalence clinical gastrointestinal symptoms vomiting nausea diarrhoea loss of appetite abdominal pain belching digestive system comorbidities liver disease gastrointestinal diseases Raw data studies effect estimates findings studies patients COVID-19 inclusion criteria studies n=6064 gastrointestinal symptoms patients COVID-19 diagnosis pooled prevalence digestive system comorbidities CI study digestive symptoms liver injury patients COVID-19 Increased attention care unique group patients',\n",
              " 'Triple combination interferon beta-1b lopinavir–ritonavir ribavirin treatment patients hospital COVID-19 open-label randomised phase 2 antiviral therapy tackling coronavirus disease COVID-19 pandemic assessed efficacy safety combined interferon beta-1b lopinavir-ritonavir ribavirin treating patients COVID-19 multicentre prospective open-label randomised phase 2 trial adults COVID-19 admitted hospitals Hong Kong Patients randomly assigned combination lopinavir ritonavir ribavirin doses million international units interferon beta-1b alternate days combination group days lopinavir ritonavir control group primary endpoint nasopharyngeal swab negative severe acute respiratory syndrome coronavirus 2 RT-PCR intention-to-treat population study ClinicalTrials.gov patients combination group assigned control group days symptom study treatment days IQR combination group study treatment negative nasopharyngeal swab days IQR control group days hazard ratio CI p=0·0010 Adverse events self-limited nausea diarrhoea groups patient control group lopinavir-ritonavir biochemical hepatitis patients died study triple antiviral therapy lopinavir-ritonavir alleviating symptoms duration viral shedding hospital stay patients mild moderate COVID-19 clinical study double antiviral therapy interferon beta-1b backbone Shaw-Foundation Richard Carol Yu May Tam Mak Mei Sanming Project Medicine',\n",
              " 'Characteristics Outcomes Children Coronavirus Disease 2019 Infection Admitted US Canadian Pediatric Intensive Care coronavirus disease COVID-19 pandemic adults COVID-19 infection evidence burden COVID-19 infection hospitalized children lesser adult counterparts reports COVID-19 pediatric intensive care units PICUs early description characterization COVID-19 infection North American PICUs presentation presence comorbidities severity disease therapeutic interventions clinical trajectory early outcomes cross-sectional study children positive COVID-19 North American PICUs April 3 follow-up Prehospital characteristics clinical trajectory hospital outcomes children admitted PICUs COVID-19 infection children COVID-19 participating PICUs male median age years patients significant preexisting comorbidities respiratory symptoms invasive ventilation patients failure organ systems Extracorporeal membrane oxygenation patient Targeted therapies patients hydroxychloroquine agent patients combination patients completion follow-up period patients died hospitalized ventilatory support extracorporeal membrane oxygenation median PICU hospital lengths discharged days days burden COVID-19 infection North American PICUs confirms severe illness children frequent adults Prehospital comorbidities factor children preliminary studies children COVID-19 infection',\n",
              " 'Association Treatment Hydroxychloroquine Azithromycin In-Hospital Mortality Patients COVID-19 New York StateHydroxychloroquine azithromycin therapeutic agent patients coronavirus disease 2019 COVID-19 data efficacy adverse events association hydroxychloroquine azithromycin clinical outcomes hospital inpatients diagnosed COVID-19 Retrospective multicenter cohort study patients sample admitted patients laboratory-confirmed COVID-19 hospitals patients COVID-19 New York metropolitan region Eligible patients admitted Medications conditions clinical measures admission outcomes adverse events medical records follow-up hydroxychloroquine azithromycin hydroxychloroquine azithromycin Primary outcome in-hospital mortality Secondary outcomes cardiac arrest abnormal electrocardiogram arrhythmia QT prolongation hospitalized patients diagnosis COVID-19 male median age years hydroxychloroquine azithromycin drug diabetes respiratory rate abnormal chest imaging findings O2 saturation aspartate aminotransferase in-hospital mortality CI probability death patients hydroxychloroquine\\u2009 azithromycin CI hydroxychloroquine CI azithromycin CI drug CI Cox proportional hazards models patients drug mortality patients hydroxychloroquine\\u2009 HR CI hydroxychloroquine HR CI azithromycin HR CI logistic models patients drug cardiac arrest patients hydroxychloroquine\\u2009 azithromycin OR CI hydroxychloroquine OR CI azithromycin OR CI logistic regression models relative likelihood abnormal electrocardiogram findings patients hospitalized metropolitan COVID-19 treatment hydroxychloroquine azithromycin treatment associated with differences in-hospital mortality interpretation findings observational design',\n",
              " 'Longitudinal hematologic immunologic variations associated with progression COVID-19 patients ChinaCrucial hematologic immunologic responses progression coronavirus disease COVID-19 dynamic changes hematologic immunologic biomarkers associations severity outcomes COVID-19 retrospective study patients COVID-19 outcome discharged deceased national cohort China Cross-sectional longitudinal variations associations severity outcomes analyzed admission counts lymphocytes T-cell subsets eosinophils platelets decreased severe/critical fatal patients Increased neutrophil count neutrophils-to-lymphocytes ratio predominant severe/critical cases nonsurvivors hospitalization eosinophils lymphocytes platelets increasing survivors lower levels dropped significantly afterwards nonsurvivors Nonsurvivors level neutrophils IL-6 procalcitonin D-dimer amyloid A protein C-reactive protein stable survivors Positive correlation CD8\\nHematologic immunologic impairment profile survivors nonsurvivors patients COVID-19 severity longitudinal variations biomarkers recovery fatal outcome',\n",
              " 'Abdominal Imaging Findings COVID-19 Preliminary ObservationsBackground target severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 surface expression lung small bowel vasculature abdominal viscera injury abdominal imaging findings patients coronavirus disease Materials Methods retrospective cross-sectional study patients admitted single quaternary care center tested positive SARS-CoV-2 Abdominal imaging studies patients reviewed salient findings Medical records reviewed clinical data Univariable analysis logistic regression patients average age years years men women evaluated abdominal imaging studies radiography',\n",
              " 'Characteristics clinical significance myocardial injury patients severe investigate characteristics clinical significance myocardial injury patients severe coronavirus disease 2019 COVID-19 hospitalized patients severe COVID-19 age years Clinical laboratory treatment data collected compared patients died survivors Risk factors death myocardial injury multivariable regression models patients died myocardial injury survivors area receiver operating characteristic curve cardiac troponin I cTnI predicting in-hospital mortality confidence interval CI sensitivity specificity cut-off point level cTnI risk in-hospital death hazard ratio HR CI CI multivariable logistic regression senior age comorbidities hypertension coronary heart disease chronic renal failure chronic obstructive pulmonary disease level C-reactive protein predictors myocardial injury risk in-hospital death patients severe COVID-19 markers myocardial injury associated with senior age inflammatory response cardiovascular comorbidities',\n",
              " 'Prevalence Duration Acute Loss of Smell Taste COVID-19 PatientsInitially acute loss of smell anosmia taste ageusia symptoms coronavirus disease COVID-19 prevalence symptoms evaluate diagnostic significance physicians Daegu Medical Association data cases anosmia ageusia telephone interview patients Daegu Korea Acute anosmia ageusia patients early stage COVID-19 patients asymptomatic-to-mild disease severity prevalence females younger individuals',\n",
              " 'Viral dynamics asymptomatic patients COVID-19Data viral load viral shedding patterns potential infectivity asymptomatic patients APs coronavirus disease 2019 COVID-19 study adult patients COVID-19 asymptomatic admission patients symptoms admission asymptomatic patients incubation period APIs patients asymptomatic hospitalization asymptomatic patients APs median cycle threshold APs interquartile range IQR APIs IQR viral load APs duration viral shedding groups days IQR days days IQR days study findings APs COVID-19 viral load viral shedding transmission asymptomatic period longitudinal surveillance asymptomatic virus nucleic acid testing',\n",
              " 'QT prolongation torsades sudden death short courses chloroquine hydroxychloroquine COVID-19 systematic reviewChloroquine hydroxychloroquine treatment COVID-19 medications QT interval patients increased risk torsades sudden death Published guidance recommendations monitoring potential adverse effects systematic review arrhythmogenic effect short courses chloroquine hydroxychloroquine MEDLINE Embase gray literature risk QT prolongation torsades ventricular arrhythmia sudden death short-term chloroquine hydroxychloroquine usage unique records qualitative synthesis data COVID-19 patients COVID-19 patients treated with drugs QT prolongation evidence ventricular arrhythmia COVID-19 patients group treated with high-dose chloroquine Limitations results follow-up publication/reporting bias evidence chloroquine hydroxychloroquine QT-interval prolongation increase risk arrhythmia Daily electrocardiographic monitoring risk mitigation harms therapy',\n",
              " 'Liver injury associated with severe Coronavirus disease 2019 infection systematic review meta-analysis retrospective studiesThe coronavirus disease COVID-19 outbreak threat human beings Lung injury outcome COVID-19 infection liver damage severe cases meta-analysis retrospective studies findings association liver injury severity COVID-19 infection Online databases PubMed Scopus Web of Science Cochrane Library detect relevant publications keywords pool data fixed- or random-effects model heterogeneity studies publication bias test sensitivity analysis retrospective studies COVID-19 infected patients severe cases mild cases meta-analysis serum levels aspartate aminotransferase weighted mean difference confidence interval CI alanine aminotransferase weighted mean difference CI total bilirubin weighted mean difference CI lower serum levels of albumin weighted mean difference CI associated with increase severity COVID-19 infection incidence liver injury assessed serum analysis aspartate aminotransferase alanine aminotransferase total bilirubin albumin levels higher patients severe COVID-19 infection',\n",
              " 'Systematic review prevalence smoking hospitalized COVID-19 patients China nicotine therapeutic effects of smoking Corona Virus Disease 2019 COVID-19 study systematically examine prevalence current smoking hospitalized patients COVID-19 China high-population smoking prevalence China systematic review literature PubMed April 1 studies clinical characteristics hospitalized COVID-19 patients China data smoking status pooled prevalence smoking studies calculated random-effect meta-analysis smokers quit hospitalization former smokers admission hospital secondary analysis former smokers smokers patients studies smoking prevalence CI CI low prevalence current smoking pooled analysis CI population smoking prevalence China secondary analysis classifying former smokers smokers estimate CI low prevalence current smoking patients COVID-19 China population smoking prevalence generalized advice quit smoking measure reduce health risk findings immunomodulatory effects nicotine pharmaceutical nicotine potential treatment COVID-19',\n",
              " 'First data analysis COVID-19 virus airborne diffusion air particulate matter PM Lombardy severe cases COVID-19 infections Italy Lombardy Brescia Bergamo areas period PM',\n",
              " 'study SARS‐CoV‐2 IgG antibody male female COVID‐19 patients reason outcome sexThe severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 China world thousands deaths study higher severe status rate mortality rate male patients China reason difference convalescent plasma level SARS-CoV-2 immunoglobulin G IgG antibody clinical therapy effects China study compare SARS-CoV-2 male female patients patients SARS-CoV-2 infection serum patients hospitalization detected SARS-CoV-2 data concentration IgG antibody mild general recovering patients male female patients severe status compared male patients female patients concentration serum SARS-CoV-2 IgG antibody generation IgG antibody female patients male patients disease early phase study discrepancy SARS-CoV-2 level male female patients outcome Coronavirus Disease sex',\n",
              " 'Kidney manifestations mild moderate severe coronavirus disease retrospective cohort studyCoronavirus disease 2019 COVID-19 pandemic affected million patients globally data Wuhan city acute kidney injury AKI proteinuria hematuria patients severe COVID-19 prevalence kidney injury cases retrospective study consecutive cohorts COVID-19 patients Sichuan Province Baseline characteristics laboratory data renal function proteinuria dipstick hematuria laboratory parameters subgroup patients weeks evaluate short-term outcome renal impairment COVID-19-positive patients study patients diagnosed mild moderate disease patients fever Tibetan cohort fever patients hospital admission proteinuria dipstick hematuria patients AKI patient analysis severe critical COVID-19 associated with risk proteinuria relative risk RR confidence interval CI Proteinuria dipstick hematuria patients COVID-19 infection severe critical cases',\n",
              " 'Prognostic Value Leukocytosis Lymphopenia Coronavirus Disease evaluate lymphopenia marker coronavirus disease severity meta-analysis studies Severe illness associated with lower lymphocyte higher leukocyte counts markers early identification patients severe disease healthcare providers therapy',\n",
              " 'Off-label hydroxychloroquine azithromycin lopinavir-ritonavir chloroquine COVID-19 survey cardiac adverse drug reactions French Network of Pharmacovigilance CentersCOVID-19 physicians scientists publicized drugs evidence efficacy hydroxychloroquine azithromycin lopinavir-ritonavir cardiac safety drugs COVID-19 deserves cardiac adverse ADRs QTc prolongation electrocardiogram arrhythmogenic consequences French Pharmacovigilance Network cardiac adverse drug reactions associated with off-label hydroxychloroquine azithromycin lopinavir-ritonavir COVID-19 Nice Regional Center of Pharmacovigilance Regional Center of assessed causality drugs analysis cardiac adverse drug reactions array risk factors electrocardiograms estimated incidence coronavirus disease month reports cardiac adverse drug reactions associated with hydroxychloroquine associated with azithromycin estimated incidence patients notwithstanding Lopinavir-ritonavir came third reports chloroquine reports sudden aborted deaths ventricular arrhythmias reports prolonged QTc reports severe conduction disorders reports cardiac causes reports automedication Off-label treatments COVID-19 increases risk cardiac ADRs drugs familiar patients risk factors infection Precautions mitigate risk efficacious',\n",
              " 'Acute Physiology Chronic Health Evaluation II Score Predictor Hospital Mortality Patients Coronavirus Disease 2019Coronavirus disease global health threat deaths China assess association Acute Physiology Chronic Health Evaluation II score hospital mortality patients coronavirus disease compare Acute Physiology Chronic Health Evaluation II score Sequential Organ Failure Confusion Urea Respiratory rate Blood pressure Age 65 Retrospective observational cohort Wuhan China patients coronavirus disease hospitalized ICU Tongji hospital patients symptoms coronavirus disease patients diagnosed cases patient cardiac arrest admission patients analysis patients died Mean Acute Physiology Chronic Health Evaluation II score higher deaths compared mean Acute Physiology Chronic Health Evaluation II score survivors Acute Physiology Chronic Health Evaluation II score associated with hospital mortality hazard ratio CI predicting hospital mortality Acute Physiology Chronic Health Evaluation II score area CI Sequential Organ Failure Assessment score area curve CI CURB65 score area curve CI cut-off value Acute Physiology Chronic Health Evaluation II score death patients coronavirus disease sensitivity specificity Kaplan-Meier analysis survivor probability patients coronavirus disease Acute Physiology Chronic Health Evaluation II score patients Acute Physiology Chronic Health Evaluation II score Chronic Health Evaluation II score effective clinical tool hospital mortality patients coronavirus disease Sequential Organ Failure CURB65 score Acute Physiology Chronic Health Evaluation II score serves early indicator death guidance clinical decisions',\n",
              " 'Impact corticosteroid therapy outcomes persons SARS-CoV-2 SARS-CoV MERS-CoV infection systematic review meta-analysisWe meta-analysis safety efficacy corticosteroids SARS-CoV-2 SARS-CoV MERS-CoV infections PubMed Web of Science Medline WanFang Chinese database ZhiWang Chinese database Boolean operators SARS-CoV-2 SARS-CoV OR MERS-CoV corticosteroids studies Review Manager meta-analysis Observational studies analyzed quality modified Newcastle-Ottawa scale randomized clinical trials Jadad scale Subjects severe-only severe cohorts published criteria Efficacy endpoints mortality hospitalization duration rates intensive care unit ICU admission mechanical ventilation composite endpoint death ICU admission mechanical ventilation reports cohort studies randomized clinical trial subjects association corticosteroids virus corticosteroids mortality hospitalization duration mechanical ventilation composite endpoint Corticosteroid use associated with delayed virus MD days confidence Interval CI days',\n",
              " 'Tocilizumab therapy reduced intensive care unit admissions mortality COVID-19 patientsNo therapy effective COVID-19 Tocilizumab TCZ patients severe COVID-19 effective treatment retrospective case-control study Nord Franche-Comté Hospital France outcome patients treated TCZ patients TCZ primary endpoint death ICU admissions Patients TCZ higher Charlson comorbidity index severe higher level oxygen therapy poorer biological severe lymphopenia sample size retrospective nature TCZ reduce ICU admissions mortality patients severe SARS-CoV-2 pneumonia',\n",
              " 'Observational Study Hydroxychloroquine Hospitalized Patients Covid-19Hydroxychloroquine administered patients Covid-19 evidence association hydroxychloroquine intubation death medical center New York City Data consecutive patients hospitalized Covid-19 died discharged hours presentation emergency department study baseline primary end point composite intubation death time-to-event analysis outcomes patients hydroxychloroquine patients multivariable Cox model inverse probability propensity score consecutive patients patients died discharged hours presentation analysis patients median follow-up days hydroxychloroquine day daily median days patients treated hours presentation emergency department hours Hydroxychloroquine-treated patients ill baseline hydroxychloroquine median ratio partial pressure arterial oxygen fraction inspired oxygen patients end-point event patients died died intubation analysis association hydroxychloroquine intubation death hazard ratio confidence interval Results multiple sensitivity analyses observational study patients Covid-19 admitted hospital hydroxychloroquine administration associated with lowered increased risk composite intubation death Randomized controlled trials hydroxychloroquine patients Covid-19 National Institutes of Health',\n",
              " \"Autopsy Findings Venous Thromboembolism Patients COVID-19 Prospective Cohort severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 deaths death virus's compare clinical findings data medical autopsy virtual autopsy virologic tests Prospective cohort study academic medical center mandated German federal state Hamburg patients polymerase chain reaction-confirmed diagnosis COVID-19 consecutive COVID-19-positive deaths autopsy postmortem computed tomography histopathologic virologic analysis Clinical data medical course evaluated Median patient age years years patients male death hospital incidence thromboembolic events COVID-19-induced coagulopathy studies investigate molecular mechanism clinical incidence COVID-19-related death therapeutic interventions University Medical Center\",\n",
              " 'Modeling shield immunity reduce COVID-19 epidemic spreadThe COVID-19 pandemic precipitated global crisis cases deaths',\n",
              " \"Tocilizumab treatment severe coronavirus disease interleukin-6 inhibitor inflammatory associated with severe COVID-19 clinical outcomes retrospective review patients laboratory-confirmed severe COVID-19 tocilizumab days follow up patients median age years interquartile range males Co-morbidities diabetes mellitus chronic kidney disease cardiovascular disease cough dyspnea commonest presenting symptoms patients concomitant investigational antiviral agents Median oral temperature day median C-reactive protein Radiological improvement patients day day patients discharged alive intensive care unit died proportion patients invasive ventilation tocilizumab initiation day day patients adverse event adverse events tocilizumab therapy patients severe COVID-19 tocilizumab associated with dramatic decline inflammatory markers radiological improvement reduced ventilatory support requirements study's limitations assessment randomized controlled trials\",\n",
              " 'Clinical Course Imaging Features Outcomes COVID-19 Kidney Transplant RecipientsCoronavirus disease 2019 COVID-19 contagious disease Severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 Older adults patients comorbidities immunosuppressive conditions severe signs symptoms death case series clinical course imaging features outcomes patients COVID-19 history kidney transplantation Patients evaluated symptoms laboratory data imaging findings outcomes cough dyspnea clinical symptoms patients patients normal white blood cell count leukopenia leukocytosis consolidation ground glass opacity predominant pattern lung computed tomography CT patients died severe COVID-19 pneumonia acute respiratory distress syndrome discharged cases unilateral peripheral involvement zone chest CT CT imaging predicting COVID-19 outcomes solid organ transplant recipients studies long-term follow up cases COVID-19 diagnosis outcome management strategies patients',\n",
              " \"COVID-19-related myocarditis pathophysiology guideline diagnosis managementHuman coronavirus-associated myocarditis coronavirus disease (COVID-19)-related myocarditis cases pathophysiology COVID-19-related myocarditis viral injury cardiac damage host's immune response COVID-19 myocarditis diagnosis coronavirus myocarditis experience clinical findings changes electrocardiogram cardiac biomarkers impaired cardiac function cardiac magnetic resonance imaging cardiac computed tomographic angiography delayed myocardial imaging coronary artery disease myocardial inflammatory COVID-19 patients cardiovascular comorbidities myocardial infarction diagnosis endomyocardial biopsy active cardiac infection viral genome amplification refine treatment systemic immunosuppression Arrhythmias COVID-19 patients pathophysiology clinicians vigilant monitoring treatment long-term impact COVID-19 myocarditis mild cases\",\n",
              " 'Occurrence prevention management psychological virus outbreaks healthcare workers rapid review psychological clinicians working viral outbreaks measures stress psychological distress Rapid review meta-analysis Cochrane Central Register of Controlled Trials PubMed/Medline PsycInfo Scopus Web of Science Embase Google Scholar psychological reactions healthcare staff working patients outbreak virus clinical setting comparison clinicians general population papers inclusion criteria severe acute respiratory syndrome SARS coronavirus disease covid-19 Middle East respiratory syndrome MERS Ebola virus disease influenza A virus subtype influenza A virus H7N9 studies psychological outcomes healthcare workers contact affected patients data pairwise meta-analysis healthcare workers high low risk exposure Compared lower risk controls staff contact affected patients levels acute post-traumatic stress odds ratio confidence interval psychological distress results continuous outcomes findings studies meta-analysis Risk factors psychological distress younger junior parents dependent children infected family member Longer quarantine practical support stigma Clear communication adequate personal protection adequate practical psychological support associated with reduced morbidity Effective interventions psychological distress staff patients disease outbreak interventions settings outbreaks review covid-19 outbreak',\n",
              " 'Prevalence Olfactory Gustatory Dysfunction COVID-19 Patients Systematic Review Meta-analysisTo pooled global prevalence olfactory gustatory dysfunction patients coronavirus COVID-19 Literature PubMed Embase Scopus articles written English prevalence olfactory gustatory dysfunction COVID-19 patients database keywords analyzed olfactory dysfunction CI prevalence patients COVID-19 studies analyzed gustatory dysfunction CI prevalence Subgroup analyses studies olfactory dysfunction nonvalidated instruments CI CI prevalence Olfactory gustatory dysfunction symptoms patients COVID-19 early symptoms clinical course infection Increased awareness diagnosis treatment heighten viral transmission meta-analysis prevalence symptoms COVID-19 patients',\n",
              " 'SARS-CoV-2 detection formalin-fixed paraffin-embedded tissue specimens surgical resection tongue squamous cell severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 pandemic pathologists exposed to infection surgical specimens Guidelines safety procedures laboratory released studies biopsy surgical resection specimens detection SARS-CoV-2 formalin-fixed paraffin-embedded samples surgical resection tongue squamous cell carcinoma patient COVID-19 postsurgery RNA SARS-CoV-2 strain detected tumour submandibular gland samples real-time PCR-based assay viral RNA metastatic reactive lymph nodes SARS-CoV-2 RNA routine histopathological samples COVID-19 disease development findings information sites infection virus reservoir handling fixation sample processing',\n",
              " 'Association Angiotensin-Converting Enzyme Inhibitors Angiotensin II Receptor Blockers Testing Coronavirus Disease angiotensin-converting enzyme inhibitors ACEI angiotensin II receptor blockers ARB coronavirus disease COVID-19 pandemic recommendations medications essential treatment chronic disease absence clinical evidence professional societies association ACEIs/ARBs likelihood testing COVID-19 study outcome data subsets patients ACEIs/ARBs tested positive severity clinical outcomes COVID-19 hospitalization intensive care unit admission requirement mechanical ventilation Retrospective cohort study overlap propensity score weighting Cleveland Clinic Health System Ohio Florida patients tested COVID-19 History ACEIs ARBs COVID-19 testing COVID-19 testing cohort patients hospitalizations intensive care unit admissions mechanical ventilation tested positive patients tested COVID-19 age years male white patients COVID-19 testing ACEIs ARBs positive COVID-19 test patients patients tested positive admitted hospital admitted intensive care unit mechanical ventilation Overlap propensity score association ACEI ARB COVID-19 test positivity overlap CI study ACEI ARB COVID-19 test positivity clinical data professional society guidelines ACEIs ARBs COVID-19 pandemic study numbers hospitalized patients ACEI ARB therapy association clinical measures COVID-19 severity',\n",
              " 'Epidemiology Risk Factors Coronavirus Infection Health Care Workers Living ReviewHealth care workers HCWs risk severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 burden SARS-CoV-2 SARS-CoV-1 Middle East respiratory syndrome (MERS)-CoV HCWs risk factors infection rapid living review methods Multiple electronic databases WHO database publications coronavirus disease medRxiv preprint server surveillance reference lists language reporting incidence outcomes associated with coronavirus infections HCWs studies association risk factors demographic characteristics exposures environmental administrative factors personal protective equipment PPE HCW infections living review methods reviewer abstracted data assessed methodological limitations verification reviewer studies inclusion criteria studies burden HCW infections SARS-CoV-2 studies risk factors SARS-CoV-2 Health care workers proportion coronavirus infections incidence unprotected exposures Illness severity non-HCWs Depression anxiety psychological distress HCWs coronavirus disease outbreak evidence risk factors PPE decreased infection risk association masks gloves gowns eye protection handwashing evidence dose-response relationship No study evaluated PPE reuse involvement intubations patient contact contact bodily secretions associated with increased infection risk Infection control training associated with decreased risk studies risk factors SARS-CoV-2 studies methodological limitations streamlined rapid review methods Health care workers burdens coronavirus infections SARS-CoV-2 PPE infection control associated with decreased infection risk exposures associated with increased risk',\n",
              " 'High risk thrombosis patients severe SARS-CoV-2 infection multicenter prospective cohort studyLittle evidence increased thrombotic risk COVID-19 patients thrombotic risk severe SARS-CoV-2 infection patients intensive care units ICUs centers French tertiary hospital acute respiratory distress syndrome ARDS COVID-19 Medical history symptoms biological data imaging Propensity score matching analyze occurrence thromboembolic events non-COVID-19 ARDS COVID-19 ARDS patients COVID-19 patients men years SAPSII Sixty-four clinically thrombotic diagnosed patients pulmonary embolisms patients continuous renal replacement therapy circuit clotting thrombotic occlusions patients centrifugal pump patients ECMO patients elevated D-dimer fibrinogen patient disseminated intravascular coagulation Von Willebrand vWF activity vWF antigen FVIII increased tested patients positive lupus anticoagulant Comparison non-COVID-19 ARDS patients COVID-19 ARDS patients thrombotic complications pulmonary embolisms Coagulation parameters groups anticoagulation patients ARDS COVID-19 life-threatening thrombotic complications anticoagulation targets critically ill patients',\n",
              " 'Development Initial Validation COVID Stress clinical observations pandemic people stress- or anxiety-related responses fear of infected fear of contact contaminated objects surfaces fear of foreigners infection disease-related xenophobia fear of socio-economic consequences pandemic compulsive checking reassurance-seeking pandemic-related threats traumatic stress pandemic nightmares intrusive thoughts 36-item COVID Stress Scales CSS measure features COVID-19 CSS assess COVID-19-related distress scales intentionally pandemics CSS population-representative samples Canada United States solution scales COVID-related stress anxiety symptoms Danger contamination fears economic xenophobia compulsive reassurance seeking traumatic stress symptoms COVID-19 scales indices reliability validity scales intercorrelated evidence COVID Stress Syndrome scales tools distress associated with COVID-19 people mental health services',\n",
              " 'Hydroxychloroquine patients mild coronavirus disease open label randomised controlled efficacy safety hydroxychloroquine standard of care standard of care adults coronavirus disease covid-19 open label randomised controlled trial government covid-19 treatment centres China patients admitted hospital laboratory covid-19 intention treat analysis patients hydroxychloroquine standard of care care Hydroxychloroquine loading dose daily days maintenance dose daily total treatment duration weeks patients mild moderate severe disease Negative conversion severe acute respiratory syndrome coronavirus days intention treat principle Adverse events safety population hydroxychloroquine recipients participants dose hydroxychloroquine hydroxychloroquine non-recipients standard of care patients mild disease severe disease mean duration symptom randomisation SD days patients standard of care care hydroxychloroquine negative conversion days patients standard of care care hydroxychloroquine negative conversion virus probability negative conversion days standard of care hydroxychloroquine group confidence interval standard care group groups confidence interval safety population adverse events hydroxychloroquine non-recipients hydroxychloroquine recipients adverse hydroxychloroquine recipients diarrhoea patients hydroxychloroquine recipients adverse events Administration hydroxychloroquine probability negative conversion standard of care patients hospital persistent mild covid-19 Adverse events hydroxychloroquine recipients non-recipients ChiCTR2000029868',\n",
              " 'Deep learning-based multi-view fusion model screening coronavirus pneumonia multicentre deep learning-based method assist radiologists fast patients COVID-19 CT images retrospectively CT images patients hospitals China datasets cases COVID-19 pneumonia training set cases COVID-19 pneumonia validation set cases COVID-19 pneumonia testing set multi-view fusion model deep learning network patients COVID-19 CT images maximum lung regions axial coronal sagittal views performance proposed model evaluated validation testing sets multi-view deep learning fusion model area receiver-operating characteristics curve AUC accuracy sensitivity specificity validation set testing AUC accuracy sensitivity specificity deep learning method diagnosis model multi-view images chest CT images improve efficacy diagnosis mitigate heavy radiologists screening COVID-19 pneumonia',\n",
              " 'Effect non-pharmaceutical COVID-19 ChinaOn 11 World Health Organization WHO coronavirus disease COVID-19 pandemic',\n",
              " 'Longitudinal association markers liver injury mortality COVID-19 ChinaCoronavirus disease 2019 COVID-19 infectious disease hepatic injury disease clinical significance multicenter retrospective cohort study adult patients COVID-19 pneumonia Hubei Province distributional temporal patterns liver injury indicators patients associated factors death risk Longitudinal liver function tests retrospectively analyzed correlated risk factors death Liver injury dynamic patterns alanine aminotransferase ALT aspartate aminotransferase AST alkaline phosphatase ALP total bilirubin TBIL AST elevated ALT severe patients ALP increased hospitalization fluctuation TBIL levels mild non-severe severe groups AST abnormality associated with mortality indicators liver injury hospitalization Common factors associated with elevated liver injury indicators lymphocyte count decrease neutrophil count increase male gender dynamic patterns liver injury indicators potential risk factors explanation COVID-19-associated liver injury elevated liver injury indicators AST associated with mortality risk study parameters monitored hospitalization',\n",
              " 'Eosinopenia elevated C-reactive protein triage COVID-19 patients fever clinic retrospective case-control studyCoronavirus disease COVID-19 severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 pandemic affecting countries cities fever clinics triage COVID-19 patients patients symptoms availability nucleic acid test long waiting time test radiographic examination quarantine therapeutic decisions mixed patients time simple laboratory biomarkers effective triage fever clinics sorting COVID-19 patients COVID-19-like symptoms clinical etiological laboratory data patients Fever Clinic Wuhan Union Hospital Wuhan China polymerase chain reaction PCR nucleic acid testing SARS-CoV-2 infection groups SARS-CoV-2-positive patients cases SARS-CoV-2-negative patients controls clinical features laboratory findings groups analyzed diagnostic performance laboratory parameters predicting SARS-CoV-2 infection relevant comparisons China diagnosis guideline normal decreased leukocytes decreased leukocytes combination eosinopenia elevated hs-CRP triage COVID-19 patients patients fever clinic COVID-19-like initial symptoms finding designing triage strategies epidemic region patients COVID-19 respiratory diseases medical resources nucleic acid tests radiographic examination',\n",
              " 'Neonatal Late Onset Infection Severe Acute Respiratory Syndrome Coronavirus 2 late-onset infection newborns mother severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 pregnancy study evaluate postdischarge SARS-CoV-2 status newborns mothers COVID-19 pregnancy birth negative SARS-CoV-2 observational study neonates born mothers coronavirus disease 2019 COVID-19 pregnant women documented SARS-CoV-2 infection evaluated institution woman spontaneous abortion weeks gestational age women recovered follow-up women newborns study birth days life newborns negative SARS-CoV-2 follow-up newborn tested positive asymptomatic findings follow-up newborns mothers COVID-19 pregnancy risk contracting infection early life long-term consequences Newborns mothers coronavirus disease 2019 COVID-19 pregnancy infection birth Newborns mothers COVID-19 pregnancy long-term follow-up tested negative birth guidelines long-term follow-up newborns mothers COVID-19 pregnancy',\n",
              " 'Psychological Impact COVID-19 Healthcare Workers Digital Learning COVID-19 psychological impacts healthcare workers frontline workers risk Actions mitigate impacts COVID-19 mental health protecting promoting psychological wellbeing healthcare workers outbreak evaluated digital learning package Agile methodology weeks UK outbreak e-package evidence-based guidance support signposting psychological wellbeing UK healthcare employees public involvement activities PPIs STEP 1 content technical development iterative peer review STEP delivery evaluation STEP 3 actions team leaders psychologically spaces staff guidance communication reducing social stigma peer family support signposting psychological first aid PFA self-care strategies rest work breaks sleep shift work fatigue healthy lifestyle behaviours managing emotions moral injury coping guilt grief fear anxiety depression preventing burnout psychological trauma e-package advice experts mental wellbeing pandemic experiences frontline public mental health guidance delivery STEP emails professional networks social media Evaluation assessment fidelity implementation qualities Essential content identified PPIs',\n",
              " 'Risk QT Interval Prolongation Associated With Use of Hydroxychloroquine Concomitant Azithromycin Hospitalized Patients Testing Positive Coronavirus Disease (COVID-19)Administration hydroxychloroquine azithromycin treatment coronavirus disease (COVID-19)-associated pneumonia increased risk corrected QT QTc prolongation cardiac arrhythmias risk degree QT prolongation patients COVID-19 association hydroxychloroquine concomitant azithromycin cohort study academic tertiary care center Boston Massachusetts patients hospitalized positive COVID-19 nasopharyngeal polymerase chain reaction test clinical findings consistent with pneumonia day hydroxychloroquine QT interval hydroxychloroquine azithromycin potential adverse drug events patients hydroxychloroquine concomitant azithromycin female SD body mass index Hypertension patients diabetes mellitus patients comorbid conditions interquartile range baseline QTc milliseconds hydroxychloroquine milliseconds hydroxychloroquine azithromycin milliseconds concomitant azithromycin median interquartile range QT interval milliseconds compared hydroxychloroquine milliseconds patients hydroxychloroquine monotherapy prolonged QTc milliseconds patients change QTc milliseconds concomitant azithromycin prolonged QTc milliseconds change QTc milliseconds likelihood prolonged QTc concomitant loop diuretics odds ratio CI baseline QTc milliseconds odds ratio CI patients hydroxychloroquine early potential adverse drug events nausea hypoglycemia torsades cohort study patients hydroxychloroquine treatment pneumonia associated with COVID-19 high risk QTc prolongation concurrent treatment azithromycin associated with changes QTc Clinicians risks benefits hydroxychloroquine azithromycin monitoring QTc concomitant medication usage',\n",
              " 'Lymphopenia associated with severe COVID-19 infections systemic review COVID-19 respiratory systemic disease quick identification critical patients meta-analysis relationship lymphocyte count severity COVID-19 comprehensive systematic literature studies published databases language literatures English Chinese Mean difference MD lymphocyte count COVID-19 patients severe disease odds ratio OR lymphopenia severe COVID-19 evaluated meta-analysis case-series cases study pooled analysis lymphocyte count severe COVID-19 patients MD Lymphopenia severe COVID-19 lymphocyte count',\n",
              " 'Prevalence socio-demographic psychological health problems Chinese adolescents outbreak COVID-19Psychological health problems emotional disorders adolescents epidemiology emotional disorders influenced stressful events study assess prevalence rate socio-demographic depressive anxiety symptoms Chinese adolescents affected outbreak COVID-19 cross-sectional study Chinese students aged years COVID-19 epidemic period online survey rapid assessment participants study online survey demographic data assess students awareness COVID-19 assess depressive anxiety symptoms Patient Health Questionnaire PHQ-9 Generalized Anxiety Disorder questionnaire prevalence depressive symptoms anxiety symptoms depressive anxiety symptoms Chinese high school students COVID-19 outbreak Multivariable logistic regression analysis female gender higher risk factor depressive anxiety symptoms grades senior high school risk factor depressive anxiety symptoms grade prevalence depressive anxiety symptoms findings prevalence psychological health problems adolescents negatively associated with level awareness COVID-19 findings government psychological health adolescents COVID-19',\n",
              " \"Evaluating serological status COVID-19 patients indirect assay FranceAn in-house assay assess serological status COVID-19 patients Marseille France Performance IFA commercial ELISA RT-qPCR-confirmed COVID-19 patients serum samples controls sera pandemic sera associated with nonspecific serological interference sera non-coronavirus pneumonia sera patient coronavirus false-positive serology clinical SARS-CoV-2 isolate antigen specificity assay IgA IgM IgG testing negative controls IFA ELISA EUROIMMUN Cohen's antibodies measured evolution days evolution rates seropositivity titre antibodies patients clinical outcome patients favourable evolution data integrated immunological phase infection detection anti-SARS-CoV-2 antibodies marker associated with COVID-19 severity IFA assay monitoring SARS-CoV-2 exposure individual population\",\n",
              " 'Clinical Epidemiological Characteristics European Patients mild‐to‐moderate Coronavirus Disease clinical presentation European patients mild-to-moderate COVID-19 infection clinical presentation COVID-19 Europe Patients positive diagnosis COVID-19 European hospitals Epidemiological clinical data standardized questionnaire Bayesian analysis relationship outcomes patients study females healthcare workers age patients years symptoms headache loss of smell nasal obstruction cough asthenia myalgia rhinorrhea gustatory dysfunction sore throat Fever duration COVID-19 symptoms mild-to-moderate patients days prevalence symptoms age sex Young patients frequently ear nose throat complaints elderly individuals fever fatigue loss of appetite Loss of smell headache nasal obstruction fatigue prevalent female patients loss of smell symptom mild-to-moderate COVID-19 patients associated with nasal obstruction rhinorrhea Loss of smell days disease cured patients clinical presentation mild-to-moderate COVID-19 age sex characteristics patients Olfactory dysfunction symptom mild-to-moderate COVID-19 WHO',\n",
              " 'Convalescent plasma transfusion treatment COVID-19 Systematic reviewThe emergence coronavirus disease 2019 COVID-19 pandemic usefulness historic convalescent plasma transfusion CPT review evaluate effectiveness CPT therapy COVID-19 patients publications systematic review convalescent plasma clinically outcomes individuals COVID-19 PubMed EMBASE Medline databases records screened protocol eligibility criteria studies CPT COVID-19 patients findings data plasma reduce mortality critically ill patients Increase neutralizing antibody titers disappearance SARS-CoV-2 RNA patients CPT therapy Beneficial effect clinical symptoms administration convalescent plasma scientific CPT therapy COVID-19 patients clinically effective reduces mortality Well-designed multicenter clinical trial studies efficacy CPT COVID-19 patients',\n",
              " 'Clinical course outcome patients infected coronavirus SARS-CoV-2 discharged hospitals Wuhan ChinaIn coronavirus disease 2019 COVID-19 outbreak Wuhan China Information clinical course prognosis COVID-19 clinical courses prognosis COVID-19 patients Retrospective case series COVID-19 patients Zhongnan Hospital Wuhan University Wuhan Xishui Hospital Hubei Province China Epidemiological demographic clinical data clinical course survivors non-survivors Risk factors death analyzed discharged patients COVID-19 clinical course COVID-19 tri-phasic pattern Week illness onset fever cough dyspnea lymphopenia radiological multi-lobar pulmonary infiltrates severe cases thrombocytopenia acute kidney injury acute myocardial injury adult respiratory distress syndrome week mild cases fever cough systemic symptoms platelet count lymphopenia persisted severe cases leukocytosis neutrophilia deteriorating multi-organ dysfunction dominant week mild cases clinically lymphopenia severe cases persistent lymphopenia severe acute respiratory dyspnea syndrome refractory shock anuric acute kidney injury coagulopathy thrombocytopenia death Older age male sex risk factors poor outcome illness days illness critical stage COVID-19 course Age male gender risk factors death COVID-19',\n",
              " 'Renin–Angiotensin–Aldosterone System Inhibitors Risk Covid-19There potential increased risk medications renin-angiotensin-aldosterone system patients exposed to coronavirus disease Covid-19 viral receptor angiotensin-converting enzyme 2 ACE2 assessed treatment ACE inhibitors angiotensin-receptor blockers beta-blockers calcium-channel blockers thiazide diuretics likelihood positive negative Covid-19 testing likelihood severe illness intensive care mechanical ventilation death patients tested positive Bayesian methods outcomes patients treated with medications untreated patients overall hypertension propensity-score medication class patients tested Covid-19 positive patients severe illness history of hypertension patients positive test patients severe illness increased likelihood positive test medications associated with increase risk severe illness patients tested positive increase likelihood positive test Covid-19 risk severe Covid-19 patients tested positive association classes antihypertensive medications',\n",
              " \"Status SARS-CoV-2 cerebrospinal fluid patients COVID-19 strokeEmergence corona virus severe acute respiratory syndrome (SARS)-CoV-2 COVID-19 pandemic COVID-19 involvement central nervous system presence absence SARS-CoV-2 particles cerebrospinal fluid CSF patients COVID-19 concurrent neurological symptoms patient man flu-like symptoms COVID-19 acute-onset severe headache loss of consciousness diagnosed Hunt Hess grade 3 subarachnoid haemorrhage ruptured aneurysm patient woman ischaemic stroke massive haemorrhagic conversion decompressive hemicraniectomy patients CSF negative real-time PCR analysis neurological disease report patients CSF devoid viral particles test positive COVID-19 nasal swab SARS-CoV-2 CSF systemic disease severity degree virus' nervous tissue tropism studies\",\n",
              " \"Effective treatment severe COVID-19 patients tocilizumabAfter immune characteristics patients severe coronavirus disease 2019 COVID-19 pathogenic T cells inflammatory interleukin 6 inflammatory storm monoclonal antibody targets IL-6 pathways assess efficacy tocilizumab severe patients COVID-19 therapeutic strategy patients diagnosed severe COVID-19 First University of Science Technology China Anhui Provincial Hospital Anhui Fuyang Second People's Hospital tocilizumab routine therapy changes clinical manifestations computerized tomography scan image laboratory examinations retrospectively analyzed Fever day symptoms days tocilizumab patients oxygen intake patient no oxygen therapy CT scans lung lesion absorbed patients lymphocytes peripheral blood decreased patients treatment patients fifth day treatment Abnormally elevated C-reactive protein decreased patients adverse reactions patients giving tocilizumab Preliminary data tocilizumab clinical outcome severe critical COVID-19 patients effective treatment reduce mortality\",\n",
              " 'Hypolipidemia associated with severity COVID-19Many patients coronavirus disease 2019 COVID-19 organ dysfunctions patients dyslipidemia study investigate pathological alterations low-density lipoprotein cholesterol LDL-c high-density lipoprotein cholesterol HDL-c total cholesterol TC COVID-19 patients relationships disease severity retrospective study serum levels LDL-c HDL-c TC COVID-19 patients mild severe hospitalized February 1 Age- gender-matched normal subjects routine laboratory lipid tests October 1 November 1 center control group LDL-c TC levels COVID-19 patients normal subjects significant gradual decreases levels LDL-c median IQR mild severe TC mild severe groups HDL-c levels decreased cases compared levels mild severe cases LDL-c TC levels correlated C-reactive protein interleukin-6 positively correlated lymphocytes patients Development hypolipidemia patients mild symptoms association disease severity',\n",
              " 'Confirmation high cumulative incidence thrombotic critically ill ICU patients COVID-19 updated cumulative incidence thrombotic critically ill patients COVID-19 intensive care units ICUs Dutch hospitals questions study database analyses re-evaluated incidence composite outcome symptomatic acute pulmonary embolism PE deep-vein thrombosis ischemic stroke myocardial infarction systemic arterial embolism COVID-19 patients admitted ICUs Dutch university hospitals Dutch teaching hospital ICU admission death ICU discharge ICU patients died discharged alive median follow-up duration increased days patients pharmacological thromboprophylaxis cumulative incidence composite outcome risk death confidence interval CI thrombotic events PE risk model chronic anticoagulation therapy admission associated with lower risk composite outcome Hazard Ratio HR Patients diagnosed thrombotic complications risk all-cause death HR therapeutic anticoagulation associated with all-cause death HR updated analysis cumulative incidence thrombotic critically ill patients COVID-19 pneumonia',\n",
              " 'Contact Tracing Assessment COVID-19 Transmission Dynamics Taiwan Risk Exposure Periods Symptom OnsetThe dynamics coronavirus disease COVID-19 transmissibility transmission dynamics development evaluation effective control policies transmission dynamics COVID-19 evaluate transmission risk exposure window periods symptom prospective case-ascertained study Taiwan laboratory-confirmed COVID-19 contacts study period contacts quarantined home days exposure to index case quarantine period relevant symptoms fever cough respiratory symptoms contacts COVID-19 test follow-up Secondary clinical attack symptomatic cases exposure time index cases exposure settings household family health care confirmed patients age years years men women contacts index-secondary cases rate CI attack rate contacts exposure to index started days symptom onset CI compared exposed later cases contacts CI contacts presymptomatic exposures risk attack rate CI attack rate household CI nonhousehold CI family contacts health care settings attack rates aged years CI aged years older CI study transmissibility COVID-19 symptom finding symptomatic patients epidemic generalized measures social distancing',\n",
              " 'Renal Involvement Early Prognosis Patients COVID-19 PneumoniaSome patients COVID-19 pneumonia kidney injury autopsy findings patients died illness renal damage clinical characteristics kidney-related complications hematuria proteinuria AKI retrospective single-center study China analyzed data electronic medical records hospitalized patients COVID-19 pneumonia information clinical laboratory radiologic characteristics information renal outcomes patients abnormal urine dipstick tests AKI patients renal involvement median duration days remission pneumonia period patients remission proteinuria patients AKI AKI criteria Kidney Disease Improving Global Outcomes definition recovery kidney function AKI cases intrinsic AKI Patients renal involvement overall mortality renal involvement Stepwise multivariate binary logistic regression severity pneumonia risk factor associated with odds proteinuric hematuric remission recovery AKI Renal abnormalities patients COVID-19 pneumonia proteinuria hematuria AKI patients weeks onset of symptoms renal complications COVID-19 associated with higher mortality',\n",
              " 'Correlation Heart fatty acid binding protein severe COVID-19 case-control studyHeart-fatty acid binding protein HFABP heart-specific marker HFABP severity COVID-19 retrospectively patients inclusion criteria weeks tested HFABP diagnosis COVID-19 monitored HFABP hospital stay patients hospital stay severe COVID-19 mild-to-severe transition features chi-square test HFABP correlation HFABP levels severity COVID-19 cases cases COVID-19 HFABP admission cases diagnosed severe COVID-19 hospitalization Odds ratio measured HFABP elevation confidence interval CI patients severe COVID-19 patients mild HFABP data elevation HFABP severity COVID-19 patients elevated HFABP development patients mild COVID-19 severe COVID-19 serum HFABP negative maybe patients mild COVID-19 data all-cause mortality study Chinese Clinical Trial Registry ChiCTR2000029829',\n",
              " 'Clinical characteristics outcomes patients severe covid-19 diabetesThis study clinical characteristics patients diabetes severe covid-19 association diabetes survival duration patients severe covid-19 single-center retrospective observational study clinical laboratory characteristics patients severe covid-19 patients severe covid-19 diabetes patients controls diabetes severe case criteria Respiratory rate Oxygen saturation PaO patients severe covid-19 diabetes Compared patients severe covid-19 diabetes patients diabetes older susceptible mechanical ventilation admission ICU higher mortality patients severe covid-19 diabetes higher levels leukocyte count neutrophil count high-sensitivity C reaction protein procalcitonin ferritin interleukin IL-6 IL-8 tumor necrosis factor α D-dimer fibrinogen lactic dehydrogenase N-terminal pro-brain natriuretic peptide patients severe covid-19 diabetes non-survivors men mortality rate patients severe covid-19 diabetes Diabetes increase risk death',\n",
              " 'Association viral load serum biomakers COVID-19 casesSince SARS-CoV-2 world data natural fluctuation viral load clinical indicators associated with measured viral loads SARS-CoV-2 pharyngeal swab IgM anti-SARS-CoV-2 CRP SAA serum COVID-19 patients admission Positive rates IgM CRP SAA IgM-positive patients viral loads trends cases severity viral loads IgM-negative patients increase time onset worsening severity positive rates CRP SAA increase CRP/SAA type associations viral loads patients severity time onset IgM CRP/SAA time onset severity suggestions viral load condition judgment COVID-19 patients',\n",
              " 'Sex-specific clinical characteristics prognosis coronavirus disease-19 infection Wuhan China retrospective study severe relationship sex progression Coronavirus Disease-19 COVID-19 potential mechanism severe patients retrospective study consecutive severe patients pathogen-confirmed COVID-19 hospitalized January Tongji Hospital Wuhan China Clinical characteristics laboratory parameters outcomes compared analyzed males females study analyzed severe patients COVID-19 males females patients diagnosed critically ill male patients died discharged female patients died discharged laboratory parameters male female patients higher clinical course patients died patients discharged logistic regression analysis males comorbidities higher risk critically ill males comorbidities OR CI association null female patients OR CI sex-specific age sex-specific clinical characteristics prognosis Male patients susceptible age comorbidities Sex biological prevention treatment COVID-19',\n",
              " 'Epidemiological clinical features asymptomatic patients SARS-CoV-2 infectionFew studies severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 infected patients asymptomatic disease course investigated epidemiological clinical features patients infected SARS-CoV-2 symptoms Patients SARS-CoV-2 infection retrospectively demographic characteristics clinical data treatment outcomes SARS-CoV-2 infected patients symptoms analyzed SARS-CoV-2 infected patients symptom course disease median exposure to diagnosis days interquartile range IQR days patients patients diagnosed tested positive SARS-CoV-2 throat swabs patient tested positive SARS-CoV-2 anal swabs hospitalization patient lymphopenia Abnormalities chest computed tomography examinations detected patients admission patients discharged SARS-CoV-2 tested negative admission days IQR days Patients symptoms SARS-CoV-2 exposure monitored tested SARS-CoV-2 anal throat infection Asymptomatic patients infected SARS-CoV-2 outcomes',\n",
              " 'Elevations serum cancer biomarkers severity retrospective study evaluated levels series serum biomarkers coronavirus disease COVID-19 patients mild severe increases levels human HE4 cytokeratin-19 fragment CYFRA21 carcinoembryonic antigen CEA carbohydrate antigens CA COVID-19 mild cases normal control subjects levels continuous significant increases severe critical cases HE4 CYFRA21-1 CA125 CEA CA153 Squamous cell carcinoma antigen SCC CA199 increased cases COVID-19 mild severe cases normal controls positive associations levels C-reactive protein levels HE4 R\\u2009 CYFRA21-1 R\\u2009 CEA R\\u2009 SCC R\\u2009 CA153 R\\u2009 CA125 R\\u2009 elevations serum cancer biomarkers positively correlated pathological progressions COVID-19 diffuse acute pathophysiological injuries COVID-19',\n",
              " 'Changes contact patterns shape dynamics COVID-19 outbreak ChinaIntense China stop transmission coronavirus disease COVID-19 transmission intensifies countries age contact patterns social distancing susceptibility infection COVID-19 dynamics unclear questions contact survey data Wuhan Shanghai outbreak contact-tracing information Hunan province Daily contacts reduced seven- to COVID-19 social period interactions household children years age susceptible severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 adults years age odds ratio confidence interval individuals years age susceptible infection odds ratio confidence interval data transmission model impact social distancing school closure transmission social distancing implemented China outbreak control COVID-19 proactive school closures transmission reduce peak incidence delay epidemic',\n",
              " 'Antibody responses SARS-CoV-2 patients COVID-19We report acute antibody SARS-CoV-2 patients COVID-19 days symptom patients tested positive antiviral immunoglobulin-G IgG Seroconversion IgG IgM simultaneously sequentially IgG IgM titers days seroconversion Serological testing diagnosis suspected patients negative RT-PCR results identification asymptomatic infections',\n",
              " 'Long-term Coexistence SARS-CoV-2 Antibody Response COVID-19 PatientsSevere acute respiratory syndrome coronavirus 2 SARS-CoV-2 infection coronavirus disease COVID-19 antibodies adaptive immune responses SARS-CoV-2 infection cases COVID-19 Jinan China examined mild clinical symptoms severe symptoms patients patients SARS-CoV-2 virus-specific IgG coexist long time cases days COVID-19 patient SARS-CoV-2-bound IgG SARS-CoV-2 days illness antibody-mediated adaptive immunity innate immunity SARS-CoV-2 report analysis innate adaptive immunity SARS-CoV-2 clearance cases',\n",
              " 'Estimating burden United States workers exposed to infection disease risk COVID-19 COVID-19 public health quantifying increased risk contracting disease Occupational characteristics interfacing public quarters workers workers high risk disease nexus disease transmission community exacerbated presenteeism term symptomatic disease workers exposed to infection disease workplace occupational groups represent public health management COVID-19 workplace infectious disease outbreaks United States workers exposed to infection disease workplace national employment data Standard Occupational Classification Bureau BLS BLS survey measure workers occupation exposed to infection disease estimate United States workers occupations exposed to disease infection month analyses United States workers occupations exposure to disease infection week United States workers occupations exposure to disease infection month exposed workers healthcare sectors occupational sectors proportions exposed workers protective service occupations police officers correctional officers firefighters office administrative support couriers messengers patient service education occupations preschool daycare teachers community social services occupations community health workers social workers counselors construction extraction occupations plumbers septic tank installers elevator repair persons occupations frequent exposure to infection disease workplaces risk response plans COVID-19 proportion United States exposed to disease infection analysis reminder workplace locus public health workers communities',\n",
              " 'COVID-19 strokeAcute stroke medical emergency COVID-19 pandemic patients COVID-19 infection constitutional respiratory symptoms atypical gastrointestinal cardiovascular neurological manifestations patients COVID-19 acute stroke hospital databases patients acute stroke concomitant features suspected COVID-19 infection patients radiographic evidence stroke PCR-confirmed COVID-19 infection study Patients admitted hospital PCR- COVID-19 disease hospital course acute stroke inpatient study Retrospective patient data electronic medical records consent identified patients radiographic confirmation acute stroke PCR-confirmed SARS-CoV-2 infection clinical characteristics imaging findings clinical course Timely assessment hyperacute treatment mortality morbidity patients acute stroke Stroke teams COVID-19 patients cerebrovascular accidents personal protective equipment suspected patient studies neurological pathology COVID-19 infection',\n",
              " 'Acute limb ischemia patients COVID-19 pneumoniaThe study incidence characteristics clinical outcomes patients coronavirus infection treated for acute limb ischemia ALI coronavirus pandemic single-center observational cohort study data patients tested positive COVID-19 ALI operative treatment database series revascularization treated arterial segment absence early re-occlusion amputation death primary outcomes revascularization early days late survival postoperative days complications limb salvage evaluated data patients ALI positive COVID-19 period January incidence rate patients ALI months incidence ALI increased COVID-19 pandemic Italian Lombardy region revascularization virus-related hypercoagulable state prolonged systemic heparin surgical treatment efficacy limb salvage overall survival',\n",
              " 'Renin-Angiotensin-Aldosterone-SARS-CoV-Axis Comprehensive ReviewCoronavirus disease 2019 COVID-19 disease severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 global morbidity mortality appearing Wuhan China countries epidemics pharmacotherapeutics lacking mitigate downstream morbidity mortality narrow renin-angiotensin-aldosterone system RAAS homeostasis cardiovascular respiratory systems SARS-CoV-2 utilises interrupts pathway renin-angiotensin-aldosterone-SARS-CoV RAAS-SCoV controversy confusion anti-hypertensive agents function pathway review knowledge RAAS-SCoV axis studies SARS-CoV relates evolving pandemic evidence-based manner review RAAS-SCoV acute lung injury effects risks benefits pharmacological axis leverage RAAS indirect viral-induced lung injury Concerns modulation exacerbate disease preclinical experimental models protective effect RAAS-SCoV axis inhibition lung injury survival clinical data RAAS modulation SARS-CoV-2 interventions SARS-CoV-2 viral microbiology inhibit viral cellular injury therapies immediate time efficacy unanswered question alternative approach modulation downstream pathophysiological virus morbidity mortality evidence clinical equipoise efficacy RAAS-based interventions imminent multisite controlled clinical trial evaluate inhibition RAAS-SCoV acute lung injury COVID-19',\n",
              " 'Epidemiology transmission COVID-19 cases contacts Shenzhen China retrospective cohort studyRapid severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 Wuhan China heightened surveillance Shenzhen China data measure metrics disease course transmission impact control measures Shenzhen Center for Disease Control Prevention SARS-CoV-2 cases cases identified symptomatic surveillance contact tracing time symptom confirmation isolation admission hospital estimated metrics disease transmission analysed factors transmission risk Cases general population mean age years balanced males females cases mild moderate clinical severity assessment cases died recovered median recovery days CI Cases isolated average days CI symptoms contact tracing reduced days CI 2·7 Household contacts travelling case risk infection odds ratio CI household contacts travelling case household secondary attack rate CI children infected adults infection children years population R CI serial interval days CI data cases infected uninfected epidemiology SARS-CoV-2 analysis isolation contact tracing reduce time cases infectious community reducing R. impact isolation contact tracing dependent asymptomatic cases children risk infection general population severe symptoms analyses transmission control Harbin Institute of Technology Emergency Response Program Peng Cheng Laboratory US Disease Control Prevention',\n",
              " 'psychiatric patients psychiatric symptoms COVID-19 pandemic Case-Control Study Service Research ImmunopsychiatryThis study assess compare immediate stress psychological impact people psychiatric illnesses peak coronavirus disease COVID-19 epidemic measures psychiatric patients healthy control subjects Chongqing China survey demographic data physical symptoms days psychiatric symptoms Impact Event Scale-Revised IES-R Depression Anxiety Stress Scale DASS-21 Insomnia Severity Index ISI IES-R measures PTSD symptoms survivorship event DASS-21 tripartite model psychopathology general distress characteristics IES-R DASS-21 anxiety depression stress subscale ISI scores psychiatric patients healthy controls worries physical health anger impulsivity intense suicidal ideation psychiatric patients healthy controls one-third psychiatric patients fulfil diagnostic criteria post-traumatic stress disorder PTSD one-quarter psychiatric patients severe severe insomnia Respondents no change poor worse physical health status psychiatric illness IES-R DASS depression anxiety stress subscale scores ISI scores study severity negative psychological impact psychiatric patients COVID-19 epidemic measures psychological impact psychiatric patients COVID-19 pandemic immunopsychiatry research pro-inflammatory cytokines psychiatric patients healthy controls pandemic',\n",
              " 'Vaginal delivery SARS-CoV-2 infected pregnant women Northern Italy retrospective delivery immediate neonatal outcome women infected COVID-19 Retrospective study hospitals northern Italy Pregnant infection infection pregnancy women admitted Data clinical records standardised questionnaire maternal medical obstetric co-morbidity course pregnancy clinical signs symptoms treatment COVID 19 infection mode of delivery neonatal data breastfeeding Data mode delivery neonatal women COVID-19 participating centres CI elective caesarean section CI cases cases indication COVID-19 infection Pneumonia diagnosed CI cases CI oxygen support CI admitted critical care unit women COVID-19 breastfed mask infection diagnosed postpartum period newborns tested positive SARS-Cov-2 infection newborn positive test vaginal operative delivery postpartum infection findings vaginal delivery associated with low intrapartum newborn study vaginal delivery associated with low intrapartum newborn',\n",
              " 'COVID-19 pandemic personal protective equipment shortage protective efficacy masks scientific methods respirator reuseThe abrupt outbreak coronavirus disease healthcare systems world shortage personal protective equipment PPE reducing increasing production promote PPE efficacy effective technique literature PubMed Scopus Cochrane database Google Scholar articles relevance impact respiratory virus epidemics surgical masks N95 respirators protective efficacy healthcare workers N95 respirators high-risk respirator energetic short-wave ultraviolet germicidal irradiation UVGI decontaminate N95 respirators viral respiratory agents UVGI type of respirator biologic target Rational use respirators shortage PPE pandemic UVGI decontamination techniques definitive answer pandemic issues artificial intelligence deep learning groundbreaking modalities high-risk patients types PPE',\n",
              " 'Effects of temperature humidity daily cases deaths COVID-19 countriesThe coronavirus disease COVID-19 pandemic global health crisis world Meteorological parameters respiratory infectious disease effect meteorological parameters COVID-19 study effects of temperature relative humidity daily cases daily deaths COVID-19 policymakers public Daily data meteorological conditions cases deaths COVID-19 countries China Log-linear generalized additive model effects of temperature relative humidity daily cases daily deaths COVID-19 confounders wind speed age national population Global Health Security Index Human Development Index population density findings temperature relative humidity negatively daily cases deaths increase temperature associated with CI reduction daily cases CI reduction daily deaths increase relative humidity associated with CI reduction daily cases CI reduction daily deaths results structures sensitivity analysis findings COVID-19 pandemic suppressed temperature humidity increases active measures infection block transmission COVID-19',\n",
              " 'Risk factors mortal COVID-19 systematic literature review epidemic Coronavirus Disease 2019 COVID-19 Public Health Emergency International Concern PHEIC risk factors progression COVID-19 reducing risk critical illness death clinical help data COVID-19 patients databases risk factors critical/mortal non-critical COVID-19 patients meta-analysis Meta-analysis patients SARS-CoV-2 infection Male smoking risk factors disease progression patients COVID-19 male OR CI age years OR CI(3.98 smoking OR CI(1.39 proportion diseases hypertension diabetes cardiovascular disease respiratory disease statistically significant critical/mortal patients non-critical patients diabetes CI hypertension OR CI cardiovascular disease OR CI(3.25 respiratory disease OR CI(2.51 Clinical manifestations fever shortness breath dyspnea associated with progression disease fever CI breath dyspnea CI Laboratory examination aspartate amino transferase(AST creatinine(Cr hypersensitive cardiac troponin I(hs-cTnI procalcitonin(PCT D-dimer deterioration disease white blood cells(WBC)<4\\u202f Male aged smoking patients risk critical mortal condition comorbidities hypertension diabetes cardiovascular disease respiratory diseases prognosis COVID-19 Clinical manifestation fever shortness breath dyspnea laboratory examination WBC AST Cr PCT LDH hs-cTnI D-dimer progression COVID-19',\n",
              " 'Transmission risk SARS-CoV-2 healthcare workers results primary care hospital epidemic Healthcare workers increased risk infection requirements protection functioning basic healthcare system availability general practitioners GPs transmission risk primary healthcare setting Healthcare worker undiagnosed COVID-19 case personal protective equipment facemasks screened nasopharyngeal swabs polymerase chain reaction tests severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 respiratory symptoms fever days initial contact details exposure to index case routine contact investigation unintentional pathogen exposure healthcare workers contacts index case healthcare workers respiratory symptoms cough low-grade fever days tested positive SARS-CoV-2 symptom onset healthcare workers tested SARS-CoV-2 days initial index healthcare workers symptoms healthcare workers cumulative exposure time gt;15 minutes cumulative contact times associated with individual contacts reduced contact time contact activities physical patient index patient SARS-CoV-2 index case hospital emergency department low risk SARS-CoV-2 transmission primary care setting findings reports highest transmission probability household settings prolonged protective measures healthcare workers adherence standard hygiene facemasks protection short periods contact symptomatic COVID-19 cases diminishing risk direct indirect transmission',\n",
              " 'Association Inpatient Use of Angiotensin Converting Enzyme Inhibitors Angiotensin II Receptor Blockers Mortality Patients Hypertension COVID-19Use of ACEIs angiotensin-converting enzyme inhibitors ARBs angiotensin II receptor blockers clinicians treating coronavirus disease COVID-19 patients hypertension association in-hospital ACEI/ARB mortality patients hypertension hospitalized COVID-19 retrospective multi-center study adult patients hypertension diagnosed COVID-19 ACEI/ARB ACEI/ARB group age interquartile range years men ACEI/ARB group age interquartile range men hospitals Hubei Province China mixed-effect Cox model treating random effect age gender comorbidities in-hospital medications detected risk all-cause mortality ACEI/ARB group group hazard ratio CI hospitalized patients COVID-19 coexisting hypertension inpatient ACEI/ARB associated with lower risk all-cause mortality ACEI/ARB nonusers study interpretation potential residual confounders in-hospital ACEI/ARB associated with increased mortality risk',\n",
              " 'COVID‐19 Coagulopathy Caucasian patientsAlthough pathophysiology severe COVID19 data lung-centric coagulopathy Elevated correlated inversely overall survival Chinese cohort studies ethnicity effects thrombotic risk lower Chinese Caucasians risk African-Americans study investigated COVID19 coagulopathy Caucasian patients findings severe COVID19 infection associated with coagulopathy correlates disease severity Caucasian COVID19 patients low molecular weight heparin overt intravascular coagulation DIC rare COVID19 cases DIC late-stage disease data diffuse bilateral pulmonary COVID19 associated with pulmonary-specific vasculopathy pulmonary intravascular coagulopathy PIC DIC thrombotic risk race evidence coagulopathy COVID19 pathogenesis findings intriguing pulmonary vasculopathy differences highlighting racial susceptibility COVID19 mortality',\n",
              " 'Aerodynamic analysis SARS-CoV-2 Wuhan hospitalsThe outbreak coronavirus disease COVID-19 global scale severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 transmitted human respiratory droplets direct contact potential aerosol transmission',\n",
              " 'Evaluation ocular symptoms tropism SARS‐CoV‐2 patients COVID‐19The SARS-CoV-2 RNA detected tears conjunctival samples infected individuals Conjunctivitis cases evaluated ocular symptoms ocular tropism SARS-CoV-2 group patients COVID-19 patients infected SARS-CoV-2 subjects medical histories electronic medical record system Ocular history ocular symptoms data communicating subjects Ocular Surface Disease Index OSDI Salisbury Eye Evaluation Questionnaire SEEQ assess anterior ocular surface condition onset of disease Patients severe COVID-19 cases hypertension mild cases subjects patients infected Wuhan patients community-infected patients physician infected patient patients face mask precaution patients aggravated ocular symptoms prodromal ocular symptoms disease onset scores OSDI questionnaire SEEQ COVID-19 significant Ocular symptoms COVID-19 disease respiratory symptoms data anecdotal transmission SARS-CoV-2 ocular surface',\n",
              " 'Aerosol Filtration Efficiency Common Fabrics Respiratory Cloth pandemic respiratory system face masks cloth masks sections public global COVID-19 performance fabrics cloth masks evaluate filtration efficiencies function aerosol particulate respiratory virus studies fabrics cotton silk chiffon flannel synthetics combinations filtration efficiencies fabrics single layer particle sizes efficiencies multiple layers combination fabrics Filtration efficiencies hybrids cotton-silk cotton-chiffon cotton-flannel particles particles enhanced performance hybrids mechanical electrostatic-based filtration Cotton material cloth masks higher densities',\n",
              " 'invade brain Translational lessons animal coronavirus disease COVID-19 outbreak severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 properties virus neurological sequelae SARS-CoV-2 infection relevance neurological impact coronavirus CoV translational perspective Animal models SARS Middle East respiratory syndrome CoVs epidemics data nervous system involvement CoVs potential central nervous system SARS-CoV-2 pathogens angiotensin-converting enzyme 2 cell entry receptor CoV SARS-CoV-2 cell membranes binds angiotensin-converting enzyme 2 affinity SARS-CoV. expression receptor neurons endothelial cells hints SARS-CoV-2 neuroinvasive potential CoVs invasiveness respiratory failure neurological damage indirect mechanisms relevance Clinical heterogeneity differential host immune-mediated responses investigation Development disease models neurological complications mechanisms direct immune-mediated pathogenicity short medium term review models CoV infections potential relevance COVID-19',\n",
              " 'Fibrinolytic abnormalities acute respiratory distress syndrome ARDS versatility thrombolytic drugs treat COVID-19The global coronavirus disease COVID-19 associated with development acute respiratory distress syndrome ARDS ventilation critically ill patients pathophysiology ARDS results acute inflammation alveolar space prevention normal gas increase proinflammatory cytokines lung recruitment leukocytes local inflammatory response ARDS deposition fibrin air spaces lung parenchyma COVID-19 patients elevated D-dimers fibrinogen Fibrin deposits lungs patients dysregulation coagulation fibrinolytic systems Tissue factor TF damaged alveolar endothelial cells surface leukocytes fibrin deposition elevated levels plasminogen activator inhibitor 1 PAI-1 lung epithelium endothelial cells hypofibrinolytic state Prophylaxis treatment COVID-19 patients low molecular weight heparin LMWH limit coagulopathy pre-existing fibrin lung promote local fibrinolysis review fibrinolytic drugs tissue-type plasminogen activator tPA treat COVID-19 ARDS tPA intravenous thrombolytic treatment nebulizer effective plastic bronchitis Phase II clinical trial Nebulizer plasminogen activators COVID-19 patients degrade fibrin improving oxygenation critically ill patients',\n",
              " 'Eculizumab treatment patients COVID-19 preliminary results real life ASL Napoli 2 Nord experienceSARS-CoV-2 Severe Acute Respiratory Syndrome Coronavirus pneumonia COVID-19 Coronavirus Disease 19 public health emergency carries morbidity mortality pharmacological treatments case series preliminary data anti-complement C5 therapy eculizumab COVID-19 patients admitted intensive care unit ICU ASL Napoli 2 Nord case series patients diagnosis SARS-CoV2 infection severe pneumonia ARDS treated with infusions eculizumab off-label agent Patients treated with anticoagulant therapy Enoxaparin subcutaneous injection antiviral therapy Lopinavir 800 mg/day Ritonavir 200 mg/day hydroxychloroquine ceftriaxone 2 vitamine C 6 days Non-Invasive Ventilation NIV treated COVID-19 patients admitted intensive care unit severe pneumonia ARDS patients treatment eculizumab Eculizumab induced drop inflammatory markers Mean C Reactive Protein levels duration disease days Eculizumab player treatment severe cases COVID-19 eculizumab off-label treatment COVID-19 confirmation SOLID-C19 trial',\n",
              " 'Prognostic value interleukin-6 C-reactive protein procalcitonin patients COVID-19The inflammatory response coronavirus disease COVID-19 inflammatory cytokine storm severity COVID-19 investigate interleukin-6 IL-6 C-reactive protein CRP procalcitonin PCT mild severe cases COVID-19 retrospective cohort study patients diagnosed COVID-19 study population groups disease severity mild group MG severe group SG Data demographic characteristics baseline clinical levels IL-6 CRP PCT admission patients levels IL-6 CRP PCT increased patients admission proportion patients increased IL-6 CRP PCT levels SG MG Cox proportional hazard model IL-6 CRP factors severity COVID-19 patients IL-6\\u2009 CRP\\u2009 severe complications serum IL-6 CRP assess disease severity outcome patients COVID-19',\n",
              " 'Direct oral anticoagulant plasma increase severe COVID‐19 respiratory syndrome patients treated antiviral agents Cremona experienceAntiviral drugs administered patients severe COVID-19 respiratory syndrome treated with oral anticoagulants DOACs Concomitant administration antiviral agents increase plasma concentration patients Cremona Thrombosis Center admitted Cremona Hospital SARS-CoV-2 started antiviral drugs DOAC therapy DOAC plasma levels hospital results hospitalization consecutive patients DOACs administration antiviral agents lopinavir ritonavir darunavir Plasma samples DOAC measurement days antiviral treatment dose intake patients dabigatran apixaban rivaroxaban edoxaban patient DOAC level expressed measured hospitalization patients hospitalized February 22 COVID-19 pneumonia candidates antiviral therapy treatment DOAC DOAC C-trough levels hospitalization pre-hospitalization period DOAC patients treated antiviral drugs alarming increase DOAC plasma levels bleeding complications physicians DOACs patients SARS-CoV-2 parenteral antithrombotic strategies long antiviral agents discharge',\n",
              " 'Estimating Effects of Asymptomatic Imported Patients COVID‐19 Epidemic Mathematical Coronavirus Disease threat public health Data Jiangsu Anhui provinces China model features asymptomatic population threshold behavior recovery parameter estimation model model epidemic asymptomatic patients ASP provinces latent periods outbreak sizes sensitive controlled interventions isolation quarantine asymptomatic cases ASP severe factor faster outbreaks outbreak sizes patients argued interventions implemented asymptomatic pool preventive strategy vaccines',\n",
              " 'Prevention therapy COVID-19 exogenous estrogen male female patientsThe results studies estrogen receptor ER innate adaptive immune responses tissue repairing processes respiratory virus infection Experimental studies respiratory virus infected mice ER signaling increased morbidity mortality males females animal experiments estrogen treatment inflammatory reactions decreases virus titers improved survival rate ideal prevention therapy COVID-19 reluctance estrogen therapy estrogen formula estrogens equine estrogens brand Premarin natural sources Premarin ER upregulative gene repairing power endogenous estrogen risk adverse reactions Premarin COVID-19 pandemic',\n",
              " 'Characteristic CT findings coronavirus disease COVID-19 influenza CT characteristics influenza coronavirus disease COVID-19 confirmed patients COVID-19 CT scans patients influenza pneumonia influenza A influenza B scanned January 1 retrospectively Pulmonary lesion distributions number attenuation lobe predomination margin contour ground-glass opacity pattern bronchial wall thickening air bronchogram tree-in-bud sign interlobular septal thickening intralobular septal thickening pleural effusion evaluated COVID-19 influenza pneumonia cohorts Peripheral non-specific distributions COVID-19 higher frequency influenza group lesions COVID-19 balanced lobe localization influenza pneumonia inferior lobe COVID-19 lesion shrinking contour influenza pneumonia COVID-19 patchy combination GGO consolidation opacities cluster-like pattern bronchial wall thickening influenza pneumonia lesion number attenuation air bronchogram tree-in-bud sign interlobular septal thickening intralobular septal thickening groups viral pneumonias imaging features characteristic CT findings COVID-19 influenza pneumonia CT diagnosis COVID-19 case epidemic exposure CT differential diagnosis influenza COVID-19 satisfactory accuracy COVID-19 patchy combination GGO consolidation opacities peripheral distribution balanced lobe predomination',\n",
              " 'Effect High Low Doses Chloroquine Diphosphate Adjunctive Therapy Patients Hospitalized Severe Acute Respiratory Syndrome Coronavirus 2 SARS-CoV-2 Randomized Clinical TrialThere antiviral therapy coronavirus disease COVID-19 In vitro studies antiviral effect chloroquine CQ concentration drug evaluate safety efficacy CQ dosages patients severe COVID-19 double-masked randomized phase IIb clinical trial adult patients hospitalized severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 infection tertiary care facility Manaus Brazilian Amazon Patients high-dosage CQ CQ twice days low-dosage CQ daily day daily days Primary outcome reduction lethality high-dosage group low-dosage group Data refer safety lethality outcomes treatment day Secondary end points participant clinical status laboratory examinations electrocardiogram Outcomes day Viral respiratory secretion detection days sample patients high-dosage group low-dosage group patients SD age years men Older age SD age years years heart disease high-dose group Viral RNA detected patients low-dosage high-dosage groups Lethality day high-dosage group low-dosage group high-dosage group QTc interval milliseconds compared low-dosage group Respiratory secretion day negative patients findings study higher CQ dosage critically ill patients COVID-19 safety hazards azithromycin oseltamivir findings patients COVID-19',\n",
              " 'Neutralization SARS-CoV-2 pseudotyped virus recombinant acute respiratory syndrome coronavirus 2 SARS-CoV-2 Wuhan China antiviral treatments vaccines SARS-CoV-2 cell entry receptor SARS-CoV angiotensin-converting enzyme 2 ACE2 report recombinant protein extracellular domain human ACE2 Fc region human immunoglobulin IgG1 fusion protein ACE2 mutant catalytic activity study fusion proteins characterized fusion proteins binding receptor-binding domains SARS-CoV SARS-CoV-2 pharmacological properties mice fusion proteins SARS-CoV SARS-CoV-2 spike proteins in vitro fusion proteins cross-reactivity coronaviruses applications diagnosis prophylaxis treatment SARS-CoV-2',\n",
              " 'SARS-CoV-2 entry factors expressed nasal epithelial cells innate immune genesWe SARS-CoV-2 tropism surveying expression viral entry-associated genes single-cell RNA-sequencing data multiple tissues healthy human donors co-detected transcripts specific respiratory corneal intestinal epithelial cells efficiency SARS-CoV-2 transmission genes co-expressed nasal epithelial cells genes innate immunity cells viral infection spread clearance study inquiry clinical samples COVID-19 patients data comprehensive open user-friendly fashion www.covid19cellatlas.org',\n",
              " 'Serological assays severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 coronavirus disease COVID-19 pandemic impacts health systems economy society Assessing infection attack rates population disease severity herd immunity public health interventions impact public health decision making objective evaluate serological assays sero-epidemiological studies MethodsWe ELISA detect IgG IgM receptor-binding domain RBD spike protein severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 sensitivity specificity combination confirmatory microneutralisation MN plaque reduction PRNT',\n",
              " 'Incidence Adverse Drug Reactions COVID-19 patients China active Hospital Pharmacovigilance SystemTo evaluate incidence type risk factors associated with adverse drug reactions ADRs patients coronavirus disease 2019 COVID-19 Hospital Pharmacovigilance System CHPS retrospective analysis patients COVID-19 First Hospital Changsha China active CHPS detect ADR signals hospital information system risk factors ADRs World Health Organization-Uppsala Monitoring Centre (WHO-UMC) system Univariate multivariate logistic regressions risk factors ADRs results prevalence ADRs patients drug-induced gastrointestinal disorders liver system disorders ADR ritonavir ADRs days hospitalization Multivariable analysis length of stay odds ratio OR confidence interval CI drugs hospital OR CI diseases OR CI risk factor ADRs patients incidence ADRs treatment period active monitoring CHPS system ADRs COVID-19 treatment real world medication clinic',\n",
              " 'Strong associations moderate predictive value early symptoms SARS-CoV-2 test positivity healthcare workers Netherlands mild symptoms severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 positive symptom questionnaire Anosmia muscle ache ocular pain headache extreme tiredness fever associated with positivity predictive model symptoms moderate sensitivity specificity models presumptive SARS-CoV-2 diagnosis molecular confirmation targeted screening strategies',\n",
              " 'Association Renin-Angiotensin System Inhibitors Severity Risk of Death Patients Hypertension Coronavirus Disease 2019 COVID-19 Infection Wuhan ChinaData patients hypertension angiotensin-converting enzyme inhibitors ACEIs angiotensin receptor blockers ARBs increased severity risk mortality hospitalization coronavirus disease COVID-19 investigate association ACEIs/ARBs severity illness mortality patients hypertension hospitalized COVID-19 infection Retrospective single-center case series hospitalized patients COVID-19 infections Central Hospital of Wuhan China COVID-19 real-time reverse transcription-polymerase chain reaction epidemiologic clinical radiologic laboratory drug therapy data analyzed patients patients hypertension ACEIs/ARBs severe illness survivors nonsurvivors patients COVID-19 median age years interquartile range years men in-hospital mortality patients hypertension total group median age years interquartile range years men ACEI/ARBs in-hospital mortality patients hypertension percentage patients hypertension ACEIs/ARBs severe infections nonsurvivors survivors findings data analyzed patients ACEIs ARBs study clinical data association ACEIs/ARBs outcomes patients hypertension hospitalized COVID-19 infections ACEIs/ARBs associated with severity mortality COVID-19 patients data guidelines societal recommendations treating hypertension COVID-19 pandemic',\n",
              " \"community-wide wearing face mask control coronavirus disease COVID-19 epidemic SARS-CoV-2Face mask healthy population community reduce risk transmission respiratory viruses assessed effect community-wide mask control coronavirus disease COVID-19 Hong Kong Special Administrative Region HKSAR Patients respiratory symptoms outpatient clinics hospital wards COVID-19 Epidemiological analysis cases persons COVID-19 mask-off mask-on settings incidence COVID-19 population HKSAR community-wide masking non-mask-wearing countries HKSAR population density healthcare system BCG vaccination social distancing community-wide masking Compliance face mask usage HKSAR community monitored days COVID-19 patients diagnosed HKSAR COVID-19 incidence HKSAR population Spain Italy Germany France U.S. U.K. Singapore South Korea compliance face mask usage HKSAR public COVID-19 clusters recreational 'mask-off' settings workplace 'mask-on' Chi square test Community-wide mask control COVID-19 reducing amount emission infected saliva respiratory droplets individuals subclinical mild COVID-19\",\n",
              " \"Evaluation auxiliary diagnostic value antibody assays detection coronavirus severe acute respiratory syndrome coronavirus-2 SARS-CoV-2 pandemic proportions affecting countries matter weeks goal study assess diagnostic values methods detecting estimating SARS-CoV-2 infection auxiliary diagnostic potential antibody assays retrospectively data viral RNAs serum immunoglobulin M-immunoglobulin G antibodies SARS-CoV-2 cases coronavirus disease Second People's Hospital Fuyang early phase illness viral RNA abundant sputum specimens throat swabs antibody assays positive cases stage sensitivity antibody assays RNA test eighth day disease onset antibody assay reverse transcription-quantitative real-time polymerase chain reaction sensitivity diagnoses cases viral RNA early stages seropositive days findings antibody detection effective supplementary indicator SARS-CoV-2 infection cases viral RNA conjunction nucleic acid detection infection\",\n",
              " 'Clinical value immune-inflammatory parameters assess severity coronavirus disease clinical value immune-inflammatory markers assess severity coronavirus disease 2019 COVID-19 consecutive hospitalized patients COVID-19 study non-severe severe groups Demographics symptoms diseases laboratory data collected assessed predictive value COVID-19 patients cases severe group interleukin-6 IL-6 C-reaction protein CRP hypertension risk factors severity COVID-19 risk model IL-6 CRP hypertension area receiver operator characteristic curve AUROC baseline IL-6 correlated immune-inflammatory parameters dynamic change IL-6 severe cases amelioration disease study level IL-6 CRP hypertension risk factors assessing severity COVID-19 risk model IL-6 CRP hypertension predictability study IL-6 severity COVID-19 monitoring process severe cases',\n",
              " 'Severe Acute Respiratory Syndrome Coronavirus 2 SARS-CoV-2 Children Adolescents Systematic severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 infection global effective preventive strategies optimal medical management data adult patients coronavirus disease 2019 COVID-19 limited reports analyzed pediatric patients infected SARS-CoV-2 evaluate pediatric cases SARS-CoV-2 infection search strategy articles published December 1 coronavirus coronavirus infection electronic databases PubMed Cochrane Library CINAHL Preferred Reporting Items Systematic Reviews Meta-analyses guidelines Retrospective cross-sectional case-control studies case series case reports bulletins national reports pediatric SARS-CoV-2 infection risk bias eligible observational studies assessed Strengthening Observational Studies Epidemiology guideline articles studies participants patients younger years aged years SARS-CoV-2 infection analysis articles research China clinical case Singapore Children age mild respiratory symptoms fever dry cough fatigue asymptomatic Bronchial thickening ground-glass opacities radiologic features findings asymptomatic patients articles severe COVID-19 infection infant No deaths children years data therapies systematic review assesses clinical features management children SARS-CoV-2 infection COVID-19 globe lack of European US data pediatric patients epidemiologic clinical studies preventive therapeutic strategies',\n",
              " 'Presenting Characteristics Comorbidities Outcomes Patients Hospitalized COVID-19 New York City AreaThere information presenting characteristics outcomes US patients hospitalization coronavirus disease COVID-19 clinical characteristics outcomes patients COVID-19 hospitalized US health care system Case series patients COVID-19 hospitals New York City Long Island Westchester County New York Northwell Health system study sequentially hospitalized patients April 4 dates severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 positive polymerase chain reaction testing nasopharyngeal sample patients admission Clinical outcomes hospitalization invasive mechanical ventilation kidney replacement therapy death Demographics baseline comorbidities vital signs test patients median age years interquartile range IQR years female comorbidities hypertension obesity diabetes triage patients febrile respiratory rate breaths/min supplemental oxygen rate respiratory virus co-infection Outcomes assessed patients discharged died study hospitalization patients median age years IQR female treated intensive care unit care invasive mechanical ventilation treated with kidney replacement therapy died patients mechanical ventilation discharged alive died hospital median postdischarge follow-up days IQR patients study period readmission days IQR readmitted patients patients hospitalized study follow-up median age years IQR follow-up censoring days IQR case series characteristics early outcomes sequentially hospitalized patients COVID-19 New York City area',\n",
              " 'Early Description Coronavirus 2019 Disease Kidney Transplant Recipients SARS-CoV-2 virus coronavirus disease COVID-19 individuals increased risk severe disease clinical presentation disease course outcomes kidney transplant recipients Columbia University kidney transplant program hospitalization confirmed COVID-19 management clinical course outcomes Patients fever cough chest x-ray bilateral infiltrates acute radiographic findings Patients immunosuppression reduction hydroxychloroquine azithromycin patients mechanical ventilation discharged home follow-up Kidney transplant recipients COVID-19 presentations general population treatment protocol associated with outcomes follow-up cohort patients',\n",
              " 'sensitivity specificity analyses ambient temperature population size transmission rate COVID-19 provinces IranOn 10 April Iran COVID-19 cumulative cases death recovery factors influence transmission rate survival coronavirus epidemiological researches ambient temperature AT population size PS transmissibility factors coronavirus analysis receiver operating characteristics ROC measuring performance classification model confusion matrix study investigate sensitivity AT PS transmission rate provinces Iran information province Iran annual average AT healthy diseased cases sensitivity specificity analyses AT PS factors AT PS low sensibility high sensitivity scientific COVID-19 cases warmer climates moderate cold climates cities/provinces population people stricter inspections controls management policy',\n",
              " 'Outcomes hydroxychloroquine usage United States veterans hospitalized Covid-19Despite conflicting evidence hydroxychloroquine combination azithromycin COVID-19 therapy retrospective study electronic health records patients hospitalized SARS-CoV-2 infection US Veterans Health Administration medical centers Patients hospitalized diagnosis exposure to hydroxychloroquine HC azithromycin HC+AZ HC treatments primary outcomes mortality mechanical ventilation patients evaluated HC group propensity score adjustment clinical characteristics risk death cause HC group hazard ratio aHR confidence interval CI HC+AZ group aHR CI propensity-score-adjusted risks mechanical ventilation death mechanical ventilation HC group aHR CI aHR CI HC+AZ group aHR CI aHR CI HC group patients hospitalized COVID-19 retrospective study reduction mortality mechanical ventilation hydroxychloroquine treatment azithromycin University of Virginia',\n",
              " 'Connecting clusters COVID-19 epidemiological serological investigationElucidation chain of disease transmission identification source coronavirus disease COVID-19 infections effective disease containment epidemiological investigation severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 serological assays clusters COVID-19 Singapore active case-finding contact tracing COVID-19 cases Diagnosis acute disease RT-PCR testing epidemiological information people nodes disease transmission illness SARS-CoV-2 IgG clusters COVID-19 locally transmitted cases Singapore clusters Church A Church B family gathering clusters Church A Church B individual Church A A2 transmitted SARS-CoV-2 primary case Church B F1 family gathering cases RT-PCR testing active disease A2 testing illness tested negative individual diagnosed infection serological testing ELISA assays optical density SARS-CoV-2 receptor binding domain titres viral neutralisation titres Development application serological assay connections COVID-19 clusters Singapore Serological testing convalescent cases people milder disease surveillance methods National Research Foundation Singapore National Natural Science Foundation China National Medical Research Council (Singapore',\n",
              " 'COVID-19 infection ketosis ketoacidosisThe study hospitalized patients COVID-19 patients ketosis admission no obvious fever diarrhoea median interquartile range IQR age years men Patients ketosis younger prevalence fatigue diabetes digestive disorders median IQR length of hospital stay days higher mortality rate patients diabetic ketosis acidosis patients diabetic ketosis died acidosis non-diabetic ketotic patients severe acidosis died acidosis COVID-19 infection ketosis ketoacidosis induced diabetic ketoacidosis diabetes Ketosis increased length of hospital stay mortality diabetes increased length of hospital stay patients ketosis no effect mortality',\n",
              " 'COVID-19-Related Severe Hypercoagulability Patients Admitted Intensive Care Unit Acute Respiratory FailureIn outbreak SARS-CoV-2 severe pneumonia COVID-19 Wuhan Hubei Province China finding COVID-19 patients levels associated with prognosis evaluate coagulation abnormalities traditional tests whole blood thromboelastometry group mean age years M consecutive patients Intensive Care Unit Padova University Hospital acute respiratory failure COVID-19 Cases significantly higher fibrinogen D-dimer plasma healthy controls',\n",
              " 'Multinational Multicentre Study Psychological Outcomes Associated Physical Symptoms Healthcare Workers COVID-19 OutbreakSince declaration COVID-19 outbreak pandemic reports increased prevalence physical symptoms general population investigated association psychological outcomes physical symptoms healthcare workers Healthcare workers hospitals care COVID-19 patients Singapore India invited participate study self-administered questionnaire period Healthcare workers doctors nurses allied healthcare workers administrators clerical staff maintenance workers questionnaire information demographics medical history symptom prevalence month Depression Anxiety Stress Scales DASS-21 Impact Events instrument prevalence physical symptoms healthcare workers associations physical symptoms psychological outcomes depression anxiety stress post-traumatic stress disorder PTSD evaluated healthcare workers survey screened positive moderate very-severe depression moderate extremely-severe anxiety extremely-severe stress severe levels psychological distress commonest symptom headache participants symptoms Participants symptoms month older pre-existing comorbidities positive depression anxiety stress PTSD age gender comorbidities depression OR CI anxiety OR CI stress OR CI PTSD OR CI associated with presence physical symptoms month Linear regression physical symptoms associated with higher IES-R DASS Anxiety Stress Depression subscales study association prevalence physical symptoms psychological outcomes healthcare workers COVID-19 outbreak association bi-directional psychological interventions healthcare workers physical symptoms infection',\n",
              " 'Multicenter guidance antivirals children COVID-19/SARS-CoV-2Although Coronavirus Disease 2019 COVID-19 mild children proportion pediatric patients develops severe critical illness Guidance agents activity severe acute respiratory syndrome coronavirus 2 pediatrics pediatric infectious diseases physicians pharmacists North American convened teleconferences web-based surveys guidance statements review evidence expert opinion mild course pediatric COVID-19 supportive care cases decision-making framework antiviral therapy risks benefits disease severity respiratory support consideration case-by-case basis potential pediatric risk factors disease progression antiviral preferred agent Hydroxychloroquine patients remdesivir remdesivir Antivirals clinical trial Antiviral therapy COVID-19 pediatric patients rare children severe critical disease guidance decision-making antivirals data evidence guidance anticipated',\n",
              " 'Psychological stress medical staffs outbreak COVID-19 adjustment strategyCOVID-19 impact public health medical staffs front-line medical staffs exposed to contact patients psychological stress status medical staffs outbreak COVID-19 random sample questionnaire survey medical staffs college students provinces China questionnaire compiled completed Questionnaire Star platform Wechat QQ social software psychological stress status groups compared analysis questionnaire provinces China medical staffs scored items psychological stress college students Wuhan medical staffs scored college students items psychological stress medical staffs group Wuhan area group Wuhan items danger self-illness family infection Poor sleep quality psychological guidance infected Psychological Stress Questionnaire item Confidence victory epidemic group Wuhan area group Wuhan emotion cognition physical mental response front-line medical staff exposure effect psychological crisis intervention',\n",
              " 'cluster trial cloth masks medical masks healthcare workersThe study compare efficacy cloth masks medical masks hospital healthcare workers HCWs null hypothesis medical masks cloth masks secondary-level/tertiary-level hospitals Hanoi Vietnam hospital HCWs aged years working full-time high-risk wards Hospital wards medical masks cloth masks control group usual practice mask wearing Participants mask consecutive weeks Clinical respiratory illness CRI influenza-like illness ILI laboratory-confirmed respiratory virus infection rates infection outcomes cloth mask arm rate ILI statistically cloth mask arm relative risk (RR)=13.00 CI medical mask arm Cloth masks rates ILI compared control arm analysis mask use ILI CI laboratory-confirmed virus CI cloth masks group medical masks group Penetration cloth masks particles medical masks study RCT cloth masks cloth masks occupational health safety Moisture retention reuse cloth masks poor filtration increased risk infection research cloth masks globally precautionary measure cloth masks HCWs high-risk situations guidelines Australian New Zealand Clinical Trials Registry ACTRN12610000887077',\n",
              " 'mask mask Modeling potential face mask public COVID-19 pandemicFace mask public limiting spread COVID-19 pandemic recommended potential intervention compartmental model community-wide impact mask general asymptomatic public portion asymptomatically infectious Model simulations data COVID-19 dynamics US New York Washington adoption face masks community transmission COVID-19 decrease peak hospitalizations deaths mask use decreases effective transmission linear proportion product mask effectiveness fraction infectious contacts blocked coverage rate fraction general population impact epidemiologic outcomes death hospitalizations nonlinear masks synergize non-pharmaceutical measures masks preventing illness healthy persons',\n",
              " \"Diagnostic performance CT real-time RT-PCR clinically coronavirus disease COVID-19 patients Wuhan ChinaChest CT sensitive diagnosing coronavirus disease COVID-19 diagnostic value CT compare performance CT RT-PCR clinically COVID-19 patients epicentre-Wuhan China Patients clinically COVID-19 infection RT-PCR chest CT time retrospectively radiologists training reviewed CT images diagnoses presence absence COVID-19 consensus serial RT-PCR reference standard performance RT-PCR chest CT RT-PCR chest CT benefit patients admitted hospital COVID-19 non-COVID-19 patients serial RT-PCR sensitivity specificity RT-PCR chest CT image readers Cohen's kappa diagnostic performance RT-PCR chest CT comprehensive sensitivity RT-PCR chest CT diagnostic performance identification suspected COVID-19 patients epidemic center compensate potential risk false-negative PCR chest CT clinically patients negative RT-PCR\",\n",
              " 'nicotinic hypothesis Covid-19 preventive therapeutic implicationsSARS-CoV-2 public health planetary scale treatments scientific knowledge hypothesis lives scientific literature epidemiological data smoking status protective factor infection SARS-CoV-2 hypothesize nicotinic acetylcholine receptor nAChR pathophysiology Covid-19 infection target prevention control Covid-19 infection problème l’échelle planétaire traitements qui fondent sur disponibles proposons mais qui moment venu sauver des vies Elle fonde littérature scientifique nouvelles qui que fumeur parait facteur proposons que nAChR rôle dans pathophysiologie l’infection Covid-19 prévention',\n",
              " 'profile peripheral blood lymphocyte subsets serum cytokines children coronavirus pneumoniaThe study investigating characteristics peripheral blood lymphocyte subsets serum cytokines children pneumonia Children pneumonia respiratory syncytial virus RSV pneumonia Data lymphocyte subsets serum cytokines collected analyzed patients study children pneumonia children RSV pneumonia children RSV pneumonia patients pneumonia count CD3+8+ lymphocyte higher percentages CD3+ CD3+8 lymphocytes CD19 lymphocyte serum IL-10 level children RSV pneumonia pneumonia child increase IL-10 severe pneumonia Immune response development pneumonia effective CD8+ T cell response influence severity pneumonia IL-10 level mild pneumonia symptoms children pneumonia bacterial co-infection risk factor severe pneumonia',\n",
              " 'Safety immunogenicity Middle East respiratory syndrome coronavirus viral-vectored vaccine dose-escalation open-label non-randomised uncontrolled phase 1 trialCases Middle East respiratory syndrome coronavirus infection Arabian Saudi Arabia MERS-CoV risk public health security absence effective countermeasures assess safety immunogenicity simian adenovirus-vectored vaccine expressing spike surface ChAdOx1 MERS humans dose-escalation open-label non-randomised uncontrolled phase 1 trial Centre Clinical Vaccinology Tropical Medicine Oxford UK healthy people aged years negative HIV antibodies hepatitis B surface antigen hepatitis C antibodies negative urinary pregnancy test women Participants intramuscular injection ChAdOx1 MERS doses low-dose group participants low-dose group intermediate-dose group high-dose group participants follow-up months low-dose group intermediate-dose group high-dose group lost follow-up months dose ChAdOx1 MERS doses ChAdOx1 MERS tested doses single dose humoral cellular responses MERS-CoV. first-in-human clinical trial clinical development progression field phase 1b trials UK Department of Health Social Care UK UK National Institute for Health Research',\n",
              " 'Viral load dynamics disease severity patients infected SARS-CoV-2 Zhejiang province China retrospective cohort evaluate viral loads stages disease progression patients infected severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 months epidemic Zhejiang province China Retrospective cohort study hospital patients covid-19 Zhejiang province China admitted patients laboratory SARS-CoV-2 infection mild disease severe disease Data Ribonucleic acid RNA viral load respiratory stool serum urine samples Cycle threshold values measure nucleic acid concentration standard curve standard product Epidemiological clinical laboratory characteristics treatment outcomes data data collection forms electronic medical records clinical data disease severity respiratory stool serum urine samples patients admission evaluated SARS-CoV-2 RNA viral load Infection patients testing sputum saliva samples RNA detected stool patients serum patients urine sample patient positive SARS-CoV-2 duration virus stool days interquartile range days respiratory days days serum samples days days median duration virus respiratory samples patients severe disease days days patients mild disease days days mild group viral loads respiratory samples week disease onset viral load week severe group Virus duration patients older years male patients duration SARS-CoV-2 stool samples respiratory serum samples management stool samples prevention control epidemic virus load respiratory tissue patients severe disease',\n",
              " 'Cerebrovascular disease associated with increased disease severity patients Coronavirus Disease 2019 COVID-19 analysis published literatureThere patients high risk coronavirus disease COVID-19 pandemic history stroke associated with increased severity disease mortality studies published literature assess association history stroke outcomes patients COVID-19 analysis studies increase odds severe COVID-19 statistically significant association stroke mortality patients COVID-19 infection findings studies sample size increase odds severe COVID-19 illness history cerebrovascular disease',\n",
              " 'Airborne transmission severe acute respiratory syndrome coronavirus-2 healthcare workers narrative reviewHealthcare workers risk infection severe acute respiratory syndrome coronavirus-2 pandemic International guidance droplet transmission airborne transmission aerosol-generating procedures Recommendations infection control healthcare worker safety presumptions mechanisms production sized respiratory particles inhaled deposit distal laryngeal activity talking coughing velocity cyclical opening closure terminal airways Sneezing coughing effective aerosol generators expiration particles sizes diameter threshold droplet airborne over-simplification multiple complex biological physical variables evidence aerosol-generating procedures comes low-quality case cohort studies transmission aerosol transmission associated with time proximity severe acute respiratory syndrome coronavirus-1 patients respiratory symptoms procedures aerosol-generating procedure airborne viral exception bronchoscopy suctioning mechanism severe acute respiratory syndrome coronavirus-2 transmission evidence airborne infected patients cough breathing increased closing capacity respiratory tract fluid producers pathogenic aerosols aerosol-generating procedures pathogen aerosolisation dyspnoeic patient Healthcare workers evidence transmission local infection prevalence Measures airborne transmission risk mechanisms risk factors transmission evidence assure healthcare worker safety',\n",
              " 'Arbidol combined LPV/r LPV/r Coronavirus Disease retrospective cohort studyCorona Virus Disease 2019 COVID-19 coronavirus SARS-CoV-2 Wuhan city China compare arbidol treatment patients COVID-19 LPV/r retrospective cohort study adults age≥18years laboratory-confirmed COVID-19 Invasive ventilation diagnosed Patients diagnosed oral arbidol LPV/r combination group oral LPV/r monotherapy group days primary endpoint negative conversion coronavirus COVID-19 day14 assessed pneumonia improving chest CT day7 analyzed patients oral arbidol LPV/r combination group oral LPV/r monotherapy group initiated diagnosis Baseline clinical laboratory chest CT characteristics groups SARS-CoV-2 detected patients nasopharyngeal specimens combination group days monotherapy group days SARS-CoV-2 detected chest CT scans patients combination group days monotherapy group patients COVID-19 apparent clinical response arbidol LPV/r LPV/r',\n",
              " 'Safety immunogenicity modified vaccinia virus Ankara vector vaccine Middle East respiratory syndrome open-label phase 1 trialThe Middle East respiratory syndrome coronavirus MERS-CoV respiratory disease case fatality public health emergency absence efficacious drugs vaccines MERS WHO priority diseases research development countermeasures safety tolerability anti-MERS-CoV modified vaccinia virus Ankara vaccine expresses MERS-CoV spike glycoprotein MVA-MERS-S healthy adults open-label phase 1 trial University Medical Center Hamburg-Eppendorf (Hamburg Germany Participants healthy men women aged years health problems medical history physical examination body-mass index Vaccination MVA-MERS-S profile serious severe adverse events Homologous prime-boost immunisation humoral cell-mediated responses MERS-CoV. reactogenicity vaccine-induced immune responses data clinical testing MVA-MERS-S cohorts MERS vaccine German Center Research',\n",
              " 'SARS-CoV-2 viral sepsis observations hypothesesSince outbreak coronavirus disease COVID-19 clinicians disease clinical features identified clinical practice severe critically ill COVID-19 patients clinical manifestations shock cold extremities weak peripheral pulses absence overt hypotension mechanism viral sepsis COVID-19 clinical care patients evidence autopsy studies COVID-19 science research severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 SARS-CoV hypotheses SARS-CoV-2 pathogenesis multiple rounds discussion science researchers pathologists clinicians working COVID-19 process viral sepsis disease mechanism COVID-19 ideas imperfect inputs directions research moment',\n",
              " 'Estimating burden SARS-CoV-2 FranceFrance affected severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 pandemic models hospital death data estimate impact lockdown population immunity infected individuals hospitalized infected die interval years age years age older ages men hospitalized enter intensive care die women reduced reproductive number reduction interventions million people population infected Population immunity control measures',\n",
              " 'D-dimer levels admission in-hospital mortality patients Covid-19The outbreak coronavirus disease Covid-19 global spreading Early effective predictors clinical outcomes management Covid-19 patients study evaluate elevated D-dimer levels mortality patients Covid-19 Patients laboratory Covid-19 retrospective Wuhan Asia D-dimer levels admission death events calculate optimum cutoff receiver operating characteristic cutoff subjects groups in-hospital mortality groups assess predictive value D-dimer level eligible patients study optimum cutoff value in-hospital mortality sensitivity specificity patients D-dimer patients D-dimer admission deaths hospitalization Patients D-dimer levels incidence mortality comparing D-dimer levels hazard ratio confidence interval admission increase in-hospital mortality patients Covid-19 D-dimer early marker management Covid-19 patients Chinese Clinical Trial Registry ChiCTR2000031428',\n",
              " 'Efficacy safety lopinavir/ritonavir arbidol adult patients mild/moderate COVID-19 exploratory randomized controlled trialAntiviral therapies coronavirus SARS-CoV-2 global respiratory illness COVID-19 study ELACOI exploratory randomized controlled trial efficacy safety lopinavir/ritonavir LPV/r monotherapy treating patients mild/moderate COVID-19 study patients mild/moderate COVID-19 LPV/r arbidol antiviral medication control Baseline characteristics groups primary endpoint rate positive-to-negative conversion SARS-CoV-2 nucleic acid groups groups secondary endpoints rates antipyresis cough alleviation improvement chest computed tomography CT days day patients LPV/r group group control group deterioration clinical status severe/critical patients LPV/r group group adverse events follow-up period apparent adverse control group LPV/r monotherapy improving clinical outcome patients hospitalized mild/moderate COVID-19 supportive care study project 2017ZX10202102 Infectious Disease Specialty Guangzhou High-level',\n",
              " 'Miller Syndrome polyneuritis cranialis COVID-19To report patients infected severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 Miller Fisher syndrome polyneuritis cranialis Patient data medical records University Hospital University Hospital Madrid Spain man anosmia ageusia right internuclear ophthalmoparesis right fascicular oculomotor palsy ataxia areflexia albuminocytologic dissociation positive testing anti-GD1b-immunoglobulin G antibody days cough headache low back pain fever man ageusia bilateral abducens palsy areflexia albuminocytologic dissociation days diarrhea low-grade fever poor general condition Oropharyngeal swab test SARS-CoV-2 qualitative real-time reverse transcriptase PCR assay positive patients negative CSF patient treated with IV immunoglobulin acetaminophen weeks patients neurologic recovery residual anosmia ageusia cases occurrence Miller polyneuritis cranialis coronavirus disease 2019 COVID-19 pandemic neurologic aberrant immune response COVID-19 clinical spectrum neurologic symptoms patients COVID-19',\n",
              " 'Cardiac injury associated with mortality critically ill pneumonia COVID-19 meta-analysisIn systematic review meta-analysis association cardiac injury mortality intensive care unit ICU acute respiratory distress syndrome ARDS severe coronavirus disease 2019 COVID-19 patients COVID-19 pneumonia comprehensive literature databases Definition cardiac injury studies sensitive cardiac troponin I percentile primary outcome mortality secondary outcomes ARDS ICU care severe COVID-19 ARDS severe COVID-19 World Health Organization WHO interim guidance severe acute respiratory infection SARI COVID-19 patients studies meta-analysis cardiac injury associated with higher mortality RR Cardiac injury associated with mortality ICU care severity disease patients COVID-19',\n",
              " \"Safety signals QT prolongation Torsades associated with azithromycin chloroquine hydroxychloroquineCombinations hydroxychloroquine HCQ azithromycin treatments COVID-19 small clinical trials assessed potential risks Risks treatment QT segment prolongation Torsades de Pointes TdP death comparative pharmacovigilance analysis risk events Data U.S. Drug Administration's FAERS reports Queries reports exposures HCQ/chloroquine CQ azithromycin HCQ/CQ\\xa0 azithromycin amoxicillin HCQ/CQ\\xa0 amoxicillin Amoxicillin control Events death TdP/QT prolongation accidents/injuries depression control events Proportional Reporting Ratios PRR confidence intervals CI calculated CI Lower95CI safety Lower95CIs HCQ/CQ safety TdP/QT prolongation death control events PRRs CIs TdP/QT prolongation HCQ/CQ use azithromycin HCQ/CQ azithromycin group PRR CI control amoxicillin signals combination HCQ/CQ HCQ/CQ associated with safety analysis FAERS data azithromycin associated with TdP/QT prolongation events caution\",\n",
              " 'Longitudinal characteristics lymphocyte responses cytokine profiles peripheral blood SARS-CoV-2 infected patientsThe lymphocyte subsets cytokines profiles patients coronavirus disease COVID-19 correlation disease severity Peripheral blood samples COVID-19 patients examined lymphocyte subsets flow cytometry cytokine profiles immunoassays COVID-19 patients severe cases significant decreases lymphocyte counts increases neutrophil counts mild cases analysis decreases counts T cells CD8\\n degree lymphopenia proinflammatory cytokine storm severe COVID-19 patients mild cases associated with disease severity N8R NLR prognostic factor identification severe COVID-19 cases National Natural Science Foundation China National Science Technology Major Project Health Commission Hubei Province Huazhong University of Science Technology Medical Faculty University of Duisburg-Essen and Stiftung Universitaetsmedizin Hospital Essen Germany',\n",
              " 'Comparison nasopharyngeal oropharyngeal swabs SARS-CoV-2 detection patients tests specimens outbreak coronavirus disease COVID-19 Wuhan cases China negative RT-PCR test respiratory tract specimens evaluation discharge hospital oropharyngeal swabs sample false negative late stage hospitalization false reviewed medical record patients tests specimens performance nasopharyngeal oropharyngeal swabs patients outpatients inpatients median age years women positive rate positive tests/total tests nasopharyngeal swabs oropharyngeal swabs inpatients Nasopharyngeal swabs inpatients higher positive rate outpatients Nasopharyngeal swabs male higher positive rate female outpatients Detection specimens increased positive rate nasopharyngeal swab consistency nasopharyngeal oropharyngeal swabs poor Kappa=0.308 study nasopharyngeal swabs oropharyngeal swab stage COVID-19 outbreak',\n",
              " 'detection SARS-CoV-2 untreated wastewater Australia concept wastewater surveillance COVID-19 communityInfection SARS-CoV-2 etiologic agent COVID-19 pandemic shedding virus stool quantification SARS-CoV-2 wastewater prevalence infections population wastewater-based epidemiology WBE SARS-CoV-2 RNA wastewater catchment Australia viral RNA reverse transcriptase quantitative polymerase chain reaction RT-qPCR positive detections day period wastewater treatment plant WWTP viral RNA copy numbers wastewater estimate infected individuals catchment Monte Carlo simulation uncertainty variation input parameters model infected persons catchment clinical observations viability WBE monitoring infectious diseases COVID-19 communities methodological molecular assay validation enveloped viruses wastewater',\n",
              " 'COVID-19 transmission Mainland China associated with temperature humidity time-series pandemic influence meteorological factors transmission spread COVID-19 study associations daily temperature AT relative humidity ARH daily counts COVID-19 Chinese provinces Hubei provinces Februarys Generalized Additive Model GAM quantify province-specific meteorological variables daily cases COVID-19 study model exponential moving averages EMAs AT ARH interaction time trend health-seeking behavior spatial distributions visualized AT ARH negative associations COVID-19 interaction confidence interval Hubei increase AT decrease daily cases ARH increase ARH decrease daily cases AT associations Mainland China',\n",
              " 'Laboratory data analysis coronavirus COVID-19 screening COVID-19 infectious early detection isolation treatment information covid-19 screening data clinical practice nucleic acid hematology data patients COVID-19 infection retrospective analysis COVID-19 influenza A B infection rates COVID-19 nucleic acid detected stool samples positive patients patients COVID-19 patients decreased lymphocyte count lymphocyte ratio patients decreased eosinophil count eosinophil ratio patients increased C-reactive protein hematological indicators blood patients COVID-19 influenza A B hematological indicators patients COVID-19 negative patients positive influenza A B infection COVID-19 pharyngeal swab collection infection fecal samples Evaluation pharyngeal swab fecal samples positive rate nucleic acid detection COVID-19 hematological indices changes',\n",
              " 'Early CT features temporal lung changes COVID-19 pneumonia Wuhan ChinaTo analyse high-resolution computed tomography HRCT coronavirus disease COVID-19 pneumonia patients COVID-19 pneumonia isolated lesion positive CT study parameters lesion sites sizes location peripheral central attenuation ground-glass opacity consolidation abnormalities supply pulmonary artery dilation air bronchogram interstitial thickening follow-up CT images CT scans development lesions evaluated lesions peripheral subpleural lesions ground-glass opacity consolidation proportion supply pulmonary artery dilation air bronchogram ﬁndings thickening intralobular interstitium halo ground glass solid nodule Cavitation calciﬁcation lymphadelopathy reticular patterns days symptoms patients days lesions absorbed patients early CT features COVID-19 pneumonia ground-glass opacity peripheral subpleural location supply pulmonary artery dilation Reticulation week patients evaluated weeks onset Long-term follow-up reticulation irreversible ﬁbrosis',\n",
              " 'Correlation Relative Nasopharyngeal Virus Load Lymphocyte Count Disease Severity Patients COVID-19The study correlation dynamic changes nasopharyngeal viral load patients infected coronavirus pneumonia lymphocyte count disease severity Cases diagnosed COVID-19 Affiliated Hospital Nanchang University analyzed retrospectively Quantitative real-time polymerase chain reaction severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 throat swab sample ΔCT values lymphocyte lymphocyte subset counts coagulation system factor levels myocardial injury indexes laboratory biochemical indicators mild group severe group correlation nasopharyngeal SARS-CoV-2 RNA severe disease symptoms analyzed patients male female lymphocyte CD4',\n",
              " \"Longitudinal Study Mental Health of General Population COVID-19 Epidemic ChinaIn public physical health emergency Coronavirus disease 2019 COVID-19 global mental health panic-buying cases soared changes levels psychological impact stress anxiety depression pandemic longitudinal study general population twice initial outbreak epidemic's weeks surveying demographics symptoms knowledge concerns precautionary measures COVID-19 respondents Chinese cities first-survey respondents s-survey respondents respondents Psychological impact mental health status assessed Impact Event Scale-Revised IES-R Depression Anxiety Stress Scale DASS-21 IES-R measures PTSD symptoms survivorship event DASS tripartite model psychopathology general distress characteristics study statistically significant longitudinal reduction IES-R scores weeks IES-R score first- and second-survey respondents cut-off scores PTSD symptoms reduction scores clinically significant evaluation moderate-to-severe stress anxiety depression longitudinal stress anxiety depression levels Protective factors level confidence doctors perceived survival likelihood low risk contracting COVID-19 satisfaction health information personal precautionary measures countries brace escalation cases Governments effective methods disseminating COVID-19 knowledge teaching correct containment methods availability essential services/commodities financial support\",\n",
              " 'Case fatality rate analysis Italian COVID-19 Italian outbreak COVID-19 cases public health emergency evaluation Italian epidemic Italy explosion COVID-19 cases Italian case fatality rate CFR countries intergenerational Italian culture-could deaths Italy analysis Italian regions deaths localized regions CFRs Italian regions rates European countries correlation CFRs social habits positive correlation social behaviors CFRs analysis social habits intergenerational contacts deaths Italy COVID-19 outbreak effort evaluate positive cases',\n",
              " 'Relationships Lymphocyte Subsets Cytokines Pulmonary Inflammation Index Coronavirus COVID-19 Infected PatientsWe relationships lymphocyte subsets cytokines pulmonary inflammation index PII disease evolution patients corona virus disease COVID-19 patients COVID-19 mild severe groups Lymphocyte subsets cytokines detected day hospital admission lung computed tomography quantified PII Difference analysis correlation analysis groups mild severe patients analysis cluster differentiation 4 CD4',\n",
              " 'Estimation effects of nationwide coronavirus infection worsening glycosylated haemoglobin increase diabetes-related complications simulation model multivariate regression coronavirus disease COVID19 India days study assess impact duration glycaemic control diabetes-related complications systematic Cochrane library simulation model glycemic data disasters impact baseline HBA1c diabetes-related data India-specific database multivariate regression analysis relationship duration lockdown glycaemic targets diabetes-related complications predictive model robust predicted outcomes period days increment HBA1c baseline days days annual increase complication rates non-proliferative diabetic retinopathy proliferative diabetic retinopathy retinal photocoagulation microalbuminuria proteinuria peripheral neuropathy extremity amputation myocardial infarction stroke infections duration lockdown proportional worsening glycaemic control diabetes-related complications increase diabetes-related healthcare system increase COVID19 infections patients uncontrolled glycemia',\n",
              " 'Central nervous system manifestations COVID-19 systematic systematic review evidence occurrence central nervous system CNS involvement neurological manifestations patients COVID-19 MEDLINE accessed PubMed Scopus systematically published articles electronic databases search strategy implemented words title/abstract COVID OR brain OR CNS OR neurologic articles neurological COVID-19 publications narrative review viewpoint authors scanned reference lists studies multiple references study investigated neurological manifestations COVID-19 document CNS manifestations patients studies investigated manifestations COVID-19 neurological manifestations COVID-19 patients severe illness CNS involvement neurological manifestations Precise targeted documentation neurological symptoms clinical neurological electrophysiological investigations patients attempts isolate SARS-CoV-2 cerebrospinal fluid autopsies COVID-19 victims virus neurological manifestations',\n",
              " 'Mental health problems social media exposure COVID-19 outbreakHuge citizens social media coronavirus disease COVID-19 Wuhan China prevalence mental health problems association social media exposure cross-sectional study Chinese citizens years Online survey assessment participants provinces autonomous regions study demographics social media exposure SME depression assessed Chinese version WHO-Five Well-Being Index WHO-5 anxiety assessed Chinese version generalized anxiety disorder scale GAD-7 multivariable logistic regressions associations social media exposure with mental health problems controlling covariates prevalence depression anxiety combination depression anxiety CDA COVID-19 outbroke Wuhan China participants exposed to social media controlling covariates SME associated with odds anxiety OR CDA OR compared SME findings prevalence mental health problems associated with SME COVID-19 outbreak findings government mental health problems depression anxiety general population infodemic combating public health emergency',\n",
              " 'Description Proposed Management Acute COVID-19 Cardiovascular SyndromeCoronavirus disease 2019 COVID-19 global pandemic severe acute respiratory syndrome coronavirus 2 morbidity mortality minority patients hospitalized acute COVID-19 cardiovascular syndrome clinical presentations acute cardiac injury cardiomyopathy ventricular arrhythmias hemodynamic instability absence obstructive coronary artery disease injury myocarditis microvascular injury systemic cytokine-mediated injury stress-related cardiomyopathy histologically severe acute respiratory syndrome coronavirus 2 replicate cardiomyocytes pericytes viral myocarditis elevated cytokines cardiotoxic myocardial injury experience severe acute respiratory syndrome coronavirus 1 evaluation therapies antiviral agents interleukin-6 inhibitors convalescent serum Management acute cardiovascular syndrome multidisciplinary team intensive care specialists infectious disease specialists cardiologists Priorities managing acute COVID-19 cardiovascular syndrome balancing goals healthcare staff exposure for testing clinical management recognition syndrome time point intervention effective review data acute COVID-19 cardiovascular syndrome epidemiology pathogenesis diagnosis treatment data surveillance diagnostic management balances potential patient healthcare staff exposure with improvement clinical outcomes',\n",
              " 'Clinical Features Outcomes Pregnant Women Suspected Coronavirus Disease coronavirus disease COVID-19 pandemic circumstance pregnant women study clinical features outcomes pregnant women COVID-19 research objects cases suspected COVID-19 pregnant women birth hospital-a babies years cases pulmonary CT scan routine blood test manifested symptoms fever cough chest tightness gastrointestinal symptoms isolated suite clinical features newborn babies cases patients assigned COVID-19 group tested positive maternal throat swab test patients assigned control group COVID-19 pneumonia coronavirus pneumonia control fever patients prenatal fever patients postpartum COVID-19 group prenatal fever patients postpartum fever patients control group cases case cough group imaging pulmonary CT scan glass opacity patch-like shadows(38.5 fiber pleural effusion pleural COVID-19 group control group prenatal postpartum period count WBC Neutrophils Lymphocyte radio Neutrophils Lymphocyte level CRP COVID-19 group control group(p<0.05 babies mother normal mother SARS-CoV-2 examination throat swab samples birth no case tested positive clinical symptoms laboratory indicators asymptomatic mild COVID-19 pregnant Pulmonary CT scan blood routine finding pregnancy women asymptomatic mild COVID-19 infection screening COVID-19 pregnant outbreak COVID-19 infection',\n",
              " \"impact COPD smoking history severity Covid-19 systemic review meta-analysisComorbidities associated with severity coronavirus disease 2019 COVID-19 meta-analysis risk severe COVID-19 patients pre-existing chronic obstructive pulmonary disease COPD smoking history comprehensive systematic literature studies published databases languages literature English Chinese prevalence severe COVID-19 patients pre-existing COPD smoking evaluated meta-analysis case series Chinese English language cases study OR COPD development severe COVID-19 fixed-effects model CI OR smoking fixed-effects model CI publication bias funnel plot Egger's test heterogeneity studies moderate COPD smoking history severity COVID-19 COPD smoking history worse progression outcome COVID-19\",\n",
              " 'Prognostic value NT-proBNP patients severe COVID-19The outbreak coronavirus disease COVID-19 severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 China public health international concern cardiac injury condition hospitalized patients COVID-19 terminal pro B type natriuretic peptide NT-proBNP outcome severe COVID-19 patients study patients severe COVID-19 continuous sample screening cases patients analyzed study primary outcome in-hospital death case fatality Research information following-up data medical records cut-off value NT-proBNP predicting in-hospital death sensitivity specificity Patients NT-proBNP values increased risk death days following-up compared low values potential risk factors NT-proBNP correlated in-hospital death NT-proBNP risk factor in-hospital death patients severe COVID-19 ClinicalTrials',\n",
              " 'Personal protective equipment preventing infectious diseases exposure to contaminated body fluids healthcare infectious diseases Ebola severe acute respiratory syndrome SARS coronavirus COVID-19 healthcare workers HCW risk infection general population contact patients contaminated body fluids Personal protective equipment PPE reduce risk exposed body parts PPE protects PPE donning remove PPE doffing train HCWs PPE instructed evaluate full-body PPE method donning doffing PPE risk contamination infection HCW training increase compliance PPE protocols CENTRAL MEDLINE Embase CINAHL controlled studies evaluated effect full-body PPE HCW exposed to infectious diseases risk infection contamination noncompliance protocols studies compared effect donning doffing PPE effects of training outcomes review studies data assessed risk bias trials random-effects meta-analyses review studies participants randomised controlled trials RCT quasi-RCT non-randomised design studies PPE studies PPE studies donning doffing processes studies training exposure with fluorescent markers harmless microbes simulation studies median contamination rates intervention control groups Evidence outcomes low stated studies indirectness evidence simulation studies risk bias PPE air-purifying respirator coverall risk contamination N95 mask gown risk ratio RR confidence interval CI non-compliance RR CI RCT participants coveralls doff isolation gowns evidence Gowns contamination aprons small patches mean difference MD CI PPE breathable material spots trunk MD CI water-repellent material user satisfaction MD CI studies tested full-body PPE ensembles contamination Modified PPE standard PPE modifications PPE design contamination standard PPE sealed glove RR CI fitting neck wrists hands RR CI cover gown-wrist interface RR CI low-certainty evidence grab masks RR CI gloves RR CI Donning doffing Centers for Disease Control CDC recommendations doffing contamination no guidance small patches MD CI One-step removal gloves gown bacterial contamination RR CI fluorescent contamination RR CI separate removal viral bacterial contamination single gloving RR CI fluorescent contamination RR CI spoken instruction errors doffing MD CI contamination MD CI Extra sanitation gloves doffing quaternary ammonium bleach decrease contamination alcohol-based hand rub Training computer simulation errors doffing MD CI video lecture PPE skills scores MD CI traditional lecture Face-to-face instruction reduce noncompliance doffing guidance odds ratio CI folders videos low-certainty body protection comes cost donning doffing user comfort PPE contamination user satisfaction Modifications PPE design grab decrease risk contamination donning doffing procedures CDC doffing guidance one-step glove gown removal double-gloving spoken instructions doffing glove disinfection reduce contamination increase compliance Face-to-face training PPE reduce errors folder-based training RCTs training long-term follow-up simulation studies participants combinations PPE procedure protects Consensus simulation exposure assessment outcome real-life evidence PPE HCW exposed to infectious diseases HCW risk infection',\n",
              " 'CT imaging clinical course asymptomatic cases COVID-19 pneumonia admission Wuhan CT imaging clinical course asymptomatic cases COVID-19 pneumonia Asymptomatic COVID-19 pneumonia SARS-COV-2 nucleic acid testing Renmin Hospital Wuhan University retrospectively characteristics CT imaging clinical feature collected analyzed asymptomatic cases COVID-19 pneumonia admitted hospital patients history exposure to SARS-CoV-2 admission patients no symptoms laboratory findings predominant CT findings cohort ground glass opacity GGO peripheral distribution unilateral location lobes characteristic signs short-term follow-up patients symptoms lower lymphocyte count higher CRP fever cough fatigue evolution lesions CT imaging patients days hospitalization days progression patients day CT imaging asymptomatic COVID-19 pneumonia characteristics asymptomatic infections covert patients short term surveillance asymptomatic patients COVID-19 CT scan screening detecting patients COVID-19 pneumonia suspicious asymptomatic negative nucleic acid testing',\n",
              " 'Spread SARS-CoV-2 Icelandic worldwide pandemic coronavirus disease Covid-19 diagnosed Iceland February data SARS-CoV-2 virus Covid-19 enters spreads population testing persons living Iceland high risk infection symptomatic high-risk countries contact infected persons population screening strategies open invitation persons sending random persons sequenced SARS-CoV-2 samples persons targeted testing positive infection SARS-CoV-2 tested general population open-invitation screening random-population screening positive virus population screened persons targeted-testing group positive tests study internationally tested positive study Children years age positive persons years age older percentages targeted testing population screening years age positive result years age older females males positive results targeted testing population screening haplotypes sequenced SARS-CoV-2 viruses diverse changed infected participants population screening duration screening population-based study Iceland children years age females incidence SARS-CoV-2 infection adolescents adults males proportion infected persons identified population screening screening consistent with effect containment efforts deCODE Genetics-Amgen',\n",
              " 'Optimizing hydroxychloroquine dosing patients COVID-19 integrative modeling effective drug repurposingHydroxychloroquine HCQ Coronavirus disease COVID-19 treatment dosing HCQ goal integrate historic pharmacological toxicity data efficacious HCQ strategies COVID-19 treatment data sources longitudinal clinical pharmacokinetic PK virologic data patients severe acute respiratory syndrome-2 SARS-CoV-2 HCQ azithromycin in vitro viral replication data SARS-CoV-2 viral inhibition HCQ population PK model HCQ model chloroquine PKs QTc prolongation mechanistic PK/virologic/QTc model HCQ externally SARS-CoV-2 rate viral decline QTc prolongation SARS-CoV-2 viral decline associated with HCQ PKs extrapolated patient half-maximal concentration EC',\n",
              " 'Hematologic biochemical immune biomarker associated with severe illness mortality coronavirus disease COVID-19 coronavirus disease COVID-19 pandemic rages identification clinical laboratory predictors progression severe fatal forms illness study evaluate hematologic biochemical immunologic biomarkers patients severe fatal forms COVID-19 electronic search Medline PubMed Scopus Web of Science China National Knowledge Infrastructure CNKI studies laboratory abnormalities patients COVID-19 Studies cohorts analysis severity severe non-severe mortality non-survivors survivors Data meta-analysis estimate weighted mean difference WMD confidence interval CI laboratory parameter studies patients laboratory parameters studies compared laboratory patients severe non-severe COVID-19 compared survivors non-survivors disease analyzed separately Patients severe fatal disease increased white blood cell WBC decreased lymphocyte platelet counts non-severe disease survivors Biomarkers inflammation cardiac muscle injury liver kidney function coagulation measures elevated patients severe fatal COVID-19 IL-6 IL-10 serum ferritin discriminators severe disease biomarkers risk stratification predicting severe fatal COVID-19 hospitalized patients respiratory distress clinicians closely monitor WBC lymphocyte count platelet count IL-6 serum ferritin markers progression illness',\n",
              " 'Efficacy face mask preventing respiratory virus systematic review recommendations masks protective effect spread respiratory viruses Preferred Reporting Items Systematic Reviews Meta-Analysis PRISMA systematic review Relevant articles PubMed Web of Science ScienceDirect Cochrane Library Chinese National Knowledge Infrastructure CNKI VIP studies inclusion criteria Meta-analyses mask significant protective effect OR CI masks healthcare workers HCWs non-healthcare workers Non-HCWs reduce risk respiratory virus infection OR CI OR CI protective effect wearing masks Asia OR Western countries OR Masks protective effect influenza viruses OR SARS OR SARS-CoV-2 OR subgroups study protective effects wearing mask cluster randomized trials observational studies study evidence enhanced protective value masks stress masks adjunctive method COVID-19 outbreak',\n",
              " 'Clinical Characteristics COVID-19 Patients Digestive Symptoms Hubei China Descriptive Cross-Sectional Multicenter StudySince outbreak Coronavirus Disease 2019 COVID-19 digestive symptoms patients infected virus study investigate prevalence outcomes COVID-19 patients digestive symptoms cross-sectional multicenter study patients COVID-19 hospitals patients real-time polymerase chain reaction analyzed clinical characteristics laboratory data treatment Data study patients COVID-19 laboratory imaging historical data analyzed age years SD men women patients hospital fever respiratory symptoms patients digestive symptom lack of appetite cases diarrhea cases vomiting cases abdominal pain cases appetite analysis gastrointestinal tract cases patients gastrointestinal-specific symptom diarrhea vomiting abdominal pain Patients digestive symptoms admission patients digestive symptoms days days cases digestive symptoms respiratory symptoms severity disease increased digestive symptoms Patients digestive symptoms mean lower monocyte count prothrombin time antimicrobial treatment digestive symptoms digestive symptoms patients COVID-19 patients admission evidence longer coagulation higher liver enzyme Clinicians digestive symptoms diarrhea features COVID-19 index of suspicion at-risk patients digestive symptoms sample studies findings',\n",
              " 'Inactivation Severe Acute Respiratory Syndrome WHO-Recommended Hand Rub Formulations AlcoholsInfection control alcohol-based hand rub inactivate severe acute respiratory syndrome coronavirus 2 virucidal activity World Health Organization-recommended hand rub formulations strength multiple dilutions active ingredients disinfectants efficient virus inactivation',\n",
              " 'Comorbidities COVID-19 Outcomes hypertensive cohort controversies renin angiotensin system pandemic data increased association heightened mortality patients COVID-19 comorbidities evaluate outcome hypertensive patients COVID-19 renin-angiotensin system blockers RASB systematically medical database published articles English language MeSH data Chinese studies characteristics comorbidities patients COVID-19 hypertension diabetes cardiovascular disease CVD patients data hints increase mortality COVID-19 patients hypertension diabetes CVD multiple confounding factors Harm benefit COVID-19 patients RASB assessed studies mechanistically plausibly benefit harm agents COVID-19 expresses tissues receptor angiotensin converting Special attention patients COVID-19 comorbidities hypertension diabetes established CVD RASB mechanistic equipoise patients COVID-19 drugs organizations advice health care provider',\n",
              " 'Inhibitors renin-angiotensin system pathogenesis COVID-19Coronavirus disease 2019 COVID-19 China countries Asia Europe America Africa Oceania cases cases increasing day published research severe cases elderly chronic disease cardiovascular diseases Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers ACEIs/ARBs drugs cardiovascular diseases clinical effect ACEIs/ARBs patients COVID-19 pathogenesis COVID-19 advice cardiologists physicians',\n",
              " 'Protecting Labor Delivery Personnel COVID-19 Second Stage LaborThe novel coronavirus disease COVID-19 spreading fast clinical workers higher risk general population COVID-19 effect pregnant women evidence asymptomatic disease projected personal protective equipment PPE aggressive attempt conservation obstetrics guidelines PPE controversial differ hospitals globally nationally centers disease control prevention CDC N95 respirators respirators higher level protection facemask aerosol-generating procedures AGP labor AGP labor time labor delivery personnel patients frequently breath cough shout vomit health care team risk COVID-19 transmission aerosol coughing sneezing CDC American College of Obstetricians and Gynecologists ACOG clarification N95 second stage labor delivery personnel caution granted protection patients labor delivery personnel PPE N95 labor adequate protection health care workers health care workers patients KEY POINTS Second stage labor exposes aerosol COVID-19 risk labor N95',\n",
              " 'CT features SARS-CoV-2 pneumonia clinical presentation retrospective analysis consecutive patients Wuhan chest computed tomography findings severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 clinical severity CT features cases severe cases symptomatic patients asymptomatic patients febrile afebrile patients retrospective analysis clinical thoracic CT consecutive patients SARS-CoV-2 pneumonia admitted tertiary university hospital January 10 Wuhan city China admission patients fever cough shortness breath myalgia fatigue diarrhea severe cases Severe patients years average comorbidities elevated lactate dehydrogenase LDH level CT findings asymptomatic symptomatic type patients afebrile febrile patients Chinese National Health Commission guidelines clinical CT features admission clinicians evaluate prognosis patients SARS-CoV-2 pneumonia Clinicians clinically silent cases CT features symptomatic patients clinical features predominant patterns abnormalities CT asymptomatic typic common severe cases findings clinicians severe patients admission Clinicians CT findings afebrile/asymptomatic patients findings patients patients quarantined chest CT screening method epidemic areas',\n",
              " 'Psychological status medical workforce COVID-19 pandemic cross-sectional studyThe coronavirus disease COVID-19 psychological stress people world medical workforce study assess psychological status authors single-center cross-sectional survey online questionnaires Occurrence fear anxiety depression measured numeric rating scale NRS fear Hamilton Anxiety Scale HAMA Hamilton Depression Scale HAMD eligible participants authors institution medical staff administrative staff severity fear anxiety depression groups non-clinical staff front line medical staff contact infected patients working departments respiratory emergency infectious disease ICU scores fear scale HAMA HAMD fear anxiety depression medical staff working above-mentioned departments susceptible psychological disorders Effective improving mental health individuals',\n",
              " 'Prevalence venous thromboembolism patients severe coronavirus severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 Wuhan China spread world Severe coronavirus pneumonia NCP patients abnormal blood coagulation function venous thromboembolism VTE prevalence incidence VTE patients severe NCP study severe NCP patients intensive care unit ICU Union Hospital Wuhan China results conventional coagulation parameters lower limb vein ultrasonography patients retrospectively analyzed incidence VTE patients patients VTE events died VTE group non-VTE group age lymphocyte counts activated partial APTT D-dimer D-dimer cut-off value VTE sensitivity specificity negative predictive value NPV incidence VTE patients severe NCP poor prognosis increase D-dimer severe NCP patients high-risk groups VTE',\n",
              " 'In vitro antiviral activity doxycycline SARS-CoV-2In December acute respiratory syndrome coronavirus SARS-CoV-2 coronavirus disease COVID-19 Wuhan China measures SARS-CoV-2 Asia Southern Europe America Africa effective antiviral drugs drug discovery evaluate drugs efficient SARS-CoV-2 Doxycycline second-generation tetracycline broad-spectrum antimicrobial antimalarial anti-inflammatory activities in vitro activity Vero E6 cells infected clinically isolated SARS-CoV-2 strain IHUMI-3 effective concentration EC',\n",
              " 'Neutrophil-to-lymphocyte Ratio Independent Risk Factor Mortality Hospitalized Patients COVID-19Several studies clinical characteristics patients coronavirus SARS-CoV-2 pneumonia COVID-19 severe patients higher neutrophil lymphocyte ratio NLR baseline NLR predictor in-hospital death Chinese COVID-19 patients investigated cohort patients COVID-19 Zhongnan Hospital Wuhan University retrospectively analyzed baseline data laboratory examinations NLR Univariate multivariate logistic regression models assess relationship baseline NLR in-hospital all-cause death sensitivity analysis converting NLR categorical variable tertile Interaction stratified analyses COVID-19 patients analyses in-hospital mortality Multivariate analysis higher risk in-hospital mortality increase NLR Odds ratio OR confidence interval CI Compared patients tertile NLR patients highest tertile higher risk death OR CI adjustment potential confounders OR mortality males increase NLR OR CI NLR risk factor in-hospital mortality COVID-19 patients male Assessment NLR high risk individuals COVID-19',\n",
              " \"Serological Immunochromatographic Approach Diagnosis SARS-CoV-2 Infected COVID-19 PatientsAn outbreak coronavirus SARS-CoV-2 Wuhan China cities nations diagnostic approach clinic nucleic acid detection real-time RT-PCR false-negative rate technique serological methods colloidal gold-based immunochromatographic ICG viral IgM IgG antibody real-time RT-PCR sensitivity ICG assay IgM IgG combinatorial detection nucleic acid cases early stage days onset intermediate stage days onset late stage days ICG detection capacity nucleic acid-negative cases concordance whole blood samples plasma Cohen's kappa value samples serological ICG strip assay detecting SARS-CoV-2 infection sensitive consistent supplementary approach clinical application\",\n",
              " 'Monotherapy Lopinavir/ritonavir Treating COVID-19Lopinavir/ritonavir arbidol treat acute respiratory syndrome- coronavirus 2 SARS-CoV-2 replication clinical practice effectiveness study evaluated antiviral effects safety lopinavir/ritonavir arbidol patients disease COVID-19 patients laboratory-confirmed COVID-19 groups lopinavir/ritonavir group cases group cases Lopinavir/ritonavir group Lopinavir/ritonavir day week group day Data patients retrospectively analyzed cycle threshold open reading nucleocapsid genes RT-PCR assay monitored antiviral therapy patients severe pneumonia ARDS fever duration groups day admission viral load detected group viral load patients treated with lopinavir/ritonavir Patients group shorter duration positive RNA test lopinavir/ritonavir group apparent side effects groups data monotherapy lopinavir/ritonavir treating COVID-19',\n",
              " 'Effect Corticosteroid Treatment Patients Coronavirus Infection Systematic Review Meta-AnalysisAn outbreak coronavirus threatens health of people pharmacological treatment corticosteroids outbreaks severe acute respiratory syndrome Middle East respiratory syndrome efficacy evaluate influence corticosteroids patients coronavirus infection comprehensive literature PubMed Embase Cochrane library China National Knowledge Infrastructure CNKI January 1 statistical analyses study stata14.0 patients studies meta-analysis critical patients corticosteroids therapy risk ratio RR confidence interval CI corticosteroid treatment associated with higher mortality RR longer length of stay weighted mean difference WMD rate bacterial infection RR hypokalemia RR hyperglycemia RR hypocalcemia RR Patients severe conditions corticosteroids Corticosteroid use associated with increased mortality patients coronavirus pneumonia',\n",
              " 'COVID-19 Children United States Intensive Care Admissions Estimated Total Infected Projected Numbers Severe Pediatric Cases surge severe cases COVID-19 coronavirus disease children challenges hospitals public health preparedness United States estimates children infected SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 projected cumulative numbers ill pediatric COVID-19 hospitalization US pandemic Empirical case projection study pediatric severity pediatric proportions clinical spatiotemporal modeling COVID-19 epidemic China period Estimates children infected SARS-CoV-2 United States US pediatric intensive care unit PICU cases pediatric Projected critically ill children COVID-19 severity criticality US population data scenarios cumulative CPIP children admitted PICUs states children infected SARS-CoV-2 infants toddlers younger years children aged years children aged years CPIP scenario children infected SARS-CoV-2 ill children hospitalization children PICU admission CPIP scenario children PICU admission hospitalization severe pneumonia million infected SARS-CoV-2 children years United States projected numbers severe cases pediatric hospital care resources moderate CPIP scenarios severity COVID-19 children adults',\n",
              " 'Diagnostic Testing Severe Acute Respiratory Syndrome-Related Coronavirus-2 Narrative ReviewDiagnostic testing persons infected severe acute respiratory syndrome-related coronavirus 2 SARS-CoV-2 infection global pandemic COVID-19 countries diagnostic testing massive scale cornerstone United States testing capacity prioritized groups persons Real-time reverse transcriptase polymerase chain reaction-based assays laboratory respiratory specimens reference standard COVID-19 diagnostics point-of-care technologies serologic immunoassays tools diagnosis symptomatic patients well-equipped laboratories screening asymptomatic persons incubation phase accurate determination live viral shedding convalescence decisions isolation affluent countries test delivery specimen collection inhibited increases testing capacity challenges low-resource settings clinical public health unprecedented global increase testing SARS-CoV-2 infection authors tests SARS-CoV-2 diagnostic capacity solutions',\n",
              " 'Severity coronavirus respiratory tract infections adults acute care Toronto OntarioThe World Health Organization improved surveillance health burden non-influenza RNA respiratory viruses Human coronaviruses CoVs respiratory gastrointestinal tract infections morbidity mortality study epidemiology CoVs tertiary care centre clinical correlates disease severity cross-sectional study patients admitted CoV respiratory tract infection Variables consistent with severe disease evaluated symptoms length of stay intensive care unit ICU admission mortality CoVs positive respiratory virus samples OC43 identified CoV. infections community-associated nosocomial average length of stay days patients ICU admission mortality multivariate model female gender smoking associated with increased likelihood admission ICU death study burden CoVs justifies surveillance acute care setting',\n",
              " 'Predictors Mortality Patients COVID-19 Pneumonia SARS-CoV-2 Prospective Cohort study factors associated with death patients COVID-19 pneumonia coronavirus SARS-CoV-2.All clinical laboratory parameters cohort patients COVID-19 pneumonia Wuhan Pulmonary Hospital Wuhan City Hubei Province China Univariate multivariate logistic regression analysis age years OR CI pre-existing concurrent cardiovascular cerebrovascular diseases OR CI CD3+CD8+ T-cells cells·μL−1 OR CI cardiac troponin I OR CI associated with increase risk mortality COVID-19 pneumonia Univariate multivariate logistic regression analysis age years OR CI pre-existing concurrent cardiovascular cerebrovascular diseases OR CI CD3+CD8+ T-cells cells·μL−1 OR CI cardiac troponin I OR CI associated with increase risk mortality COVID-19 pneumonia comorbid CD3',\n",
              " 'immunotherapy COVID-19 systematic reviewThe coronavirus pathogen late December severe respiratory infection humans outbreak COVID-19 international attention treatment control options immunotherapies immunotherapy method viral infections SARS-CoV MERS-CoV. methods vaccines monoclonal antibody candidates systematic review evaluate evidence experience immunotherapy Web of Science ISI PubMed Scopus databases keywords coronavirus Immunotherapy interleukin vaccine words relevant publications systematic review PRISMA protocol Data extraction quality valuation articles reviewers articles results search inclusions exclusions criteria articles review studies research subject writing studies viruses immunotherapy virus',\n",
              " 'Detection SARS-CoV-2 Residents Staff Members Independent Assisted Living Community Older Adults Seattle Washington Seattle Washington metropolitan area COVID-19 United States community-level outbreak evidence spread morbidity mortality older adults long-term care SNFs COVID-19 morbidity residents senior independent assisted living communities residents residents SNFs skilled nursing services residents senior independent assisted living community Seattle hospitalized COVID-19 infection social distancing preventive measures implemented community UW Medicine health system University of Washington Public Health Seattle & King County CDC investigation facility residents staff facility tested SARS-CoV-2 virus COVID-19 questionnaire symptoms residents tested days residents staff members initial phase residents staff members positive test residents no symptoms testing cough resolved resident negative test initial phase positive test days resident asymptomatic days explanations cases COVID-19 residential community SNFs morbidity mortality social distancing residents contact health care providers early implementation isolation protective measures identification COVID-19 cases effective spread virus investigating outbreak COVID-19 senior independent assisted living communities symptom screening persons infected SARS-CoV-2 Adherence CDC guidance prevent COVID-19 transmission senior independent assisted living communities instrumental preventing facility outbreak',\n",
              " 'Comparative Performance SARS-CoV-2 Detection Assays Primer/Probe Sets people infected SARS-CoV-2 virus countries United States cluster US cases Seattle metropolitan area Washington increase local cases availability of accurate high-throughput SARS-CoV-2 testing public health SARS-CoV-2 testing University of Washington Clinical Virology Lab tested assays primer/probe sets assay kit sensitive assays E-gene primer/probe set Corman https://doi.org/10.2807/1560-7917.ES.2020.25.3.2000045) N2 set CDC Division Viral Diseases Centers for Disease Control Prevention assays tested SARS-CoV-2 respiratory viruses analyses primer/probe set kit results invaluable information clinical laboratories SARS-CoV-2 testing protocols increased testing capacity',\n",
              " 'Compassionate Remdesivir Patients Severe Covid-19Remdesivir nucleotide analogue prodrug inhibits viral RNA polymerases in vitro activity SARS-CoV-2 compassionate-use basis patients hospitalized Covid-19 illness infection SARS-CoV-2 Patients SARS-CoV-2 infection oxygen saturation ambient air oxygen support Patients remdesivir administered intravenously day daily days treatment report data patients remdesivir period January clinical data day patients dose remdesivir data analyzed patients post-treatment data dosing error patients data analyzed United States Europe Canada Japan baseline patients mechanical ventilation extracorporeal membrane oxygenation follow-up days patients improvement oxygen-support class patients mechanical ventilation extubated patients discharged patients died mortality patients invasive ventilation invasive ventilation cohort patients hospitalized severe Covid-19 treated with compassionate-use remdesivir clinical improvement patients Measurement efficacy randomized placebo-controlled trials remdesivir therapy Gilead Sciences',\n",
              " \"Clinical efficacy lopinavir/ritonavir treatment Coronavirus disease Coronavirus disease 2019 COVID-19 outbroke low cure therapeutic scheme COVID-19 study investigate lopinavir/ritonavir LPV/r pneumonia-associated adjuvant drugs therapeutic effect COVID-19 patients COVID-19 infection admitted Rui'an People's Hospital collected patients test group control group treated with LPV/r hospitalization Patients test group treated with LPV/r adjuvant medicine control group treated with adjuvant medicine changes body temperature blood routine blood biochemistry groups observed compared groups therapeutic effect body temperature patients decreased admission day treatment body temperature patients test group decreased faster control group Blood routine indexes control group abnormal proportion white blood cells lymphocytes C-reactive protein test group reduced Blood biochemical indexes proportion patients abnormal alanine aminotransferase aspartate aminotransferase test group control group days nCoV-RNA turning negative treatment decreased test group control group Compared treatment pneumonia-associated adjuvant drugs combination treatment LPV/r adjuvant drugs therapeutic effect lowering body temperature physiological mechanisms toxic side effects conclusions LPV/r pneumonia-associated adjuvant drugs clinical treatment patients COVID-19\",\n",
              " \"Prediction Progression Risk Patients COVID-19 Pneumonia CALL ScoreWe high-risk factors coronavirus disease COVID-19 multivariate analysis predictive model disease progression clinicians choose therapeutic strategy consecutive patients COVID-19 Fuyang Second People's Hospital Fifth Medical Center of Chinese PLA January clinical data retrospectively Multivariate Cox regression risk factors associated with progression nomogram prediction scoring model ROC assess performance model patients stable group progressive group conditions hospitalization Univariate multivariate analyses comorbidity older age lower lymphocyte count higher lactate dehydrogenase presentation high-risk factors COVID-19 progression factors nomogram concordance indexes confidence interval CI well-fitted calibration curves scoring model CALL area ROC CI cutoff points positive negative predictive values CALL score model clinicians improve therapeutic effect reduce mortality COVID-19 accurate efficient medical resources\",\n",
              " 'Effect throat washings detection novel coronavirusThe coronavirus detected self-collected throat positive testing throat washing nasopharyngeal swabs Throat washing screening monitoring noninvasiveness reliability',\n",
              " 'Timing antiviral treatment initiation reduce SARS-Cov-2 viral loadWe viral dynamics untreated patients infected severe acute respiratory syndrome-coronavirus 2 infer viral growth parameters effects of antiviral treatments peak viral logs drug efficacy treatment administered symptom onset efficacy treatment symptom onset pharmacokinetic/pharmacodynamic properties investigated drugs efficacy control virus administered early effect ill patients',\n",
              " 'High prevalence obesity severe acute respiratory syndrome coronavirus-2 SARS-CoV-2 invasive mechanical ventilationThe COVID-19 pandemic spreading Europe North America obesity obesity severe acute respiratory syndrome coronavirus-2 SARS-CoV-2 documented retrospective cohort study relationship clinical BMI requirement invasive mechanical ventilation IMV consecutive patients admitted intensive care SARS-CoV-2 French center Obesity BMI severe obesity BMI cases patients IMV proportion patients IMV increased BMI categories study frequency obesity patients admitted intensive care SARS-CoV-2 Disease severity increased BMI Obesity risk factor SARS-CoV-2 severity increased attention preventive measures susceptible individuals',\n",
              " 'Susceptibility ferrets cats dogs domesticated animals SARS-coronavirus acute respiratory syndrome-coronavirus 2 SARS-CoV-2 infectious disease COVID-19 coronavirus disease Wuhan China disease COVID-19 countries global pandemic SARS-CoV-2 bats intermediate animal sources virus study investigated susceptibility ferrets animals contact humans SARS-CoV-2 SARS-CoV-2 replicates poorly dogs pigs chickens ducks ferrets cats infection cats susceptible airborne transmission study animal models SARS-CoV-2 animal management COVID-19 control',\n",
              " 'First-wave COVID-19 transmissibility severity China Hubei control measures second-wave scenario planning impact cases deaths coronavirus disease COVID-19 mainland China Hubei province-the outbreak-had late January massive public health implemented outbreak impact assessment transmissibility severity COVID-19 mainland Chinese locations Hubei instantaneous reproduction number cities provinces COVID-19 outside Hubei aggressive non-pharmaceutical viral reintroduction overseas importation monitoring R\\nHealth Medical Research Fund Hong Kong China',\n",
              " 'Excess cases influenza-like illnesses synchronous coronavirus disease COVID-19 epidemic France coronavirus disease COVID-19 increase ILI cases',\n",
              " 'Face mask general population optimal resource allocation COVID-19 pandemicThe coronavirus disease COVID-19 pandemic infected millions no vaccine interventions mitigate transmission travel restrictions social distancing limiting recommendations face mask inconsistent mathematical modeling epidemiological impact face masks resource limitations supply demand dynamics protective effect face masks infections deaths peak time epidemic random distribution masks suboptimal prioritized elderly outcomes resources detected cases mitigation scenarios Face mask pathogen asymptomatic carriage effective intervention optimized distribution resources',\n",
              " 'Neonatal Resuscitation Postresuscitation Care Infants Born Mothers Suspected Confirmed SARS-CoV-2 coronavirus disease COVID-19 severe acute respiratory syndrome-coronavirus 2 SARS-CoV-2 November2019 progression global pandemic COVID-19 medical social economic Pregnant women newborns vulnerable population impact virus fetus neonate protection health care workers born infants delivery COVID-19 mother essential disagreement expert organizations resource surge volume risk transmission manuscript precautions resuscitation newborn born COVID-19 mother optional variations standards shared-decision making parents perinatal management resuscitation newborn disposition nutrition postdischarge care availability resources application guidelines evidence research assess risk vertical horizontal transmission SARS-CoV-2 impact fetal neonatal outcomes KEY POINTS risk vertical transmission unclear transmission family members/providers neonates Optimal personal-protective-equipment airborne droplet/contact precautions providers prevent transmission Parents decision-making options rooming skin-to-skin contact breastfeeding',\n",
              " 'Quarantine combination public health control COVID-19 reviewCoronavirus disease COVID-19 disease pandemic World Health Organization WHO WHO recommendations quarantine review effectiveness quarantine severe coronavirus outbreaks assess effects of quarantine measures individuals contact cases COVID-19 countries outbreak live regions transmission disease information PubMed Ovid MEDLINE Global Index Medicus Embase CINAHL WHO records daily searches Chinese databases Cohort studies case-control-studies case series time series time series mathematical modelling studies assessed effect type quarantine control COVID-19 studies SARS severe acute respiratory syndrome MERS Middle East respiratory syndrome indirect evidence coronavirus outbreak review records author review authors full-text publications review author data assessed evidence quality GRADE review assessment certainty evidence primary outcomes incidence onward transmission mortality resource use studies studies COVID-19 observational studies SARS MERS methods measurement analysis outcomes meta-analysis narrative synthesis evidence review GRADE rates evidence Modeling studies benefit quarantine measures quarantine people exposed to cases incident cases deaths measures scenarios incident cases studies COVID-19 SARS mortality studies COVID-19 SARS low-certainty evidence evidence quarantine measures implemented cost savings SARS evidence effect quarantine travellers country outbreak reducing incidence deaths studies SARS models quarantine prevention control measures school closures travel restrictions social distancing models effect reduction cases transmissions deaths individual measures incident cases studies COVID-19 onward transmission studies COVID-19 mortality studies COVID-19 low-certainty evidence Studies SARS MERS consistent with findings studies COVID-19 evidence COVID-19 studies parameter assumptions current fragmented knowledge Findings quarantine reducing incidence mortality COVID-19 pandemic Early implementation quarantine quarantine public health effectiveness balance measures decision makers outbreak impact measures implemented Testing samples settings assess infection reduce uncertainty modelling assumptions review WHO Danube-University-Krems',\n",
              " 'Intensive care management coronavirus disease COVID-19 challenges recommendationsAs coronavirus disease COVID-19 world intensive care unit ICU community associated with pandemic rapid diagnosis isolation clinical management infection prevention patients COVID-19 health-care workers patients risk nosocomial transmission Management acute respiratory failure haemodynamics ICU practitioners hospital administrators governments policy makers increase critical care capacity infrastructure supplies staff management Critical care triage ICU resources Researchers repurposed experimental therapies Collaboration local regional national international level chance survival critically ill',\n",
              " 'High-Dose Intravenous Immunoglobulin Therapeutic Option Deteriorating Patients Coronavirus Disease outbreak coronavirus disease COVID-19 China effective treatment identified patients severe COVID-19 high-dose intravenous immunoglobulin IVIg satisfactory recovery observations randomized studies high-dose IVIg deteriorating patients infected COVID-19',\n",
              " 'High Contagiousness Spread Severe Acute Respiratory Syndrome Coronavirus acute respiratory syndrome coronavirus 2 causative agent coronavirus disease estimates early dynamics outbreak Wuhan China doubling time infected persons days',\n",
              " 'Olfactory gustatory dysfunctions clinical presentation mild-to-moderate coronavirus disease COVID-19 multicenter European investigate occurrence olfactory gustatory dysfunctions patients laboratory-confirmed COVID-19 infection Patients laboratory-confirmed COVID-19 infection European hospitals epidemiological clinical outcomes age sex ethnicity comorbidities general otolaryngological symptoms Patients olfactory gustatory questionnaires smell taste National Health and Nutrition Examination Survey version Questionnaire Olfactory Disorders-Negative Statements sQOD-NS mild-to-moderate COVID-19 patients study females general symptoms cough myalgia loss of appetite Face pain nasal obstruction otolaryngological symptoms patients olfactory gustatory dysfunctions association disorders Olfactory dysfunction OD symptoms cases sQO-NS scores patients anosmia compared normosmic hyposmic individuals patients nasal obstruction rhinorrhea hyposmic anosmic early olfactory recovery rate Females affected olfactory gustatory dysfunctions males Olfactory gustatory disorders symptoms European COVID-19 patients nasal symptoms sudden anosmia ageusia international scientific community symptoms COVID-19 infection',\n",
              " 'Effectiveness convalescent plasma therapy severe COVID-19 patientsCurrently antiviral agents coronavirus disease COVID-19 study severe patients real-time viral RNA test dose convalescent plasma CP donors neutralizing antibody titers patients maximal supportive care antiviral agents primary endpoint safety CP transfusion endpoints improvement clinical symptoms laboratory parameters CP transfusion illness CP transfusion CP transfusion level neutralizing antibody increased cases cases maintained level clinical symptoms increase saturation parameters improve pretransfusion increased lymphocyte counts',\n",
              " 'Evidence Vitamin D Supplementation Reduce Risk Influenza COVID- 19 Infections DeathsThe world grip COVID-19 pandemic Public health reduce risk infection death quarantines reviews vitamin D reducing risk respiratory tract infections knowledge epidemiology influenza COVID-19 vitamin D supplementation measure reduce risk mechanisms vitamin D reduce risk infections mechanisms inducing cathelicidins defensins viral replication rates reducing concentrations pro-inflammatory cytokines inflammation lining lungs pneumonia increasing concentrations anti-inflammatory cytokines observational studies clinical trials vitamin D supplementation risk influenza Evidence vitamin D reducing risk COVID-19 outbreak winter 25-hydroxyvitamin D 25(OH)D concentrations cases Southern Hemisphere summer low vitamin D deficiency acute respiratory distress syndrome case-fatality rates increase age chronic disease comorbidity associated with lower 25(OH)D concentration reduce risk infection people risk influenza COVID-19 vitamin D',\n",
              " 'Generalized Pustular Figurate Erythema A Severe Cutaneous Drug Reaction HydroxychloroquineA severe acute generalized exanthematous pustulosis ingestion hydroxychloroquine documented incubation period morphology urticarial targetoid arcuate plaques recalcitrance therapy longer duration anticipated surge hydroxychloroquine benefits coronavirus disease recognition entity generalized pustular figurate erythema',\n",
              " 'cardiovascular coronavirus disease COVID-19 congenital heart diseaseCoronavirus disease COVID-19 betacoronavirus acute respiratory syndrome coronavirus 2 SARS-CoV-2 cluster patients pneumonia symptoms Wuhan China months COVID-19 worldwide pandemic documented cases SARS-CoV-2 virus zoonotic effective human-to-human transmission COVID-19 mild symptoms infected patients severe lung injury cardiac injury death COVID-19 treatment supportive care public-health measures person-to-person transmission COVID-19 implemented curb spread disease reduce burden healthcare systems vulnerable populations elderly medical comorbidities infectious disease data effects infection patients cardiovascular disease congenital heart disease early experience COVID-19 applicability patients cardiovascular disease general congenital heart disease',\n",
              " 'comparative-descriptive analysis clinical characteristics Coronavirus-infected children adultsAcute respiratory disease China Children adults clinical course study clinical characteristics infection children adults discrepancies medical records adults children cases acute respiratory diseases reviewed retrospectively children family clusters adult patients local residents Wuhan history Wuhan contact people Wuhan numbers median incubation period children adults days ranged days days ranged days Diarrhoea vomiting demic World Health Organiza children adults myalgia fatigue admission percentage children pneumonia adults adults leucopoenia leukocytosis frequently children children elevated creatine kinase isoenzyme Antiviral therapy adult patients children children adults clinical diagnosis discussion age-specific coronavirus infection',\n",
              " 'Extracorporeal membrane oxygenation ECMO treatment severe COVID-19?The severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 Wuhan city China countries treatment effective SARS-CoV-2 infection World Health Organization WHO management coronavirus disease 19 COVID-19 infection prevention case detection monitoring supportive care experience extracorporeal membrane oxygenation ECMO effective therapy treatment respiratory failure acute respiratory distress syndrome ARDS principle ECMO effective therapy treatment severe COVID-19 study clinical outcomes ECMO ARDS patients ECMO severe COVID-19 China indications ECMO use associated with ECMO',\n",
              " 'Potential harmful effects discontinuing ACE-inhibitors ARBs COVID-19 patientsThe discovery angiotensin converting enzyme-2 ACE-2 receptor SARS- CoV-2 Severe Acute Respiratory Syndrome Coronavirus-2 renin-angiotensin-aldosterone system acute respiratory distress syndrome ARDS respiratory failure patients coronavirus disease-19 COVID-19 angiotensin converting II-angiotensin AT',\n",
              " 'Impact school closures COVID-19 US health-care net mortality modelling studyThe coronavirus disease 2019 COVID-19 pandemic social physical policies USA actions governments schools evidence mandatory school closures cases mortality comes experience influenza models effect school closure health-care labour force benefits school closures costs health-care worker associated with child-care obligations study measure child-care obligations US health-care workers school closures social distancing measure assessed contribution health-care workers reducing mortality absenteeism child-care obligations undo benefits school closures reducing cases modelling analysis data monthly releases US Population Survey family structure child-care US health-care workers occupation health-care sector state household structure segments health-care exposed to child-care school closures estimates critical level health-care labour supply increasing survival probability patient COVID-19 undo benefits school closures increase cumulative mortality January January US Population Survey information individuals households US health-care sector child-care obligations USA CI health-care children aged years non-working adults sibling aged years older child care health-care child care school closure variation health-care system parameters COVID-19 case reduction school closings baseline mortality decrease health-care labour force decrease survival probability health-care worker lost school closure increase cumulative mortality model infection mortality COVID-19 increases health-care school closures deaths prevent School closures trade-offs child-care obligations contagion prevention school closures weighted potential loss health-care workers reducing cumulative mortality COVID-19 absence mitigating measures',\n",
              " 'Diagnostic value dynamic variance serum antibody coronavirus disease investigate diagnostic value serological testing dynamic variance serum antibody coronavirus disease COVID-19 study retrospectively patients laboratory-confirmed infection patients infection disease IgM/IgG titer severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 chemiluminescence immunoassay analysis molecular detection sensitivities serum IgM IgG diagnose COVID-19 specificities COVID-19 group IgM-positive rate increased decreased IgG-positive rate increased higher IgM IgM-positive rate titer conversion virus-negative IgG-positive rate conversion virus-negative median IgG conversion virus-negative difference significant Viral serological testing diagnosis SARS-CoV-2 infection positive rate titer variance IgG IgM COVID-19',\n",
              " \"Baseline Characteristics Outcomes Patients Infected SARS-CoV-2 ICUs Lombardy Region Italy coronavirus severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 China pandemic Information clinical characteristics infected patients intensive care patients coronavirus disease 2019 COVID-19 treatment intensive care unit ICU Lombardy region Italy Retrospective case series consecutive patients laboratory-confirmed COVID-19 ICU admission coordinator center Fondazione IRCCS Ca' Granda Milan Italy COVID-19 Lombardy ICU Network treated ICUs hospitals network follow-up SARS-CoV-2 real-time reverse transcriptase-polymerase chain reaction RT-PCR nasal pharyngeal swabs Demographic clinical data data clinical management respiratory failure patient mortality Data coordinator center electronic worksheet telephone calls staff COVID-19 Lombardy ICU Network patients study median IQR age years male patients data comorbidity hypertension patients respiratory support data CI respiratory support CI mechanical ventilation CI noninvasive ventilation median positive PEEP IQR H2O Fio2 patients Pao2/Fio2 IQR median PEEP level younger patients aged years older patients aged years IQR IQR H2O CI Median Fio2 younger patients IQR IQR median difference CI median Pao2/Fio2 younger patients IQR IQR median CI Patients hypertension older hypertension median IQR age years years median IQR median difference CI patients ICU disposition data patients CI ICU CI discharged ICU CI died ICU Older patients age years higher mortality younger patients age years CI case series critically ill patients laboratory-confirmed COVID-19 ICUs Lombardy Italy older men proportion mechanical ventilation PEEP ICU mortality\",\n",
              " 'Remdesivir severe acute respiratory syndrome coronavirus 2 COVID-19 evaluation evidenceThe coronavirus infection attention infectious cases increased outbreak pandemic situation drug Relevant reports pointed coronavirus homology SARS difficulty synthesized drug patients conventional drug solution medication patients US drug China immediate action clinical trials clinical therapeutics Corona Virus Disease 2019 COVID-19 structure immunogenicity pathogenesis coronavirus infections analyzed pharmacological trials feasibility experiments COVID-19',\n",
              " 'Difference coagulation severe pneumonia induced SARS-CoV2 coronavirus disease COVID-19 coagulopathy coagulation severe pneumonia induced SARS-CoV2 analyzed Coagulation clinical features consecutive patients severe pneumonia induced SARS-CoV2 COVID group non-COVID group Tongji hospital retrospectively analyzed compared patients elevated D-dimer anticoagulant treatment evaluated COVID patients non-COVID patients study mortality COVID group mortality non-COVID group COVID group older years higher platelet count',\n",
              " 'Incidence novel coronavirus infection people home quarantine Shenzhen ChinaSince outbreak December Chinese government implemented measures travel bans centralized treatments home quarantines transmission country study estimate incidence infection people home quarantine Shenzhen China stratified multistage random sampling method recruit participants collected demographic information laboratory people home quarantine descriptive analysis estimate characteristics calculate incidence study population people home quarantine study participants questionnaire response rate Mean age participants years years people travel history people Wuhan city people cities Hubei province days home quarantine participants contact history cases trip arrived Shenzhen incidence COVID-19 sample CI Home quarantine effective preventing early transmission COVID-19 early detection COVID-19 infection',\n",
              " 'Cardiovascular disease COVID-19Many patients coronavirus disease 2019 COVID-19 cardiovascular acute cardiac injury course illness COVID-19 CV disease optimum management patients literature PubMed Google search engines narrative review Respiratory illness clinical manifestation COVID-19 CV involvement Acute cardiac injury elevation cardiac troponins cardiac abnormality COVID-19 patients myocardial injury viral involvement cardiomyocytes effect systemic inflammation mechanisms cardiac injury information CV manifestations COVID-19 pre-existing CV disease development acute cardiac injury associated with worse outcome patients reports COVID-19 CV manifestations patients burden illness adverse prognostic impact cardiac involvement research incidence mechanisms clinical presentation outcomes CV manifestations COVID-19 patients',\n",
              " 'Blockchain Artificial Intelligence Technology Coronavirus Disease-19 coronavirus disease COVID-19 spreading rising death toll transmission rate high income countries low income countries healthcare systems poor disease surveillance systems resource-limited settings COVID-19 outbreak strategic response settings low cost blockchain artificial intelligence-coupled self-testing tracking systems COVID-19 infectious diseases Prompt deployment implementation system curb transmissions COVID-19 mortalities poor access laboratory infrastructure',\n",
              " 'Favipiravir pharmacokinetics concerns clinical trials infectionAn outbreak infection world antiviral drugs treatment COVID-2019 antiviral drugs interferon-ɑ lopinavir/ritonavir ribavirin chloroquine phosphate clinical trials virus RNA-dependent RNA polymerase RdRp inhibitors initiated Favipiravir purine nucleic acid analog RdRp inhibitor influenza clinical trials pharmacokinetic characteristics favipiravir drug-drug interactions view drug metabolism design clinical trials favipiravir COVID-2019 data in vitro virus inhibition efficacy preclinical animal studies',\n",
              " 'Systematic Review COVID-19 Epidemiology EvidenceAs SARS-CoV-2 globe evidence epidemiological characteristics SARS-CoV-2 effectiveness control measures policymakers leaders management guidelines directions research systematic review published literature preprints coronavirus disease COVID-19 outbreak eligibility criteria research PubMed preprint inclusion criteria review evidence days epidemic double size estimates reproduction incubation period days serial interval days true case fatality model-based estimates outside China research mitigation impact society',\n",
              " 'Respiratory virus shedding exhaled breath efficacy face identified seasonal human coronaviruses influenza viruses rhinoviruses exhaled breath coughs children adults acute respiratory illness Surgical face masks reduced detection influenza virus RNA respiratory droplets coronavirus RNA aerosols reduced detection coronavirus RNA respiratory droplets results surgical face masks prevent transmission human coronaviruses influenza viruses symptomatic individuals',\n",
              " 'Severe Acute Respiratory Syndrome Coronavirus 2 RNA Detected Blood DonationsBecause coronavirus disease Wuhan China Wuhan Blood Center severe acute respiratory syndrome coronavirus 2 RNA donations real-time retrospectively plasma samples positive viral RNA asymptomatic donors',\n",
              " 'FDA-approved Drug Ivermectin inhibits replication SARS-CoV-2 vitroAlthough clinical trials test therapies response COVID-19 outbreak monitoring/containment Ivermectin FDA-approved anti-parasitic anti-viral activity in vitro inhibitor causative virus SARS-CoV-2 Vero-hSLAM cells post infection SARS-CoV-2 effect reduction viral RNA Ivermectin warrants investigation benefits humans',\n",
              " 'Meningitis/Encephalitis associated with SARS-Coronavirus-2Novel coronavirus SARS-Coronavirus-2:SARS-CoV-2 Wuhan China multiple countries meningitis associated with SARS-CoV-2 ambulance convulsion unconsciousness foreign countries generalized fatigue fever day doctors day prescribed Laninamivir antipyretic agents His family home unconsciousness lying floor hospital ambulance day emergency transport transient generalized seizures minute neck stiffness SARS-CoV-2 RNA nasopharyngeal swab detected CSF HSV 1 varicella-zoster IgM antibodies serum samples brain MRI hyperintensity wall right lateral ventricle hyperintense signal right mesial temporal lobe hippocampus SARS-CoV-2 meningitis physicians patients CNS symptoms',\n",
              " 'Breastfeeding Coronavirus Disease-2019 Italian Society of Neonatology Union European Neonatal & Perinatal SocietiesThe COVID-19 pandemic Italy heavy consequences public health economics consequences COVID-19 infection pregnant woman fetus effect neonatal outcome management mother-newborn dyad compatibility maternal COVID-19 breastfeeding Italian Society Neonatology SIN scientific knowledge compatibility breastfeeding COVID-19 mother statements Health Care Organizations indications endorsed Union European Neonatal & Perinatal Societies UENPS mother COVID-19 positive investigation COVID-19 asymptomatic paucisymptomatic delivery rooming-in breastfeeding measures infection control contrary mother COVID-19 sick newborn neonate separately fed fresh expressed breast milk human milk vehicle COVID-19 guidance knowledge COVID-19 pandemic perinatal transmission SARS-CoV-2 clinical characteristics cases neonatal COVID-19',\n",
              " 'Coronavirus Disease Elderly Patients Characteristics Prognostic Factors 4-week investigate characteristics prognostic factors elderly patients COVID-19 Consecutive cases years COVID-19 Renmin Hospital Wuhan University primary outcomes death survival Data demographics clinical features comorbidities laboratory tests complications collected compared outcomes Cox regression prognostic factors patients COVID-19 years,173 females severe moderate cases comorbidities hypertension diabetes cardiovascular disease Common symptoms fever cough dyspnea fatigue Lymphocytopenia laboratory finding complications bacterial infection liver enzyme abnormalities acute respiratory distress syndrome cases discharged cases stayed hospital cases dead Shorter length of stay dead survivors Symptoms dyspnea HR comorbidities cardiovascular disease HR chronic obstructive pulmonary disease HR acute respiratory distress syndrome HR predictors death level lymphocytes outcome HR severe cases fatality rate elderly COVID-19 patients Rapid disease progress dead median survival time days admission Dyspnea lymphocytopenia comorbidities cardiovascular disease chronic obstructive pulmonary disease acute respiratory distress syndrome poor outcome monitoring treatment elderly patients high risk',\n",
              " 'Estimates Severity Coronavirus Disease Model-Based AnalysisIn face changing data case fatality estimates coronavirus disease COVID-19 magnitude robust estimates censoring ascertainment biases individual-case data patients died COVID-19 Hubei mainland China national provincial health commissions cases outside mainland China government ministry health websites media reports countries Hong Kong Macau individual-case data symptoms outcome death discharge hospital age-stratified estimates case fatality ratio aggregate distribution cases cumulative deaths China constant attack age demography age-based location-based under-ascertainment case fatality ratio line-list data cases outside mainland China data prevalence PCR-confirmed international residents China age-stratified estimates infection fatality ratio data age-stratified severity cases China estimate proportion infected individuals hospitalisation data deaths mainland China recoveries China mean duration symptoms death days credible interval CrI hospital discharge days laboratory clinically diagnosed cases mainland China crude case fatality ratio censoring CrI demography under-ascertainment estimate case fatality ratio China ratios older age aged years 5·7 aged years aged years older Estimates case fatality ratio international age consistent with China parametric estimate aged years aged years overall infection China increasing profile age estimates proportion infected individuals hospitalised increased age aged years older early estimates indication fatality ratio spectrum COVID-19 disease age gradient risk death Medical Research Council',\n",
              " 'Italian Experience Lung Ultrasound Identification Grading Serial Follow-up Severity Lung Involvement Management Patients COVID-19Lung ultrasound LU assessment patients stricken COVID-19 months January February modality identification lung pulmonary severity patients suspected documented COVID-19 infection LU clinical decision making reduced chest x-rays computed tomography CT',\n",
              " 'Nervous System Involvement Infection COVID-19 CoronavirusesViral infections detrimental impacts neurological functions severe neurological damage coronaviruses CoV severe acute respiratory syndrome SARS-CoV-2 properties neurological diseases CoV brain cerebrospinal fluid pathobiology neuroinvasive viruses impact CoV infections nervous system research neurological complications CoV infections mechanisms damage nervous system',\n",
              " 'Potential utilities mask wearing instant hand hygiene SARS‐CoV‐2The surge patients pandemic COVID-19 coronavirus SARS-CoV-2 medical systems countries Mask-wearing handwashing virus masks countries handwashing study efficacy masks instant hand wiping evaluated avian influenza virus mock coronavirus Virus quantification real-time reverse transcription-polymerase chain reaction mask-wearing reviewed results instant hand wiping wet towel soaked water soap powder active chlorine active chlorine sodium hypochlorite virus hands N95 masks medical masks homemade masks four-layer one-layer cloth virus aerosols Medical mask-wearing studies studies judgment data mask-wearing instant hand hygiene MIH exponential virus MIH experiences countries COVID-19 exponential SARS-CoV-2 experiments literature review control experiences',\n",
              " 'Diabetes risk factor progression prognosis COVID‐19To diabetes risk factor progression prognosis coronavirus disease COVID-19 consecutive patients COVID-19 Demographic data medical history symptoms signs laboratory findings chest computed tomography CT treatment collected analysed COVID-19 patients comorbidities diabetes risk severe pneumonia release tissue injury-related enzymes inflammation responses hypercoagulable state associated with dysregulation glucose metabolism serum levels inflammation-related biomarkers IL-6 C-reactive protein serum ferritin coagulation index D-dimer significantly higher diabetic patients compared patients diabetes susceptible inflammatory storm deterioration COVID-19 data notion diabetes risk factor progression bad prognosis COVID-19 patients diabetes rapid deterioration',\n",
              " 'Experience High-Flow Nasal Cannula Hospitalized Patients Novel Coronavirus-Infected Pneumonia Hospitals Chongqing ChinaThe outbreak pneumonia NCIP China critically ill patients high-flow nasal cannula HFNC oxygen therapy HFNC population retrospectively patients NCIP hospitals Chongqing China patients severe acute respiratory failure patients treated with HFNC first-line therapy patients treated with noninvasive ventilation NIV patient treated with invasive ventilation HFNC failure NIV intubation rescue therapy HFNC patients HFNC failure HFNC rate patients PaO study HFNC ventilation patients NCIP Patients PaO',\n",
              " 'Prevalence Underlying Diseases Hospitalized Patients COVID-19 Systematic Review Meta-AnalysisIn outbreak corona virus headlines world Exponential growth affected virus threat meta-analysis estimate prevalence disorders hospitalized COVID-19 patients comprehensive systematic search PubMed Scopus Web of science Google scholar articles published relevant articles clinical characteristics epidemiological information hospitalized COVID-19 patients analysis data patients articles study meta-analysis prevalence hypertension cardiovascular disease smoking history diabetes people infected SARS-CoV-2 findings study hypertension cardiovascular diseases diabetes mellitus smoking chronic obstructive pulmonary disease COPD malignancy chronic kidney disease diseases hospitalized COVID-19 patients',\n",
              " 'Analysis heart injury laboratory parameters COVID‐19 patients hospital Wuhan ChinaAn outbreak severe acute respiratory syndrome SARS-CoV-2 epidemic SARS-CoV-2 infection seriously fatally respiratory enteric cardiovascular neurological diseases study detected analyzed laboratory indicators heart injury creatine kinase isoenzyme-MB CK-MB myohemoglobin MYO cardiac troponin I ultra-TnI N-terminal pro-brain natriuretic peptide NT-proBNP patients COVID-19 investigated correlation heart injury severity disease higher concentration venous blood CK-MB MYO ultra-TnI NT-proBNP associated with severity case fatality COVID-19 monitoring myocardiac enzyme profiles reducing complications mortality patients COVID-19',\n",
              " 'ACE2 expression human heart potential mechanism heart injury patients infected SARS-CoV-2A pneumonia coronavirus SARS-CoV-2 outbreaks China spreads countries disease COVID-19 patients infected SARS-CoV MERS-CoV patients severe condition Cardiac injury complication severe patients disease severity coronavirus disease COVID-19 patients Angiotensin-converting enzyme 2 ACE2 host cellular receptor SARS-CoV-2 multiple organs cellular distribution human heart study adult human heart pericytes expression ACE2 target cardiac cell SARS-CoV-2 pericytes injury virus infection capillary endothelial cells microvascular dysfunction patients heart failure disease increased ACE2 expression mRNA protein levels infected virus patients risk heart attack critically ill condition finding study rate severe cases COVID-19 patients cardiovascular disease results clinical treatment cardiac injury severe patients infected SARS-CoV-2',\n",
              " 'Stability Issues RT-PCR Testing SARS-CoV-2 Hospitalized Patients Clinically Diagnosed study hospitalized patients Wuhan February 2 false real-time reverse-transcriptase polymerase chain reaction RT-PCR testing SARS-CoV-2 hospitalized patients clinically diagnosed COVID-19 outbreak RT-PCR results tests points patients course diagnosis treatment patients emphasis RT-PCR testing clinical indicators computed tomography images diagnosis treatment isolation recovery/discharge transferring hospitalized patients clinically diagnosed COVID-19 epidemic results standard procedures sampling anatomic sites sample transportation optimization RT-PCR serology SARS-CoV-2 infection diagnosis respiratory diseases fluenza infections',\n",
              " 'Early antiviral treatment alleviate severity improve prognosis patients coronavirus disease severity patients infected severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 focal point factors associated with severity prognosis patients infected SARS-CoV-2 retrospectively investigated clinical imaging laboratory characteristics cases coronavirus disease COVID-19 age patients mild group years severe group years proportion patients aged years severe group mild group severe patients diabetes cardiovascular diseases mild group Patients mild group initiation antiviral treatment days severe group study comorbidity time illness antiviral treatment age risk factors COVID-19 progression comorbidity time illness antiviral treatment risk factors COVID-19 recovery elderly patients diseases severe progression COVID-19 antiviral treatment disease progression improve prognosis',\n",
              " 'effect human mobility control measures COVID-19 epidemic ChinaThe COVID-19 outbreak China behavioral clinical state interventions mitigate epidemic prevent persistence virus human populations China worldwide unprecedented interventions travel restrictions affected COVID-19 spread China real-time mobility data Wuhan case data travel case importation transmission cities China impact control measures spatial distribution COVID-19 cases China human mobility data implementation control measures correlation growth rates negative locations shifts demographics cases indicative local chains transmission Wuhan study drastic control implemented China mitigated spread COVID-19',\n",
              " 'Temporal profiles viral load posterior oropharyngeal serum antibody responses infection SARS-CoV-2 observational cohort studyCoronavirus disease 2019 COVID-19 severe community nosocomial outbreaks Comprehensive data serial respiratory viral load serum antibody responses patients infected severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 Nasopharyngeal throat swabs serial viral load respiratory infections gathering specimens discomfort patients health-care workers risk serial respiratory viral load SARS-CoV-2 posterior oropharyngeal deep throat saliva samples patients COVID-19 serum antibody responses cohort study hospitals Hong Kong patients laboratory-confirmed COVID-19 samples blood urine posterior oropharyngeal saliva rectal swabs Serial viral load reverse transcriptase quantitative PCR RT-qPCR Antibody levels SARS-CoV-2 internal nucleoprotein NP surface spike protein receptor binding domain RBD EIA Whole-genome sequencing mutations infection patients inclusion median age years median viral load posterior oropharyngeal saliva respiratory specimens presentation non-invasive specimen patients health-care workers acute respiratory syndrome patients COVID-19 viral load presentation fast-spreading nature epidemic finding stringent infection control early antiviral agents combination high-risk individuals Serological assay RT-qPCR diagnosis Carol Yu May Tam Mak Mei Shaw Foundation Michael Marina Lee Government Consultancy Service Sanming Project Medicine',\n",
              " \"nationwide survey psychological distress Chinese people COVID-19 epidemic implications policy COVID-19 epidemic Wuhan China spread nationwide dozen countries implementation quarantine measures China people isolation affected people's lives psychological problems panic disorder anxiety depression study psychological distress general population China COVID-19 epidemic\",\n",
              " 'Cardiovascular Implications Fatal Outcomes Patients Coronavirus Disease numbers cases mortality coronavirus disease COVID-19 countries continents Information impact cardiovascular complication fatal outcome evaluate association cardiovascular disease CVD myocardial injury fatal outcomes patients COVID-19 retrospective single-center case series analyzed patients COVID-19 Seventh Hospital Wuhan City China Analysis Demographic data laboratory findings comorbidities treatments collected analyzed patients elevation troponin T TnT levels patients COVID-19 patients discharged patients died mean age years CVD hypertension coronary heart disease cardiomyopathy myocardial injury elevated TnT levels mortality hospitalization patients CVD normal TnT levels CVD normal TnT levels CVD elevated TnT levels CVD elevated TnTs Patients CVD elevation TnT levels patients CVD Plasma TnT levels high positive linear correlation plasma N-terminal pro-brain natriuretic peptide NT-proBNP Plasma TnT NT-proBNP levels hospitalization median interquartile range IQR impending death median IQR increased admission values median IQR patients died dynamic TnT median IQR NT-proBNP median IQR survivors hospitalization patients elevated TnT levels frequent malignant arrhythmias glucocorticoid therapy mechanical ventilation compared patients normal TnT levels mortality patients angiotensin-converting enzyme inhibitors/angiotensin receptor blockers Myocardial injury associated with fatal outcome COVID-19 prognosis patients CVD myocardial injury Myocardial injury associated with cardiac dysfunction arrhythmias Inflammation mechanism myocardial injury Aggressive treatment patients high risk myocardial injury',\n",
              " \"High-resolution computed tomography manifestations COVID-19 infections patients agesWe compare chest HRCT scans aged patients COVID-19 infections patients diagnosed COVID-19 infection Hangzhou City Zhejiang Province China collected chest HRCT signs infected patients age groups years years years years Small patchy ground-glass opacity GGO consolidations HRCT signs patients COVID-19 infections Patients aged years aged years bilateral lung lung lobe lung field involvement lesion numbers patients years GGO interlobular septa thickening crazy-paving pattern consolidation air bronchogram sign patients aged years years aged years aged years Chest HRCT manifestations patients COVID-19 patient's HRCT signs younger patients\",\n",
              " \"Treatment Critically Ill Patients COVID-19 Convalescent PlasmaCoronavirus disease 2019 COVID-19 pandemic therapeutic agents substantial mortality treatments convalescent plasma transfusion treatment critically ill patients severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 patients laboratory-confirmed COVID-19 acute respiratory distress syndrome ARDS criteria severe pneumonia progression viral load antiviral treatment mechanical ventilation treated with plasma transfusion study infectious disease department Shenzhen Third People's Hospital Shenzhen China follow-up Clinical outcomes plasma transfusion Patients transfusion convalescent plasma SARS-CoV-2-specific antibody IgG binding titer end point dilution titer enzyme-linked immunosorbent assay ELISA neutralization end point dilution titer patients COVID-19 plasma administered days admission body temperature Sequential Organ Failure Assessment scores severe illness Pao2/Fio2 viral load serum antibody titer routine blood biochemical index ARDS ventilatory extracorporeal membrane oxygenation ECMO plasma transfusion patients age range years women mechanical ventilation treatment antiviral agents methylprednisolone plasma transfusion body temperature normalized days patients SOFA score decreased Pao2/Fio2 increased days Viral loads decreased negative days transfusion SARS-CoV-2-specific ELISA neutralizing antibody titers increased transfusion day ARDS patients days transfusion patients mechanical ventilation weeks treatment patients hospital length of stay days stable condition days transfusion case series ill patients COVID-19 ARDS administration convalescent plasma neutralizing antibody improvement clinical status sample size study effectiveness treatment observations evaluation clinical trials\",\n",
              " 'Anticoagulant treatment associated with decreased mortality severe coronavirus disease patients coagulopathyA mortality severe coronavirus disease 2019 COVID-19 worrying application heparin COVID-19 expert consensus risk disseminated intravascular coagulation venous thromboembolism efficacy Coagulation medications outcomes consecutive patients severe COVID-19 Tongji hospital retrospectively analyzed mortality heparin users nonusers compared risk coagulopathy stratified sepsis-induced coagulopathy SIC score D-dimer result patients severe COVID-19 study heparin low molecular weight heparin days longer D-dimer prothrombin time age positively platelet count negatively correlated mortality multivariate analysis mortality heparin users nonusers mortality heparin users nonusers patients SIC score D-dimer\\xa0 upper limit of normal Anticoagulant therapy low molecular weight heparin associated with prognosis severe COVID-19 patients SIC criteria elevated',\n",
              " 'Clinical analysis neonates born mothers pneumoniaThe originated Wuhan Hubei province central China cases neonates born mothers pneumonia clinical features cases evidence prevention control infections neonates clinical features outcomes neonates twins born mothers infection hospitals retrospectively analyzed pregnant women infection clinical symptoms delivery cases day delivery cases delivery cases cases fever cough symptoms patient diarrhea newborns born mothers male female full-term infants born premature small-for-gestational-age SGA infants large-for-gestational-age LGA infant singletons twins neonates Pediatric Critical Illness Score PCIS score Clinically symptom neonates shortness breath symptoms fever thrombocytopenia abnormal liver function rapid heart rate vomiting pneumothorax neonates discharged died neonates hospital stable condition Pharyngeal swab specimens neonates days birth nucleic acid amplification negative infection adverse effects newborns problems fetal distress premature labor respiratory distress thrombocytopenia abnormal liver function death vertical transmission',\n",
              " 'Potential Rapid Diagnostics Vaccine Therapeutics Systematic ReviewRapid diagnostics vaccines therapeutics interventions management outbreak systematically review potential interventions Middle East respiratory syndrome-Coronavirus MERS-CoV severe acute respiratory syndrome policymakers prioritization resources research development systematic search electronic databases PubMed Embase Cochrane Library published studies Preferred Reporting Items Systematic Reviews Meta-Analyses PRISMA guidelines Supplementary strategies Google Search personal communications studies criteria review laboratory protocols confirmation cases real-time reverse transcription polymerase chain reaction RT-PCR commercial RT-PCR kit Beijing Genomic Institute China Asia serological assays point-of-care testing kits vaccine pipeline Phase 1 vaccine trial synthetic DNA-based compounds therapeutics licensed conditions in vitro efficacy tested clinical trials MERS-CoV SARS-CoV clinical trials effective antivirals drug combinations high-level evidence',\n",
              " 'Controversial treatments Coronavirus Disease severe acute respiratory syndrome-related coronavirus 2 infection threats international health economy absence specific treatment virus experience lessons China case-fatality rate coronavirus disease patients complications RNAaemia acute respiratory distress syndrome multiple organ dysfunction limitations differential treatments review complications treatments antiviral therapy remdesivir ribavirin chloroquine glucocorticoid therapy extracorporeal support artificial liver system extracorporeal membrane oxygenation evidence result antiviral therapy organ reduce mortality mild patients critical patients',\n",
              " 'Review Article Gastrointestinal Features COVID-19 Faecal TransmissionThere gastrointestinal features COVID-19 gastrointestinal manifestations pathological findings patients COVID-19 faecal transmission reviewed gastrointestinal features faecal test results COVID-19 case reports retrospective clinical studies digestive system outbreak incidence gastrointestinal symptoms COVID-19 anorexia diarrhoea 2 vomiting nausea 1 abdominal pain gastrointestinal bleeding 4 Diarrhoea gastrointestinal symptom children adults duration days diagnosis Vomiting prominent children adult children patients vomiting Adult children patients digestive symptoms absence respiratory symptoms incidence digestive manifestations early stage epidemic digestive symptoms regions group patients proportion severe cases proportion gastrointestinal symptoms severe patients patients anorexia abdominal pain group patients severe rate proportion gastrointestinal symptoms severe cases nausea vomiting Angiotensin enzyme 2 virus nucleocapsid protein detected gastrointestinal epithelial cells infectious virus particles isolated faeces Faecal PCR testing accurate respiratory specimen PCR detection faecal PCR positive days sputum PCR positive Faecal excretion sputum excretion patients days Gastrointestinal symptoms patients COVID-19 increased prevalence epidemic China SARS-CoV-2 gastrointestinal epithelial cells faeces COVID-19 patients infectious',\n",
              " 'Clinical characteristics deceased patients coronavirus disease retrospective clinical characteristics patients coronavirus disease covid-19 died Retrospective case series Tongji Hospital Wuhan China cohort patients died diagnosis covid-19 Data Clinical characteristics laboratory findings electronic medical records data collection forms age deceased patients years recovered patients years Male sex predominant deceased patients recovered patients Chronic hypertension cardiovascular comorbidities frequent deceased patients recovered patients chest tightness disorder consciousness deceased patients recovered patients median disease death deceased patients interquartile range days Leukocytosis patients died recovered lymphopenia Concentrations alanine aminotransferase aspartate aminotransferase creatinine creatine kinase lactate dehydrogenase cardiac troponin I N-terminal pro-brain natriuretic peptide D-dimer deceased patients recovered patients complications deceased patients acute respiratory distress syndrome type I respiratory failure sepsis acute cardiac injury heart failure alkalosis hyperkalaemia acute kidney injury hypoxic encephalopathy Patients cardiovascular comorbidity cardiac complications Regardless history cardiovascular disease acute cardiac injury heart failure deceased patients acute respiratory syndrome coronavirus 2 infection pulmonary systemic inflammation multi-organ dysfunction patients high risk Acute respiratory distress syndrome respiratory failure sepsis acute cardiac injury heart failure critical complications exacerbation covid-19',\n",
              " 'TH17 responses cytokine storm COVID-19 target JAK2 inhibitor FedratinibCOVID-19 pandemic disease high mortality Development effective prevention treatment reviewed TH17 responses patients SARS-CoV-2 FDA JAK2 inhibitor Fedratinib reducing mortality patients TH17 type immune profiles',\n",
              " 'Identifying Locations Possible Undetected Imported Severe Acute Respiratory Syndrome Cases Importation Predictions Cases severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 infection mainland China outbreaks countries countries SARS-CoV-2 cases virus early detection SARS-CoV-2 cases air volume estimates Wuhan China international destinations generalized linear regression model locations cases model exportation cases locations virus spreads information importations transmission becomes Early detection control measures risk transmission locations',\n",
              " 'Coronavirus Disease COVID-19 CT Findings Temporal Progression Disease Coronavirus disease infection High resolution computed tomography CT evaluation lung lesions pathogenesis disease serial CT occurrence development prognosis disease imaging phases early phase progressive phase severe phase dissipative phase CT appearance phase temporal imaging findings',\n",
              " 'Epidemiological clinical characteristics cases SARS- CoV-2 abnormal imaging investigate epidemiological clinical characteristics COVID-19 patients abnormal imaging Patients SARS-CoV-2 infection Zhejiang province CT X-ray Epidemiological clinical data analyzed abnormal normal imaging findings patients normal images patients abnormalities affecting lung lobes radiographic negative correlation score oxygenation index Patients abnormal images older rate coexisting condition rate exposure history onset confirmation days non-pneumonia patients rate fever cough expectoration headache level lymphocytes albumin serum sodium levels creatine kinase lactate dehydrogenase C-reactive protein levels pneumonia patients Muscle ache shortness breath nausea vomiting lower lymphocytes levels higher serum creatinine radiographic score admission predictive factors severe/critical subtype Patients abnormal images clinical manifestations laboratory clinical features radiographic scores severe/critical types',\n",
              " 'Characterization receptor-binding domain RBD implication development RBD protein viral attachment inhibitor vaccineThe outbreak Coronavirus Disease 2019 COVID-19 threat global public health calling development effective prophylactics therapeutics infection causative agent severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 CoV viral attachment fusion entry serves target development antibodies entry inhibitors vaccines receptor-binding domain RBD SARS-CoV-2 S protein RBD protein human bat angiotensin-converting enzyme 2 SARS-CoV-2 RBD binding ACE2 receptor SARS-CoV RBD binding attachment SARS-CoV-2 RBD SARS-CoV RBD ACE2-expressing cells inhibiting infection host cells SARS-CoV RBD-specific antibodies cross-react SARS-CoV-2 RBD protein SARS-CoV RBD-induced antisera cross-neutralize SARS-CoV-2 potential SARS-CoV RBD-based vaccines prevention SARS-CoV-2 SARS-CoV infection',\n",
              " 'Factors Associated With Mental Health Health Care Exposed to Coronavirus Disease exposed to coronavirus disease COVID-19 psychologically stressed assess magnitude mental health associated factors health care workers treating patients exposed to COVID-19 China cross-sectional survey-based region-stratified study demographic data mental health health care workers hospitals February 3 China Health care workers hospitals fever clinics wards patients COVID-19 symptoms depression anxiety insomnia distress assessed Chinese versions 9-item Patient Health Questionnaire Generalized Anxiety Disorder scale 7-item Insomnia Severity Index 22-item Impact Event Scale-Revised Multivariable logistic regression analysis factors associated with mental health outcomes individuals survey participation rate aged years women participants nurses physicians hospitals Wuhan frontline health care workers participants symptoms depression anxiety insomnia distress Nurses women frontline health care workers working Wuhan China severe degrees measurements mental health symptoms health care workers median IQR Patient Health Questionnaire scores physicians nurses median interquartile range Generalized Anxiety Disorder scale scores men women median IQR Insomnia Severity Index frontline second-line workers median IQR Impact Event Scale-Revised scores Wuhan Hubei Wuhan Hubei Hubei outside Wuhan Hubei Multivariable logistic regression analysis participants Hubei province associated with lower risk symptoms distress compared Wuhan odds ratio OR CI Frontline health care workers direct diagnosis treatment care patients COVID-19 associated with risk symptoms depression OR CI anxiety OR CI insomnia OR CI distress OR CI survey heath care workers hospitals fever clinics wards patients COVID-19 Wuhan regions China participants psychological burden nurses women Wuhan frontline health care workers diagnosis treatment care patients COVID-19',\n",
              " 'Coronavirus disease harms information non-evidence-based measuresThe coronavirus disease COVID-19 pandemic',\n",
              " \"characteristics clinical value chest CT images coronavirus investigate characteristics clinical value chest computed tomography CT images coronavirus pneumonia NCP Clinical data CT images cases NCP clinical manifestations laboratory test patients lesions lung segment patient's chest CT images Lesions scored length diffusivity clinical manifestations fever dry cough fatigue white sputum diarrhoea scored lesions CT images patients lesions subpleural area lungs lesions ground-glass opacity fusions increase range subpleural area Pulmonary consolidation lesions cases patients bilateral lung disease patients unilateral lung disease patients cord shadow CT NCP patients bilateral subpleural area lung progressive lesions consolidation no migratory lesions Pleural effusions mediastinal lymphadenopathy rare patients inflammatory changes lungs negative chest CT combination epidemiological laboratory tests examination evaluate disease curative effect\",\n",
              " 'psychological quarantine reduce review evidenceThe coronavirus disease outbreak countries people contact infection isolate home quarantine Decisions quarantine evidence Review psychological impact quarantine electronic databases papers Review studies negative psychological effects post-traumatic stress symptoms confusion anger Stressors quarantine duration infection fears frustration boredom inadequate supplies inadequate information financial loss stigma researchers long-lasting situations quarantine officials quarantine individuals rationale quarantine information protocols sufficient supplies Appeals altruism reminding public benefits quarantine society',\n",
              " 'emotional impact Coronavirus 2019-nCoV Coronavirus disease)A Coronavirus Wuhan confused evolving situation situational framework patients front-line healthcare workers Studies large-circulation international journals electronic databases Scopus Embase Populations patients interventions older adults international migrant Older adults psychiatric conditions distress COVID-19 epidemic gaps mental health services emergencies health professionals isolation units hospitals training mental health care Fear consequence mass quarantine',\n",
              " 'Profiling Early Humoral Response Diagnose Novel Coronavirus Disease emergence coronavirus disease 2019 COVID-19 healthcare threat method detection quantitative polymerase chain reaction technique identifies viral nucleic acids sufficient quantity False-negative results failure quarantine infected patient setback viral transmission kinetics antibodies SARS-CoV-2 evaluate potential antibody testing diagnose COVID-19 host humoral response SARS-CoV-2 IgA IgM IgG response ELISA-based assay recombinant viral nucleocapsid protein plasma samples cases qPCR negative manifestation diagnostic value IgM evaluated cohort duration IgM IgA antibody detection IQR days IgG detected IQR days symptom positive rate cases positive rates IgM antibodies detection efficiency IgM ELISA qPCR days symptom onset positive detection increased IgM ELISA PCR patient qPCR test humoral response SARS-CoV-2 diagnosis COVID-19 subclinical cases',\n",
              " 'Rhabdomyolysis Potential Late Complication Associated with COVID-19We patient Wuhan China severe acute respiratory syndrome coronavirus 2 infection progressive pulmonary lesions rhabdomyolysis manifestations lower limb pain fatigue clinical recognition rhabdomyolysis symptoms patients severe acute respiratory syndrome coronavirus 2 infection lifesaving',\n",
              " 'CT manifestations coronavirus disease-2019 retrospective analysis cases disease CT coronavirus disease-2019 COVID-19 patients disease severity CT manifestations clinical data patients COVID-19 retrospectively hospitals analyzed initial follow-up CT features patients disease severity Guidelines Diagnosis Treatment New Coronavirus Pneumonia patients diagnosed mild type pneumonia patients abnormal CT findings manifested mild lung infection patients type multiple ground-glass opacities GGO lungs interlobular septal thickening patients severe GGO pulmonary consolidation cases cases white lung atelectasis pleural effusion critical type patients resolutive phase disease CT abnormalities resolution residual linear opacities CT features disease severity COVID-19 stratification',\n",
              " 'Laboratory Diagnosis Human Coronavirus Infections State ArtThe outbreaks human coronavirus HCoV twenty-first century accurate fast diagnostic testing methods laboratory diagnostic methods human coronavirus development assays availability updated tests laboratory methods sensitive specific conventional gold standards presentation laboratory methods testing coronavirus disease 2019 COVID-19 outbreak going Wuhan Viral pneumonias production purulent sputum nasopharyngeal swab collection method specimen testing Nasopharyngeal specimens infections specimen bronchoscopy repeated testing likelihood SARS-CoV-2 nasopharynx increases integrated random-access point-of-care molecular devices development fast accurate diagnosis SARS-CoV-2 infections assays fast local hospitals clinics burden identifying treating patients',\n",
              " \"Coronavirus endoribonuclease viral polyuridine sequences activating host CoVs positive-sense RNA viruses endemic reservoirs infect zoonotically morbidity mortality CoVs encode endoribonuclease EndoU facilitates evasion host MDA5 target EndoU activity EndoU 5'-polyuridines negative-sense viral RNA PUN RNA polyA-templated RNA synthesis virus EndoU catalytic-inactive mutation detected abundance PUN RNA cytoplasm wild-type-infected cells PUN RNA cells stimulates robust MDA5-dependent interferon response removal polyuridine extension RNA response results study PUN RNA CoV MDA5-dependent pathogen-associated molecular pattern PAMP mechanism EndoU activity cleave accumulation PAMP EndoU activity CoVs inhibiting activity therapeutic CoV infections\",\n",
              " 'Recommendations prevention mitigation containment SARS-CoV-2 COVID-19 pandemic haemodialysis centresCOVID-19 disease coronavirus global human threat turned pandemic coronavirus morbidity elderly comorbid populations Uraemic patients dialysis intrinsic fragility burden comorbidities patients treated area haemodialysis centres infected intensity dialysis specialized resources staff requirements isolation control prevention healthcare systems exceptional strain measures pandemic control incidence rates seriously review European Dialysis EUDIAL Working Group ERA-EDTA recommendations prevention mitigation containment haemodialysis centres COVID-19 pandemic management patients dialysis affected COVID-19 protocols risk patients personnel taking patients Measures prevention protection screening isolation distribution efficient settings essential management pandemic early disease',\n",
              " 'Expert consensus managing pregnant women neonates born mothers suspected coronavirus clinical management coronavirus COVID-19 pregnancy multidisciplinary teleconference Chinese physicians researchers medical management COVID-19 infection pregnancy recommendations management COVID-19 infections pregnancy evidence optimal delivery safety vaginal delivery cesarean delivery vertical transmission delivery route of delivery delivery timing individualized obstetrical indications maternal-fetal status',\n",
              " 'Drive-Through Screening Center COVID-19 Screening System Massive Community OutbreakAs coronavirus disease COVID-19 outbreak individuals tested COVID-19 increasing efficient screening COVID-19 drive-through DT screening centers implemented Korea concept advantages limitations COVID-19 DT screening centers DT registration examination specimen collection instructions service minutes testee leaving cars Increased testing capacity tests day prevention cross-infection testees waiting space protection staff outdoor implemented countries cope global COVID-19 outbreak situations',\n",
              " 'Hypothesis potential pathogenesis SARS-CoV-2 infection review immune changes patients viral pneumoniaCoronavirus disease 2019 COVID-19 infectious disease severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 droplets contact transmission Wuhan China outbreak official data Chinese health commission diagnosed patients declining epidemic controlled patients mild symptoms good prognosis infection patients severe die organ complications pathogenesis SARS-CoV-2 infection humans Immune function defense invasive pathogens antiviral drug virus reviews immunological coronaviruses SARS MERS viral pneumonia SARS-CoV-2 published literature potential pathogenesis COVID-19 treatment recommendations high-doses intravenous immunoglobulin low-molecular-weight heparin severe type patients',\n",
              " \"Clinical features severe pediatric patients coronavirus disease Wuhan single center's outbreak coronavirus disease COVID-19 SARS-CoV-2 detected Wuhan Hubei China People ages susceptible SARS-CoV-2 infection severe pediatric patients COVID-19 clinical features severe pediatric patients COVID-19 severe critically ill patients COVID-19 treated Intensive Care Unit ICU Wuhan Children's Hospital information demographic data symptoms imaging data laboratory findings treatments clinical outcomes patients severe COVID-19 patients months years boys symptoms polypnea fever cough Chest imaging patch-like patients ground-glass opacity Laboratory findings normal increased whole blood counts increased C-reactive protein procalcitonin lactate dehydrogenase abnormal liver function findings decreased CD16\\u2009 CD56 Th/Ts*(1/8 increased CD3 CD4 CD8 (1/8 IL-6 IL-10 IFN-γ Treatment modalities symptomatic respiratory support critically ill patients invasive mechanical ventilation patients treatment ICU recovered discharged home severe pediatric patients Wuhan polypnea symptom fever cough imaging multiple patch-like shadows ground-glass opacity cytokine storm patients critically ill patients\",\n",
              " 'Autopsy suspected COVID-19 casesThe acute respiratory syndrome CoV-2 outbreak Wuhan China countries world UK increasing death toll increase suspected coronavirus disease (COVID-19)-related deaths autopsy Royal College of Pathologists release briefing autopsy practice COVID-19 article interpretation guidelines description hazard group 3 organisms category SARS-CoV-2 assigned description pathological autopsy findings COVID-19 recommendations suspected COVID-19 cases techniques diagnosis autopsy clinicopathological correlation notification cases',\n",
              " \"Intubation Ventilation amid COVID-19 Outbreak Wuhan's ExperienceThe COVID-19 outbreak diagnosed cases deaths mainland China data patients COVID-19 intubation invasive ventilation disease course practices intubation ventilation patients COVID-19 amid risk cross-infection undertaking authors experience caring critically ill patients COVID-19 Wuhan self-protection precautions premature intubation oxygen debt high-flow oxygen therapy bilevel positive airway pressure preparation satisfactory preoxygenation modified rapid sequence intubation video laryngoscope intubation Wuhan Lung-protective ventilation prone position ventilation adequate sedation analgesia ventilation management\",\n",
              " \"doubt introduction SARS-CoV-2 Italy overviewThe emergence novel betacoronavirus severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 concerns virus's dissemination information genomic epidemiology SARS-CoV-2 circulating Italy surveillance studies complete genomic sequences SARS-CoV-2 introduction country dynamics Italy analyzed complete genomes SARS-CoV-2 isolates clinical samples phylogenetic reconstructions introduction SARS-CoV-2 genomic surveillance strategies improve monitoring SARS-CoV-2 epidemics attenuate public health infectious diseases\",\n",
              " 'Natural small molecules inhibitors coronavirus lipid-dependent host cells reducing SARS-COV-2 infectivity?Viral interactions components host cell plasma membrane virus envelope review advance SARS-COV-2 epidemic lipid structures lipid rafts cholesterol process endocytosis viruses cells studies substances cyclodextrin sterols infectivity viruses coronavirus family lipid-dependent human host cells molecules reduce infectivity coronaviruses inhibiting viral lipid-dependent host cells research molecules methods mechanism transmission SARS-COV-2 antiviral strategies',\n",
              " 'Influenza-associated pneumonia assess seriousness coronavirus disease (COVID-19)Information severity coronavirus disease COVID-19 transmissibility disease seriousness impact preparation healthcare sectors assess disease seriousness cohort pneumonia patients sentinel hospitals comparisons rate COVID-19 patients ventilation case fatalities COVID-19 patients comorbidities reference cohort Hospitals utilisation ventilation intensive care resources',\n",
              " 'Trial Lopinavir–Ritonavir Adults Hospitalized Severe Covid-19No therapeutics effective treatment severe illness SARS-CoV-2 randomized controlled open-label trial hospitalized adult patients SARS-CoV-2 infection respiratory illness Covid-19 oxygen saturation patients laboratory-confirmed SARS-CoV-2 randomization assigned lopinavir-ritonavir group standard-care group Treatment lopinavir-ritonavir associated with standard care clinical improvement hazard ratio clinical improvement confidence interval CI Mortality days lopinavir-ritonavir group standard-care group CI percentages patients detectable viral RNA time points modified intention-to-treat analysis lopinavir-ritonavir clinical improvement shorter day standard care hazard ratio CI Gastrointestinal adverse events lopinavir-ritonavir group adverse events standard-care group Lopinavir-ritonavir treatment early patients adverse events hospitalized adult patients severe Covid-19 lopinavir-ritonavir treatment standard care trials patients severe illness confirm treatment National Science Technology New Drug Creation Development Chinese Clinical Trial Register number ChiCTR2000029308',\n",
              " 'Association radiologic findings mortality patients infected coronavirus Wuhan ChinaRadiologic characteristics coronavirus NCIP diagnosing predicting prognosis retrospective consecutive patients NCIP clinical characteristics CT findings collected association radiologic findings mortality patients evaluated patients men women age years IQR patients discharged condition patients died hospital age mortality group survival group IQR IQR comorbidity rate mortality group survival group predominant CT characteristics ground glass opacity bilateral sides peripheral central distribution zone involvement median CT score mortality group survival group IQR IQR frequency consolidation air bronchogram cutoff value CT score sensitivity specificity prediction mortality elderly people chronic comorbidities CT findings NCIP predominant ground glass opacities consolidations peripheral combined peripheral central distributions bilateral lower lung zones CT scoring method mortality',\n",
              " 'COVID-19 coronavirus infection advances prospects designing developing vaccines immunotherapeutics therapeuticsThe coronavirus infection COVID-19 Coronavirus disease Wuhan Hubei province China countries vaccines human coronavirus CoV infections MERS SARS decades licensed antiviral treatment vaccine MERS SARS CoV vaccines drugs target spike glycoprotein S protein neutralizing antibodies candidates efficacy',\n",
              " 'COVID-2019 patients pneumonia Wuhan City Hubei Province China pathogen cases coronavirus World Health Organization diagnosis pathogen SARSCoV-2 disease SARSCoV-2 Corona Virus Disease COVID-2019 virus infectious pathogenic human-to-human transmission SARSCoV-2 rampant world Zhengzhou City Henan Province serves people infected SARSCoV-2 children youngest years perspective clinical pediatricians epidemic clinical characteristics prevention control measures outcomes diagnosis treatment pediatric cases',\n",
              " 'Diagnostic Utility Clinical Laboratory Patients Severe COVID-The clinical laboratory differential diagnosis severe COVID-19 study warning index severe COVID-19 patients investigated adult patients COVID-19 patients mild group patients severe group patients comparison hematological parameters mild severe groups interleukin-6 IL-6 d-dimer d-D glucose thrombin time fibrinogen C-reactive protein threshold area receiver operator characteristic curve ROC IL-6 d-D area ROC curve IL-6 d-D specificity predicting severity COVID-19 IL-6 d-D tandem testing sensitivity IL-6 d-D parallel test severe COVID-19 IL-6 d-D occurrence severe COVID-19 adult patients combined detection specificity sensitivity early prediction severity COVID-19 patients clinical value',\n",
              " 'Hydroxychloroquine azithromycin treatment COVID-19 results label non-randomized clinical trialChloroquine hydroxychloroquine efficient SARS-CoV-2 efficient Chinese COV-19 patients evaluate effect hydroxychloroquine respiratory viral loads French COVID-19 patients arm protocol patients asymptomatic upper respiratory tract infection symptoms respiratory tract infection symptoms treated study reduction viral carriage D6-post inclusion controls average duration litterature untreated patients Azithromycin hydroxychloroquine efficient virus elimination sample size survey hydroxychloroquine treatment associated with viral load reduction/disappearance COVID-19 patients effect azithromycin',\n",
              " 'Liver injury pathogenic human severe acute respiratory syndrome coronavirus 2 SARS-Cov-2 pathogen coronavirus disease COVID-19 threat global public health WHO outbreak SARS-CoV-2 international public health emergency Lung lesions damage SARS-CoV-2 infection liver injury course disease severe cases studies liver damage patients infected pathogenic coronavirus severe acute respiratory syndrome coronavirus SARS-CoV Middle East respiratory syndrome coronavirus MERS-CoV associated with severity diseases review characteristics mechanism liver injury SARS-CoV MERS-CoV SARS-CoV-2 infection summarized studies liver injury COVID-19',\n",
              " 'Coronavirus Disease 2019 COVID-19 Eyes Review of Coronaviruses Ocular Implications Humans AnimalsIn CoV epidemic severe acute respiratory syndrome coronavirus SARS-CoV-2 China virus coronavirus disease COVID-19 anecdotal reports ocular infection ocular human CoV infections CoVs ocular infections animals Clinical entities conjunctivitis anterior uveitis retinitis optic neuritis documented feline murine models evidence human CoV infection ocular tissue reviewed review article animal CoVs ocular infections research ocular human CoV infections',\n",
              " 'CT image quantitative evaluation clinical classification coronavirus disease relationship imaging manifestations clinical classification COVID-19 retrospective single-center study patients COVID-19 Zhuhai China Patients Chinese guideline mild patients minimal symptoms negative CT findings severe-critical patients positive CT findings clinical manifestations CT visual evaluation summing acute lung inflammatory lobe total severity score TSS summing lobe scores consistency observers evaluated TSS clinical classification ROC diagnosis TSS severe-critical type study patients males females mild severe-critical cases median TSS severe-critical-type group type ICC observers CI ROC analysis area AUC TSS diagnosing severe-critical type TSS cutoff sensitivity specificity proportion clinical mild-type patients COVID-19 CT screening tool CT visual quantitative analysis consistency clinical classification COVID-19 CT visual evaluation ICC observers median TSS severe-critical type group type ROC analysis area AUC TSS diagnosing severe-critical type CI TSS cutoff sensitivity specificity proportion COVID-19 patients normal chest CT CT screening modality',\n",
              " 'Risk Factors Associated With Acute Respiratory Distress Syndrome Death Patients Coronavirus Disease 2019 Pneumonia Wuhan ChinaCoronavirus disease 2019 COVID-19 infectious disease Wuhan China spread Risk factors clinical outcomes COVID-19 pneumonia clinical characteristics outcomes patients COVID-19 pneumonia acute respiratory distress syndrome ARDS died Retrospective cohort study patients COVID-19 pneumonia admitted Wuhan Jinyintan Hospital China follow-up COVID-19 pneumonia development ARDS death Epidemiological demographic clinical laboratory management treatment outcome data collected analyzed patients median age years interquartile range years patients men patients ARDS patients died ARDS compared patients dyspnea patients patients CI comorbidities hypertension patients patients CI diabetes patients patients CI bivariate Cox regression analysis risk factors associated with development ARDS progression ARDS death older age hazard ratio HR CI HR CI neutrophilia HR CI HR CI organ coagulation dysfunction lactate dehydrogenase HR CI HR CI D-dimer HR CI HR CI High fever associated with higher likelihood ARDS development HR CI lower death HR CI patients ARDS treatment methylprednisolone decreased risk of death HR CI Older age associated with risk development ARDS death immune response high fever associated with development ARDS associated with outcomes patients ARDS treatment methylprednisolone patients ARDS',\n",
              " 'Clinical laboratory imaging features COVID-19 systematic review meta-analysisAn epidemic Coronavirus Disease 2019 COVID-19 China Public Health Emergency International Concern PHEIC Clinical laboratory imaging features observational studies systematic reviews COVID-19 systematic literature review meta-analysis databases clinical laboratory imaging features outcomes COVID-19 cases Observational studies case reports analyzed separately random-effects model meta-analysis calculate pooled prevalences confidence intervals articles time frame screening articles full-text assessment qualitative quantitative analyses case report articles analyzed separately patients fever cough dyspnea prevalent manifestations patients intensive care unit ICU acute respiratory distress syndrome ARDS shock hospitalized patients fatal outcomes case fatality rate CFR COVID-19 burden healthcare facilities patients comorbidities ICU polymorbid COVID-19 infected patients hospitalization associated with CFR virus spreads countries prepare human resources infrastructure facilities treat severe COVID-19',\n",
              " 'Thrombocytopenia associated with severe COVID-19 infections COVID-19 infectious disease laboratory markers evaluate illness severity study investigate platelet count COVID-19 patients severe disease evaluate thrombocytopenia associated with severe COVID-19 electronic search Medline Scopus Web of Science studies data platelet count COVID-19 patients meta-analysis calculation weighted mean difference WMD platelet number COVID-19 patients severe disease odds ratio OR thrombocytopenia severe COVID-19 studies COVID-19 patients severe disease meta-analysis pooled analysis platelet count patients severe COVID-19 WMD Low platelet count associated with increased risk severe disease mortality patients COVID-19 clinical indicator worsening illness hospitalization',\n",
              " \"Coronavirus pregnancy delivery reviewThere case series impact women affected coronavirus pregnancy women severe acute respiratory syndrome SARS Middle East respiratory syndrome MERS case fatality affected pregnancy non-pregnant women health policy management women affected COVID-19 pregnancy Royal College of Obstetricians guidelines COVID-19 infection pregnancy Searches PubMed MedRxiv primary case reports case series observational studies randomized controlled trials women affected coronavirus pregnancy Data relevant papers review guidelines Royal College of Paediatrics Child Health RCPCH RCOG expert consensus areas data lacking PubMed MedRxiv studies case reports case series identified reports women affected COVID-19 pregnancy babies twins pregnancies asymptomatic admitted intensive care unit ICU extracorporeal membrane oxygenation No maternal deaths Delivery Cesarean section cases vaginal delivery delivered preterm stillbirth neonatal death babies vertical transmission tested reverse transcription polymerase chain reaction delivery Case fatality SARS MERS SARS associated with miscarriage intrauterine death cases fetal growth restriction pregnancies affected SARS morbidity women COVID-19 ICU care Compared SARS MERS COVID-19 lethal cases woman Preterm delivery women hospitalized COVID-19 neonatal services UK's worst-case scenario population affected review RCOG consultation RCPCH guidance delivery neonatal care pregnancies affected COVID-19 delivery obstetric indication recommends routine separation affected mothers babies review maternity neonatal services response COVID-19 Authors Ultrasound Obstetrics & Gynecology behalf International Society of Ultrasound Obstetrics Gynecology\",\n",
              " 'Patients COVID-19 lopinavir-combined regimen increase eosinophil outcome COVID-19 epidemiological information clinical characteristics therapeutic outcomes temporal progression laboratory findings 2019-coronavirus disease COVID-19 patients exposed to lopinavir data COVID-19 patients admitted Xixi hospital Hangzhou China patients secondary tertiary quartus patients incubation period days symptoms cough low fever asymptomatic case normal radiography ground glass opacities cases transferred discharged exposed to lopinavir hospitalization patients stopped lopinavir adverse effects deteriorated hospitalized sustained lopinavir Levels potassium albumin lymphocytes low increased treatment Eosinophil values low initial hospitalization discharge Viral load SARS-CoV-2 radiography eosinophil days eosinophils indicator COVID-19 improvement COVID-19 patients sustained lopinavir research',\n",
              " 'Clinical characteristics severe acute respiratory syndrome coronavirus 2 reactivation pneumonia outbreak coronavirus disease COVID-19 information general population data severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 study evaluate clinical characteristics SARS-CoV-2 reactivation Clinical records laboratory results chest CT scans retrospectively reviewed patients laboratory-confirmed COVID-19 pneumonia throat swab samples positive SARS-CoV-2 admitted Zhongnan Hospital Wuhan University Wuhan China patients history epidemiological COVID-19 patients discharged hospital SARS-CoV-2 reactivation reactivated patients symptoms fever cough sore throat fatigue patients progressive lymphopenia Findings group cases evidence reactivation SARS-CoV-2 clinical characteristics',\n",
              " 'Early dynamics transmission control COVID-19 mathematical modelling outbreak severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 early transmission dynamics infection evaluating effectiveness control measures potential sustained transmission areas mathematical model severe SARS-CoV-2 transmission datasets outside Wuhan transmission Wuhan December February estimates assess potential sustained human-to-human locations Wuhan cases stochastic transmission model data cases coronavirus disease 2019 COVID-19 Wuhan international originated Wuhan transmission time January February estimates probability cases outbreaks areas early dynamics transmission Wuhan stochastic transmission dynamic model datasets cases Wuhan internationally Wuhan datasets daily internationally cases lack thereof onset daily cases Wuhan exposure onset Dec 1 cases China proportion infected passengers evacuation flights datasets comparison model outputs daily exported Wuhan lack thereof countries connectivity Wuhan at-risk countries confirmation data cases Wuhan median daily results COVID-19 transmission Wuhan late January introduction travel control cases arrive international transmission Wuhan control measures chains transmission initially outbreaks Wellcome Trust Health Data Research UK Bill & Melinda Foundation National Institute for Health Research',\n",
              " 'Safety efficacy anesthetic regimens parturients COVID-19 Cesarean delivery case series patients management safety epidural general anesthesia Cesarean delivery parturients coronavirus disease COVID-19 newborns evaluate standardized procedures medical staff retrospectively reviewed cases parturients diagnosed severe acute respiratory syndrome coronavirus SARS-CoV-2 infection disease COVID-19 epidemiologic history chest computed tomography scans laboratory measurements SARS-CoV-2 nucleic acid evaluated patients demographic clinical characteristics anesthesia surgery-related data maternal neonatal complications health status medical staff clinical characteristics pregnant women infected SARS-CoV-2 non-pregnant adult patients patients Cesarean delivery anesthesia standardized anesthesia/surgery procedures patients continuous epidural anesthesia intraoperative hypotension patients general anesthesia tracheal intubation emergency surgery parturients Cesarean delivery in-hospital treatment COVID-19 neonates born no deaths neonatal neonatal SARS-CoV-2 nucleic acid tests negative infected patient care period epidural general anesthesia Cesarean delivery parturients COVID-19 incidence hypotension epidural anesthesia excessive patient transfer medical staff access procedures effective biosafety precautions medical staff COVID-19',\n",
              " 'systematic review efficacy safety chloroquine treatment COVID-19COVID-19 (coronavirus disease public health emergency international concern effective pharmaceutical treatment patient severe disease systematic review evidence chloroquine treatment COVID-19 PubMed EMBASE trial Registries studies chloroquine patients COVID-19 articles narrative letter in-vitro study editorial expert consensus paper national guideline documents clinical trials China Chloroquine effective limiting replication SARS-CoV-2 virus COVID-19 in vitro rationale pre-clinical evidence effectiveness evidence safety long-time clinical use indications clinical research chloroquine patients COVID-19 clinical use Monitored Emergency Unregistered Interventions MEURI ethically trial World Health Organization Safety data data high-quality clinical trials',\n",
              " 'Detection Novel Coronavirus RT-PCR Stool Specimen Asymptomatic Child ChinaWe asymptomatic child positive coronavirus reverse transcription PCR stool specimen days virus exposure child virus positive stool specimens days Respiratory tract specimens negative reverse transcription PCR',\n",
              " 'effect travel restrictions spread 2019novel coronavirus COVID-19 outbreak coronavirus disease COVID-19 mainland China global metapopulation disease impact travel national international epidemic model internationally cases travel Wuhan Chinese cities infected travelers travel quarantine Wuhan delayed epidemic progression days mainland China effect international scale case importations reduced mid-February Modeling travel restrictions mainland China epidemic trajectory unless higher reduction transmission community',\n",
              " 'Clinical Characteristics Coronavirus Disease ChinaSince coronavirus disease Covid-19 Wuhan city China data clinical characteristics affected patients data patients laboratory-confirmed Covid-19 hospitals provinces autonomous regions municipalities mainland China primary composite intensive care unit ICU mechanical ventilation death age patients years patients female primary composite patients admitted ICU invasive mechanical ventilation died patients history contact wildlife nonresidents Wuhan contact residents Wuhan visited city symptoms fever admission hospitalization cough Diarrhea uncommon median incubation period days interquartile range admission ground-glass opacity radiologic finding chest computed tomography CT No radiographic CT abnormality patients nonsevere disease patients severe disease Lymphocytopenia patients admission months outbreak Covid-19 China degrees illness Patients fever abnormal radiologic findings National Health Commission China']"
            ]
          },
          "metadata": {
            "tags": []
          },
          "execution_count": 21
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "0Z2YmVMt-83L"
      },
      "source": [
        "On remplace les textes concaténés par les nouveaux textes obtenues"
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "29Ea_0JbXVmF"
      },
      "source": [
        "df_bibliovid['cat_text'] = new_text2"
      ],
      "execution_count": 22,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "1iSyr4i-be_y",
        "outputId": "29afaa52-89bc-4cf8-f559-1208a7f87d1f"
      },
      "source": [
        "df_bibliovid"
      ],
      "execution_count": 23,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/html": [
              "<div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>id</th>\n",
              "      <th>slug</th>\n",
              "      <th>title</th>\n",
              "      <th>has_other_authors</th>\n",
              "      <th>impact_factor</th>\n",
              "      <th>goals_plain</th>\n",
              "      <th>verbose_date</th>\n",
              "      <th>authors</th>\n",
              "      <th>document_link</th>\n",
              "      <th>specialties</th>\n",
              "      <th>category</th>\n",
              "      <th>journal</th>\n",
              "      <th>link</th>\n",
              "      <th>results</th>\n",
              "      <th>synthesis</th>\n",
              "      <th>strength_of_evidence_details</th>\n",
              "      <th>goals</th>\n",
              "      <th>methods</th>\n",
              "      <th>pubmed_id</th>\n",
              "      <th>doi</th>\n",
              "      <th>abstract</th>\n",
              "      <th>topics</th>\n",
              "      <th>author_list</th>\n",
              "      <th>publication_date</th>\n",
              "      <th>vect_specs</th>\n",
              "      <th>cat_text</th>\n",
              "      <th>len</th>\n",
              "      <th>len_sentence</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>769</td>\n",
              "      <td>body-mass-index-and-risk-for-intubation-or-dea...</td>\n",
              "      <td>Body Mass Index and Risk for Intubation or Dea...</td>\n",
              "      <td>True</td>\n",
              "      <td>{'id': 3, 'name': 'Intermédiaire', 'posts_coun...</td>\n",
              "      <td>- Déterminer si l'obésité est associée à l'int...</td>\n",
              "      <td>31.07.2020</td>\n",
              "      <td>Anderson MR</td>\n",
              "      <td>https://www.acpjournals.org/doi/10.7326/M20-3214</td>\n",
              "      <td>[{'id': 4, 'name': 'Anesthésie-Réanimation'}, ...</td>\n",
              "      <td>{'id': 6, 'name': 'Pronostique', 'icon': 'icon...</td>\n",
              "      <td>{'id': 41, 'name': 'Ann Intern Med'}</td>\n",
              "      <td>https://www.acpjournals.org/doi/10.7326/M20-3214</td>\n",
              "      <td>*Description de l'échantillon: 2112 patients c...</td>\n",
              "      <td>- Environ 2-3% des patients atteints de la COV...</td>\n",
              "      <td>-cohorte pronostique- puissance de l'étude sup...</td>\n",
              "      <td>- Déterminer si l'obésité est associée à l'int...</td>\n",
              "      <td>Cohorte rétrospective portant sur 2466 patient...</td>\n",
              "      <td>32726151</td>\n",
              "      <td>10.7326/M20-3214</td>\n",
              "      <td>Obesity is a risk factor for pneumonia and acu...</td>\n",
              "      <td>[Pronostique, Anesthésie-Réanimation, Infectio...</td>\n",
              "      <td>[{'id': 714, 'name': 'Anderson MR'}]</td>\n",
              "      <td>2020-07-31</td>\n",
              "      <td>[0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, ...</td>\n",
              "      <td>Body Mass Index Risk Intubation Death SARS-CoV...</td>\n",
              "      <td>259</td>\n",
              "      <td>18</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>742</td>\n",
              "      <td>an-mrna-vaccine-against-sars-cov-2-preliminary...</td>\n",
              "      <td>An mRNA Vaccine against SARS-CoV-2 - Prelimina...</td>\n",
              "      <td>True</td>\n",
              "      <td>{'id': 3, 'name': 'Intermédiaire', 'posts_coun...</td>\n",
              "      <td>Développement du vaccin accéléré mRNA-1273 Mod...</td>\n",
              "      <td>15.07.2020</td>\n",
              "      <td>Jackson LA</td>\n",
              "      <td>https://www.nejm.org/doi/10.1056/NEJMoa2022483</td>\n",
              "      <td>[{'id': 22, 'name': 'Immunité'}, {'id': 5, 'na...</td>\n",
              "      <td>{'id': 4, 'name': 'Thérapeutique', 'icon': 'ic...</td>\n",
              "      <td>{'id': 22, 'name': 'NEJM'}</td>\n",
              "      <td>https://www.nejm.org/doi/10.1056/NEJMoa2022483</td>\n",
              "      <td>Après la première vaccination, les réponses an...</td>\n",
              "      <td>Le vaccin mRNA-1273 est plutôt bien toléré. De...</td>\n",
              "      <td>Les résultats du rapport ne sont que prélimina...</td>\n",
              "      <td>Développement du vaccin accéléré mRNA-1273 Mod...</td>\n",
              "      <td>Essai de vaccination de Phase 1, ouvert inclua...</td>\n",
              "      <td>32663912</td>\n",
              "      <td>10.1056/NEJMoa2022483</td>\n",
              "      <td>The severe acute respiratory syndrome coronavi...</td>\n",
              "      <td>[Thérapeutique, Immunité, Virologie, Infectiol...</td>\n",
              "      <td>[{'id': 690, 'name': 'Jackson LA'}]</td>\n",
              "      <td>2020-07-15</td>\n",
              "      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, ...</td>\n",
              "      <td>mRNA Vaccine SARS-CoV-2 Preliminary ReportThe ...</td>\n",
              "      <td>269</td>\n",
              "      <td>14</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>739</td>\n",
              "      <td>pathophysiology-transmission-diagnosis-and-tre...</td>\n",
              "      <td>Pathophysiology, Transmission, Diagnosis, and ...</td>\n",
              "      <td>True</td>\n",
              "      <td>{'id': 2, 'name': 'Faible', 'posts_count': 505...</td>\n",
              "      <td>Etat des lieux bibliographique des connaissanc...</td>\n",
              "      <td>14.07.2020</td>\n",
              "      <td>Joost Wiersinga W</td>\n",
              "      <td>https://jamanetwork.com/journals/jama/fullarti...</td>\n",
              "      <td>[{'id': 7, 'name': 'Transversale'}, {'id': 12,...</td>\n",
              "      <td>{'id': 2, 'name': 'Autres', 'icon': 'icon-other'}</td>\n",
              "      <td>{'id': 183, 'name': 'JAMA Network Open'}</td>\n",
              "      <td>https://jamanetwork.com/journals/jama/fullarti...</td>\n",
              "      <td>La transmission du SARS-CoV-2 est plus favorab...</td>\n",
              "      <td>Actualisation générale des connaissances (rech...</td>\n",
              "      <td>Revue orientée d'études pré-sélectionnées par ...</td>\n",
              "      <td>Etat des lieux bibliographique des connaissanc...</td>\n",
              "      <td>Bases de données indexées (générale et récente...</td>\n",
              "      <td>32648899</td>\n",
              "      <td>10.1001/jama.2020.12839</td>\n",
              "      <td>The coronavirus disease 2019 (COVID-19) pandem...</td>\n",
              "      <td>[Autres, Transversale, Infectiologie]</td>\n",
              "      <td>[{'id': 687, 'name': 'Joost Wiersinga W'}]</td>\n",
              "      <td>2020-07-14</td>\n",
              "      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, ...</td>\n",
              "      <td>Pathophysiology Transmission Diagnosis Treatme...</td>\n",
              "      <td>436</td>\n",
              "      <td>33</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>735</td>\n",
              "      <td>introductions-and-early-spread-of-sars-cov-2-i...</td>\n",
              "      <td>Introductions and Early Spread of SARS-CoV-2 i...</td>\n",
              "      <td>True</td>\n",
              "      <td>{'id': 4, 'name': 'Indéterminé', 'posts_count'...</td>\n",
              "      <td>Etudier comment l'épidémie de SARS-Cov-2 a com...</td>\n",
              "      <td>10.07.2020</td>\n",
              "      <td>Gambaro F</td>\n",
              "      <td>https://www.eurosurveillance.org/content/10.28...</td>\n",
              "      <td>[{'id': 7, 'name': 'Transversale'}, {'id': 5, ...</td>\n",
              "      <td>{'id': 5, 'name': 'Epidémiologique', 'icon': '...</td>\n",
              "      <td>{'id': 46, 'name': 'Eurosurveillance'}</td>\n",
              "      <td>https://www.eurosurveillance.org/content/10.28...</td>\n",
              "      <td>Le virus a été introduit plusieurs fois dans l...</td>\n",
              "      <td>Le virus SARS-Cov-2 a été introduit plusieurs ...</td>\n",
              "      <td>Les données de cette étude semblent disponible...</td>\n",
              "      <td>Etudier comment l'épidémie de SARS-Cov-2 a com...</td>\n",
              "      <td>Données. 97 séquences de SARS-Cov-2 recueillie...</td>\n",
              "      <td>32643599\\n32289214\\n32070465\\n32109013\\n321797...</td>\n",
              "      <td>10.2807/1560-7917.ES.2020.25.26.2001200</td>\n",
              "      <td>Following SARS-CoV-2 emergence in China, a spe...</td>\n",
              "      <td>[Epidémiologique, Transversale, Virologie]</td>\n",
              "      <td>[{'id': 628, 'name': 'Gambaro F'}]</td>\n",
              "      <td>2020-07-10</td>\n",
              "      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, ...</td>\n",
              "      <td>Introductions Early Spread SARS-CoV-2 France S...</td>\n",
              "      <td>88</td>\n",
              "      <td>4</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>724</td>\n",
              "      <td>how-to-safely-reopen-colleges-and-universities...</td>\n",
              "      <td>How to Safely Reopen Colleges and Universities...</td>\n",
              "      <td>True</td>\n",
              "      <td>{'id': 2, 'name': 'Faible', 'posts_count': 505...</td>\n",
              "      <td>Décrire l'expérience des universités de Taïwan...</td>\n",
              "      <td>03.07.2020</td>\n",
              "      <td>Cheng SY</td>\n",
              "      <td>https://www.acpjournals.org/doi/10.7326/M20-2927</td>\n",
              "      <td>[{'id': 21, 'name': 'Confinement/Déconfinement...</td>\n",
              "      <td>{'id': 5, 'name': 'Epidémiologique', 'icon': '...</td>\n",
              "      <td>{'id': 41, 'name': 'Ann Intern Med'}</td>\n",
              "      <td>https://www.acpjournals.org/doi/10.7326/M20-2927</td>\n",
              "      <td>A Taïwan jusqu'au 18 juin 2020 seuls 7 cas con...</td>\n",
              "      <td>Les universités de Taïwan ont adopté des mesur...</td>\n",
              "      <td>- retour d'expérience d'une seule université T...</td>\n",
              "      <td>Décrire l'expérience des universités de Taïwan...</td>\n",
              "      <td>Retour d'expérience de Taïwan sur la gestion d...</td>\n",
              "      <td>32614638</td>\n",
              "      <td>10.7326/M20-2927</td>\n",
              "      <td>Reopening colleges and universities during the...</td>\n",
              "      <td>[Epidémiologique, Confinement/Déconfinement, I...</td>\n",
              "      <td>[{'id': 675, 'name': 'Cheng SY'}]</td>\n",
              "      <td>2020-07-03</td>\n",
              "      <td>[0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, ...</td>\n",
              "      <td>Reopen Colleges Universities COVID-19 Experien...</td>\n",
              "      <td>239</td>\n",
              "      <td>9</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>...</th>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>366</th>\n",
              "      <td>116</td>\n",
              "      <td>safety-and-efficacy-of-different-anesthetic-re...</td>\n",
              "      <td>Safety and efficacy of different anesthetic re...</td>\n",
              "      <td>True</td>\n",
              "      <td>{'id': 2, 'name': 'Faible', 'posts_count': 505...</td>\n",
              "      <td>Evaluer la gestion et la sécurité de l'anesthé...</td>\n",
              "      <td>10.03.2020</td>\n",
              "      <td>Chen R</td>\n",
              "      <td>https://www.dropbox.com/s/qml1fvabro6e92l/Chen...</td>\n",
              "      <td>[{'id': 9, 'name': 'Pédiatrie'}]</td>\n",
              "      <td>{'id': 4, 'name': 'Thérapeutique', 'icon': 'ic...</td>\n",
              "      <td>{'id': 64, 'name': 'Can J Anaesth'}</td>\n",
              "      <td>https://www.dropbox.com/s/qml1fvabro6e92l/Chen...</td>\n",
              "      <td>17 femmes enceintes avec un accouchement par c...</td>\n",
              "      <td>12/14 patientes ont fait une hypotension per-o...</td>\n",
              "      <td>Faible1) Monocentrique mais unique centre à Wu...</td>\n",
              "      <td>Evaluer la gestion et la sécurité de l'anesthé...</td>\n",
              "      <td>Etude monocentrique, rétrospective, descriptiv...</td>\n",
              "      <td>32180175\\n32015507\\n12682352\\n32075786\\n321513...</td>\n",
              "      <td>10.1007/s12630-020-01630-7</td>\n",
              "      <td>To assess the management and safety of epidura...</td>\n",
              "      <td>[Thérapeutique, Pédiatrie]</td>\n",
              "      <td>[{'id': 122, 'name': 'Chen R'}]</td>\n",
              "      <td>2020-03-10</td>\n",
              "      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, ...</td>\n",
              "      <td>Safety efficacy anesthetic regimens parturient...</td>\n",
              "      <td>268</td>\n",
              "      <td>18</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>367</th>\n",
              "      <td>118</td>\n",
              "      <td>a-systematic-review-on-the-efficacy-and-safety...</td>\n",
              "      <td>A systematic review on the efficacy and safety...</td>\n",
              "      <td>True</td>\n",
              "      <td>{'id': 3, 'name': 'Intermédiaire', 'posts_coun...</td>\n",
              "      <td>Evaluer la sécurité et l'efficacité de la chlo...</td>\n",
              "      <td>10.03.2020</td>\n",
              "      <td>Cortegiani A</td>\n",
              "      <td>https://www.dropbox.com/s/p10eq1pt587vvsj/10.1...</td>\n",
              "      <td>[{'id': 7, 'name': 'Transversale'}]</td>\n",
              "      <td>{'id': 4, 'name': 'Thérapeutique', 'icon': 'ic...</td>\n",
              "      <td>{'id': 79, 'name': 'J Crit Care'}</td>\n",
              "      <td>https://www.dropbox.com/s/p10eq1pt587vvsj/10.1...</td>\n",
              "      <td>Il y a un rationnel pour l'efficacité de la ch...</td>\n",
              "      <td>Effet chloroquine IN VIVO reste à démontrerEff...</td>\n",
              "      <td>Intermédiaire :1) Revue systématique très succ...</td>\n",
              "      <td>Evaluer la sécurité et l'efficacité de la chlo...</td>\n",
              "      <td>Revue systématique de la littérature</td>\n",
              "      <td>32173110</td>\n",
              "      <td>10.1016/j.jcrc.2020.03.005</td>\n",
              "      <td>COVID-19 (coronavirus disease 2019) is a publi...</td>\n",
              "      <td>[Thérapeutique, Transversale]</td>\n",
              "      <td>[{'id': 124, 'name': 'Cortegiani A'}]</td>\n",
              "      <td>2020-03-10</td>\n",
              "      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, ...</td>\n",
              "      <td>systematic review efficacy safety chloroquine ...</td>\n",
              "      <td>196</td>\n",
              "      <td>10</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>368</th>\n",
              "      <td>119</td>\n",
              "      <td>detection-of-novel-coronavirus-by-rt-pcr-in-st...</td>\n",
              "      <td>Detection of Novel Coronavirus by RT-PCR in St...</td>\n",
              "      <td>True</td>\n",
              "      <td>{'id': 2, 'name': 'Faible', 'posts_count': 505...</td>\n",
              "      <td>Décrire un cas asymptomatique positif chez l'e...</td>\n",
              "      <td>09.03.2020</td>\n",
              "      <td>Tang</td>\n",
              "      <td>https://wwwnc.cdc.gov/eid/article/26/6/20-0301...</td>\n",
              "      <td>[{'id': 9, 'name': 'Pédiatrie'}]</td>\n",
              "      <td>{'id': 3, 'name': 'Diagnostique', 'icon': 'ico...</td>\n",
              "      <td>{'id': 80, 'name': 'Emerge Inf Dis'}</td>\n",
              "      <td>https://wwwnc.cdc.gov/eid/article/26/6/20-0301...</td>\n",
              "      <td>Description d'un cas d'enfant de 10 ans asympt...</td>\n",
              "      <td>Intérêt du dépistage des cas asymptomatiques c...</td>\n",
              "      <td>Faible : 1) Lettre à l'éditeur sans processus ...</td>\n",
              "      <td>Décrire un cas asymptomatique positif chez l'e...</td>\n",
              "      <td>Case report</td>\n",
              "      <td>32150527\\n31978945\\n32030925\\n32004427\\n320478...</td>\n",
              "      <td>10.3201/eid2606.200301</td>\n",
              "      <td>We report an asymptomatic child who was positi...</td>\n",
              "      <td>[Diagnostique, Pédiatrie]</td>\n",
              "      <td>[{'id': 125, 'name': 'Tang'}]</td>\n",
              "      <td>2020-03-09</td>\n",
              "      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, ...</td>\n",
              "      <td>Detection Novel Coronavirus RT-PCR Stool Speci...</td>\n",
              "      <td>62</td>\n",
              "      <td>4</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>369</th>\n",
              "      <td>120</td>\n",
              "      <td>the-effect-of-travel-restrictions-on-the-sprea...</td>\n",
              "      <td>The effect of travel restrictions on the sprea...</td>\n",
              "      <td>True</td>\n",
              "      <td>{'id': 5, 'name': 'Fort', 'posts_count': 6, 'c...</td>\n",
              "      <td>Modéliser l'effet des restrictions de circulat...</td>\n",
              "      <td>06.03.2020</td>\n",
              "      <td>Chinazzi e</td>\n",
              "      <td>https://www.dropbox.com/s/zvuj4h7mo22muuo/scie...</td>\n",
              "      <td>[{'id': 7, 'name': 'Transversale'}]</td>\n",
              "      <td>{'id': 2, 'name': 'Autres', 'icon': 'icon-other'}</td>\n",
              "      <td>{'id': 66, 'name': 'Science'}</td>\n",
              "      <td>https://www.dropbox.com/s/zvuj4h7mo22muuo/scie...</td>\n",
              "      <td>Au début de l'interdiction de voyager depuis W...</td>\n",
              "      <td>Intérêt des restrictions de circulation surtou...</td>\n",
              "      <td>Forte : 1) Modélisation robuste basée sur l'en...</td>\n",
              "      <td>Modéliser l'effet des restrictions de circulat...</td>\n",
              "      <td>Etude d'impact par modélisation basée sur les ...</td>\n",
              "      <td>32144116\\n12766206\\n32309796\\n23341757\\n320141...</td>\n",
              "      <td>10.1126/science.aba9757</td>\n",
              "      <td>Motivated by the rapid spread of coronavirus d...</td>\n",
              "      <td>[Autres, Transversale]</td>\n",
              "      <td>[{'id': 126, 'name': 'Chinazzi e'}]</td>\n",
              "      <td>2020-03-06</td>\n",
              "      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, ...</td>\n",
              "      <td>effect travel restrictions spread 2019novel co...</td>\n",
              "      <td>158</td>\n",
              "      <td>6</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>370</th>\n",
              "      <td>121</td>\n",
              "      <td>clinical-characteristics-of-coronavirus-diseas...</td>\n",
              "      <td>Clinical Characteristics of Coronavirus Diseas...</td>\n",
              "      <td>True</td>\n",
              "      <td>{'id': 3, 'name': 'Intermédiaire', 'posts_coun...</td>\n",
              "      <td>Description des caractétistiques cliniques des...</td>\n",
              "      <td>28.02.2020</td>\n",
              "      <td>Guan WJ</td>\n",
              "      <td>https://www.dropbox.com/s/crvl0mtzn6b7o4y/nejm...</td>\n",
              "      <td>[{'id': 7, 'name': 'Transversale'}]</td>\n",
              "      <td>{'id': 5, 'name': 'Epidémiologique', 'icon': '...</td>\n",
              "      <td>{'id': 22, 'name': 'NEJM'}</td>\n",
              "      <td>https://www.dropbox.com/s/crvl0mtzn6b7o4y/nejm...</td>\n",
              "      <td>Sur 1099 patients testés positifs provenant de...</td>\n",
              "      <td>Médiane d'âge des patients infectés de 47 ans,...</td>\n",
              "      <td>Intermédiaire :1) Etude épidémiologique de coh...</td>\n",
              "      <td>Description des caractétistiques cliniques des...</td>\n",
              "      <td>Large étude de cohorte multicentrique</td>\n",
              "      <td>32109013\\n31986261\\n32007145\\n31995857\\n319789...</td>\n",
              "      <td>10.1056/NEJMoa2002032</td>\n",
              "      <td>Since December 2019, when coronavirus disease ...</td>\n",
              "      <td>[Epidémiologique, Transversale]</td>\n",
              "      <td>[{'id': 127, 'name': 'Guan WJ'}]</td>\n",
              "      <td>2020-02-28</td>\n",
              "      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, ...</td>\n",
              "      <td>Clinical Characteristics Coronavirus Disease C...</td>\n",
              "      <td>280</td>\n",
              "      <td>34</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>371 rows × 28 columns</p>\n",
              "</div>"
            ],
            "text/plain": [
              "      id                                               slug  ...  len  len_sentence\n",
              "0    769  body-mass-index-and-risk-for-intubation-or-dea...  ...  259            18\n",
              "1    742  an-mrna-vaccine-against-sars-cov-2-preliminary...  ...  269            14\n",
              "2    739  pathophysiology-transmission-diagnosis-and-tre...  ...  436            33\n",
              "3    735  introductions-and-early-spread-of-sars-cov-2-i...  ...   88             4\n",
              "4    724  how-to-safely-reopen-colleges-and-universities...  ...  239             9\n",
              "..   ...                                                ...  ...  ...           ...\n",
              "366  116  safety-and-efficacy-of-different-anesthetic-re...  ...  268            18\n",
              "367  118  a-systematic-review-on-the-efficacy-and-safety...  ...  196            10\n",
              "368  119  detection-of-novel-coronavirus-by-rt-pcr-in-st...  ...   62             4\n",
              "369  120  the-effect-of-travel-restrictions-on-the-sprea...  ...  158             6\n",
              "370  121  clinical-characteristics-of-coronavirus-diseas...  ...  280            34\n",
              "\n",
              "[371 rows x 28 columns]"
            ]
          },
          "metadata": {
            "tags": []
          },
          "execution_count": 23
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "3a_15Tlc_FjK"
      },
      "source": [
        "Ici la longueur des textes concaténés avant le traitement par spacy "
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 298
        },
        "id": "OCs9JBIl_RZu",
        "outputId": "e5fe50d3-94eb-4a63-f751-4ef6dea6f42d"
      },
      "source": [
        "import numpy as np\r\n",
        "import matplotlib.pyplot as plt\r\n",
        "longueurs = df_bibliovid.len\r\n",
        "longueurs.hist(bins = np.arange(0,700,50))\r\n",
        "plt.title(\"Number of words per 'title+abstract'\")\r\n",
        "plt.ylabel('Number of documents', fontsize=12)\r\n",
        "plt.xlabel('Number of words', fontsize=12)\r\n",
        "plt.show()"
      ],
      "execution_count": 25,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "image/png": "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\n",
            "text/plain": [
              "<Figure size 432x288 with 1 Axes>"
            ]
          },
          "metadata": {
            "tags": [],
            "needs_background": "light"
          }
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "o1DiNsyCKZPW"
      },
      "source": [
        "texts = list(df_bibliovid['cat_text'].apply(lambda x: len(x.split(' '))))\r\n",
        "df_bibliovid['len'] = texts"
      ],
      "execution_count": 26,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "n2OoyEzO_Thf"
      },
      "source": [
        "Ici la longueur des textes concaténés après le traitement avec Spacy"
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 298
        },
        "id": "5WQTa5DVbvSX",
        "outputId": "b177ef6f-cc08-4512-d0b1-18de7ab7a46d"
      },
      "source": [
        "import matplotlib.pyplot as plt\r\n",
        "longueurs = df_bibliovid.len\r\n",
        "longueurs.hist(bins = np.arange(0,700,50))\r\n",
        "plt.title(\"Number of words per 'title+abstract'\")\r\n",
        "plt.ylabel('Number of documents', fontsize=12)\r\n",
        "plt.xlabel('Number of words', fontsize=12)\r\n",
        "plt.show()"
      ],
      "execution_count": 27,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "image/png": "iVBORw0KGgoAAAANSUhEUgAAAYgAAAEZCAYAAACNebLAAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4yLjIsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+WH4yJAAAgAElEQVR4nO3deZgdVZ3/8fdnWEJIMwQINEtigoIggqA024BMBxQZ4BHnGWRk2AXy03FBxZGgjiDKCOOw6DA6gyxhZElQQZigI4h0MCAwQZGwGAwQzAIJSxIJshjy/f1Rp6Fyqe5UL9V1b/rzep77pOrU9r3VN/d765yqcxQRmJmZNfqLugMwM7Pm5ARhZmaFnCDMzKyQE4SZmRVygjAzs0JOEGZmVsgJwnolaYqkr9d0bEm6QtJSSffWEUOKo1PSgrqO31+Sfirp+F6WD+nfVtIJkmYO1fFs4JwgWoykeZKWSBqVKztZUleNYVVlP+D9wNiI2LPuYJqNpC5JnWn6LElX5ZdHxN9ExJVpect+OVcde1GiTP/PJlR1zFbhBNGa1gFOrTuIvpK0Th83GQ/Mi4gXq4iniKR1h+pYfdGPc1eZlIzOqjuOvGY6P2sTJ4jW9E3g85JGNy6QNEFS5L/o0i/Nk9P0CZLulHShpGWSHpf0V6l8fro6aayWGCPpVkkvSJohaXxu3zumZc9LmiPpyNyyKZK+K+knkl4EJhbEu7Wkm9L2cyWdkspPAi4F9pG0QtJXC7Z9UtLuafro9L7f2b29pB+n6RGSLpK0KL0ukjQiLeuUtEDS6ZKeBq6QNDLFvlTSw8AeDcc9XdLCdD7mSDqw6I+U9vGfVZ273LoHA18E/j6dq9+m8q50dfkO4D9z53JZD/s5TNL96XNxl6R39XTMXmKZLOmx9H4flvS3b15FF0taLul3+XOXPoOPp22fSH/TwtiLzo+kQyX9RtIf02f5rIYD75fe17K0/ARJk4CjgS+k/f9PX9/zWi0i/GqhFzAPeB9wPfD1VHYy0JWmJwABrJvbpgs4OU2fAKwETiS7Evk68AfgP4ARwEHAC0BbWn9Kmt8/Lf8WMDMtGwXMT/taF3g38CywU27b5cC+ZD9GNih4P3cA3wE2AHYDngEOyMU6s5dz8d/AaWn6EuAx4OO5ZZ9N02cDdwNbAJsDdwFfS8s60/k4L72/kcC5wC+BTYFxwIPAgrT+Duk9b50732/rIb5Kz13Dsc4Crmooa/y7zyyIr/sz9G5gCbBX+lwcT/ZZG9HDsc7qIY4PA1unmP8eeBHYquGz91lgvbR8eTrPo4A/AjukdbcC3rmG2Fc7P+lvuUuafxewGPhQWn98+lsclY69GbBb43nwa/WXryBa11eAT0navB/bPhERV0TEa8A0si/BsyPilYi4BXgV2C63/s0RcUdEvAJ8iezX3DjgMLIqoCsiYmVE/Ab4EdmXRLcbI+LOiFgVES/ng0j72Bc4PSJejoj7ya4ajiv5PmYAf52m3wt8Izf/12k5ZL8Qz46IJRHxDPBV4NjcflYBZ6b3/xJwJHBORDwfEfOBb+fWfY3sy34nSetFxLyIeKyXGCs5dxWYBPxXRNwTEa9F1nbxCrB3X3YSET+IiEUp5mnA74F8+9ES4KKI+HNaPgc4NC1bBewsaWREPBURD63hcKudn4joiojZaf4B4Fre+Dz8A/DziLg2Hfu59HmzXjhBtKiIeBCYDkzux+aLc9Mvpf01lrXl5ufnjrsCeJ7sV+J4YK90yb4sXf4fDWxZtG2BrYHnI+KFXNmTwDYl38cM4L2StiL71XsdsK+yxsWNge4vgK3TfvPH2Do3/0zDF/DWDXG/vm1EzAU+Q/YreomkqZLy+2pU1bkbbOOB0xriGZdiRdL0XPlkYHJu3endO5F0XK6aahmwMzAmd5yFEZHvIfRJsquxF8muKD4GPCXpZkk7riHm1c6PpL0k3S7pGUnL0766jz2O7ArT+sAJorWdCZzC6l+o3Q26G+bK8l86/TGue0JSG1mVwCKy/6AzImJ07tUWER/Pbdtbd8GLgE0lbZQrewuwsExQ6cv6T8CngDsi4o/A02S/hmdGxKrcccbnNn1LKuspxqfIvee0fv6410TEfmmfQVY91ZOqzl2jNa27puXzya6a8vFsGBHXAkTEYd3lZFVw5+bWOyy9v/HA94BPApuldR8ElDvONpLy86//LSLiZxHxfrLqpd+lffUWe2P5NcBNwLiI2Jis7aL7WPOBt5XcjyVOEC0sfUFOAz6dK3uG7Av2GEnrSPooPf/HKOuQ1MC3PvA14O5U9TIdeLukYyWtl157pIbFMvHPJ2sP+IakDVKj6EnAVb1vuZoZZF9I3dVJXQ3zkFU1fFnS5pLGkFXP9XaM64AzJG0iaSxZAgJA0g6SDlDWyP0y2dXWqh72AxWduwKLgQmSevo/vRgYm+Io8j3gY+lXuCSNSo2+G/WwfpFRZF+2zwBIOpHsCiJvC+DT6f1+GHgH8BNJ7ZIOV3b79ivACt44r2uKvdtGZFekL0vak6xaqdvVwPskHSlpXUmbSdott/+39uF9DhtOEK3vbLL/mHmnAP8EPAe8k+xLeCCuIbtaeR7YHTgGIFUNHQR8hOxX4NO80dhb1lFkDb2LgBvI2gJ+3oftZ5B9MdzRwzxkDfGzgAeA2cCvU1lPvkpW9fEEcAvw/dyyEWS/oJ8le79bAGf0sq8qz13eD9K/z0n6dcHyXwAPAU9LerZxYUTMIvvcXAwsBeaSNQ6XFhEPA+cDvyL70t0FuLNhtXuA7cnO3znAERHxHNl30efIzsXzZG0H3VdTvcae84/A2ZJeIPsRcF0utj8AhwCnpf3fD+yaFl9G1qa0TOnON8to9epAMxsskqaQ3f305bpjMesPX0GYmVkhJwgzMyvkKiYzMyvkKwgzMyvUlB2T9ceYMWNiwoQJ/dr2xRdfZNSoxhuBWoNjr4djr0erxt7Mcd93333PRkRhjwxrTYKYMGECs2bN6te2XV1ddHZ2Dm5AQ8Sx18Ox16NVY2/muCU92dMyVzGZmVkhJwgzMyvkBGFmZoWcIMzMrJAThJmZFXKCMDOzQk4QZmZWyAnCzMwKOUGYmVmhteZJ6uFq9sLlnDD55sr2P+/cQ9e8kpmtlXwFYWZmhZwgzMyskBOEmZkVcoIwM7NCThBmZlbIdzENgQkV3mV02i6V7drMhjlfQZiZWSEnCDMzK+QEYWZmhZwgzMyskBOEmZkVcoIwM7NCThBmZlbICcLMzAo5QZiZWSEnCDMzKzQkCULS5ZKWSHowV/ZNSb+T9ICkGySNzi07Q9JcSXMkfWAoYjQzs9UN1RXEFODghrJbgZ0j4l3Ao8AZAJJ2Aj4CvDNt8x1J6wxRnGZmlgxJgoiIO4DnG8puiYiVafZuYGyaPhyYGhGvRMQTwFxgz6GI08zM3qCIGJoDSROA6RGxc8Gy/wGmRcRVki4G7o6Iq9Kyy4CfRsQPC7abBEwCaG9v333q1Kn9im3FihW0tbX1a9syZi9cXtm+20fC4pcq2z27bLNxZfuu+rxXybHXo1Vjb+a4J06ceF9EdBQtq727b0lfAlYCV/d124i4BLgEoKOjIzo7O/sVQ1dXF/3dtowTKu3ueyXnz67uzzjv6M7K9l31ea+SY69Hq8beqnHXmiAknQAcBhwYb1zKLATG5VYbm8rMzGwI1Xabq6SDgS8AH4yIP+UW3QR8RNIISdsC2wP31hGjmdlwNiRXEJKuBTqBMZIWAGeS3bU0ArhVEmTtDh+LiIckXQc8TFb19ImIeG0o4jQzszcMSYKIiKMKii/rZf1zgHOqi8jMzNbET1KbmVkhJwgzMyvkBGFmZoWcIMzMrJAThJmZFXKCMDOzQk4QZmZWqFSCkDQxPdWMpK0kXSnpCklbVhuemZnVpewVxHeA7qeZzwfWA1aROsozM7O1T9knqbeJiD9IWhf4ADAeeBVYVFlkZmZWq7IJ4o+S2oGdgYcjYoWk9cmuJMzMbC1UNkH8O/B/wPrAZ1LZvsDvqgjKzMzqVypBRMR5km4AXouIx1LxQuCkyiIzM7Nalb2L6caIeDSXHIiIR4GzK4vMzMxqVfYupok9lHcOUhxmZtZkeq1iktR9hbB+brrbW4EnK4nKzMxqt6Y2iO6xof+C1ceJDmA+cFYFMZmZWRPoNUFExIkAku6KiO8NTUhmZtYMyt7F9D1JGwM7AG0Ny35RRWBmZlavUglC0gnAfwArgD/lFgVZW4SZma1lyj4odw5wRET8tMpgzMyseZS9zXVd4JYqAzEzs+ZSNkGcB3xZUr/Gj5B0uaQlkh7MlW0q6VZJv0//bpLKJenbkuZKekDSe/pzTDMzG5iyX/ifBb4MvCDpD/lXye2nAAc3lE0GbouI7YHb0jzA3wDbp9ck4Lslj2FmZoOobBvEMQM5SETcIWlCQ/HhvPEk9pVAF3B6Kv/viAjgbkmjJW0VEU8NJAYzM+sbZd/DQ3CgLEFMj4id0/yyiBidpgUsjYjRkqYD50bEzLTsNuD0iJhVsM9JZFcZtLe37z516tR+xbZixQra2trWvGI/zV64vLJ9t4+ExS9Vtnt22WbjyvZd9XmvkmOvR6vG3sxxT5w48b6I6ChaVvY21xHAV4CjgM0iYmNJBwFvj4iLBxpgRISkPmeqiLiENKpdR0dHdHZ29uv4XV1d9HfbMk6YfHNl+z5tl5WcP7vshWDfzTu6s7J9V33eq+TY69Gqsbdq3GXbIC4kGyzoaLJnHwAeAj4+gGMvlrQVZONcA0tS+UJW79ZjbCozM7MhVDZB/C3wDxHxK7KxqImIhcA2Azj2TcDxafp44MZc+XHpbqa9geVufzAzG3pl6yZebVxX0ubAc2U2lnQtWYP0GEkLgDOBc4HrJJ1E1ivskWn1nwCHAHPJnto+sWSMZmY2iMomiB8AV0r6LLxeJXQRUKpVOCKO6mHRgQXrBvCJknGZmVlFylYxfRF4ApgNjAZ+DyzCI8qZma21yvbm+irZw3KfTVVLz8ZQ3R9rZma1KH1/pKQNge3IuvvePnt0ASLirmpCMzOzOpV9DuI44GKyxur8Y1kBvKWCuMzMrGZlryD+Ffi7iLi1ymDMzKx5lG2kfpWsryQzMxsmyiaIfwYukDSmymDMzKx5lE0QjwIfJOse47X0WiXptQpjMzOzGpVtg/g+8N/ANFZvpDYzs7VU2QSxGfAVP/tgZjZ8lK1iugI4tspAzMysuZS9gtgT+KSkLwGL8wsiYv9Bj8rMzGpXNkF8L73MzGyYKNsX05VVB2JmZs2lbFcbH+1pWURcPnjhmJlZsyhbxdTYQL0l8DbgTsAJwsxsLVS2imliY1m6qnjHoEdkZmZNoextrkWmACcNUhxmZtZkyrZBNCaSDYFjgGWDHpGZmTWFsm0QK8nGfshbCEwa3HDMzKxZlE0Q2zbMvxgRzw52MGZm1jz6cgXxp4hY2l0gaRNgZEQsqiQyMzOrVdlG6h8DYxvKxgI3DDQASZ+V9JCkByVdK2kDSdtKukfSXEnTJK0/0OOYmVnflE0QO0TE7HxBmt9xIAeXtA3waaAjInYG1gE+ApwHXBgR2wFL8d1SZmZDrmyCWCJpu3xBmn9uEGJYFxgpaV2yu6OeAg4AfpiWXwl8aBCOY2ZmfaAyQzxI+iLw98CXgMfJnqL+GnBdRPzLgAKQTgXOIRuI6BbgVODudPWApHHAT9MVRuO2k0h3UrW3t+8+derUfsWwYsUK2tra+vcGSpi9cHll+24fCYsrHMJpl202rmzfVZ/3Kjn2erRq7M0c98SJE++LiI6iZWUbqc8F/gz8GzAOmA9cClwwkMBSQ/fhZHdJLQN+ABxcdvuIuAS4BKCjoyM6Ozv7FUdXVxf93baMEybfXNm+T9tlJefPLvtn7Lt5R3dWtu+qz3uVHHs9WjX2Vo27bFcbq4Bvptdgeh/wREQ8AyDpemBfYLSkdSNiJVlj+MJBPq6Zma1B6a42JHVKulzSz9K/b+qfqR/+AOwtaUNJAg4EHgZuB45I6xwP3DgIxzIzsz4olSAknQxcBzwNXE/WkHytpFMGcvCIuIesMfrXwOwUzyXA6cDnJM0lGw/7soEcx8zM+q5s5fUXgPdHxG+7CyRNA37EAEeai4gzgTMbih8nG+bUzMxqUraKaTOyqp+8OcCmgxuOmZk1i7IJYiZwgaQNASSNImuwvquqwMzMrF5lE8THgF2B5ZIWk92Suivw/6oKzMzM6lX2NtengP3TQ2tbAYsiYkGlkZmZWa16TBAFgwRB9jzCwvzy9IyEmZmtZXq7gigaJKjIOoMUi5mZNZHeEkR+kKBDyR5c+wbwJDCe7FmFH1UXmpmZ1anHBBERT3ZPS/ocWZfc3WNQPyppFjAL+G61IZqZWR3K3sW0MVlX3HkbpnIzM1sLlX2S+krg55IuIuvJdRzZQD9XVhWYmZnVqy9dbcwlGxNia7K+mC5mgN1smJlZ8+pLd9//mV5mZjYMlO7u28zMhhcnCDMzK+QEYWZmhXpMEJLuzk03jtdgZmZrud6uIN4uaYM0fdpQBGNmZs2jt7uYbiR7YnoeMFLSHUUrRcT+VQRmZmb16q2rjRMl7QdMAPbA40KbmQ0rvT4HEREzgZmS1o8IPzVtZjaMlH1Q7nJJncBxwDZkY0J8PyJurzA2MzOrUanbXCWdDFwHPA1cT9bVxrWSTqkwNjMzq1Ff+mJ6f0T8trtA0jSy8SAG1B+TpNHApcDOZAMUfRSYA0wja/+YBxwZEUsHchwzM+ubsg/KbQY83FA2B9h0EGL4FvC/EbEjsCvwCDAZuC0itgduS/NmZjaEyiaImcAFkjYEkDQK+CZw10AOLmljYH/SHVIR8WoalOhw3uhK/ErgQwM5jpmZ9Z0i1jzstKStyKp89gGeJ7tyuAs4KiIW9fvg0m7AJWRXJ7sC9wGnAgsjYnRaR8DS7vmG7ScBkwDa29t3nzp1ar/iWLFiBW1tbf3atozZC5dXtu/2kbD4pcp2zy7bVDcmVNXnvUqOvR6tGnszxz1x4sT7IqKjaFmpBPH6ytJYsvEgFkXEgoEGJqkDuBvYNyLukfQt4I/Ap/IJQdLSiNikt311dHTErFmz+hVHV1cXnZ2d/dq2jAmTb65s36ftspLzZ5dtSuq7eeceWtm+qz7vVXLs9WjV2Js5bkk9Jog+ddYXEQsi4t7BSA7JAmBBRNyT5n8IvAdYnK5auq9elgzS8czMrKTqfnqWEBFPS5ovaYeImAMcSFbd9DBwPHBu+vfGGsMc1qq8+ply8KjK9m1mA1drgkg+BVwtaX3gceBEsiub6ySdBDwJHFljfGZmw9IaE4SkvwA6gZkR8epgBxAR9wNF9V8HDvaxzMysvDW2QaTxqG+sIjmYmVnzKttIfYekvSuNxMzMmkrZNogngZ9KuhGYT9YlBgAR8ZUqAjMzs3qVTRAjgR+n6bEVxWJmZk2kbHffJ1YdiJmZNZfSt7lK2hH4MNAeEZ+UtAMwIiIeqCw6MzOrTdnxID4M/JJssKDjUvFGwAUVxWVmZjUrexfT2cD7IuJjwGup7LdkHeyZmdlaqGyC2ALorkqK3L/le/ozM7OWUjZB3Acc21D2EeDewQ3HzMyaRdlG6k8Dt6S+kUZJ+hnwduCgyiIzM7Nalb3N9XfpLqbDgOlkD8tNj4gVVQZnZmb1KX2ba0T8SdKdwBNkAwY5OZiZrcXK3ub6Fkm/BOYBNwPzJP1S0vgqgzMzs/qUbaS+kqyhenREbAFsAsxK5WZmthYqW8W0O3BQRPwZICJWSDodeK6yyMzMrFZlryDuBvZsKOsAfjW44ZiZWbPo8QpC0tm52ceAn0i6mewOpnHAIcA11YZnZmZ16a2KaVzD/PXp3y2AV4AbgA2qCMrMzOrXY4JwF99mZsNbX7r73hDYDmjLl0fEXYMdlJmZ1a9UgpB0HHAx8CrwUm5RAG+pIC4zM6tZ2buY/hX4u4gYExHjcq9BSQ6S1pH0G0nT0/y2ku6RNFfSNEnrD8ZxzMysvLIJ4lWgq8I4TgUeyc2fB1wYEdsBS4GTKjy2mZkVKJsg/hm4QNKYwQ5A0ljgUODSNC/gAOCHaZUrgQ8N9nHNzKx3ZRPEo8AHgcWSXkuvVZJeW9OGJVwEfAFYleY3A5ZFxMo0v4BsqFMzMxtCiljzoHCS5gLXAtNYvZGaiHis3weXDgMOiYh/lNQJfB44Abg7VS8haRzw04jYuWD7ScAkgPb29t2nTp3arzhWrFhBW1vbmlfsp9kLl1e27/aRsPilNa/XjLbdeJ1Kz3uVqv7MVMmxD71mjnvixIn3RURH0bKyCWIpsGmUWbkPJH2DbKS6lWQP3f0l2QN4HwC2jIiVkvYBzoqID/S2r46Ojpg1a1a/4ujq6qKzs7Nf25YxYfLNle37tF1Wcv7s0ncrN5UpB4+q9LxXqerPTJUc+9Br5rgl9ZggylYxXcGbhxwdsIg4IyLGRsQEsiFMfxERRwO3A0ek1Y4HbhzsY5uZWe/KJog9gUslzZF0R/5VUVynA59LVVubAZdVdBwzM+tB2bqJ76VXZSKii3QrbUQ8zpt7j63M7IXLOaHCaiAzs1ZUdkxqDwxkZjbMlO1q46M9LYuIywcvHDMzaxZlq5gaG6i3BN4G3Ak4QZiZrYXKVjFNbCxLVxXvGPSIzMysKZS9i6nIFNxHkpnZWqtsG0RjItkQOAZYNugRmZlZUyjbBrGSbOyHvIXAKYMbjpmZNYuyCWLbhvkXI+LZwQ7GzMyaR9lG6ierDsTMzJpLrwlC0u28uWopLyLiwMENyczMmsGariCu6qF8G+DTZI3VZma2Fuo1QUTEap3kSdoMOIOscXoacHZ1oZmZWZ1KPQch6S8lfQ2YC7QD74mISRGxoNLozMysNr0mCEkjJZ0BPE721PR+EXHsQEaRMzOz1rCmNoh5ZEnkX4FZQLuk9vwKEfGLakIzM7M6rSlBvER2F9PHe1gewFsHNSIzM2sKa2qknjBEcZiZWZMZSGd9Zma2FnOCMDOzQk4QZmZWyAnCzMwKOUGYmVmhWhOEpHGSbpf0sKSHJJ2ayjeVdKuk36d/N6kzTjOz4ajuK4iVwGkRsROwN/AJSTsBk4HbImJ74LY0b2ZmQ6jWBBERT0XEr9P0C8AjZD3FHg5cmVa7EvhQPRGamQ1fdV9BvE7SBODdwD1Ae0Q8lRY9TdZBoJmZDSFF9DYe0BAFIbUBM4BzIuJ6ScsiYnRu+dKIeFM7hKRJwCSA9vb23adOndqv4y95fjmLX+pf7HVrH0nLxr7txuvQ1tZWdxj9smLFCsdeg1aNvZnjnjhx4n0R0VG0rOyY1JWRtB7wI+DqiLg+FS+WtFVEPCVpK2BJ0bYRcQlwCUBHR0d0dnb2K4Z/v/pGzp9d+6nol9N2WdmysU85eBT9/ZvVraury7HXoFVjb9W4676LScBlwCMRcUFu0U3A8Wn6eODGoY7NzGy4q/un577AscBsSfensi8C5wLXSToJeBI4sqb4zMyGrVoTRETMBNTD4gOHMhYzM1td09zFZGZmzcUJwszMCjlBmJlZIScIMzMr5ARhZmaFnCDMzKyQE4SZmRWq+0E5G8ZmL1zOCZNvrmTf8849tJL9mg0nvoIwM7NCThBmZlbICcLMzAo5QZiZWSEnCDMzK+QEYWZmhZwgzMyskBOEmZkVcoIwM7NCThBmZlbICcLMzAo5QZiZWSEnCDMzK+QEYWZmhZwgzMysUFMnCEkHS5ojaa6kyXXHY2Y2nDTtgEGS1gH+A3g/sAD4P0k3RcTD9UZmrWBCRQMRdZty8KhK918lD9RkZTXzFcSewNyIeDwiXgWmAofXHJOZ2bChiKg7hkKSjgAOjoiT0/yxwF4R8cncOpOASWl2B2BOPw83Bnh2AOHWybHXw7HXo1Vjb+a4x0fE5kULmraKqYyIuAS4ZKD7kTQrIjoGIaQh59jr4djr0aqxt2rczVzFtBAYl5sfm8rMzGwINHOC+D9ge0nbSlof+AhwU80xmZkNG01bxRQRKyV9EvgZsA5weUQ8VNHhBlxNVSPHXg/HXo9Wjb0l427aRmozM6tXM1cxmZlZjZwgzMys0LBPEM3enYekyyUtkfRgrmxTSbdK+n36d5NULknfTu/lAUnvqTHucZJul/SwpIckndpCsW8g6V5Jv02xfzWVbyvpnhTjtHTzBJJGpPm5afmEumLvJmkdSb+RND3Nt0TskuZJmi3pfkmzUlnTf2ZSPKMl/VDS7yQ9ImmfVom9J8M6QeS68/gbYCfgKEk71RvVm0wBDm4omwzcFhHbA7elecjex/bpNQn47hDFWGQlcFpE7ATsDXwindtWiP0V4ICI2BXYDThY0t7AecCFEbEdsBQ4Ka1/ErA0lV+Y1qvbqcAjuflWin1iROyWe26gFT4zAN8C/jcidgR2JTv/rRJ7sYgYti9gH+BnufkzgDPqjqsgzgnAg7n5OcBWaXorYE6a/i/gqKL16n4BN5L1q9VSsQMbAr8G9iJ7Enbdxs8O2Z12+6TpddN6qjHmsWRfRgcA0wG1UOzzgDENZU3/mQE2Bp5oPHetEHtvr2F9BQFsA8zPzS9IZc2uPSKeStNPA+1puinfT6q2eDdwDy0Se6qiuR9YAtwKPAYsi4iVBfG9HntavhzYbGgjXs1FwBeAVWl+M1on9gBukXRf6koHWuMzsy3wDHBFqtq7VNIoWiP2Hg33BNHyIvv50bT3KktqA34EfCYi/phf1syxR8RrEbEb2a/xPYEdaw6pFEmHAUsi4r66Y+mn/SLiPWRVMJ+QtH9+YRN/ZtYF3gN8NyLeDbzIG9VJQFPH3qPhniBatTuPxZK2Akj/LknlTfV+JK1HlhyujojrU3FLxN4tIpYBt5NVy4yW1P1waT6+12NPyzcGnhviULvtC3xQ0jyyHpAPIKsbb4XYiYiF6d8lwA1kybkVPjMLgAURcU+a/yFZwmiF2Hs03BNEq3bncRNwfJo+nqx+v7v8uHSHxN7A8tzl7ZCSJOAy4JGIuCC3qBVi31zS6DQ9kqzt5BGyRHFEWq0x9u73dATwi/RrcchFxBkRMTYiJpB9nn8REUfTArFLGiVpo+5p4CDgQVrgMxMRTwPzJe2Qig4EHvsPc8YAAAUMSURBVKYFYu9V3Y0gdb+AQ4BHyeqYv1R3PAXxXQs8BfyZ7FfKSWR1xLcBvwd+Dmya1hXZXVmPAbOBjhrj3o/scvoB4P70OqRFYn8X8JsU+4PAV1L5W4F7gbnAD4ARqXyDND83LX9r3Z+bFFcnML1VYk8x/ja9Hur+/9gKn5kUz27ArPS5+TGwSavE3tPLXW2YmVmh4V7FZGZmPXCCMDOzQk4QZmZWyAnCzMwKOUGYmVkhJwizRNIUSV+v6diSdIWkpZLurSOGFEenpAV1Hd+aixOENa3U9fOS9NBUd9nJkrpqDKsq+5E9kDc2IvasOxgzcIKw5rcOWdfVLSV1Jd8X44F5EfFiFfEUyXW9YVbICcKa3TeBz3d3fZEnaYKkyH/RSeqSdHKaPkHSnZIulLRM0uOS/iqVz09XJ8c37HZMGtjlBUkzJI3P7XvHtOx5ZYNMHZlbNkXSdyX9RNKLwMSCeLeWdFPafq6kU1L5ScClwD6SVigNUNSw7ZOSdk/TR6f3/c7u7SX9OE2PkHSRpEXpdZGkEWlZp6QFkk6X9DRZz6MjU+xLJT0M7NFw3NMlLUznY46kA3v9a9laxQnCmt0soAv4fD+334us64PNgGvIOrDbA9gOOAa4WFmPs92OBr4GjCHrHuRqeL1voFvTPrYg6+foO1p9gKl/AM4BNgJmFsQylay7lK3J+j36F0kHRMRlwMeAX0VEW0ScWbDtDLKuMwD+Gngc2D83PyNNf4lsgKbdyAat2RP4cm4/WwKbkl2xTALOBN6WXh/gjX6DSP0KfRLYIyI2SsvnFcRmayknCGsFXwE+JWnzfmz7RERcERGvAdPIetA8OyJeiYhbgFfJkkW3myPijoh4hezLdh9J44DDyKqAroiIlRHxG7Keaj+c2/bGiLgzIlZFxMv5INI+9gVOj4iXI+J+squG40q+jxlkiQDgvcA3cvP5BHF0en9LIuIZ4KvAsbn9rALOTO//JeBI4JyIeD4i5gPfzq37GjAC2EnSehExLyIeKxmvrQWcIKzpRcSDZCOj9WfM8MW56ZfS/hrL8lcQrw/iEhErgOfJfvGPB/ZKVVXLJC0j+zLesmjbAlsDz0fEC7myJyk/SMwM4L2py+h1gOuAfZUNxrQx2dVO93GebDjG1rn5ZxqS19YNcb++bUTMBT4DnAUskTRVUn5ftpZzgrBWcSZwCqt/oXY36G6YK8t/YffH6330p6qnTYFFZF+iMyJidO7VFhEfz23bW8+Xi4BNu7uzTt5CyTEA0pf1n4BPAXdENvjS02TVRDMjonv0uEVkySx/jEW9xPgUq49L8JaG414TEfulfQbNMWa1DREnCGsJ6QtyGvDpXNkzZF+wxygbIvSjZHXpA3GIpP2UjQ/yNeDuVPUyHXi7pGMlrZdee0h6R8n45wN3Ad+QtIGkd5F13X5VH2KbQdYm0F2d1NUwD1n38F9WNqbFGLLqud6OcR1whqRNJI0lS0BA1gYh6YDUyP0y2dXWqh72Y2shJwhrJWcDoxrKTgH+iWwUtHeSfQkPxDVkVyvPA7uTNWSTqoYOImucXkT26/08sjr6so4CJqTtbyBrC/h5H7afQdYAfkcP8wBf540xCWYDv05lPfkqWbXSE8AtwPdzy0YA5wLPkr3fLYAz+hCvtTiPB2FmZoV8BWFmZoWcIMzMrJAThJmZFXKCMDOzQk4QZmZWyAnCzMwKOUGYmVkhJwgzMyv0/wGxgdSiagGUQwAAAABJRU5ErkJggg==\n",
            "text/plain": [
              "<Figure size 432x288 with 1 Axes>"
            ]
          },
          "metadata": {
            "tags": [],
            "needs_background": "light"
          }
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "fODsjS4fcGC9",
        "outputId": "daaede10-8e1a-4c1f-c3bd-6b854c86d4cd"
      },
      "source": [
        "df_bibliovid_augmented = df_bibliovid.copy()\r\n",
        "df_bibliovid_augmented"
      ],
      "execution_count": 28,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/html": [
              "<div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>id</th>\n",
              "      <th>slug</th>\n",
              "      <th>title</th>\n",
              "      <th>has_other_authors</th>\n",
              "      <th>impact_factor</th>\n",
              "      <th>goals_plain</th>\n",
              "      <th>verbose_date</th>\n",
              "      <th>authors</th>\n",
              "      <th>document_link</th>\n",
              "      <th>specialties</th>\n",
              "      <th>category</th>\n",
              "      <th>journal</th>\n",
              "      <th>link</th>\n",
              "      <th>results</th>\n",
              "      <th>synthesis</th>\n",
              "      <th>strength_of_evidence_details</th>\n",
              "      <th>goals</th>\n",
              "      <th>methods</th>\n",
              "      <th>pubmed_id</th>\n",
              "      <th>doi</th>\n",
              "      <th>abstract</th>\n",
              "      <th>topics</th>\n",
              "      <th>author_list</th>\n",
              "      <th>publication_date</th>\n",
              "      <th>vect_specs</th>\n",
              "      <th>cat_text</th>\n",
              "      <th>len</th>\n",
              "      <th>len_sentence</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>769</td>\n",
              "      <td>body-mass-index-and-risk-for-intubation-or-dea...</td>\n",
              "      <td>Body Mass Index and Risk for Intubation or Dea...</td>\n",
              "      <td>True</td>\n",
              "      <td>{'id': 3, 'name': 'Intermédiaire', 'posts_coun...</td>\n",
              "      <td>- Déterminer si l'obésité est associée à l'int...</td>\n",
              "      <td>31.07.2020</td>\n",
              "      <td>Anderson MR</td>\n",
              "      <td>https://www.acpjournals.org/doi/10.7326/M20-3214</td>\n",
              "      <td>[{'id': 4, 'name': 'Anesthésie-Réanimation'}, ...</td>\n",
              "      <td>{'id': 6, 'name': 'Pronostique', 'icon': 'icon...</td>\n",
              "      <td>{'id': 41, 'name': 'Ann Intern Med'}</td>\n",
              "      <td>https://www.acpjournals.org/doi/10.7326/M20-3214</td>\n",
              "      <td>*Description de l'échantillon: 2112 patients c...</td>\n",
              "      <td>- Environ 2-3% des patients atteints de la COV...</td>\n",
              "      <td>-cohorte pronostique- puissance de l'étude sup...</td>\n",
              "      <td>- Déterminer si l'obésité est associée à l'int...</td>\n",
              "      <td>Cohorte rétrospective portant sur 2466 patient...</td>\n",
              "      <td>32726151</td>\n",
              "      <td>10.7326/M20-3214</td>\n",
              "      <td>Obesity is a risk factor for pneumonia and acu...</td>\n",
              "      <td>[Pronostique, Anesthésie-Réanimation, Infectio...</td>\n",
              "      <td>[{'id': 714, 'name': 'Anderson MR'}]</td>\n",
              "      <td>2020-07-31</td>\n",
              "      <td>[0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, ...</td>\n",
              "      <td>Body Mass Index Risk Intubation Death SARS-CoV...</td>\n",
              "      <td>148</td>\n",
              "      <td>18</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>742</td>\n",
              "      <td>an-mrna-vaccine-against-sars-cov-2-preliminary...</td>\n",
              "      <td>An mRNA Vaccine against SARS-CoV-2 - Prelimina...</td>\n",
              "      <td>True</td>\n",
              "      <td>{'id': 3, 'name': 'Intermédiaire', 'posts_coun...</td>\n",
              "      <td>Développement du vaccin accéléré mRNA-1273 Mod...</td>\n",
              "      <td>15.07.2020</td>\n",
              "      <td>Jackson LA</td>\n",
              "      <td>https://www.nejm.org/doi/10.1056/NEJMoa2022483</td>\n",
              "      <td>[{'id': 22, 'name': 'Immunité'}, {'id': 5, 'na...</td>\n",
              "      <td>{'id': 4, 'name': 'Thérapeutique', 'icon': 'ic...</td>\n",
              "      <td>{'id': 22, 'name': 'NEJM'}</td>\n",
              "      <td>https://www.nejm.org/doi/10.1056/NEJMoa2022483</td>\n",
              "      <td>Après la première vaccination, les réponses an...</td>\n",
              "      <td>Le vaccin mRNA-1273 est plutôt bien toléré. De...</td>\n",
              "      <td>Les résultats du rapport ne sont que prélimina...</td>\n",
              "      <td>Développement du vaccin accéléré mRNA-1273 Mod...</td>\n",
              "      <td>Essai de vaccination de Phase 1, ouvert inclua...</td>\n",
              "      <td>32663912</td>\n",
              "      <td>10.1056/NEJMoa2022483</td>\n",
              "      <td>The severe acute respiratory syndrome coronavi...</td>\n",
              "      <td>[Thérapeutique, Immunité, Virologie, Infectiol...</td>\n",
              "      <td>[{'id': 690, 'name': 'Jackson LA'}]</td>\n",
              "      <td>2020-07-15</td>\n",
              "      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, ...</td>\n",
              "      <td>mRNA Vaccine SARS-CoV-2 Preliminary ReportThe ...</td>\n",
              "      <td>116</td>\n",
              "      <td>14</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>739</td>\n",
              "      <td>pathophysiology-transmission-diagnosis-and-tre...</td>\n",
              "      <td>Pathophysiology, Transmission, Diagnosis, and ...</td>\n",
              "      <td>True</td>\n",
              "      <td>{'id': 2, 'name': 'Faible', 'posts_count': 505...</td>\n",
              "      <td>Etat des lieux bibliographique des connaissanc...</td>\n",
              "      <td>14.07.2020</td>\n",
              "      <td>Joost Wiersinga W</td>\n",
              "      <td>https://jamanetwork.com/journals/jama/fullarti...</td>\n",
              "      <td>[{'id': 7, 'name': 'Transversale'}, {'id': 12,...</td>\n",
              "      <td>{'id': 2, 'name': 'Autres', 'icon': 'icon-other'}</td>\n",
              "      <td>{'id': 183, 'name': 'JAMA Network Open'}</td>\n",
              "      <td>https://jamanetwork.com/journals/jama/fullarti...</td>\n",
              "      <td>La transmission du SARS-CoV-2 est plus favorab...</td>\n",
              "      <td>Actualisation générale des connaissances (rech...</td>\n",
              "      <td>Revue orientée d'études pré-sélectionnées par ...</td>\n",
              "      <td>Etat des lieux bibliographique des connaissanc...</td>\n",
              "      <td>Bases de données indexées (générale et récente...</td>\n",
              "      <td>32648899</td>\n",
              "      <td>10.1001/jama.2020.12839</td>\n",
              "      <td>The coronavirus disease 2019 (COVID-19) pandem...</td>\n",
              "      <td>[Autres, Transversale, Infectiologie]</td>\n",
              "      <td>[{'id': 687, 'name': 'Joost Wiersinga W'}]</td>\n",
              "      <td>2020-07-14</td>\n",
              "      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, ...</td>\n",
              "      <td>Pathophysiology Transmission Diagnosis Treatme...</td>\n",
              "      <td>209</td>\n",
              "      <td>33</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>735</td>\n",
              "      <td>introductions-and-early-spread-of-sars-cov-2-i...</td>\n",
              "      <td>Introductions and Early Spread of SARS-CoV-2 i...</td>\n",
              "      <td>True</td>\n",
              "      <td>{'id': 4, 'name': 'Indéterminé', 'posts_count'...</td>\n",
              "      <td>Etudier comment l'épidémie de SARS-Cov-2 a com...</td>\n",
              "      <td>10.07.2020</td>\n",
              "      <td>Gambaro F</td>\n",
              "      <td>https://www.eurosurveillance.org/content/10.28...</td>\n",
              "      <td>[{'id': 7, 'name': 'Transversale'}, {'id': 5, ...</td>\n",
              "      <td>{'id': 5, 'name': 'Epidémiologique', 'icon': '...</td>\n",
              "      <td>{'id': 46, 'name': 'Eurosurveillance'}</td>\n",
              "      <td>https://www.eurosurveillance.org/content/10.28...</td>\n",
              "      <td>Le virus a été introduit plusieurs fois dans l...</td>\n",
              "      <td>Le virus SARS-Cov-2 a été introduit plusieurs ...</td>\n",
              "      <td>Les données de cette étude semblent disponible...</td>\n",
              "      <td>Etudier comment l'épidémie de SARS-Cov-2 a com...</td>\n",
              "      <td>Données. 97 séquences de SARS-Cov-2 recueillie...</td>\n",
              "      <td>32643599\\n32289214\\n32070465\\n32109013\\n321797...</td>\n",
              "      <td>10.2807/1560-7917.ES.2020.25.26.2001200</td>\n",
              "      <td>Following SARS-CoV-2 emergence in China, a spe...</td>\n",
              "      <td>[Epidémiologique, Transversale, Virologie]</td>\n",
              "      <td>[{'id': 628, 'name': 'Gambaro F'}]</td>\n",
              "      <td>2020-07-10</td>\n",
              "      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, ...</td>\n",
              "      <td>Introductions Early Spread SARS-CoV-2 France S...</td>\n",
              "      <td>34</td>\n",
              "      <td>4</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>724</td>\n",
              "      <td>how-to-safely-reopen-colleges-and-universities...</td>\n",
              "      <td>How to Safely Reopen Colleges and Universities...</td>\n",
              "      <td>True</td>\n",
              "      <td>{'id': 2, 'name': 'Faible', 'posts_count': 505...</td>\n",
              "      <td>Décrire l'expérience des universités de Taïwan...</td>\n",
              "      <td>03.07.2020</td>\n",
              "      <td>Cheng SY</td>\n",
              "      <td>https://www.acpjournals.org/doi/10.7326/M20-2927</td>\n",
              "      <td>[{'id': 21, 'name': 'Confinement/Déconfinement...</td>\n",
              "      <td>{'id': 5, 'name': 'Epidémiologique', 'icon': '...</td>\n",
              "      <td>{'id': 41, 'name': 'Ann Intern Med'}</td>\n",
              "      <td>https://www.acpjournals.org/doi/10.7326/M20-2927</td>\n",
              "      <td>A Taïwan jusqu'au 18 juin 2020 seuls 7 cas con...</td>\n",
              "      <td>Les universités de Taïwan ont adopté des mesur...</td>\n",
              "      <td>- retour d'expérience d'une seule université T...</td>\n",
              "      <td>Décrire l'expérience des universités de Taïwan...</td>\n",
              "      <td>Retour d'expérience de Taïwan sur la gestion d...</td>\n",
              "      <td>32614638</td>\n",
              "      <td>10.7326/M20-2927</td>\n",
              "      <td>Reopening colleges and universities during the...</td>\n",
              "      <td>[Epidémiologique, Confinement/Déconfinement, I...</td>\n",
              "      <td>[{'id': 675, 'name': 'Cheng SY'}]</td>\n",
              "      <td>2020-07-03</td>\n",
              "      <td>[0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, ...</td>\n",
              "      <td>Reopen Colleges Universities COVID-19 Experien...</td>\n",
              "      <td>109</td>\n",
              "      <td>9</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>...</th>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>366</th>\n",
              "      <td>116</td>\n",
              "      <td>safety-and-efficacy-of-different-anesthetic-re...</td>\n",
              "      <td>Safety and efficacy of different anesthetic re...</td>\n",
              "      <td>True</td>\n",
              "      <td>{'id': 2, 'name': 'Faible', 'posts_count': 505...</td>\n",
              "      <td>Evaluer la gestion et la sécurité de l'anesthé...</td>\n",
              "      <td>10.03.2020</td>\n",
              "      <td>Chen R</td>\n",
              "      <td>https://www.dropbox.com/s/qml1fvabro6e92l/Chen...</td>\n",
              "      <td>[{'id': 9, 'name': 'Pédiatrie'}]</td>\n",
              "      <td>{'id': 4, 'name': 'Thérapeutique', 'icon': 'ic...</td>\n",
              "      <td>{'id': 64, 'name': 'Can J Anaesth'}</td>\n",
              "      <td>https://www.dropbox.com/s/qml1fvabro6e92l/Chen...</td>\n",
              "      <td>17 femmes enceintes avec un accouchement par c...</td>\n",
              "      <td>12/14 patientes ont fait une hypotension per-o...</td>\n",
              "      <td>Faible1) Monocentrique mais unique centre à Wu...</td>\n",
              "      <td>Evaluer la gestion et la sécurité de l'anesthé...</td>\n",
              "      <td>Etude monocentrique, rétrospective, descriptiv...</td>\n",
              "      <td>32180175\\n32015507\\n12682352\\n32075786\\n321513...</td>\n",
              "      <td>10.1007/s12630-020-01630-7</td>\n",
              "      <td>To assess the management and safety of epidura...</td>\n",
              "      <td>[Thérapeutique, Pédiatrie]</td>\n",
              "      <td>[{'id': 122, 'name': 'Chen R'}]</td>\n",
              "      <td>2020-03-10</td>\n",
              "      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, ...</td>\n",
              "      <td>Safety efficacy anesthetic regimens parturient...</td>\n",
              "      <td>142</td>\n",
              "      <td>18</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>367</th>\n",
              "      <td>118</td>\n",
              "      <td>a-systematic-review-on-the-efficacy-and-safety...</td>\n",
              "      <td>A systematic review on the efficacy and safety...</td>\n",
              "      <td>True</td>\n",
              "      <td>{'id': 3, 'name': 'Intermédiaire', 'posts_coun...</td>\n",
              "      <td>Evaluer la sécurité et l'efficacité de la chlo...</td>\n",
              "      <td>10.03.2020</td>\n",
              "      <td>Cortegiani A</td>\n",
              "      <td>https://www.dropbox.com/s/p10eq1pt587vvsj/10.1...</td>\n",
              "      <td>[{'id': 7, 'name': 'Transversale'}]</td>\n",
              "      <td>{'id': 4, 'name': 'Thérapeutique', 'icon': 'ic...</td>\n",
              "      <td>{'id': 79, 'name': 'J Crit Care'}</td>\n",
              "      <td>https://www.dropbox.com/s/p10eq1pt587vvsj/10.1...</td>\n",
              "      <td>Il y a un rationnel pour l'efficacité de la ch...</td>\n",
              "      <td>Effet chloroquine IN VIVO reste à démontrerEff...</td>\n",
              "      <td>Intermédiaire :1) Revue systématique très succ...</td>\n",
              "      <td>Evaluer la sécurité et l'efficacité de la chlo...</td>\n",
              "      <td>Revue systématique de la littérature</td>\n",
              "      <td>32173110</td>\n",
              "      <td>10.1016/j.jcrc.2020.03.005</td>\n",
              "      <td>COVID-19 (coronavirus disease 2019) is a publi...</td>\n",
              "      <td>[Thérapeutique, Transversale]</td>\n",
              "      <td>[{'id': 124, 'name': 'Cortegiani A'}]</td>\n",
              "      <td>2020-03-10</td>\n",
              "      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, ...</td>\n",
              "      <td>systematic review efficacy safety chloroquine ...</td>\n",
              "      <td>91</td>\n",
              "      <td>10</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>368</th>\n",
              "      <td>119</td>\n",
              "      <td>detection-of-novel-coronavirus-by-rt-pcr-in-st...</td>\n",
              "      <td>Detection of Novel Coronavirus by RT-PCR in St...</td>\n",
              "      <td>True</td>\n",
              "      <td>{'id': 2, 'name': 'Faible', 'posts_count': 505...</td>\n",
              "      <td>Décrire un cas asymptomatique positif chez l'e...</td>\n",
              "      <td>09.03.2020</td>\n",
              "      <td>Tang</td>\n",
              "      <td>https://wwwnc.cdc.gov/eid/article/26/6/20-0301...</td>\n",
              "      <td>[{'id': 9, 'name': 'Pédiatrie'}]</td>\n",
              "      <td>{'id': 3, 'name': 'Diagnostique', 'icon': 'ico...</td>\n",
              "      <td>{'id': 80, 'name': 'Emerge Inf Dis'}</td>\n",
              "      <td>https://wwwnc.cdc.gov/eid/article/26/6/20-0301...</td>\n",
              "      <td>Description d'un cas d'enfant de 10 ans asympt...</td>\n",
              "      <td>Intérêt du dépistage des cas asymptomatiques c...</td>\n",
              "      <td>Faible : 1) Lettre à l'éditeur sans processus ...</td>\n",
              "      <td>Décrire un cas asymptomatique positif chez l'e...</td>\n",
              "      <td>Case report</td>\n",
              "      <td>32150527\\n31978945\\n32030925\\n32004427\\n320478...</td>\n",
              "      <td>10.3201/eid2606.200301</td>\n",
              "      <td>We report an asymptomatic child who was positi...</td>\n",
              "      <td>[Diagnostique, Pédiatrie]</td>\n",
              "      <td>[{'id': 125, 'name': 'Tang'}]</td>\n",
              "      <td>2020-03-09</td>\n",
              "      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, ...</td>\n",
              "      <td>Detection Novel Coronavirus RT-PCR Stool Speci...</td>\n",
              "      <td>34</td>\n",
              "      <td>4</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>369</th>\n",
              "      <td>120</td>\n",
              "      <td>the-effect-of-travel-restrictions-on-the-sprea...</td>\n",
              "      <td>The effect of travel restrictions on the sprea...</td>\n",
              "      <td>True</td>\n",
              "      <td>{'id': 5, 'name': 'Fort', 'posts_count': 6, 'c...</td>\n",
              "      <td>Modéliser l'effet des restrictions de circulat...</td>\n",
              "      <td>06.03.2020</td>\n",
              "      <td>Chinazzi e</td>\n",
              "      <td>https://www.dropbox.com/s/zvuj4h7mo22muuo/scie...</td>\n",
              "      <td>[{'id': 7, 'name': 'Transversale'}]</td>\n",
              "      <td>{'id': 2, 'name': 'Autres', 'icon': 'icon-other'}</td>\n",
              "      <td>{'id': 66, 'name': 'Science'}</td>\n",
              "      <td>https://www.dropbox.com/s/zvuj4h7mo22muuo/scie...</td>\n",
              "      <td>Au début de l'interdiction de voyager depuis W...</td>\n",
              "      <td>Intérêt des restrictions de circulation surtou...</td>\n",
              "      <td>Forte : 1) Modélisation robuste basée sur l'en...</td>\n",
              "      <td>Modéliser l'effet des restrictions de circulat...</td>\n",
              "      <td>Etude d'impact par modélisation basée sur les ...</td>\n",
              "      <td>32144116\\n12766206\\n32309796\\n23341757\\n320141...</td>\n",
              "      <td>10.1126/science.aba9757</td>\n",
              "      <td>Motivated by the rapid spread of coronavirus d...</td>\n",
              "      <td>[Autres, Transversale]</td>\n",
              "      <td>[{'id': 126, 'name': 'Chinazzi e'}]</td>\n",
              "      <td>2020-03-06</td>\n",
              "      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, ...</td>\n",
              "      <td>effect travel restrictions spread 2019novel co...</td>\n",
              "      <td>58</td>\n",
              "      <td>6</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>370</th>\n",
              "      <td>121</td>\n",
              "      <td>clinical-characteristics-of-coronavirus-diseas...</td>\n",
              "      <td>Clinical Characteristics of Coronavirus Diseas...</td>\n",
              "      <td>True</td>\n",
              "      <td>{'id': 3, 'name': 'Intermédiaire', 'posts_coun...</td>\n",
              "      <td>Description des caractétistiques cliniques des...</td>\n",
              "      <td>28.02.2020</td>\n",
              "      <td>Guan WJ</td>\n",
              "      <td>https://www.dropbox.com/s/crvl0mtzn6b7o4y/nejm...</td>\n",
              "      <td>[{'id': 7, 'name': 'Transversale'}]</td>\n",
              "      <td>{'id': 5, 'name': 'Epidémiologique', 'icon': '...</td>\n",
              "      <td>{'id': 22, 'name': 'NEJM'}</td>\n",
              "      <td>https://www.dropbox.com/s/crvl0mtzn6b7o4y/nejm...</td>\n",
              "      <td>Sur 1099 patients testés positifs provenant de...</td>\n",
              "      <td>Médiane d'âge des patients infectés de 47 ans,...</td>\n",
              "      <td>Intermédiaire :1) Etude épidémiologique de coh...</td>\n",
              "      <td>Description des caractétistiques cliniques des...</td>\n",
              "      <td>Large étude de cohorte multicentrique</td>\n",
              "      <td>32109013\\n31986261\\n32007145\\n31995857\\n319789...</td>\n",
              "      <td>10.1056/NEJMoa2002032</td>\n",
              "      <td>Since December 2019, when coronavirus disease ...</td>\n",
              "      <td>[Epidémiologique, Transversale]</td>\n",
              "      <td>[{'id': 127, 'name': 'Guan WJ'}]</td>\n",
              "      <td>2020-02-28</td>\n",
              "      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, ...</td>\n",
              "      <td>Clinical Characteristics Coronavirus Disease C...</td>\n",
              "      <td>111</td>\n",
              "      <td>34</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>371 rows × 28 columns</p>\n",
              "</div>"
            ],
            "text/plain": [
              "      id                                               slug  ...  len  len_sentence\n",
              "0    769  body-mass-index-and-risk-for-intubation-or-dea...  ...  148            18\n",
              "1    742  an-mrna-vaccine-against-sars-cov-2-preliminary...  ...  116            14\n",
              "2    739  pathophysiology-transmission-diagnosis-and-tre...  ...  209            33\n",
              "3    735  introductions-and-early-spread-of-sars-cov-2-i...  ...   34             4\n",
              "4    724  how-to-safely-reopen-colleges-and-universities...  ...  109             9\n",
              "..   ...                                                ...  ...  ...           ...\n",
              "366  116  safety-and-efficacy-of-different-anesthetic-re...  ...  142            18\n",
              "367  118  a-systematic-review-on-the-efficacy-and-safety...  ...   91            10\n",
              "368  119  detection-of-novel-coronavirus-by-rt-pcr-in-st...  ...   34             4\n",
              "369  120  the-effect-of-travel-restrictions-on-the-sprea...  ...   58             6\n",
              "370  121  clinical-characteristics-of-coronavirus-diseas...  ...  111            34\n",
              "\n",
              "[371 rows x 28 columns]"
            ]
          },
          "metadata": {
            "tags": []
          },
          "execution_count": 28
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "RWDKOlhU_yyz"
      },
      "source": [
        "Le nouveau notebook obtenu peut ensuite remplacer celui utilisé dans le  notebook \"baseline\" sur le notebook \"multilabel_specialities_from_bibliovid\" et ainsi voir l'amélioration des résultats (décrits dans le rapport)"
      ]
    }
  ]
}